<?xml version="1.0" encoding="UTF-8"?>
<data>
	<node>
		<modelid><![CDATA[90-001-01]]></modelid>
		<pubmedid><![CDATA[2144989]]></pubmedid>
		<author><![CDATA[Sahasakul]]></author>
		<year><![CDATA[1990]]></year>
		<journal><![CDATA[British Heart Journal]]></journal>
		<title><![CDATA[Multivariate analysis in the prediction of death in hospital after acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[111]]></modelsamplesize>
		<cohortsamplesize><![CDATA[111]]></cohortsamplesize>
		<numberofevents><![CDATA[17]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Wall Motion Score Index]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Aspartate Aminotransferases/blood; Cardiomegaly/etiology; Creatine Kinase/blood; Electrocardiography; Female; Humans; L-Lactate Dehydrogenase/blood; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/complications/enzymology/*mortality/physiopathology; Prognosis; Prospective Studies; Risk Factors; Stroke Volume]]></mh>
	</node>
	<node>
		<modelid><![CDATA[90-001-02]]></modelid>
		<pubmedid><![CDATA[2246419]]></pubmedid>
		<author><![CDATA[Kentsch]]></author>
		<year><![CDATA[1990]]></year>
		<journal><![CDATA[Intensive Care Medicine]]></journal>
		<title><![CDATA[Early prediction of prognosis in out-of-hospital cardiac arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[205]]></modelsamplesize>
		<cohortsamplesize><![CDATA[205]]></cohortsamplesize>
		<numberofevents><![CDATA[23]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Bystander Resuscitation, ECG, Respiration, Pupil Shape, Aspiration, Age]]></covariates>
		<mh><![CDATA[Aged; Decision Making; Electrocardiography; Emergency Medical Services/*standards; Female; Germany, West/epidemiology; Heart Arrest/*mortality/physiopathology/therapy; Humans; Male; Middle Aged; Outcome and Process Assessment (Health Care); Predictive Value of Tests; Prognosis; Resuscitation/*standards; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[90-001-03]]></modelid>
		<pubmedid><![CDATA[2330896]]></pubmedid>
		<author><![CDATA[Cabin]]></author>
		<year><![CDATA[1990]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Risk for systemic embolization of atrial fibrillation without mitral stenosis]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Systemic Embolization]]></outcome>
		<modelsamplesize><![CDATA[272]]></modelsamplesize>
		<cohortsamplesize><![CDATA[272]]></cohortsamplesize>
		<numberofevents><![CDATA[27]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Structural Heart Disease, Sex, Left Atrial Size]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/*complications; Echocardiography; Embolism/epidemiology/*etiology; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Incidence; Intracranial Embolism and Thrombosis/etiology; Male; Mitral Valve; Mitral Valve Stenosis/*complications; Multivariate Analysis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-01]]></modelid>
		<pubmedid><![CDATA[1657248]]></pubmedid>
		<author><![CDATA[Nieuwenhuis]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Blood]]></journal>
		<title><![CDATA[Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[194]]></modelsamplesize>
		<cohortsamplesize><![CDATA[194]]></cohortsamplesize>
		<numberofevents><![CDATA[23]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Bleeding Diathesis, BSA, Recent Trauma or Surgery, WHO Grade]]></covariates>
		<mh><![CDATA[Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa/metabolism; Factor Xa Inhibitors; Female; Hemorrhage/*chemically induced; Heparin/administration & dosage/*adverse effects/therapeutic use; Heparin, Low-Molecular-Weight/administration & dosage/*adverse; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Regression Analysis; Risk Factors; Thromboembolism/*drug therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-02]]></modelid>
		<pubmedid><![CDATA[1661018]]></pubmedid>
		<author><![CDATA[Marwick]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction of survival from resuscitation: a progostic index derived from multivariate logistic model analysis]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[710]]></modelsamplesize>
		<cohortsamplesize><![CDATA[710]]></cohortsamplesize>
		<numberofevents><![CDATA[193]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Asystole, CPR Delay, Defibrillation Delay, Ventricular Fibrillation]]></covariates>
		<mh><![CDATA[Aged; Cardiopulmonary Resuscitation/standards/*utilization; Female; Heart Arrest/mortality/*therapy; Hospital Bed Capacity, 500 and over; Humans; Male; Models, Statistical; Outcome Assessment (Health Care)/*statistics & numerical data; Prognosis; ROC Curve; Regression Analysis; Survival Analysis; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-03]]></modelid>
		<pubmedid><![CDATA[1661018]]></pubmedid>
		<author><![CDATA[Marwick]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction of survival from resuscitation: a prognostic index derived from multivariate logistic model analysis]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[710]]></modelsamplesize>
		<cohortsamplesize><![CDATA[710]]></cohortsamplesize>
		<numberofevents><![CDATA[193]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Asystole, CPR Delay, Defibrillation, Defibrillation Delay, Intubation, Ventricular Fibrillation]]></covariates>
		<mh><![CDATA[Aged; Cardiopulmonary Resuscitation/standards/*utilization; Female; Heart Arrest/mortality/*therapy; Hospital Bed Capacity, 500 and over; Humans; Male; Models, Statistical; Outcome Assessment (Health Care)/*statistics & numerical data; Prognosis; ROC Curve; Regression Analysis; Survival Analysis; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-04]]></modelid>
		<pubmedid><![CDATA[1661018]]></pubmedid>
		<author><![CDATA[Marwick]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction of survival from resuscitation: a prognostic index derived from multivariate logistic model analysis]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[710]]></modelsamplesize>
		<cohortsamplesize><![CDATA[710]]></cohortsamplesize>
		<numberofevents><![CDATA[106]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Asytole, Defibrillation, Defibrillation Delay, Intubation]]></covariates>
		<mh><![CDATA[Aged; Cardiopulmonary Resuscitation/standards/*utilization; Female; Heart Arrest/mortality/*therapy; Hospital Bed Capacity, 500 and over; Humans; Male; Models, Statistical; Outcome Assessment (Health Care)/*statistics & numerical data; Prognosis; ROC Curve; Regression Analysis; Survival Analysis; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-05]]></modelid>
		<pubmedid><![CDATA[1745078]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Medical Care]]></journal>
		<title><![CDATA[A time-insensitive predictive instrument for acute myocardial infarction mortality: a multicenter study]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4099]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4099]]></cohortsamplesize>
		<numberofevents><![CDATA[623]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Pulse, Q Waves, SBP, T Waves]]></covariates>
		<mh><![CDATA[Adult; Female; *Hospital Mortality; Humans; Likelihood Functions; *Logistic Models; Male; Middle Aged; Myocardial Infarction/*mortality; New England/epidemiology; Prognosis; Prospective Studies; Quality Assurance, Health Care; ROC Curve; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-06]]></modelid>
		<pubmedid><![CDATA[1869731]]></pubmedid>
		<author><![CDATA[Wilcox]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[107]]></modelsamplesize>
		<cohortsamplesize><![CDATA[107]]></cohortsamplesize>
		<numberofevents><![CDATA[29]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Evolutionary T Wave Changes, Low RPP, Positive ECG, Rest Pain]]></covariates>
		<mh><![CDATA[Angina, Unstable/diagnosis/*epidemiology/therapy; Diabetes Mellitus/epidemiology; *Electrocardiography; *Exercise Test; Female; Humans; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-07]]></modelid>
		<pubmedid><![CDATA[1885480]]></pubmedid>
		<author><![CDATA[Rodrigues]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Journal of the Association of Physicians of India]]></journal>
		<title><![CDATA[Predicting the immediate outcome of patients with cerebrovascular accident: a prognostic score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[120]]></modelsamplesize>
		<cohortsamplesize><![CDATA[120]]></cohortsamplesize>
		<numberofevents><![CDATA[40]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Altered Consciousness, Aspiration Pneumonitis, Hemiplegia, MOD at Onset, PAC, Previous Stroke, Seizures]]></covariates>
		<mh><![CDATA[Brain Damage, Chronic/diagnosis/*mortality; Cerebrovascular Disorders/diagnosis/*mortality; Female; Glasgow Coma Scale; Humans; Male; Middle Aged; Neurologic Examination; Prognosis; Survival Rate; Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-08]]></modelid>
		<pubmedid><![CDATA[1932933]]></pubmedid>
		<author><![CDATA[Tunstall-Pedoe]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[The Dundee coronary risk-disk for management of change in risk factors]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[5203]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5203]]></cohortsamplesize>
		<numberofevents><![CDATA[331]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Cholesterol/blood; Coronary Disease/blood/etiology/*prevention & control; Female; Humans; Hypertension/complications; Male; Middle Aged; Risk Factors; Smoking/adverse effects; Statistics as Topic/*instrumentation/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-09]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, SBP, Total Cholesterol, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-10]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, SBP, Total Cholesterol, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-11]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, SBP, Total Cholesterol, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-12]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, SBP, Total Cholesterol, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-13]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, SBP, Total Cholesterol, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-14]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, SBP, Total Cholesterol, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-15]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, DBP, Total Cholestero, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-16]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, DBP, Total Cholestero, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-17]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, DBP, Total Cholestero, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-18]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, DBP, Total Cholestero, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-19]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, DBP, Total Cholestero, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-20]]></modelid>
		<pubmedid><![CDATA[1985385]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Cardiovascular disease risk profiles]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5573]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5573]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Sex, LVH, Age, DBP, Total Cholestero, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*epidemiology; Cohort Studies; Coronary Disease/*epidemiology; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Statistical; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-21]]></modelid>
		<pubmedid><![CDATA[1988385]]></pubmedid>
		<author><![CDATA[Marik]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Heart & Lung]]></journal>
		<title><![CDATA[Myocardial infarction prognostic scoring system]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[200]]></modelsamplesize>
		<cohortsamplesize><![CDATA[200]]></cohortsamplesize>
		<numberofevents><![CDATA[28]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Infarction Location, Killip Class, Maximal ST Segment Elevation]]></covariates>
		<mh><![CDATA[Analysis of Variance; Electrocardiography; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/*diagnosis; Prognosis; Risk Factors; Streptokinase/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-22]]></modelid>
		<pubmedid><![CDATA[2001088]]></pubmedid>
		<author><![CDATA[Kernan]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[A prognostic system for transient ischemia or minor stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)/Minor Stroke]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[142]]></modelsamplesize>
		<cohortsamplesize><![CDATA[142]]></cohortsamplesize>
		<numberofevents><![CDATA[21]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHD, Diabetes, Hypertension, Stroke]]></covariates>
		<mh><![CDATA[Aged; Carotid Arteries/ultrasonography; Cerebrovascular Disorders/mortality/*physiopathology/ultrasonography; Cohort Studies; Female; Humans; Ischemic Attack, Transient/mortality/*physiopathology/ultrasonography; Male; Middle Aged; Prognosis; Recurrence; Risk Factors; Statistics as Topic]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-23]]></modelid>
		<pubmedid><![CDATA[2003301]]></pubmedid>
		<author><![CDATA[Wolf]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Probability of stroke: a risk profile from the Framingham Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[2372]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2372]]></cohortsamplesize>
		<numberofevents><![CDATA[213]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CVD, Smoking, Diabetes, LVH, SBP, Antihypertensive Medication]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Blood Pressure; Cerebrovascular Disorders/*etiology; Female; Follow-Up Studies; Humans; Male; Massachusetts; Middle Aged; Probability; Risk Factors; Sex Characteristics]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-24]]></modelid>
		<pubmedid><![CDATA[2003301]]></pubmedid>
		<author><![CDATA[Wolf]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Probability of stroke: a risk profile from the Framingham Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3362]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3362]]></cohortsamplesize>
		<numberofevents><![CDATA[259]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CVD, Smoking, Diabetes, LVH, SBP, Antihypertensive Medication]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Blood Pressure; Cerebrovascular Disorders/*etiology; Female; Follow-Up Studies; Humans; Male; Massachusetts; Middle Aged; Probability; Risk Factors; Sex Characteristics]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-25]]></modelid>
		<pubmedid><![CDATA[2013140]]></pubmedid>
		<author><![CDATA[Mark]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy. Results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[289]]></modelsamplesize>
		<cohortsamplesize><![CDATA[289]]></cohortsamplesize>
		<numberofevents><![CDATA[38]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.802]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Hypotension/Shock, LVEF, CAD, VT/VF]]></covariates>
		<mh><![CDATA[*Angioplasty, Balloon, Coronary; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/complications/epidemiology/*therapy; *Patient Discharge; Registries; Risk Factors; *Thrombolytic Therapy; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-26]]></modelid>
		<pubmedid><![CDATA[2072767]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[Medical Care]]></journal>
		<title><![CDATA[A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Acute Coronary Syndrome (ACS)]]></outcome>
		<modelsamplesize><![CDATA[3453]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3453]]></cohortsamplesize>
		<numberofevents><![CDATA[1251]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Pain, EKG Results, Age, Sex]]></covariates>
		<mh><![CDATA[Adult; Coronary Care Units/*utilization; Coronary Disease/*diagnosis; Emergencies; Female; Health Services Research/methods; Humans; Male; Middle Aged; Models, Statistical; New England; Patient Admission/*statistics & numerical data; Predictive Value of Tests; Probability; Regression Analysis; Retrospective Studies; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[91-001-27]]></modelid>
		<pubmedid><![CDATA[2741977]]></pubmedid>
		<author><![CDATA[George]]></author>
		<year><![CDATA[1991]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[Pre-arrest morbidity and other correlates of survival after in-hospital cardiopulmonary arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[140]]></modelsamplesize>
		<cohortsamplesize><![CDATA[140]]></cohortsamplesize>
		<numberofevents><![CDATA[111]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AMI, Angina, BUN, Cirrhosis, Coma, NYHA Class, Functional Status, Ventilation, Oliguria, Pneumonia, Cerebrovascular Event, S3 Gallop, Sepsis, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases/*complications/mortality; Female; Heart Arrest/etiology/*mortality/therapy; Hospitalization; Humans; Life Style; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; *Resuscitation; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-01]]></modelid>
		<pubmedid><![CDATA[1315072]]></pubmedid>
		<author><![CDATA[Woodhouse]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction of hospital discharge in immediate survivors of ventricular fibrillation or asystole]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[112]]></modelsamplesize>
		<cohortsamplesize><![CDATA[112]]></cohortsamplesize>
		<numberofevents><![CDATA[62]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Asystole/VF, Defibrillation Delay, Defibrillation, Intubation, Age, Respiratory State, SBP]]></covariates>
		<mh><![CDATA[Aged; Heart Arrest/*mortality; Humans; Patient Discharge; Prognosis; ROC Curve; *Resuscitation; Risk Factors; Treatment Outcome; Ventricular Fibrillation/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-02]]></modelid>
		<pubmedid><![CDATA[1315072]]></pubmedid>
		<author><![CDATA[Woodhouse]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction of hospital discharge in immediate survivors of ventricular fibrillation or asystole]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[112]]></modelsamplesize>
		<cohortsamplesize><![CDATA[112]]></cohortsamplesize>
		<numberofevents><![CDATA[62]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Conscious State, Respiratory State, SBP]]></covariates>
		<mh><![CDATA[Aged; Heart Arrest/*mortality; Humans; Patient Discharge; Prognosis; ROC Curve; *Resuscitation; Risk Factors; Treatment Outcome; Ventricular Fibrillation/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-03]]></modelid>
		<pubmedid><![CDATA[1433740]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5827]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5827]]></cohortsamplesize>
		<numberofevents><![CDATA[37]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.884]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[LVEF, Sex, Hemodynamic Status, Shock]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*adverse effects/mortality/statistics & numerical ; Coronary Artery Bypass/statistics & numerical data; Female; Hospital Mortality; Humans; Male; Multivariate Analysis; Myocardial Infarction/mortality; New York; Outcome Assessment (Health Care); Risk Factors; *Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-04]]></modelid>
		<pubmedid><![CDATA[1433740]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5827]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5827]]></cohortsamplesize>
		<numberofevents><![CDATA[187]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.673]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Hemodynamic Status, Previous Angioplasty, Shock, Worst Lesion Attempted]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*adverse effects/mortality/statistics & numerical ; Coronary Artery Bypass/statistics & numerical data; Female; Hospital Mortality; Humans; Male; Multivariate Analysis; Myocardial Infarction/mortality; New York; Outcome Assessment (Health Care); Risk Factors; *Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-05]]></modelid>
		<pubmedid><![CDATA[1433740]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[5827]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5827]]></cohortsamplesize>
		<numberofevents><![CDATA[757]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.695]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[COPD, Previous Angioplasty, Number of Vessels Attempted, Worst Lesion Attempted]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*adverse effects/mortality/statistics & numerical ; Coronary Artery Bypass/statistics & numerical data; Female; Hospital Mortality; Humans; Male; Multivariate Analysis; Myocardial Infarction/mortality; New York; Outcome Assessment (Health Care); Risk Factors; *Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-06]]></modelid>
		<pubmedid><![CDATA[1470037]]></pubmedid>
		<author><![CDATA[Dilger]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Methods of Information in Medicine]]></journal>
		<title><![CDATA[Simple computer-assisted diagnosis of acute myocardial infarction in patients with acute thoracic pain]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[87]]></modelsamplesize>
		<cohortsamplesize><![CDATA[87]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cause of Admission, CK, Duration of Pain, Glucose, Leukocytosis, ST Elevation]]></covariates>
		<mh><![CDATA[Adult; Aged; Chest Pain/*etiology; *Diagnosis, Computer-Assisted; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction/complications/*diagnosis; Prospective Studies; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-07]]></modelid>
		<pubmedid><![CDATA[1527533]]></pubmedid>
		<author><![CDATA[Hankey]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, and Psychiatry]]></journal>
		<title><![CDATA[Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[469]]></modelsamplesize>
		<cohortsamplesize><![CDATA[469]]></cohortsamplesize>
		<numberofevents><![CDATA[118]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, TIA, LVH, Sex, PVD, Neurological Signs]]></covariates>
		<mh><![CDATA[Aged; Carotid Stenosis/complications/mortality; *Cause of Death; Cerebral Infarction/*mortality; Cohort Studies; Female; Humans; Ischemic Attack, Transient/complications/*mortality; Male; Middle Aged; Myocardial Infarction/mortality; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Vascular Diseases/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-08]]></modelid>
		<pubmedid><![CDATA[1527533]]></pubmedid>
		<author><![CDATA[Hankey]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, and Psychiatry]]></journal>
		<title><![CDATA[Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[469]]></modelsamplesize>
		<cohortsamplesize><![CDATA[469]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, TIA, LVH, Sex, PVD, Neurological Signs]]></covariates>
		<mh><![CDATA[Aged; Carotid Stenosis/complications/mortality; *Cause of Death; Cerebral Infarction/*mortality; Cohort Studies; Female; Humans; Ischemic Attack, Transient/complications/*mortality; Male; Middle Aged; Myocardial Infarction/mortality; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Vascular Diseases/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-09]]></modelid>
		<pubmedid><![CDATA[1527533]]></pubmedid>
		<author><![CDATA[Hankey]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, and Psychiatry]]></journal>
		<title><![CDATA[Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[469]]></modelsamplesize>
		<cohortsamplesize><![CDATA[469]]></cohortsamplesize>
		<numberofevents><![CDATA[58]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, TIA, LVH, Sex, PVD, Neurological Signs]]></covariates>
		<mh><![CDATA[Aged; Carotid Stenosis/complications/mortality; *Cause of Death; Cerebral Infarction/*mortality; Cohort Studies; Female; Humans; Ischemic Attack, Transient/complications/*mortality; Male; Middle Aged; Myocardial Infarction/mortality; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Vascular Diseases/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-10]]></modelid>
		<pubmedid><![CDATA[1533427]]></pubmedid>
		<author><![CDATA[Davis]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[310]]></modelsamplesize>
		<cohortsamplesize><![CDATA[310]]></cohortsamplesize>
		<numberofevents><![CDATA[46]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ANP, CHF]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor/*blood; Cohort Studies; Female; Follow-Up Studies; Heart Failure/blood/*diagnosis/etiology; Humans; Male; Medical Records; Odds Ratio; Physical Examination; Predictive Value of Tests; Prospective Studies; Risk Factors; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-11]]></modelid>
		<pubmedid><![CDATA[1555675]]></pubmedid>
		<author><![CDATA[Jivegard]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[European Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Preoperative assessment of the risk for cardiac death following thrombo-embolectomy for acute lower limb ischaemia]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[117]]></modelsamplesize>
		<cohortsamplesize><![CDATA[117]]></cohortsamplesize>
		<numberofevents><![CDATA[19]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Decompensation, Hemoglobin, BP, MI, Proximal Ischemia]]></covariates>
		<mh><![CDATA[Aged; Amputation; Cause of Death; Female; Heart Failure/*mortality; Humans; Ischemia/mortality/*surgery; Leg/*blood supply; Male; Myocardial Infarction/*mortality; Postoperative Complications/*mortality; Risk Factors; Thromboembolism/mortality/*surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-12]]></modelid>
		<pubmedid><![CDATA[1564774]]></pubmedid>
		<author><![CDATA[Higgins]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5051]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5051]]></cohortsamplesize>
		<numberofevents><![CDATA[126]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Hematocrit, Stenosis, Cerebrovascular Disease, COPD, Diabetes, Urgency, Mitral Valve Insufficiency, Prior Vascular Surgery, Reoperation, Creatinine, Left Ventricular Dysfunction, Weight]]></covariates>
		<mh><![CDATA[Aged; Coronary Artery Bypass/*mortality; Female; Hospitals; Humans; Logistic Models; Male; Morbidity; Outcome Assessment (Health Care)/*methods; Regression Analysis; Retrospective Studies; Risk Factors; *Severity of Illness Index; Treatment Outcome; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-13]]></modelid>
		<pubmedid><![CDATA[1564774]]></pubmedid>
		<author><![CDATA[Higgins]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5051]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5051]]></cohortsamplesize>
		<numberofevents><![CDATA[680]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Hematocrit, COPD, Urgency, Mitral Valve Insufficiency, Prior Vascular Surgery, Reoperation, Creatinine, Left Ventricular Dysfunction]]></covariates>
		<mh><![CDATA[Aged; Coronary Artery Bypass/*mortality; Female; Hospitals; Humans; Logistic Models; Male; Morbidity; Outcome Assessment (Health Care)/*methods; Regression Analysis; Retrospective Studies; Risk Factors; *Severity of Illness Index; Treatment Outcome; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-14]]></modelid>
		<pubmedid><![CDATA[1591830]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3055]]></cohortsamplesize>
		<numberofevents><![CDATA[132]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, Comorbidities, LVEF, Sex, Left Ventricular End Diastolic Pressure, CABG, Priority]]></covariates>
		<mh><![CDATA[Aged; Comorbidity; Coronary Artery Bypass/*mortality; Female; *Hospital Mortality; Humans; Male; Middle Aged; Multivariate Analysis; New England/epidemiology; Prospective Studies; ROC Curve; Regression Analysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-15]]></modelid>
		<pubmedid><![CDATA[1591894]]></pubmedid>
		<author><![CDATA[Esdaile]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Clinical & Investigative Medicine]]></journal>
		<title><![CDATA[Response to initial therapy and new onset as predictors of prognosis in patients hospitalized with congestive heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[185]]></modelsamplesize>
		<cohortsamplesize><![CDATA[185]]></cohortsamplesize>
		<numberofevents><![CDATA[17]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.876]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Severity, Chest Pain, Jugulovenous Distension, New Onset, Response to Treatment]]></covariates>
		<mh><![CDATA[Aged; Chest Pain; Female; Heart/physiopathology; Heart Failure/mortality/pathology/*therapy; Humans; Jugular Veins/pathology; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Recurrence]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-16]]></modelid>
		<pubmedid><![CDATA[1609179]]></pubmedid>
		<author><![CDATA[Hadorn]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Statistics in Medicine]]></journal>
		<title><![CDATA[Cross-validation performance of mortality prediction models]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1728]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2853]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.63]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[APS Score, Cardiac Function, Comorbidities, BP, Age, CHF, Location]]></covariates>
		<mh><![CDATA[Discriminant Analysis; Health Care Rationing; Humans; Logistic Models; *Models, Statistical; Myocardial Infarction/*mortality; Regression Analysis; Reproducibility of Results; *Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-17]]></modelid>
		<pubmedid><![CDATA[1623792]]></pubmedid>
		<author><![CDATA[Tuman]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Morbidity and duration of ICU stay after cardiac surgery: a model for preoperative risk assessment]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[3156]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3156]]></cohortsamplesize>
		<numberofevents><![CDATA[701]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Previous MI, Valve Replacement, Cerebrovascular Disease, CHF, CABG, Emergency Surgery, Sex, LV Dysfunction, Multivalve Procedure, Hypertension, Renal Dysfunction, Reoperation]]></covariates>
		<mh><![CDATA[Aged; *Cardiac Surgical Procedures; Coronary Care Units; Female; Humans; *Length of Stay; Logistic Models; Male; Morbidity; Odds Ratio; Postoperative Complications/*epidemiology/mortality; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-18]]></modelid>
		<pubmedid><![CDATA[1736607]]></pubmedid>
		<author><![CDATA[Rodriguez]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[206]]></modelsamplesize>
		<cohortsamplesize><![CDATA[206]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Solatol, MI to VT/VF Interval, VT/VF]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Myocardial Infarction/*complications; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tachycardia/*etiology; Time Factors; Ventricular Fibrillation/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[92-001-19]]></modelid>
		<pubmedid><![CDATA[1739359]]></pubmedid>
		<author><![CDATA[Hubbard]]></author>
		<year><![CDATA[1992]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Identification of severe coronary artery disease using simple clinical parameters]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[680]]></modelsamplesize>
		<cohortsamplesize><![CDATA[680]]></cohortsamplesize>
		<numberofevents><![CDATA[215]]></numberofevents>
		<followupduration><![CDATA[]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Sex, Previous MI, Angina]]></covariates>
		<mh><![CDATA[Coronary Angiography; Coronary Disease/*diagnosis/radiography/radionuclide imaging; Electrocardiography; Female; Heart/radionuclide imaging; Humans; Male; Middle Aged; Probability; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-01]]></modelid>
		<pubmedid><![CDATA[8213274]]></pubmedid>
		<author><![CDATA[Niskanen]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Acta Neurochirurgica]]></journal>
		<title><![CDATA[One-year outcome in early aneurysm surgery: prediction of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[620]]></modelsamplesize>
		<cohortsamplesize><![CDATA[929]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Blood in CT, Grade, Intraventricular Bleeding, Vasospasm]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aneurysm, Ruptured/mortality/radiography/*surgery; Brain Damage, Chronic/mortality/radiography; Cerebral Angiography; Child; Female; Follow-Up Studies; Humans; Intracranial Aneurysm/mortality/radiography/*surgery; Ischemic Attack, Transient/mortality/radiography/surgery; Male; Middle Aged; Neurologic Examination; Postoperative Complications/mortality/radiography; Subarachnoid Hemorrhage/mortality/radiography/surgery; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-02]]></modelid>
		<pubmedid><![CDATA[8213274]]></pubmedid>
		<author><![CDATA[Niskanen]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Acta Neurochirurgica]]></journal>
		<title><![CDATA[One-year outcome in early aneurysm surgery: prediction of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[559]]></modelsamplesize>
		<cohortsamplesize><![CDATA[839]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Blood in CT, Grade, Time from Bleeding to Operation, Intraventricular Bleeding, Ligation of Major Vessel, Prior Bleeding]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aneurysm, Ruptured/mortality/radiography/*surgery; Brain Damage, Chronic/mortality/radiography; Cerebral Angiography; Child; Female; Follow-Up Studies; Humans; Intracranial Aneurysm/mortality/radiography/*surgery; Ischemic Attack, Transient/mortality/radiography/surgery; Male; Middle Aged; Neurologic Examination; Postoperative Complications/mortality/radiography; Subarachnoid Hemorrhage/mortality/radiography/surgery; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-03]]></modelid>
		<pubmedid><![CDATA[8213274]]></pubmedid>
		<author><![CDATA[Niskanen]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Acta Neurochirurgica]]></journal>
		<title><![CDATA[One-year outcome in early aneurysm surgery: prediction of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[559]]></modelsamplesize>
		<cohortsamplesize><![CDATA[839]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aneurysm Site, Cardiopulmonary Event, Grade, Hypodense Areas on CT, Intraventricular Bleeding, Ligation of Major Vessel, Prior Bleeding, Post-Op ICH]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aneurysm, Ruptured/mortality/radiography/*surgery; Brain Damage, Chronic/mortality/radiography; Cerebral Angiography; Child; Female; Follow-Up Studies; Humans; Intracranial Aneurysm/mortality/radiography/*surgery; Ischemic Attack, Transient/mortality/radiography/surgery; Male; Middle Aged; Neurologic Examination; Postoperative Complications/mortality/radiography; Subarachnoid Hemorrhage/mortality/radiography/surgery; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-04]]></modelid>
		<pubmedid><![CDATA[8241212]]></pubmedid>
		<author><![CDATA[Campana]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Journal of Heart & Lung Transplantation]]></journal>
		<title><![CDATA[Predictors of prognosis in patients awaiting heart transplantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[388]]></modelsamplesize>
		<cohortsamplesize><![CDATA[388]]></cohortsamplesize>
		<numberofevents><![CDATA[99]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Output, PAP, NYHA Class, Systemic Arterial Pressure, Third Heart Sound, VHD]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Blood Pressure/physiology; Cardiac Output/physiology; Cardiomyopathy, Dilated/drug therapy/physiopathology; Child; Coronary Disease/drug therapy/physiopathology; Electrocardiography; Female; Follow-Up Studies; Forecasting; Heart Diseases/*physiopathology; Heart Transplantation/physiology/*statistics & numerical data; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Risk Factors; Stroke Volume/physiology; Survival Rate; Ventricular Function, Left/physiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-05]]></modelid>
		<pubmedid><![CDATA[8403305]]></pubmedid>
		<author><![CDATA[Thompson]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predicting early and intermediate-term outcome of coronary angioplasty in the elderly]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[982]]></modelsamplesize>
		<cohortsamplesize><![CDATA[982]]></cohortsamplesize>
		<numberofevents><![CDATA[62]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Number of Lesions, Age]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Angioplasty, Balloon, Coronary/adverse effects/*statistics & numerical data; Coronary Disease/*mortality/*therapy; Female; Follow-Up Studies; Hospital Mortality; Humans; Logistic Models; Male; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Rate; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-06]]></modelid>
		<pubmedid><![CDATA[8403305]]></pubmedid>
		<author><![CDATA[Thompson]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predicting early and intermediate-term outcome of coronary angioplasty in the elderly]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[982]]></modelsamplesize>
		<cohortsamplesize><![CDATA[982]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Number of Lesions, CHF, Comorbidities]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Angioplasty, Balloon, Coronary/adverse effects/*statistics & numerical data; Coronary Disease/*mortality/*therapy; Female; Follow-Up Studies; Hospital Mortality; Humans; Logistic Models; Male; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Rate; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-07]]></modelid>
		<pubmedid><![CDATA[8428285]]></pubmedid>
		<author><![CDATA[Kalra]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[British Journal of Surgery]]></journal>
		<title><![CDATA[Myocardial infarction after reconstruction of the abdominal aorta]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[555]]></modelsamplesize>
		<cohortsamplesize><![CDATA[555]]></cohortsamplesize>
		<numberofevents><![CDATA[35]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, TIA, Creatinine]]></covariates>
		<mh><![CDATA[Aorta, Abdominal/*surgery; Aortic Diseases/*surgery; Arrhythmias, Cardiac/etiology; Female; Humans; Male; Middle Aged; Myocardial Infarction/*etiology; *Postoperative Complications; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-08]]></modelid>
		<pubmedid><![CDATA[8445178]]></pubmedid>
		<author><![CDATA[Young]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Inability to validate a predictive score for infective endocarditis in intravenous drug users]]></title>
		<primaryindexcondition><![CDATA[Endocarditis]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Endocarditis]]></outcome>
		<modelsamplesize><![CDATA[125]]></modelsamplesize>
		<cohortsamplesize><![CDATA[125]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.926]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CXR, Differential, Partial Pressure, Medical History, WBC]]></covariates>
		<mh><![CDATA[Adult; Emergencies; Endocarditis, Bacterial/*diagnosis; False Positive Reactions; Female; Humans; Male; Predictive Value of Tests; Retrospective Studies; Risk Factors; *Substance Abuse, Intravenous]]></mh>
	</node>
	<node>
		<modelid><![CDATA[93-001-09]]></modelid>
		<pubmedid><![CDATA[8460854]]></pubmedid>
		<author><![CDATA[Morrow]]></author>
		<year><![CDATA[1993]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2546]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2546]]></cohortsamplesize>
		<numberofevents><![CDATA[163]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[SBP, CHF or Digoxin, ST Depression, METs]]></covariates>
		<mh><![CDATA[Aged; Coronary Disease/*mortality/physiopathology; Electrocardiography; Exercise Test; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-01]]></modelid>
		<pubmedid><![CDATA[7934270]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[Medical Care]]></journal>
		<title><![CDATA[A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[401]]></modelsamplesize>
		<cohortsamplesize><![CDATA[401]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.9]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, T Waves, Sinus Rhythm, SBP]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Discriminant Analysis; Evaluation Studies as Topic; Female; Health Services Research/*methods; Heart Failure/*mortality; *Hospital Mortality; Hospitals/classification; Humans; *Logistic Models; Male; New England/epidemiology; Outcome Assessment (Health Care); Prospective Studies; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-02]]></modelid>
		<pubmedid><![CDATA[8049922]]></pubmedid>
		<author><![CDATA[Samy]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[Cardiovascular Surgery]]></journal>
		<title><![CDATA[Glasgow aneurysm score]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[500]]></modelsamplesize>
		<cohortsamplesize><![CDATA[500]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cerebrovascular Disease, Myocardial Disease, Renal Disease, Shock]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aortic Aneurysm, Abdominal/*mortality/surgery; Aortic Rupture; Cerebrovascular Disorders/complications; Female; Heart Diseases/complications; Humans; Kidney Diseases/complications; Male; Multivariate Analysis; Prognosis; Risk Factors; Shock/complications]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-03]]></modelid>
		<pubmedid><![CDATA[8109553]]></pubmedid>
		<author><![CDATA[Morley]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[138]]></modelsamplesize>
		<cohortsamplesize><![CDATA[138]]></cohortsamplesize>
		<numberofevents><![CDATA[88]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Output or Cardiac Index, PASP, PCWP, Vascular Resistance, RAP, Transpulmonary Gradient]]></covariates>
		<mh><![CDATA[Atrial Function/physiology; Blood Pressure/physiology; Cardiac Output/physiology; Cardiotonic Agents/therapeutic use; Cause of Death; Female; Heart Failure/physiopathology; Heart Transplantation/*statistics & numerical data; Hemodynamics/*physiology; Humans; Lung/blood supply; Male; Middle Aged; Myocardial Ischemia/physiopathology; Outcome Assessment (Health Care); Philadelphia/epidemiology; Prognosis; Pulmonary Wedge Pressure/physiology; Risk Factors; Survival Rate; Vascular Resistance/physiology; *Waiting Lists]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-04]]></modelid>
		<pubmedid><![CDATA[8266381]]></pubmedid>
		<author><![CDATA[D'Agostino]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[2372]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2372]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CVD, Smoking, Diabetes, LVH, Medications, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Antihypertensive Agents/*therapeutic use; Blood Pressure/drug effects; Cerebrovascular Disorders/*etiology; Cohort Studies; Female; Humans; Male; Middle Aged; Probability; Proportional Hazards Models; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-05]]></modelid>
		<pubmedid><![CDATA[8266381]]></pubmedid>
		<author><![CDATA[D'Agostino]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3362]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3362]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CVD, Smoking, Diabetes, LVH, Medications, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Antihypertensive Agents/*therapeutic use; Blood Pressure/drug effects; Cerebrovascular Disorders/*etiology; Cohort Studies; Female; Humans; Male; Middle Aged; Probability; Proportional Hazards Models; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-06]]></modelid>
		<pubmedid><![CDATA[8290048]]></pubmedid>
		<author><![CDATA[Lisk]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[75]]></modelsamplesize>
		<cohortsamplesize><![CDATA[75]]></cohortsamplesize>
		<numberofevents><![CDATA[9]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Admission Interval, Age, DBP, GCS, Hemorrhage Diameter, Hemorrhage Location, Hyperventilation, Mannitol/Glycerol, Mental Status, Subarachnoid Blood, Surgery, SBP, Ventricular Enlargement, Ventricular Extension]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage/physiopathology/*surgery; Emergency Medical Services; Female; Forecasting; Glasgow Coma Scale; Guidelines as Topic; Humans; Male; Middle Aged; *Models, Theoretical; Multivariate Analysis; Regression Analysis; Retrospective Studies; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[94-001-07]]></modelid>
		<pubmedid><![CDATA[8290048]]></pubmedid>
		<author><![CDATA[Lisk]]></author>
		<year><![CDATA[1994]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[75]]></modelsamplesize>
		<cohortsamplesize><![CDATA[75]]></cohortsamplesize>
		<numberofevents><![CDATA[35]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Admission Interval, Age, DBP, GCS, Hemorrhage Diameter, Hemorrhage Location, Hyperventilation, Sex, Mass Effect, Mental Status, Pupil Abnormality, Subarachnoid Blood, Surgery, SBP, Ventricular Extension]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage/physiopathology/*surgery; Emergency Medical Services; Female; Forecasting; Glasgow Coma Scale; Guidelines as Topic; Humans; Male; Middle Aged; *Models, Theoretical; Multivariate Analysis; Regression Analysis; Retrospective Studies; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-01]]></modelid>
		<pubmedid><![CDATA[7495587]]></pubmedid>
		<author><![CDATA[Roques]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Quality of care in adult heart surgery: proposal for a self-assessment approach based on a French multicenter study]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[7181]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7181]]></cohortsamplesize>
		<numberofevents><![CDATA[294]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AAD, Age, Respiratory Disease, Creatinine, LVEF, Reoperation, MI, PVD, Ventricular Septal Defect, VT/VF, Intubation, Embolectomy, Graft, Transplantation, Tricuspid Surgery, UA]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; *Cause of Death; Critical Care; Data Interpretation, Statistical; Female; France; Heart Diseases/mortality/*surgery; *Hospital Mortality; Humans; Male; Middle Aged; *Outcome and Process Assessment (Health Care); Postoperative Complications/*mortality/therapy; *Quality of Health Care; Risk Factors; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-02]]></modelid>
		<pubmedid><![CDATA[7560620]]></pubmedid>
		<author><![CDATA[Kimmel]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[10622]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10622]]></cohortsamplesize>
		<numberofevents><![CDATA[240]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AMI, Age, Valve Disease, CHF, Emergency Procedure, Geographic Region, Lab Volume, Left Main Coronary Artery Attempted, Multivessel Disease, CABG, Catheterization, Valve Surgery, Shock, UA, Sex, Worst Lesion Type Attempted]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary/*adverse effects/statistics & numerical data; Coronary Artery Bypass; Coronary Disease/epidemiology/*therapy; Emergencies; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/epidemiology; Prognosis; ROC Curve; Registries; Risk Assessment; Risk Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-03]]></modelid>
		<pubmedid><![CDATA[7594082]]></pubmedid>
		<author><![CDATA[Mehra]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study]]></title>
		<primaryindexcondition><![CDATA[Heart Transplant]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Graft Vasculopathy]]></outcome>
		<modelsamplesize><![CDATA[101]]></modelsamplesize>
		<cohortsamplesize><![CDATA[138]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BP, Donor Age, Biopsy Score, Triglycerides]]></covariates>
		<mh><![CDATA[Adult; Aged; Confounding Factors (Epidemiology); Coronary Vessels/*pathology/*ultrasonography; Death, Sudden, Cardiac/etiology; Female; Graft Rejection/immunology; Heart Transplantation/*adverse effects/immunology/pathology/*ultrasonography; Humans; Immunosuppression; Logistic Models; Male; Middle Aged; Myocardial Infarction/etiology; Predictive Value of Tests; Prospective Studies; Risk Factors; Sensitivity and Specificity; Transplantation, Homologous; Tunica Intima/pathology/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-04]]></modelid>
		<pubmedid><![CDATA[7612319]]></pubmedid>
		<author><![CDATA[Coppola]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[British Journal of General Practice]]></journal>
		<title><![CDATA[Scoring system to identify men at high risk of stroke: a strategy for general practice]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[7735]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7735]]></cohortsamplesize>
		<numberofevents><![CDATA[61]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Analysis of Variance; Cerebrovascular Disorders/*etiology/prevention & control; Family Practice; Follow-Up Studies; *Health Status Indicators; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-05]]></modelid>
		<pubmedid><![CDATA[7625160]]></pubmedid>
		<author><![CDATA[Mase]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Acta Neurologica Scandinavica]]></journal>
		<title><![CDATA[Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[138]]></modelsamplesize>
		<cohortsamplesize><![CDATA[138]]></cohortsamplesize>
		<numberofevents><![CDATA[38]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[GCS Score, ICH Size, Intraventricular Bleed]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Blood Volume; Cerebral Hemorrhage/*diagnosis/mortality; Cerebral Ventricles/pathology; Female; *Glasgow Coma Scale; Humans; Male; Middle Aged; Prognosis; Sensitivity and Specificity; Survival Rate; *Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-06]]></modelid>
		<pubmedid><![CDATA[7744536]]></pubmedid>
		<author><![CDATA[Feinberg]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Early risk stratification of patients with a first inferior wall acute myocardial infarction. SPRINT Study Group]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1841]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1841]]></cohortsamplesize>
		<numberofevents><![CDATA[179]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Glucose, Diabetes, Angina, Killip Class]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Female; Follow-Up Studies; *Hospital Mortality; Humans; Israel; Male; Middle Aged; Myocardial Infarction/*mortality/prevention & control; Nifedipine/therapeutic use; Odds Ratio; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-07]]></modelid>
		<pubmedid><![CDATA[7752753]]></pubmedid>
		<author><![CDATA[Wells]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[Accuracy of clinical assessment of deep-vein thrombosis]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[529]]></modelsamplesize>
		<cohortsamplesize><![CDATA[529]]></cohortsamplesize>
		<numberofevents><![CDATA[85]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Alternative Diagnosis, Risk Factors]]></covariates>
		<mh><![CDATA[*Decision Trees; Femoral Vein/radiography/ultrasonography; Fibula/blood supply; Follow-Up Studies; Humans; Iliac Vein/radiography; Observer Variation; Phlebography; Pilot Projects; Popliteal Vein/radiography/ultrasonography; Predictive Value of Tests; Prevalence; Probability; Prospective Studies; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thrombophlebitis/*diagnosis/radiography/ultrasonography; Thrombosis/radiography/ultrasonography; Tibia/blood supply]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-08]]></modelid>
		<pubmedid><![CDATA[7799494]]></pubmedid>
		<author><![CDATA[Calvin]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Risk stratification in unstable angina. Prospective validation of the Braunwald classification]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[393]]></modelsamplesize>
		<cohortsamplesize><![CDATA[393]]></cohortsamplesize>
		<numberofevents><![CDATA[77]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ST Depression, Beta Blockers, MI, IV Nitroglycerin]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Angina, Unstable/*classification/*complications/mortality/therapy; Comorbidity; Diabetes Complications; Female; Heart Failure/epidemiology; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/epidemiology; Odds Ratio; Prospective Studies; Risk; Tachycardia, Ventricular/epidemiology; Ventricular Fibrillation/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-09]]></modelid>
		<pubmedid><![CDATA[7828293]]></pubmedid>
		<author><![CDATA[Tu]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Multicenter Validation of a Risk Index for Mortality, Intensive Care Unit Stay, and Overall Hospital Length of Stay After Cardiac Surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6213]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6213]]></cohortsamplesize>
		<numberofevents><![CDATA[229]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Complex Surgery, Elective Surgery, Emergent Surgery, Sex, LV Function, Repeat Operation, Valve Surgery, CABG, Urgent Surgery]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiac Surgical Procedures/*mortality; Female; Humans; Intensive Care Units; *Length of Stay; Male; Middle Aged; Regression Analysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[95-001-10]]></modelid>
		<pubmedid><![CDATA[7882472]]></pubmedid>
		<author><![CDATA[Lee]]></author>
		<year><![CDATA[1995]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[41021]]></modelsamplesize>
		<cohortsamplesize><![CDATA[41021]]></cohortsamplesize>
		<numberofevents><![CDATA[2851]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.836]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Race, Cerebrovascular Disease, Country, Diabetes, Family History, Sex, Hypercholesterolemia, Hypertension, Infarct Location, Killip Class, Smoking, Angina, MI, Angioplasty, CABG]]></covariates>
		<mh><![CDATA[Aged; Blood Pressure; Body Height; Body Weight; Chi-Square Distribution; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction/*drug therapy/mortality/physiopathology; Predictive Value of Tests; Streptokinase/*therapeutic use; *Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator/*therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-01]]></modelid>
		<pubmedid><![CDATA[8558727]]></pubmedid>
		<author><![CDATA[Hardman]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Ruptured abdominal aortic aneurysms: who should be offered surgery?]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[154]]></modelsamplesize>
		<cohortsamplesize><![CDATA[154]]></cohortsamplesize>
		<numberofevents><![CDATA[60]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, Ischemia on EKG, Hemoglobin, Loss of Consciousness]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/diagnosis/mortality/*surgery; Aortic Rupture/diagnosis/mortality/*surgery; Chi-Square Distribution; Female; Health Care Rationing/statistics & numerical data; Humans; Logistic Models; Male; Middle Aged; New South Wales/epidemiology; Prognosis; Refusal to Treat/statistics & numerical data; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-02]]></modelid>
		<pubmedid><![CDATA[8613603]]></pubmedid>
		<author><![CDATA[L'Italien]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1081]]></cohortsamplesize>
		<numberofevents><![CDATA[46]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, CHF, Diabetes, MI, CABG]]></covariates>
		<mh><![CDATA[Aged; Bayes Theorem; Cohort Studies; Dipyridamole; Female; Heart Diseases/*epidemiology/radionuclide imaging; Humans; Logistic Models; Male; *Models, Statistical; Postoperative Complications/*epidemiology/radionuclide imaging; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thallium Radioisotopes; Vascular Diseases/*surgery; Vasodilator Agents]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-03]]></modelid>
		<pubmedid><![CDATA[8613603]]></pubmedid>
		<author><![CDATA[L'Italien]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1081]]></cohortsamplesize>
		<numberofevents><![CDATA[46]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Fixed or Reversible Defect, Ischemic ST Changes]]></covariates>
		<mh><![CDATA[Aged; Bayes Theorem; Cohort Studies; Dipyridamole; Female; Heart Diseases/*epidemiology/radionuclide imaging; Humans; Logistic Models; Male; *Models, Statistical; Postoperative Complications/*epidemiology/radionuclide imaging; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thallium Radioisotopes; Vascular Diseases/*surgery; Vasodilator Agents]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-04]]></modelid>
		<pubmedid><![CDATA[8614117]]></pubmedid>
		<author><![CDATA[Normand]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10936]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14581]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, MI Location, BMI, Cardiac Arrest, Cardiomegaly, Conduction Disturbance, CHF, Creatinine, Cancer, MAP, Urea Nitrogen, Mobility Status, Respiratory Rate, S3 Gallop Rhythm, Shock, Ventricular Rate]]></covariates>
		<mh><![CDATA[Aged; Alabama/epidemiology; Connecticut/epidemiology; *Hospital Mortality; Hospitals/standards; Humans; Iowa/epidemiology; Logistic Models; *Models, Statistical; Myocardial Infarction/*mortality/therapy; *Outcome Assessment (Health Care); Retrospective Studies; Severity of Illness Index; Survival Rate; Wisconsin/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-05]]></modelid>
		<pubmedid><![CDATA[8798109]]></pubmedid>
		<author><![CDATA[Grzybowsky]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Journal of Cardiac Failure]]></journal>
		<title><![CDATA[Determinants of prognosis in nonischemic dilated cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[144]]></modelsamplesize>
		<cohortsamplesize><![CDATA[144]]></cohortsamplesize>
		<numberofevents><![CDATA[77]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[LVEF, LV End Diastolic Dimension, PASP]]></covariates>
		<mh><![CDATA[Adult; Cardiomyopathy, Dilated/*diagnosis/mortality/surgery; Female; Follow-Up Studies; Heart Transplantation; Hemodynamics; Humans; Male; Multivariate Analysis; Prognosis; Retrospective Studies; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-06]]></modelid>
		<pubmedid><![CDATA[8890808]]></pubmedid>
		<author><![CDATA[Magovern]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A model that predicts morbidity and mortality after coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1567]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, Anemia, Arrhythmia, Shock, Cardiomegaly, Catheterization, Cerebrovascular Disease, COPD, Creatinine, CHF, BUN, Emergency Operation, Sex, Diabetes, BMI, PVD, Reoperation, LVEF]]></covariates>
		<mh><![CDATA[Aged; Coronary Artery Bypass/*mortality; Female; Health Care Costs; Humans; Male; Middle Aged; *Models, Cardiovascular; Morbidity; Prognosis; Prospective Studies; Retrospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-07]]></modelid>
		<pubmedid><![CDATA[8901662]]></pubmedid>
		<author><![CDATA[Iung]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[1088]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1514]]></cohortsamplesize>
		<numberofevents><![CDATA[968]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Previous Commissurotomy, Double Balloon, Echocardiographic Group, Effective Balloon Dilating Area, Valve Area]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; *Catheterization; Child; Decision Making; Humans; Logistic Models; Middle Aged; Mitral Valve/anatomy & histology/surgery; Mitral Valve Stenosis/*surgery; Patient Selection; Prospective Studies; Reproducibility of Results]]></mh>
	</node>
	<node>
		<modelid><![CDATA[96-001-08]]></modelid>
		<pubmedid><![CDATA[8901723]]></pubmedid>
		<author><![CDATA[Newman]]></author>
		<year><![CDATA[1996]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[2107]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2107]]></cohortsamplesize>
		<numberofevents><![CDATA[68]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.778]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Neurological Disease, Pulmonary Disease, Vascular Disease, CABG, UA]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders/*etiology; Coronary Artery Bypass/*adverse effects; Female; Humans; Male; Middle Aged; Postoperative Complications/etiology; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-01]]></modelid>
		<pubmedid><![CDATA[9002560]]></pubmedid>
		<author><![CDATA[Karlson]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Improvement of ED prediction of cardiac mortality among patients with symptoms suggestive of acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5362]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5362]]></cohortsamplesize>
		<numberofevents><![CDATA[604]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CHF, Age, Diabetes, Hypertension, Suspicion of Infarct, Loss of Consciousness, EKG, Sex, Acute Ischemia, ST Elevation, Unspecific Symptoms]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Chest Pain/*mortality; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Myocardial Infarction/*diagnosis/*mortality; Prognosis; *Proportional Hazards Models; Risk Factors; Survival Analysis; Sweden]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-02]]></modelid>
		<pubmedid><![CDATA[9002560]]></pubmedid>
		<author><![CDATA[Karlson]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Improvement of ED prediction of cardiac mortality among patients with symptoms suggestive of acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5362]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5362]]></cohortsamplesize>
		<numberofevents><![CDATA[1795]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Angina, CHF, MI, Suspicion of Infarction, Loss of Consciousness, ST Depression, Unspecific Symptoms]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Chest Pain/*mortality; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Myocardial Infarction/*diagnosis/*mortality; Prognosis; *Proportional Hazards Models; Risk Factors; Survival Analysis; Sweden]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-03]]></modelid>
		<pubmedid><![CDATA[9105802]]></pubmedid>
		<author><![CDATA[Pons]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Assessing open heart surgery mortality in Catalonia (Spain) through a predictive risk model]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[916]]></modelsamplesize>
		<cohortsamplesize><![CDATA[916]]></cohortsamplesize>
		<numberofevents><![CDATA[100]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, CABG/Valve Surgery, Creatinine, Functional Class, Aneurysm, Liver Disease, Valve Surgery, Mechanical Ventilation, Priority Status, Recent MI, Reoperation, Aortic Surgery]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*mortality; Cause of Death; Female; *Hospital Mortality; Humans; Male; Middle Aged; Models, Statistical; Risk; Spain/epidemiology; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-04]]></modelid>
		<pubmedid><![CDATA[9193435]]></pubmedid>
		<author><![CDATA[Aaronson]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[268]]></modelsamplesize>
		<cohortsamplesize><![CDATA[268]]></cohortsamplesize>
		<numberofevents><![CDATA[81]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiomyopathy, IVCD, LVEF, BP, Peak VO2, Heart Rate, Sodium]]></covariates>
		<mh><![CDATA[Cardiac Output, Low/physiopathology/surgery; Evaluation Studies as Topic; Female; *Heart Transplantation; Humans; Male; Middle Aged; Models, Cardiovascular; *Outpatients; Prognosis; Proportional Hazards Models; Prospective Studies; *Referral and Consultation; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-05]]></modelid>
		<pubmedid><![CDATA[9193435]]></pubmedid>
		<author><![CDATA[Aaronson]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[231]]></modelsamplesize>
		<cohortsamplesize><![CDATA[231]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiomyopathy, IVCD, LVEF, BP, PCWP, Peak VO2, Heart Rate, Sodium]]></covariates>
		<mh><![CDATA[Cardiac Output, Low/physiopathology/surgery; Evaluation Studies as Topic; Female; *Heart Transplantation; Humans; Male; Middle Aged; Models, Cardiovascular; *Outpatients; Prognosis; Proportional Hazards Models; Prospective Studies; *Referral and Consultation; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-06]]></modelid>
		<pubmedid><![CDATA[9200390]]></pubmedid>
		<author><![CDATA[Califf]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Selection of thrombolytic therapy for individual patients: development of a clinical model]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[41021]]></modelsamplesize>
		<cohortsamplesize><![CDATA[41021]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, MI Location, Prior MI, SBP]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Anticoagulants/administration & dosage/therapeutic use; Blood Pressure; Fibrinolytic Agents/administration & dosage/therapeutic use; Forecasting; Heart Rate; Heparin/administration & dosage/therapeutic use; Humans; Injections, Intravenous; Injections, Subcutaneous; Logistic Models; Middle Aged; Models, Statistical; Myocardial Infarction/*drug therapy; Plasminogen Activators/administration & dosage/therapeutic use; Prognosis; Risk Factors; Streptokinase/administration & dosage/therapeutic use; Survival Rate; *Thrombolytic Therapy; Tissue Plasminogen Activator/administration & dosage/therapeutic use; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-07]]></modelid>
		<pubmedid><![CDATA[9200394]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[1521]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1521]]></cohortsamplesize>
		<numberofevents><![CDATA[301]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Heart Rate, Rales, Mean Arterial Pressure, MI Location, Number of MIs]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Blood Pressure; Cardiac Output, Low/complications; Cohort Studies; Coronary Angiography; Coronary Disease/complications; Demography; Diabetes Complications; Electrocardiography; Female; Follow-Up Studies; Forecasting; Heart Failure/*etiology; Hospitalization; Humans; Length of Stay; Longitudinal Studies; Male; Middle Aged; Mitral Valve Insufficiency/complications; Myocardial Infarction/*drug therapy; Myocardial Ischemia/complications; Prospective Studies; Recurrence; Regression Analysis; Sex Factors; Survival Rate; Thrombolytic Therapy/*adverse effects; Treatment Outcome; Vascular Patency]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-08]]></modelid>
		<pubmedid><![CDATA[9217616]]></pubmedid>
		<author><![CDATA[Morise]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[915]]></modelsamplesize>
		<cohortsamplesize><![CDATA[915]]></cohortsamplesize>
		<numberofevents><![CDATA[170]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Diabetes, Estrogen Status, Family History, Sex, Hyperlipidemia, Hypertension, Obesity, Smoking, Symptoms]]></covariates>
		<mh><![CDATA[Aged; Coronary Angiography; Coronary Disease/*diagnosis; Electrocardiography; Exercise Test; Female; Humans; Logistic Models; Male; Middle Aged; Probability; Retrospective Studies]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-09]]></modelid>
		<pubmedid><![CDATA[9227690]]></pubmedid>
		<author><![CDATA[Fogelholm]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[282]]></modelsamplesize>
		<cohortsamplesize><![CDATA[282]]></cohortsamplesize>
		<numberofevents><![CDATA[120]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Glucose, Mental Status, Arterial Pressure, Midline Shift, Subarachnoid Spread, Vomiting]]></covariates>
		<mh><![CDATA[Aged; *Blood Pressure; Cerebral Hemorrhage/mortality/*radiography; Consciousness; Female; Humans; Logistic Models; Male; Middle Aged; Orientation; Predictive Value of Tests; Prognosis; Survival Analysis; Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-10]]></modelid>
		<pubmedid><![CDATA[9313022]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2525]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2525]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AMI Location, Heart Rate, Diabetes, Thrombolytics, Age, Q Waves, RBBB, ST Segment Elevation, SBP, Time to EKG]]></covariates>
		<mh><![CDATA[Cerebral Hemorrhage/etiology; Electrocardiography; *Emergency Service, Hospital; Heart Arrest/etiology; Hemorrhage/etiology; Humans; Information Systems; Logistic Models; Myocardial Infarction/complications/mortality/*therapy; Patient Selection; *Therapy, Computer-Assisted; *Thrombolytic Therapy; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-11]]></modelid>
		<pubmedid><![CDATA[9313022]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2369]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2369]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AMI Location, Heart Rate, Q Waves, Age, RBBB]]></covariates>
		<mh><![CDATA[Cerebral Hemorrhage/etiology; Electrocardiography; *Emergency Service, Hospital; Heart Arrest/etiology; Hemorrhage/etiology; Humans; Information Systems; Logistic Models; Myocardial Infarction/complications/mortality/*therapy; Patient Selection; *Therapy, Computer-Assisted; *Thrombolytic Therapy; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-12]]></modelid>
		<pubmedid><![CDATA[9313022]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Cardiac Arrest]]></outcome>
		<modelsamplesize><![CDATA[9999999]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9999999]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[QT Interval, EKG Size of AMI, Age, ST Segment Elevation, SBP, Time Interval, Thrombolytics]]></covariates>
		<mh><![CDATA[Cerebral Hemorrhage/etiology; Electrocardiography; *Emergency Service, Hospital; Heart Arrest/etiology; Hemorrhage/etiology; Humans; Information Systems; Logistic Models; Myocardial Infarction/complications/mortality/*therapy; Patient Selection; *Therapy, Computer-Assisted; *Thrombolytic Therapy; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-32]]></modelid>
		<pubmedid><![CDATA[20233732]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Age & Ageing]]></journal>
		<title><![CDATA[Predicting functional outcome after stroke by modelling baseline clinical and CT variables]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[310]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.901]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Able to Walk, Age, Arm Power, CT Abnormality, Leukoaraiosis, Pre-Stroke Independence, Stroke Severity]]></covariates>
		<mh><![CDATA[Activities of Daily Living; Acute Disease; Aged; Aged, 80 and over; Area Under Curve; Female; Humans; Male; Middle Aged; *Models, Statistical; Outcome Assessment (Health Care)/*methods; Predictive Value of Tests; Prognosis; ROC Curve; Severity of Illness Index; Stroke/mortality/*radiography/*rehabilitation; Survival Rate; *Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-13]]></modelid>
		<pubmedid><![CDATA[9313022]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[9999999]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9999999]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Pulse BP, Age]]></covariates>
		<mh><![CDATA[Cerebral Hemorrhage/etiology; Electrocardiography; *Emergency Service, Hospital; Heart Arrest/etiology; Hemorrhage/etiology; Humans; Information Systems; Logistic Models; Myocardial Infarction/complications/mortality/*therapy; Patient Selection; *Therapy, Computer-Assisted; *Thrombolytic Therapy; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-14]]></modelid>
		<pubmedid><![CDATA[9313022]]></pubmedid>
		<author><![CDATA[Selker]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[9999999]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9999999]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Heart Rate, SBP, Hypertension, Age, Sex, Thrombolytic Dose]]></covariates>
		<mh><![CDATA[Cerebral Hemorrhage/etiology; Electrocardiography; *Emergency Service, Hospital; Heart Arrest/etiology; Hemorrhage/etiology; Humans; Information Systems; Logistic Models; Myocardial Infarction/complications/mortality/*therapy; Patient Selection; *Therapy, Computer-Assisted; *Thrombolytic Therapy; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-15]]></modelid>
		<pubmedid><![CDATA[9354526]]></pubmedid>
		<author><![CDATA[Higgins]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2440]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2440]]></cohortsamplesize>
		<numberofevents><![CDATA[78]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Arterial Bicarbonate, Cardiac Index, CPB Time, Heart Rate, PVD, Albumin, IABP]]></covariates>
		<mh><![CDATA[Coronary Artery Bypass/*mortality; *Coronary Care Units; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Postoperative Complications/*epidemiology; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-16]]></modelid>
		<pubmedid><![CDATA[9354526]]></pubmedid>
		<author><![CDATA[Higgins]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2440]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2440]]></cohortsamplesize>
		<numberofevents><![CDATA[78]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CPB Time, Intervention for PVD, ICU Admission Physiology, Albumin, Creatinine, Prior Heart Operation, BSA, IABP]]></covariates>
		<mh><![CDATA[Coronary Artery Bypass/*mortality; *Coronary Care Units; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Postoperative Complications/*epidemiology; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-17]]></modelid>
		<pubmedid><![CDATA[9354526]]></pubmedid>
		<author><![CDATA[Higgins]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2440]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2440]]></cohortsamplesize>
		<numberofevents><![CDATA[254]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Prior Heart Operations, A-a Gradient, Age, Arterial Bicarbonate, BSA, Cardiac Index, CPB Time, Central Venous Pressure, Heart Rate, PVD, Albumin, Creatinine, IABP]]></covariates>
		<mh><![CDATA[Coronary Artery Bypass/*mortality; *Coronary Care Units; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Postoperative Complications/*epidemiology; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-18]]></modelid>
		<pubmedid><![CDATA[9354526]]></pubmedid>
		<author><![CDATA[Higgins]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2440]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2440]]></cohortsamplesize>
		<numberofevents><![CDATA[254]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Hematocrit, Cerebrovascular Disease, COPD, Diabetes, Emergency, Stenosis, Mitral Valve Insufficiency, Prior Cardiac Operation, Vascular Surgery, Creatinine, LV Dysfunction, Weight]]></covariates>
		<mh><![CDATA[Coronary Artery Bypass/*mortality; *Coronary Care Units; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Postoperative Complications/*epidemiology; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-19]]></modelid>
		<pubmedid><![CDATA[9386139]]></pubmedid>
		<author><![CDATA[Siu]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk and predictors for pregnancy-related complications in women with heart disease]]></title>
		<primaryindexcondition><![CDATA[Pregnancy]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[221]]></modelsamplesize>
		<cohortsamplesize><![CDATA[221]]></cohortsamplesize>
		<numberofevents><![CDATA[45]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Left Heart Obstruction, Myocardial Dysfunction, NYHA Class or Cyanosis, Arrhythmia, Prior Cardiac Events]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Female; Heart Diseases/*complications; Humans; Infant, Newborn; Multivariate Analysis; Pregnancy; *Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-20]]></modelid>
		<pubmedid><![CDATA[9396421]]></pubmedid>
		<author><![CDATA[Valenzuela]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[205]]></modelsamplesize>
		<cohortsamplesize><![CDATA[205]]></cohortsamplesize>
		<numberofevents><![CDATA[169]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.783]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Collapse to CPR Interval, Collapse to Defibrillation Interval]]></covariates>
		<mh><![CDATA[Adolescent; Aged; Cardiopulmonary Resuscitation; Electric Countershock; Evaluation Studies as Topic; Female; Heart Arrest/etiology/*mortality/*therapy; Humans; Male; Middle Aged; Models, Cardiovascular; Regression Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome; Ventricular Fibrillation/complications/therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-21]]></modelid>
		<pubmedid><![CDATA[9425461]]></pubmedid>
		<author><![CDATA[Knuiman]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Journal of Epidemiology & Community Health]]></journal>
		<title><![CDATA[Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1923]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1923]]></cohortsamplesize>
		<numberofevents><![CDATA[116]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterok Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cholesterol/blood; Coronary Disease/etiology/*mortality; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Surveys; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Smoking/adverse effects; Western Australia/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-22]]></modelid>
		<pubmedid><![CDATA[9425461]]></pubmedid>
		<author><![CDATA[Knuiman]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Journal of Epidemiology & Community Health]]></journal>
		<title><![CDATA[Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1968]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1968]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cholesterol/blood; Coronary Disease/etiology/*mortality; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Surveys; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Smoking/adverse effects; Western Australia/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-23]]></modelid>
		<pubmedid><![CDATA[9425461]]></pubmedid>
		<author><![CDATA[Knuiman]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Journal of Epidemiology & Community Health]]></journal>
		<title><![CDATA[Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1923]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1923]]></cohortsamplesize>
		<numberofevents><![CDATA[116]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cholesterol, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cholesterol/blood; Coronary Disease/etiology/*mortality; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Surveys; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Smoking/adverse effects; Western Australia/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-24]]></modelid>
		<pubmedid><![CDATA[9425461]]></pubmedid>
		<author><![CDATA[Knuiman]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Journal of Epidemiology & Community Health]]></journal>
		<title><![CDATA[Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1968]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1968]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cholesterol, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cholesterol/blood; Coronary Disease/etiology/*mortality; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Surveys; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Smoking/adverse effects; Western Australia/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[97-001-25]]></modelid>
		<pubmedid><![CDATA[9428249]]></pubmedid>
		<author><![CDATA[Wells]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[Value of assessment of pretest probability of deep-vein thrombosis in clinical management.]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[593]]></modelsamplesize>
		<cohortsamplesize><![CDATA[593]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cancer, Alternative Diagnosis, Leg Swelling, Collateral Superficial Veins, Tenderness, Paralysis, Pitting Edema, Bedridden]]></covariates>
		<mh><![CDATA[Algorithms; Female; Humans; Male; Middle Aged; Models, Biological; Probability; Prospective Studies; Thrombophlebitis/diagnosis/therapy/*ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-01]]></modelid>
		<pubmedid><![CDATA[9487327]]></pubmedid>
		<author><![CDATA[Wells]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Journal of Internal Medicine]]></journal>
		<title><![CDATA[A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process.]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[495]]></modelsamplesize>
		<cohortsamplesize><![CDATA[495]]></cohortsamplesize>
		<numberofevents><![CDATA[135]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Alternative Diagnosis, Cancer, Dilated Superficial Veins, Leg Swelling, Immobilization, Paralysis, Pitting Edema, Tender Deep Veins]]></covariates>
		<mh><![CDATA[Diagnosis, Differential; Humans; Logistic Models; Multivariate Analysis; Odds Ratio; *Plethysmography, Impedance; Prospective Studies; Sensitivity and Specificity; Thrombophlebitis/*diagnosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-02]]></modelid>
		<pubmedid><![CDATA[9487327]]></pubmedid>
		<author><![CDATA[Wells]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Journal of Internal Medicine]]></journal>
		<title><![CDATA[A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process.]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[495]]></modelsamplesize>
		<cohortsamplesize><![CDATA[495]]></cohortsamplesize>
		<numberofevents><![CDATA[135]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Anticoagulant Therapy, Impedance Plethysmography, Post-Test Probability, Ultrasonography, Venography]]></covariates>
		<mh><![CDATA[Diagnosis, Differential; Humans; Logistic Models; Multivariate Analysis; Odds Ratio; *Plethysmography, Impedance; Prospective Studies; Sensitivity and Specificity; Thrombophlebitis/*diagnosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-03]]></modelid>
		<pubmedid><![CDATA[9603539]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of coronary heart disease using risk factor categories]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2489]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2489]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BP, Diabetes, HDL Cholesterol, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; *Blood Pressure; Body Mass Index; Cholesterol/*blood; Cholesterol, LDL/classification; Cohort Studies; Comorbidity; Coronary Disease/*epidemiology; Diabetes Mellitus/epidemiology; Female; Follow-Up Studies; Humans; Lipids/blood; Male; Middle Aged; National Health Programs; Proportional Hazards Models; Risk Factors; Smoking/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-04]]></modelid>
		<pubmedid><![CDATA[9603539]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of coronary heart disease using risk factor categories]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2856]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2856]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BP, Diabetes, HDL Cholesterol, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; *Blood Pressure; Body Mass Index; Cholesterol/*blood; Cholesterol, LDL/classification; Cohort Studies; Comorbidity; Coronary Disease/*epidemiology; Diabetes Mellitus/epidemiology; Female; Follow-Up Studies; Humans; Lipids/blood; Male; Middle Aged; National Health Programs; Proportional Hazards Models; Risk Factors; Smoking/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-05]]></modelid>
		<pubmedid><![CDATA[9603539]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of coronary heart disease using risk factor categories]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2489]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2489]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BP, Diabetes, HDL Cholesterol, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; *Blood Pressure; Body Mass Index; Cholesterol/*blood; Cholesterol, LDL/classification; Cohort Studies; Comorbidity; Coronary Disease/*epidemiology; Diabetes Mellitus/epidemiology; Female; Follow-Up Studies; Humans; Lipids/blood; Male; Middle Aged; National Health Programs; Proportional Hazards Models; Risk Factors; Smoking/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-06]]></modelid>
		<pubmedid><![CDATA[9603539]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of coronary heart disease using risk factor categories]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2856]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2856]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BP, Diabetes, HDL Cholesterol, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; *Blood Pressure; Body Mass Index; Cholesterol/*blood; Cholesterol, LDL/classification; Cohort Studies; Comorbidity; Coronary Disease/*epidemiology; Diabetes Mellitus/epidemiology; Female; Follow-Up Studies; Humans; Lipids/blood; Male; Middle Aged; National Health Programs; Proportional Hazards Models; Risk Factors; Smoking/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-07]]></modelid>
		<pubmedid><![CDATA[9645975]]></pubmedid>
		<author><![CDATA[Arboix]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Predictive clinical factors of in-hospital mortality in 231 consecutive patients with cardioembolic cerebral infarction]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[231]]></modelsamplesize>
		<cohortsamplesize><![CDATA[231]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Mental Status, CHF, Limb Weakness, Sex]]></covariates>
		<mh><![CDATA[Cerebral Infarction/etiology/*mortality; Female; Heart Diseases/*complications; *Hospital Mortality; Humans; Intracranial Embolism and Thrombosis/*complications; Logistic Models; Male; Multivariate Analysis; Prognosis; Prospective Studies; Recurrence; Registries; Regression Analysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-08]]></modelid>
		<pubmedid><![CDATA[9645975]]></pubmedid>
		<author><![CDATA[Arboix]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Predictive clinical factors of in-hospital mortality in 231 consecutive patients with cardioembolic cerebral infarction]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[231]]></modelsamplesize>
		<cohortsamplesize><![CDATA[231]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Mental Status, CHF, Recurrent Embolism, Limb Weakness, Sex]]></covariates>
		<mh><![CDATA[Cerebral Infarction/etiology/*mortality; Female; Heart Diseases/*complications; *Hospital Mortality; Humans; Intracranial Embolism and Thrombosis/*complications; Logistic Models; Male; Multivariate Analysis; Prognosis; Prospective Studies; Recurrence; Registries; Regression Analysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-09]]></modelid>
		<pubmedid><![CDATA[9660379]]></pubmedid>
		<author><![CDATA[Wardlaw]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[993]]></modelsamplesize>
		<cohortsamplesize><![CDATA[993]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[GCS Verbal Score, Age, Smoking, Dyspraxia, Lives Alone, mRS, Arm Power, Unable to Walk]]></covariates>
		<mh><![CDATA[Acute Disease; Brain Ischemia/mortality/*physiopathology/*radiography; Cerebral Infarction/*radiography; Cerebrovascular Disorders/mortality/*physiopathology/*radiography; Humans; Multivariate Analysis; Prognosis; Prospective Studies; Regression Analysis; Risk Factors; Severity of Illness Index; *Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-10]]></modelid>
		<pubmedid><![CDATA[9727814]]></pubmedid>
		<author><![CDATA[Beyth]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[The American Journal of Medicine]]></journal>
		<title><![CDATA[Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[556]]></modelsamplesize>
		<cohortsamplesize><![CDATA[556]]></cohortsamplesize>
		<numberofevents><![CDATA[65]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, GI Bleed, Stroke, Recent MI]]></covariates>
		<mh><![CDATA[Aged; Anticoagulants/*adverse effects; *Decision Support Techniques; Evaluation Studies as Topic; Female; Follow-Up Studies; Hemorrhage/*chemically induced/prevention & control; Humans; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Risk Factors; Warfarin/*adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-11]]></modelid>
		<pubmedid><![CDATA[9794342]]></pubmedid>
		<author><![CDATA[Polanczyk]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Medical Care]]></journal>
		<title><![CDATA[A new casemix adjustment index for hospital mortality among patients with congestive heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2320]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4608]]></cohortsamplesize>
		<numberofevents><![CDATA[148]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cerebrovascular Disease, COPD, Hyponatremia, Hypotension/Shock, Malignancy, Metastatic Disease, Liver Disease, Renal Disease, Hydro-Electrolytic Disturbance, Transferred Admission, Ventricular Arrhythmia]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cause of Death; Comorbidity; Diagnosis-Related Groups/*statistics & numerical data; Female; Heart Failure/classification/*mortality; *Hospital Mortality; Hospitals, General/statistics & numerical data; Humans; Logistic Models; Male; Massachusetts; Middle Aged; New York; Odds Ratio; Prognosis; Risk Adjustment; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[98-001-12]]></modelid>
		<pubmedid><![CDATA[9875774]]></pubmedid>
		<author><![CDATA[Gordon]]></author>
		<year><![CDATA[1998]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Pacemaker Placement]]></outcome>
		<modelsamplesize><![CDATA[10421]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10421]]></cohortsamplesize>
		<numberofevents><![CDATA[255]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.804]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Ablative Arrhythmia Operation, Endocarditis, Age, AVR, Cardioplegia, MVR, Renal Failure, Reoperation]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Arrhythmias, Cardiac/surgery; *Cardiac Pacing, Artificial; *Cardiac Surgical Procedures; Catheter Ablation; Confidence Intervals; Female; Heart Arrest, Induced; Heart Valves/surgery; Humans; Logistic Models; Male; Middle Aged; Mitral Valve/surgery; Odds Ratio; Postoperative Care; Prospective Studies; Regression Analysis; Renal Insufficiency/complications; Reoperation; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-01]]></modelid>
		<pubmedid><![CDATA[10074953]]></pubmedid>
		<author><![CDATA[Kuijer]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[241]]></modelsamplesize>
		<cohortsamplesize><![CDATA[241]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Malignancy, Sex]]></covariates>
		<mh><![CDATA[Anticoagulants/*adverse effects; Female; Hemorrhage/*chemically induced; Humans; Incidence; Male; Middle Aged; Models, Statistical; Odds Ratio; Predictive Value of Tests; Risk; Risk Factors; Thromboembolism/*drug therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-02]]></modelid>
		<pubmedid><![CDATA[10102459]]></pubmedid>
		<author><![CDATA[Kahn]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Thrombosis & Haemostasis]]></journal>
		<title><![CDATA[Clinical prediction of deep vein thrombosis in patients with leg symptoms]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[271]]></modelsamplesize>
		<cohortsamplesize><![CDATA[271]]></cohortsamplesize>
		<numberofevents><![CDATA[73]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Sex, Orthopedic Surgery, Venous Dilation, Warmth]]></covariates>
		<mh><![CDATA[Adult; Aged; Diagnostic Techniques, Cardiovascular; Female; Humans; Leg/physiopathology; Male; Middle Aged; Predictive Value of Tests; Prevalence; Regression Analysis; Risk Factors; Thrombophlebitis/*diagnosis/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-03]]></modelid>
		<pubmedid><![CDATA[10334424]]></pubmedid>
		<author><![CDATA[Philbin]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[42731]]></modelsamplesize>
		<cohortsamplesize><![CDATA[42731]]></cohortsamplesize>
		<numberofevents><![CDATA[9112]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.62]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Race, Lung Disease, Diabetes, Discharge to Nursing Facility, Home Health Care Services, Cardiomyopathy, IHD, Insurance, Catheterization, Echocardiography, Prior Cardiac Surgery, Renal Disease, Rural Hospital, Telemetry Monitoring, VHD]]></covariates>
		<mh><![CDATA[African Americans/statistics & numerical data; African Continental Ancestry Group; Aged; Aged, 80 and over; Comorbidity; European Continental Ancestry Group/statistics & numerical data; Female; Heart Failure/*epidemiology/ethnology/rehabilitation; Humans; Male; Medicaid/statistics & numerical data; Medicare/statistics & numerical data; Middle Aged; New York/epidemiology; Outcome and Process Assessment (Health Care); Patient Readmission/*statistics & numerical data; Risk; *Severity of Illness Index; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-04]]></modelid>
		<pubmedid><![CDATA[10356104]]></pubmedid>
		<author><![CDATA[Hart]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1853]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1853]]></cohortsamplesize>
		<numberofevents><![CDATA[101]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Alcohol Use, Sex, Hypertension, Stroke/TIA, SBP]]></covariates>
		<mh><![CDATA[Aged; Alcohol Drinking/physiopathology; Anticoagulants/*therapeutic use; Aspirin/*therapeutic use; Atrial Fibrillation/*drug therapy; Brain Ischemia/*etiology; Cerebrovascular Disorders/*etiology/prevention & control; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Estrogen Replacement Therapy/adverse effects; Female; Humans; Male; Multivariate Analysis; Regression Analysis; Risk Factors; Warfarin/administration & dosage/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-05]]></modelid>
		<pubmedid><![CDATA[10361048]]></pubmedid>
		<author><![CDATA[Staat]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Severe morbidity after coronary artery surgery: development and validation of a simple predictive clinical score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[452]]></modelsamplesize>
		<cohortsamplesize><![CDATA[679]]></cohortsamplesize>
		<numberofevents><![CDATA[156]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, CPB Time, Pulmonary Disease, Reoperation, ST Changes, Surgeons, HF, Ventricular Arrhythmia]]></covariates>
		<mh><![CDATA[Adult; Coronary Artery Bypass/*adverse effects; Coronary Disease/surgery; Female; Humans; Logistic Models; Male; Morbidity; Predictive Value of Tests; Retrospective Studies; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-12]]></modelid>
		<pubmedid><![CDATA[24010545]]></pubmedid>
		<author><![CDATA[Seiffge]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[European Journal of Neurology]]></journal>
		<title><![CDATA[Simple variables predict miserable outcome after intravenous thrombolysis]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[1346]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1346]]></cohortsamplesize>
		<numberofevents><![CDATA[180]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.807]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Able to Lift Arms, Able to Walk, Age, Independence, Glasgow Coma Scale]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-03]]></modelid>
		<pubmedid><![CDATA[24239921]]></pubmedid>
		<author><![CDATA[Goff]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[11240]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11240]]></cohortsamplesize>
		<numberofevents><![CDATA[902]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8058]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Age, HDL Cholesterol, Total Cholesterol, Treated/Untreated SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-04]]></modelid>
		<pubmedid><![CDATA[24239921]]></pubmedid>
		<author><![CDATA[Goff]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2641]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2641]]></cohortsamplesize>
		<numberofevents><![CDATA[290]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8182]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Age, HDL Cholesterol, Total Cholesterol, Treated/Untreated SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-05]]></modelid>
		<pubmedid><![CDATA[24239921]]></pubmedid>
		<author><![CDATA[Goff]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[9098]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9098]]></cohortsamplesize>
		<numberofevents><![CDATA[1259]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.7462]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Age, HDL Cholesterol, Total Cholesterol, Treated/Untreated SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-06]]></modelid>
		<pubmedid><![CDATA[24239921]]></pubmedid>
		<author><![CDATA[Goff]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1647]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1647]]></cohortsamplesize>
		<numberofevents><![CDATA[238]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.713]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Age, HDL Cholesterol, Total Cholesterol, Treated/Untreated SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-07]]></modelid>
		<pubmedid><![CDATA[20428727]]></pubmedid>
		<author><![CDATA[Guaragna]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Arquivos Brasileiros de Cardiologia]]></journal>
		<title><![CDATA[Proposed preoperative risk score for patients candidate to cardiac valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1086]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1086]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CABG, Creatinine, Dialysis, LVEF, Priority Status, Sex, NYHA Class, Pulmonary Hypertension]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-08]]></modelid>
		<pubmedid><![CDATA[23899075]]></pubmedid>
		<author><![CDATA[Herman]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Cardiothoracic Surgery]]></journal>
		<title><![CDATA[Development of a predictive model for major adverse cardiac events in a coronary artery bypass and valve population]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[4270]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4270]]></cohortsamplesize>
		<numberofevents><![CDATA[669]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.764]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BMI, COPD, Creatinine, CVD, Diabetes, LVEF, Sex, Frailty, Hemoglobin, NYHA Class, Procedure Type, PVD, Sternotomy, Priority Status]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-09]]></modelid>
		<pubmedid><![CDATA[20031785]]></pubmedid>
		<author><![CDATA[Keenan]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation: Cardiovascular and Quality Outcomes]]></journal>
		<title><![CDATA[An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients with Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[283919]]></modelsamplesize>
		<cohortsamplesize><![CDATA[283919]]></cohortsamplesize>
		<numberofevents><![CDATA[67005]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.6]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ACS, Age, Arrhythmia, Asthma, Cancer, Cardiorespiratory Failure/Shock, Atherosclerosis, COPD, CHF, Ulcer, Dementia, Depression, Diabetes, Electrolyte Disorders, Substance Abuse, ESRD or Dialysis, Chronic Lung Disorders, Functional Disability, CABG, Anemia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-10]]></modelid>
		<pubmedid><![CDATA[9202355]]></pubmedid>
		<author><![CDATA[Chin]]></author>
		<year><![CDATA[1997]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Correlates of Early Hospital Readmission or Death in Patients with Congestive Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[257]]></modelsamplesize>
		<cohortsamplesize><![CDATA[257]]></cohortsamplesize>
		<numberofevents><![CDATA[82]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Charlson Comorbidity Index, SBP, ST-T-Wave Changes on EKG, Marital Status]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-11]]></modelid>
		<pubmedid><![CDATA[10618565]]></pubmedid>
		<author><![CDATA[Krumholz]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predictors of readmission among elderly survivors of admission with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[1129]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1129]]></cohortsamplesize>
		<numberofevents><![CDATA[570]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Diabetes, Prior Admission, Heart Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-12]]></modelid>
		<pubmedid><![CDATA[10618565]]></pubmedid>
		<author><![CDATA[Krumholz]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predictors of readmission among elderly survivors of admission with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[1129]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1129]]></cohortsamplesize>
		<numberofevents><![CDATA[287]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Diabetes, Prior Admission, Heart Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-13]]></modelid>
		<pubmedid><![CDATA[10618565]]></pubmedid>
		<author><![CDATA[Krumholz]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predictors of readmission among elderly survivors of admission with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1129]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1129]]></cohortsamplesize>
		<numberofevents><![CDATA[644]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Diabetes, Prior Admission, Heart Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-14]]></modelid>
		<pubmedid><![CDATA[15599835]]></pubmedid>
		<author><![CDATA[Felker]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of Cardiac Failure]]></journal>
		<title><![CDATA[Risk Stratification After Hospitalization for Decompensated Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[937]]></modelsamplesize>
		<cohortsamplesize><![CDATA[949]]></cohortsamplesize>
		<numberofevents><![CDATA[90]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BUN, NYHA Class, SBP, Sodium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-142]]></modelid>
		<pubmedid><![CDATA[23570474]]></pubmedid>
		<author><![CDATA[Stiell]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Academic Emergency Medicine]]></journal>
		<title><![CDATA[A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[493]]></modelsamplesize>
		<cohortsamplesize><![CDATA[559]]></cohortsamplesize>
		<numberofevents><![CDATA[65]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.752]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[EKG, CVD, Heart Rate, Intubation, Saturated Oxygen, CO2, Troponin, Urea]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-06]]></modelid>
		<pubmedid><![CDATA[10368115]]></pubmedid>
		<author><![CDATA[Krumholz]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[82359]]></modelsamplesize>
		<cohortsamplesize><![CDATA[82359]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, MI Location, Cardiac Arrest, CHF, Creatinine, SBP, WBC]]></covariates>
		<mh><![CDATA[Age Factors; *Aged; Cohort Studies; Creatinine/blood; Female; Heart Arrest; Heart Failure; Humans; Leukocyte Count; Male; Medicare; Models, Statistical; Myocardial Infarction/*mortality/physiopathology; Reproducibility of Results; Risk Adjustment; Systole; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-07]]></modelid>
		<pubmedid><![CDATA[10371227]]></pubmedid>
		<author><![CDATA[Kannel]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Profile for estimating risk of heart failure.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[6354]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6354]]></cohortsamplesize>
		<numberofevents><![CDATA[252]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiomegaly, Congenital Heart Disease, Diabetes, Heart Rate, LVH, SBP, Valve Disease, Vital Capacity]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Coronary Disease/*complications/physiopathology; Diagnosis, Differential; Female; Heart Failure/diagnosis/*etiology/physiopathology; Heart Valve Diseases/*complications/physiopathology; Humans; Hypertension/*complications/physiopathology; Logistic Models; Male; Middle Aged; Odds Ratio; Prognosis; Risk; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-08]]></modelid>
		<pubmedid><![CDATA[10371227]]></pubmedid>
		<author><![CDATA[Kannel]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Profile for estimating risk of heart failure.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[8913]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8913]]></cohortsamplesize>
		<numberofevents><![CDATA[234]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiomegaly, Congenital Heart Disease, Diabetes, Heart Rate, LVH, SBP, Valve Disease, Vital Capacity]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Coronary Disease/*complications/physiopathology; Diagnosis, Differential; Female; Heart Failure/diagnosis/*etiology/physiopathology; Heart Valve Diseases/*complications/physiopathology; Humans; Hypertension/*complications/physiopathology; Logistic Models; Male; Middle Aged; Odds Ratio; Prognosis; Risk; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-09]]></modelid>
		<pubmedid><![CDATA[10371227]]></pubmedid>
		<author><![CDATA[Kannel]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Profile for estimating risk of heart failure.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[6354]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6354]]></cohortsamplesize>
		<numberofevents><![CDATA[252]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Congenital Heart Disease, Diabetes, Heart Rate, LVH, SBP, Valve Disease]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Coronary Disease/*complications/physiopathology; Diagnosis, Differential; Female; Heart Failure/diagnosis/*etiology/physiopathology; Heart Valve Diseases/*complications/physiopathology; Humans; Hypertension/*complications/physiopathology; Logistic Models; Male; Middle Aged; Odds Ratio; Prognosis; Risk; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-10]]></modelid>
		<pubmedid><![CDATA[10371227]]></pubmedid>
		<author><![CDATA[Kannel]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Profile for estimating risk of heart failure.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[8913]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8913]]></cohortsamplesize>
		<numberofevents><![CDATA[234]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Congenital Heart Disease, Diabetes, Heart Rate, LVH, SBP, Valve Disease]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Coronary Disease/*complications/physiopathology; Diagnosis, Differential; Female; Heart Failure/diagnosis/*etiology/physiopathology; Heart Valve Diseases/*complications/physiopathology; Humans; Hypertension/*complications/physiopathology; Logistic Models; Male; Middle Aged; Odds Ratio; Prognosis; Risk; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-11]]></modelid>
		<pubmedid><![CDATA[10382694]]></pubmedid>
		<author><![CDATA[Rothwell]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1799]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1799]]></cohortsamplesize>
		<numberofevents><![CDATA[147]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CV Event, Stenosis, Cerebral vs Ocular Events, Plaque Surface Irregularity]]></covariates>
		<mh><![CDATA[Actuarial Analysis; Brain Ischemia/prevention & control; Carotid Stenosis/*diagnosis/surgery; Cerebrovascular Disorders/*prevention & control; *Decision Support Techniques; *Endarterectomy, Carotid; Humans; Models, Cardiovascular; *Patient Selection; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-12]]></modelid>
		<pubmedid><![CDATA[10382694]]></pubmedid>
		<author><![CDATA[Rothwell]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1208]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1208]]></cohortsamplesize>
		<numberofevents><![CDATA[117]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Sex, PVD, SBP]]></covariates>
		<mh><![CDATA[Actuarial Analysis; Brain Ischemia/prevention & control; Carotid Stenosis/*diagnosis/surgery; Cerebrovascular Disorders/*prevention & control; *Decision Support Techniques; *Endarterectomy, Carotid; Humans; Models, Cardiovascular; *Patient Selection; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-13]]></modelid>
		<pubmedid><![CDATA[10441096]]></pubmedid>
		<author><![CDATA[Jacobs]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6134]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6134]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BBB or Infarction, MI, Stroke, Angina, Hypertension, EKG Severity, Shock]]></covariates>
		<mh><![CDATA[Adult; Aged; Angina, Unstable/*epidemiology/therapy; Cause of Death; Cohort Studies; Death Certificates; Digitalis Glycosides/therapeutic use; Female; Follow-Up Studies; Forms and Records Control; Heart Failure/epidemiology; Hospitalization; Humans; Male; Middle Aged; Minnesota/epidemiology; Mortality; Myocardial Infarction/*epidemiology/therapy; Patient Discharge; Prognosis; Risk; *Severity of Illness Index; Shock, Cardiogenic/epidemiology; Thrombolytic Therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-14]]></modelid>
		<pubmedid><![CDATA[10456395]]></pubmedid>
		<author><![CDATA[Nashef]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[European system for cardiac operative risk evaluation (EuroSCORE)]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[13302]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14799]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Endocarditis, Age, Pulmonary Disease, Critical State, Emergency Operation, Arteriopathy, Sex, LV Dysfunction, Neurological Dysfunction, Other Surgery, Septal Rupture, Cardiac Surgery, Hypertension, Creatinine, UA]]></covariates>
		<mh><![CDATA[Cardiac Surgical Procedures/*mortality; Europe/epidemiology; Evaluation Studies as Topic; Humans; Logistic Models; Quality of Health Care; ROC Curve; Regression Analysis; Risk Assessment/methods; Risk Factors; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-15]]></modelid>
		<pubmedid><![CDATA[10460525]]></pubmedid>
		<author><![CDATA[Urwin]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anaesthesia]]></journal>
		<title><![CDATA[Prognostic indicators following emergency aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[135]]></modelsamplesize>
		<cohortsamplesize><![CDATA[135]]></cohortsamplesize>
		<numberofevents><![CDATA[11]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CPR, Hypotension, Rupture]]></covariates>
		<mh><![CDATA[Aged; Aortic Aneurysm, Abdominal/*surgery; Cohort Studies; Emergencies; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-16]]></modelid>
		<pubmedid><![CDATA[10460525]]></pubmedid>
		<author><![CDATA[Urwin]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anaesthesia]]></journal>
		<title><![CDATA[Prognostic indicators following emergency aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[124]]></modelsamplesize>
		<cohortsamplesize><![CDATA[124]]></cohortsamplesize>
		<numberofevents><![CDATA[38]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Blood Loss, Rupture]]></covariates>
		<mh><![CDATA[Aged; Aortic Aneurysm, Abdominal/*surgery; Cohort Studies; Emergencies; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-17]]></modelid>
		<pubmedid><![CDATA[10460525]]></pubmedid>
		<author><![CDATA[Urwin]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anaesthesia]]></journal>
		<title><![CDATA[Prognostic indicators following emergency aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[43]]></modelsamplesize>
		<cohortsamplesize><![CDATA[43]]></cohortsamplesize>
		<numberofevents><![CDATA[1]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Blood Loss, Rupture]]></covariates>
		<mh><![CDATA[Aged; Aortic Aneurysm, Abdominal/*surgery; Cohort Studies; Emergencies; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-18]]></modelid>
		<pubmedid><![CDATA[10460525]]></pubmedid>
		<author><![CDATA[Urwin]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anaesthesia]]></journal>
		<title><![CDATA[Prognostic indicators following emergency aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[41]]></modelsamplesize>
		<cohortsamplesize><![CDATA[41]]></cohortsamplesize>
		<numberofevents><![CDATA[4]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BP, Age, Blood Loss]]></covariates>
		<mh><![CDATA[Aged; Aortic Aneurysm, Abdominal/*surgery; Cohort Studies; Emergencies; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-19]]></modelid>
		<pubmedid><![CDATA[10477528]]></pubmedid>
		<author><![CDATA[Lee]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2893]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2893]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.759]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[High Risk Surgery, Cerebrovascular Disease, CHF, Insulin for Diabetes, IHD, Creatinine]]></covariates>
		<mh><![CDATA[Aged; Cerebrovascular Disorders/complications; Cohort Studies; Creatine/blood; Female; Heart Diseases/epidemiology/*etiology; Humans; Incidence; Insulin/therapeutic use; Male; Middle Aged; *Postoperative Complications; Prognosis; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-20]]></modelid>
		<pubmedid><![CDATA[10483948]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group.]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[15331]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15331]]></cohortsamplesize>
		<numberofevents><![CDATA[165]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.88]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, PVD, Shock, CHF, Creatinine, LVEF, Priority, Lesion Type, IABP, AMI Therapy]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality/statistics & numerical data; Coronary Disease/*mortality/therapy; Data Collection/methods; Female; Hospital Mortality/*trends; Humans; Male; Middle Aged; Multivariate Analysis; New England/epidemiology; Prognosis; ROC Curve; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-21]]></modelid>
		<pubmedid><![CDATA[10488702]]></pubmedid>
		<author><![CDATA[Ben-Ari]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Journal of Hepatology]]></journal>
		<title><![CDATA[A predictive model for failure to control bleeding during acute variceal haemorrhage]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[695]]></modelsamplesize>
		<cohortsamplesize><![CDATA[695]]></cohortsamplesize>
		<numberofevents><![CDATA[268]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Time to Admission, Urea, Active Bleeding, Encephalopathy, Hematemesis, Alcoholism, Platelets]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Gastrointestinal Hemorrhage/*etiology/mortality; Humans; Male; Middle Aged; Prognosis; Recurrence; Risk Factors; Sclerotherapy; Treatment Failure; Varicose Veins/*complications]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-22]]></modelid>
		<pubmedid><![CDATA[10519495]]></pubmedid>
		<author><![CDATA[Wong]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anesthesiology]]></journal>
		<title><![CDATA[Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Delayed Extubation]]></outcome>
		<modelsamplesize><![CDATA[885]]></modelsamplesize>
		<cohortsamplesize><![CDATA[885]]></cohortsamplesize>
		<numberofevents><![CDATA[221]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.728]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Arrhythmia, Bleeding, Inotropes, IABP]]></covariates>
		<mh><![CDATA[Aged; Anesthesia, General/*adverse effects/*methods; Coronary Artery Bypass/*adverse effects/*methods; Female; Humans; Intensive Care Units; Intubation, Intratracheal/*adverse effects/*methods; Length of Stay; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-23]]></modelid>
		<pubmedid><![CDATA[10519495]]></pubmedid>
		<author><![CDATA[Wong]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anesthesiology]]></journal>
		<title><![CDATA[Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[885]]></modelsamplesize>
		<cohortsamplesize><![CDATA[885]]></cohortsamplesize>
		<numberofevents><![CDATA[148]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.889]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, MI, Arrhythmia, Bleeding, Inotropes, IABP, Renal Insufficiency]]></covariates>
		<mh><![CDATA[Aged; Anesthesia, General/*adverse effects/*methods; Coronary Artery Bypass/*adverse effects/*methods; Female; Humans; Intensive Care Units; Intubation, Intratracheal/*adverse effects/*methods; Length of Stay; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-24]]></modelid>
		<pubmedid><![CDATA[10519495]]></pubmedid>
		<author><![CDATA[Wong]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Anesthesiology]]></journal>
		<title><![CDATA[Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[885]]></modelsamplesize>
		<cohortsamplesize><![CDATA[885]]></cohortsamplesize>
		<numberofevents><![CDATA[23]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.725]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Emergency Surgery, Sex, Left Ventricle Grade]]></covariates>
		<mh><![CDATA[Aged; Anesthesia, General/*adverse effects/*methods; Coronary Artery Bypass/*adverse effects/*methods; Female; Humans; Intensive Care Units; Intubation, Intratracheal/*adverse effects/*methods; Length of Stay; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-25]]></modelid>
		<pubmedid><![CDATA[10571089]]></pubmedid>
		<author><![CDATA[Anyanwu]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[A simple approach to risk stratification in adult heart transplantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Graft Survival]]></outcome>
		<modelsamplesize><![CDATA[377]]></modelsamplesize>
		<cohortsamplesize><![CDATA[377]]></cohortsamplesize>
		<numberofevents><![CDATA[332]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Sternotomy, Age, Inotropes, Diabetes, Sex, Drug Abuse, Ischemic Time, BSA, Circulatory Support, Ventilatory Support, Pulmonary Vascular Resistance, Retransplant]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Female; Graft Rejection/etiology; Graft Survival; Heart Diseases/surgery; *Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment/methods; Risk Factors; Sex Factors; Tissue Donors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[99-001-26]]></modelid>
		<pubmedid><![CDATA[17219872]]></pubmedid>
		<author><![CDATA[Habil]]></author>
		<year><![CDATA[1999]]></year>
		<journal><![CDATA[Journal of the Egyptian Public Health Association]]></journal>
		<title><![CDATA[Predictive model of coronary heart disease in Egypt (a disease with multiple risk factors)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[240]]></modelsamplesize>
		<cohortsamplesize><![CDATA[240]]></cohortsamplesize>
		<numberofevents><![CDATA[119]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.873]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Diabetes, Hypercholesterolemia, Hypertension, Sleep, Physical Activity]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Analysis of Variance; Case-Control Studies; Coronary Disease/*epidemiology/*etiology/prevention & control; Diabetes Complications/complications; Educational Status; Egypt/epidemiology; Humans; Hypercholesterolemia/complications; Hypertension/complications; Life Style; *Logistic Models; Male; Middle Aged; Obesity/complications; Primary Prevention; Risk Assessment/*organization & administration; Risk Factors; Risk Reduction Behavior; Sensitivity and Specificity; Smoking/adverse effects; Socioeconomic Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-01]]></modelid>
		<pubmedid><![CDATA[10654481]]></pubmedid>
		<author><![CDATA[John]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[19224]]></modelsamplesize>
		<cohortsamplesize><![CDATA[19224]]></cohortsamplesize>
		<numberofevents><![CDATA[269]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Calcified Aorta, CPB, Vascular Disease, Diabetes, PVD, Stroke, Renal Failure, Smoking]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Aortic Diseases/epidemiology; Calcinosis/epidemiology; Cardiopulmonary Bypass; Carotid Artery Diseases/epidemiology; *Coronary Artery Bypass/adverse effects; Databases as Topic; Diabetes Mellitus/epidemiology; Female; Hospital Mortality; Humans; Incidence; Length of Stay/statistics & numerical data; Logistic Models; Male; Middle Aged; New York/epidemiology; Odds Ratio; Peripheral Vascular Diseases/epidemiology; Postoperative Complications; Renal Insufficiency/epidemiology; Risk Factors; Smoking/epidemiology; Stroke/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-02]]></modelid>
		<pubmedid><![CDATA[10657421]]></pubmedid>
		<author><![CDATA[Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A predictive risk model for outcomes of ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[221]]></modelsamplesize>
		<cohortsamplesize><![CDATA[221]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Volume, NIHSS, Diabetes, Disability, Stroke, Small Vessel, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; *Models, Statistical; Neuroprotective Agents/administration & dosage; Pregnatrienes/administration & dosage; *Prognosis; Stroke/drug therapy/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-03]]></modelid>
		<pubmedid><![CDATA[10657421]]></pubmedid>
		<author><![CDATA[Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A predictive risk model for outcomes of ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[229]]></modelsamplesize>
		<cohortsamplesize><![CDATA[229]]></cohortsamplesize>
		<numberofevents><![CDATA[125]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Volume, NIHSS, Diabetes, Disability, Stroke, Small Vessel, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; *Models, Statistical; Neuroprotective Agents/administration & dosage; Pregnatrienes/administration & dosage; *Prognosis; Stroke/drug therapy/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-04]]></modelid>
		<pubmedid><![CDATA[10657421]]></pubmedid>
		<author><![CDATA[Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A predictive risk model for outcomes of ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[229]]></modelsamplesize>
		<cohortsamplesize><![CDATA[229]]></cohortsamplesize>
		<numberofevents><![CDATA[108]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Volume, NIHSS, Diabetes, Disability, Stroke, Small Vessel, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; *Models, Statistical; Neuroprotective Agents/administration & dosage; Pregnatrienes/administration & dosage; *Prognosis; Stroke/drug therapy/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-05]]></modelid>
		<pubmedid><![CDATA[10657421]]></pubmedid>
		<author><![CDATA[Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A predictive risk model for outcomes of ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[221]]></modelsamplesize>
		<cohortsamplesize><![CDATA[221]]></cohortsamplesize>
		<numberofevents><![CDATA[94]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Volume, NIHSS, Diabetes, Disability, Stroke, Small Vessel, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; *Models, Statistical; Neuroprotective Agents/administration & dosage; Pregnatrienes/administration & dosage; *Prognosis; Stroke/drug therapy/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-06]]></modelid>
		<pubmedid><![CDATA[10657421]]></pubmedid>
		<author><![CDATA[Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A predictive risk model for outcomes of ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[229]]></modelsamplesize>
		<cohortsamplesize><![CDATA[229]]></cohortsamplesize>
		<numberofevents><![CDATA[70]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.88]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Volume, NIHSS, Diabetes, Disability, Stroke, Small Vessel, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; *Models, Statistical; Neuroprotective Agents/administration & dosage; Pregnatrienes/administration & dosage; *Prognosis; Stroke/drug therapy/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-07]]></modelid>
		<pubmedid><![CDATA[10657421]]></pubmedid>
		<author><![CDATA[Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A predictive risk model for outcomes of ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[229]]></modelsamplesize>
		<cohortsamplesize><![CDATA[229]]></cohortsamplesize>
		<numberofevents><![CDATA[77]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Volume, NIHSS, Diabetes, Disability, Stroke, Small Vessel, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; *Models, Statistical; Neuroprotective Agents/administration & dosage; Pregnatrienes/administration & dosage; *Prognosis; Stroke/drug therapy/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-08]]></modelid>
		<pubmedid><![CDATA[10735672]]></pubmedid>
		<author><![CDATA[Coselli]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1220]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1220]]></cohortsamplesize>
		<numberofevents><![CDATA[89]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aneurysms, Renal Insufficiency, Symptomatic]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/*mortality; Aortic Aneurysm, Thoracic/*mortality; Cardiac Surgical Procedures/mortality; Female; Humans; Male; Middle Aged; Paraplegia/*etiology; *Postoperative Complications; Risk Assessment; Risk Factors; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-09]]></modelid>
		<pubmedid><![CDATA[10735672]]></pubmedid>
		<author><![CDATA[Coselli]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[1206]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1206]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Aneurysms]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/*mortality; Aortic Aneurysm, Thoracic/*mortality; Cardiac Surgical Procedures/mortality; Female; Humans; Male; Middle Aged; Paraplegia/*etiology; *Postoperative Complications; Risk Assessment; Risk Factors; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-10]]></modelid>
		<pubmedid><![CDATA[10744147]]></pubmedid>
		<author><![CDATA[Wells]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Thrombosis and Haemostasis]]></journal>
		<title><![CDATA[Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1008]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1260]]></cohortsamplesize>
		<numberofevents><![CDATA[222]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Alternative Diagnosis More Likely, DVT Symptoms, Heart Rate, Hemoptysis, Immobilization, Malignancy, Previous DVT/PE]]></covariates>
		<mh><![CDATA[Algorithms; Cohort Studies; Fibrin Fibrinogen Degradation Products/*metabolism; Humans; *Models, Biological; Probability; Prospective Studies; Pulmonary Embolism/*blood/*diagnosis; Regression Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-11]]></modelid>
		<pubmedid><![CDATA[10750767]]></pubmedid>
		<author><![CDATA[Bernstein]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Annals of Thoracic surgery]]></journal>
		<title><![CDATA[Bedside estimation of risk as an aid for decision-making in cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8593]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10703]]></cohortsamplesize>
		<numberofevents><![CDATA[455]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.811]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aneurysm, Immunodeficiency, Neoplasm, Endocarditis, Regurgitation, MI, Age, Valve Surgery, Bypass Surgery, Asthma, Carotid Disease, Blood Products, Shock, Cardiomegaly, COPD, Cirrhosis, Cold Agglutinins, CHF, Diabetes, Dialysis, LVEF, Angioplasty or Cathe]]></covariates>
		<mh><![CDATA[Aged; *Cardiac Surgical Procedures; *Decision Support Techniques; Female; Humans; Logistic Models; Male; Patient Participation; Preoperative Care; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-12]]></modelid>
		<pubmedid><![CDATA[10783225]]></pubmedid>
		<author><![CDATA[Alla]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[182]]></modelsamplesize>
		<cohortsamplesize><![CDATA[182]]></cohortsamplesize>
		<numberofevents><![CDATA[55]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, Decompensation, Creatinine, Sodium]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated/classification/*diagnosis/mortality; Female; France; Heart Failure/classification/*diagnosis/mortality; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia/classification/*diagnosis/mortality; Prognosis; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-13]]></modelid>
		<pubmedid><![CDATA[10783225]]></pubmedid>
		<author><![CDATA[Alla]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[219]]></modelsamplesize>
		<cohortsamplesize><![CDATA[219]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Comorbidity, Dependency, Heart Rate, Cardiomyopathy, Creatinine, Sodium]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated/classification/*diagnosis/mortality; Female; France; Heart Failure/classification/*diagnosis/mortality; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia/classification/*diagnosis/mortality; Prognosis; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-14]]></modelid>
		<pubmedid><![CDATA[10809270]]></pubmedid>
		<author><![CDATA[Qureshi]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Critical Care Medicine]]></journal>
		<title><![CDATA[Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Vasospasm]]></outcome>
		<modelsamplesize><![CDATA[283]]></modelsamplesize>
		<cohortsamplesize><![CDATA[283]]></cohortsamplesize>
		<numberofevents><![CDATA[93]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aneurysmal Rupture, GCS Score, MCA-MFV, Thickness of Clot]]></covariates>
		<mh><![CDATA[Adult; Analysis of Variance; Chi-Square Distribution; Female; Glasgow Coma Scale; Humans; Intracranial Aneurysm/complications/*diagnosis; Logistic Models; Male; Middle Aged; North America; Prognosis; Prospective Studies; Risk Factors; Subarachnoid Hemorrhage/complications/*diagnosis; Time Factors; Vasospasm, Intracranial/*diagnosis/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-15]]></modelid>
		<pubmedid><![CDATA[10811588]]></pubmedid>
		<author><![CDATA[Califf]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[41021]]></modelsamplesize>
		<cohortsamplesize><![CDATA[41021]]></cohortsamplesize>
		<numberofevents><![CDATA[1084]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Pulse, Age, EKG, Arrhythmic Complication, Race, CHF or Edema, Heart Rate, Smoking, Angiography, Angioplasty, CABG, IABP, Shock, Stroke, Ventilator, Cerebrovascular Disease, Previous Infarction, QRS Duration, Weight]]></covariates>
		<mh><![CDATA[Aged; Coronary Disease/*drug therapy; Female; Fibrinolytic Agents/*therapeutic use; Humans; Male; Middle Aged; Myocardial Infarction/mortality/*therapy; Prognosis; Proportional Hazards Models; Streptokinase/*therapeutic use; Survival Analysis; *Thrombolytic Therapy; Tissue Plasminogen Activator/*therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-16]]></modelid>
		<pubmedid><![CDATA[10811588]]></pubmedid>
		<author><![CDATA[Califf]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[41021]]></modelsamplesize>
		<cohortsamplesize><![CDATA[41021]]></cohortsamplesize>
		<numberofevents><![CDATA[1084]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.805]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, EKG, Arrhythmic Complication, Race, LVEF, Heart Rate, Smoking, HF or Edema, Angiography, CABG, Shock, Stroke Ventilator, Cerebrovascular Disease, Previous Infarction, QRS Duration, Weight]]></covariates>
		<mh><![CDATA[Aged; Coronary Disease/*drug therapy; Female; Fibrinolytic Agents/*therapeutic use; Humans; Male; Middle Aged; Myocardial Infarction/mortality/*therapy; Prognosis; Proportional Hazards Models; Streptokinase/*therapeutic use; Survival Analysis; *Thrombolytic Therapy; Tissue Plasminogen Activator/*therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-17]]></modelid>
		<pubmedid><![CDATA[10840005]]></pubmedid>
		<author><![CDATA[Boersma]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9461]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9461]]></cohortsamplesize>
		<numberofevents><![CDATA[342]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.814]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Heart Rate, Rales, ST Depression, SBP, CCS Class]]></covariates>
		<mh><![CDATA[Age Distribution; Aged; Angina Pectoris/diagnosis/drug therapy/mortality; *Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/*diagnosis/drug therapy/*mortality; Peptides/administration & dosage; Platelet Aggregation Inhibitors/administration & dosage; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Predictive Value of Tests; Prognosis; Risk Factors; Sex Distribution]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-18]]></modelid>
		<pubmedid><![CDATA[10840005]]></pubmedid>
		<author><![CDATA[Boersma]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[9461]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9461]]></cohortsamplesize>
		<numberofevents><![CDATA[1417]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.669]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Heart Rate, Rales, ST Depression, SBP, CCS Class]]></covariates>
		<mh><![CDATA[Age Distribution; Aged; Angina Pectoris/diagnosis/drug therapy/mortality; *Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/*diagnosis/drug therapy/*mortality; Peptides/administration & dosage; Platelet Aggregation Inhibitors/administration & dosage; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Predictive Value of Tests; Prognosis; Risk Factors; Sex Distribution]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-19]]></modelid>
		<pubmedid><![CDATA[10862595]]></pubmedid>
		<author><![CDATA[Wynne-Jones]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. The North West Regional Cardiac Surgery Audit Steering Group]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8210]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8210]]></cohortsamplesize>
		<numberofevents><![CDATA[286]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Acute State, Age, CABG/Valve, LVEF, Hypertension, Priority, Reoperation, Renal Failure, Ventilation]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Algorithms; Analysis of Variance; England; Female; Forecasting; Heart Diseases/mortality/*surgery; Hospitals, General; Humans; Male; Prospective Studies; Risk Assessment; Risk Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-20]]></modelid>
		<pubmedid><![CDATA[10938172]]></pubmedid>
		<author><![CDATA[Antman]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1957]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1957]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CAD Risk Factors, Cardiac Markers, Angina, Stenosis, ST Deviation, Aspirin]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable/*complications/*drug therapy/mortality; Decision Making; Double-Blind Method; Enoxaparin/*therapeutic use; Fibrinolytic Agents/*therapeutic use; Heparin/*therapeutic use; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Myocardial Infarction/*complications/*drug therapy/mortality; Prognosis; Reproducibility of Results; *Risk Assessment; *Thrombolytic Therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-21]]></modelid>
		<pubmedid><![CDATA[11006890]]></pubmedid>
		<author><![CDATA[Kornitzer]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Journal of Cardiovascular Risk]]></journal>
		<title><![CDATA[Multifactorial approach to the prevention of coronary heart disease: from computer to paper and pencil?]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4310]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4310]]></cohortsamplesize>
		<numberofevents><![CDATA[84]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, Smoking, HDL Cholesterol, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Cholesterol/blood; Cholesterol, HDL/blood; Coronary Disease/blood/mortality/*prevention & control; Female; Humans; Male; Middle Aged; Risk; Risk Factors; Sex Factors; Smoking/adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-22]]></modelid>
		<pubmedid><![CDATA[11041906]]></pubmedid>
		<author><![CDATA[von Kodolitsch]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Clinical prediction of acute aortic dissection]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Dissection]]></secondaryindexcondition>
		<outcome><![CDATA[Aortic Dissection]]></outcome>
		<modelsamplesize><![CDATA[250]]></modelsamplesize>
		<cohortsamplesize><![CDATA[250]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aortic Pain, Mediastinal or Aortic Widening, Pulse or BP Differential]]></covariates>
		<mh><![CDATA[Aged; Algorithms; Aneurysm, Dissecting/*diagnosis; Aortic Aneurysm/*diagnosis; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-23]]></modelid>
		<pubmedid><![CDATA[11044416]]></pubmedid>
		<author><![CDATA[Morrow]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[14114]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14114]]></cohortsamplesize>
		<numberofevents><![CDATA[946]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.779]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anterior MI or LBB, Diabetes, Heart Rate, Hypertension, Killip Class, Angina, SBP, Time to Thrombolytic, Weight]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Female; Fibrinolytic Agents/therapeutic use; Humans; Male; Models, Statistical; Myocardial Infarction/*diagnosis/drug therapy/mortality/physiopathology; Point-of-Care Systems; Predictive Value of Tests; Prognosis; Reproducibility of Results; Risk Assessment/*methods; Thrombolytic Therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-24]]></modelid>
		<pubmedid><![CDATA[11057848]]></pubmedid>
		<author><![CDATA[Wicki]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Thrombosis & Haemostasis]]></journal>
		<title><![CDATA[Predicting adverse outcome in patients with acute pulmonary embolism: a risk score]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[296]]></modelsamplesize>
		<cohortsamplesize><![CDATA[296]]></cohortsamplesize>
		<numberofevents><![CDATA[30]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.853]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cancer, DVT on Ultrasound, HF, Peripheral Arterial Blood O2, Previous DVT, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Pulmonary Embolism/*physiopathology; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-25]]></modelid>
		<pubmedid><![CDATA[11147987]]></pubmedid>
		<author><![CDATA[Claiborne Johnston]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Short-term prognosis after emergency department diagnosis of TIA]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1707]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1707]]></cohortsamplesize>
		<numberofevents><![CDATA[180]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Duration of Episode, Speech Impairment, Weakness]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; *Emergency Service, Hospital; Female; Hospitalization; Humans; *Ischemic Attack, Transient/complications/diagnosis/mortality/therapy; Logistic Models; Male; Middle Aged; Prognosis; Risk Factors; Stroke/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-26]]></modelid>
		<pubmedid><![CDATA[11265730]]></pubmedid>
		<author><![CDATA[Grzybowski]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[Journal of Electrocardiology]]></journal>
		<title><![CDATA[A prediction model for prehospital triage of patients with suspected cardiac ischemia]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[244]]></modelsamplesize>
		<cohortsamplesize><![CDATA[244]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Respiratory Rate, SBP]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty, Balloon, Coronary; Chi-Square Distribution; Electrocardiography; *Emergency Medical Services; Female; Humans; Logistic Models; Male; Michigan/epidemiology; Myocardial Infarction/diagnosis/*mortality/*therapy; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors; Survival Analysis; *Triage]]></mh>
	</node>
	<node>
		<modelid><![CDATA[00-001-27]]></modelid>
		<pubmedid><![CDATA[12000046]]></pubmedid>
		<author><![CDATA[L'Italien]]></author>
		<year><![CDATA[2000]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[The Cardiovascular Event Reduction Tool (CERT)--a simplified cardiac risk prediction model developed from the West of Scotland Coronary Prevention Study (WOSCOPS)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hyperlipidemia]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[6595]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6595]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, DBP, Smoking, Diabetes, Family History, Nitrate Use, Angina, Pravastatin]]></covariates>
		<mh><![CDATA[Age Factors; Anticholesteremic Agents/therapeutic use; Cholesterol/blood; Cholesterol, HDL/blood; Coronary Disease/epidemiology/*prevention & control; Humans; Male; Middle Aged; Pravastatin/therapeutic use; Proportional Hazards Models; Risk Assessment; Risk Factors; Scotland/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-01]]></modelid>
		<pubmedid><![CDATA[11146703]]></pubmedid>
		<author><![CDATA[Wicki]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1090]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1090]]></cohortsamplesize>
		<numberofevents><![CDATA[296]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CXR, PaCO2 kPA, DVT/PE, Pulse, Recent Surgery]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Databases as Topic; *Decision Support Techniques; *Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Probability; Pulmonary Embolism/*diagnosis; Regression Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-02]]></modelid>
		<pubmedid><![CDATA[11176081]]></pubmedid>
		<author><![CDATA[Dupuis]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Anesthesiology]]></journal>
		<title><![CDATA[The Cardiac Anesthesia Risk Evaluation score: a clinically useful predictor of mortality and morbidity after cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2000]]></cohortsamplesize>
		<numberofevents><![CDATA[68]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.782]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stable CAD, Comorbidities, Complex Surgery, Emergency Surgery]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Anesthesia/*adverse effects; Cardiac Surgical Procedures/*mortality; Female; Humans; Male; Middle Aged; Morbidity; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-03]]></modelid>
		<pubmedid><![CDATA[11283388]]></pubmedid>
		<author><![CDATA[Claude Hemphill]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[The ICH score: a simple, reliable grading scale for intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[152]]></modelsamplesize>
		<cohortsamplesize><![CDATA[152]]></cohortsamplesize>
		<numberofevents><![CDATA[68]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, GCS Score, ICH Origin, Hemorrhage Volume, Intraventricular Hemorrhage]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; California/epidemiology; Cerebral Hemorrhage/*diagnosis/epidemiology/*mortality; Cohort Studies; Disease Management; Female; Glasgow Coma Scale; Humans; Logistic Models; Male; Middle Aged; Prognosis; Risk Assessment; *Severity of Illness Index; Survival Rate; Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-04]]></modelid>
		<pubmedid><![CDATA[11296578]]></pubmedid>
		<author><![CDATA[Qureshi]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of Neuroimaging]]></journal>
		<title><![CDATA[Who should be screened for asymptomatic carotid artery stenosis? Experience from the Western New York Stroke Screening Program]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[887]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1331]]></cohortsamplesize>
		<numberofevents><![CDATA[170]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Smoking, Hypercholesterolemia, Sex]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Carotid Stenosis/epidemiology/etiology/*ultrasonography; Comorbidity; Coronary Disease/epidemiology/etiology; Cross-Sectional Studies; Female; Humans; Incidence; Male; *Mass Screening; Middle Aged; Risk Factors; *Ultrasonography, Doppler, Duplex]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-05]]></modelid>
		<pubmedid><![CDATA[11308166]]></pubmedid>
		<author><![CDATA[LeMaire]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[A new predictive model for adverse outcomes after elective thoracoabdominal aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1108]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1108]]></cohortsamplesize>
		<numberofevents><![CDATA[144]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aneurysms, Renal Insufficiency, Symptomatic]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Aneurysm, Dissecting/mortality/*surgery; Aneurysm, Ruptured/mortality/*surgery; Aortic Aneurysm, Abdominal/mortality/*surgery; Aortic Aneurysm, Thoracic/mortality/*surgery; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Probability; Risk Assessment; Survival Analysis; Treatment Outcome; Vascular Surgical Procedures/*methods/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-06]]></modelid>
		<pubmedid><![CDATA[11401607]]></pubmedid>
		<author><![CDATA[Gage]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1733]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1733]]></cohortsamplesize>
		<numberofevents><![CDATA[94]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Hypertension, Stroke/TIA, CHF]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Atrial Fibrillation/*complications/epidemiology; Cohort Studies; Comorbidity; Female; Humans; Male; Proportional Hazards Models; Risk Assessment; *Severity of Illness Index; Stroke/epidemiology/*etiology/*prevention & control; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-07]]></modelid>
		<pubmedid><![CDATA[11423050]]></pubmedid>
		<author><![CDATA[Resnic]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1877]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1877]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.885]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AMI, Age, Shock, Chronic Renal Insufficiency, CHF, Left Main Intervention, Stent, Tachycardia, Lesion Type, UA]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary/*adverse effects; Cardiopulmonary Bypass; Coronary Disease/*mortality/therapy; Female; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/mortality; Neural Networks (Computer); Postoperative Complications/epidemiology/*mortality; Predictive Value of Tests; Prognosis; Prospective Studies; ROC Curve; Risk Assessment/*methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-08]]></modelid>
		<pubmedid><![CDATA[11423050]]></pubmedid>
		<author><![CDATA[Resnic]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1877]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1877]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.767]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AMI, Age, Shock, Chronic Renal Insufficiency, CHF, Left Main Intervention, Stent, Tachycardia, Lesion Type, Unscheduled Case, UA]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary/*adverse effects; Cardiopulmonary Bypass; Coronary Disease/*mortality/therapy; Female; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/mortality; Neural Networks (Computer); Postoperative Complications/epidemiology/*mortality; Predictive Value of Tests; Prognosis; Prospective Studies; ROC Curve; Risk Assessment/*methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-09]]></modelid>
		<pubmedid><![CDATA[11445104]]></pubmedid>
		<author><![CDATA[Baird]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[A three-item scale for the early prediction of stroke recovery]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[66]]></modelsamplesize>
		<cohortsamplesize><![CDATA[66]]></cohortsamplesize>
		<numberofevents><![CDATA[37]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[DWI Lesion, NIHSS, Time from Onset]]></covariates>
		<mh><![CDATA[Activities of Daily Living; Aged; Brain Ischemia/*diagnosis/*physiopathology; *Echo-Planar Imaging; Female; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prognosis; Severity of Illness Index; Statistics, Nonparametric; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-10]]></modelid>
		<pubmedid><![CDATA[11451781]]></pubmedid>
		<author><![CDATA[Pocock]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9999999]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9999999]]></cohortsamplesize>
		<numberofevents><![CDATA[27987]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Creatinine, Diabetes, Height, MI, Stroke, LVH, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Antihypertensive Agents/therapeutic use; Cardiovascular Diseases/etiology/*mortality/prevention & control; Coronary Disease/mortality/prevention & control; Female; Humans; Hypertension/complications/drug therapy/*mortality; Male; Middle Aged; Multivariate Analysis; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sex Factors; Stroke/mortality/prevention & control; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-11]]></modelid>
		<pubmedid><![CDATA[11451781]]></pubmedid>
		<author><![CDATA[Pocock]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9999999]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9999999]]></cohortsamplesize>
		<numberofevents><![CDATA[20802]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Creatinine, Diabetes, Height, MI, Stroke, LVH, Sex, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Antihypertensive Agents/therapeutic use; Cardiovascular Diseases/etiology/*mortality/prevention & control; Coronary Disease/mortality/prevention & control; Female; Humans; Hypertension/complications/drug therapy/*mortality; Male; Middle Aged; Multivariate Analysis; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sex Factors; Stroke/mortality/prevention & control; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-12]]></modelid>
		<pubmedid><![CDATA[11454829]]></pubmedid>
		<author><![CDATA[Dorsch]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[A simple benchmark for evaluating quality of care of patients following acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1092]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1092]]></cohortsamplesize>
		<numberofevents><![CDATA[257]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Benchmarking/*methods; Cohort Studies; England/epidemiology; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/diagnosis/*mortality/*therapy; Outcome Assessment (Health Care)/*methods; Risk Assessment/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-13]]></modelid>
		<pubmedid><![CDATA[11457742]]></pubmedid>
		<author><![CDATA[Moscucci]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10729]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10729]]></cohortsamplesize>
		<numberofevents><![CDATA[168]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.9]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Arrest, Creatinine, LVEF, Sex, MI, Diseased Vessels, PVD, Shock, Thrombus]]></covariates>
		<mh><![CDATA[Age Factors; Angioplasty, Balloon, Coronary/*mortality; Cardiovascular Diseases; Coronary Disease/classification/mortality/*therapy; Female; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; ROC Curve; Renal Insufficiency; Reproducibility of Results; Risk Assessment/methods; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-14]]></modelid>
		<pubmedid><![CDATA[11470384]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[A prognostic index for 30-day mortality after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[233]]></modelsamplesize>
		<cohortsamplesize><![CDATA[440]]></cohortsamplesize>
		<numberofevents><![CDATA[22]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Temperature, Dysphagia, Hyperglycemia, Consciousness, Urinary Incontinence]]></covariates>
		<mh><![CDATA[Aged; Consciousness Disorders/complications; Deglutition Disorders/complications; Diabetes Complications; Female; Humans; Male; Middle Aged; New South Wales; Predictive Value of Tests; Prognosis; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke/classification/*mortality; Urinary Incontinence/complications]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-15]]></modelid>
		<pubmedid><![CDATA[11479246]]></pubmedid>
		<author><![CDATA[Siu]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prospective multicenter study of pregnancy outcomes in women with heart disease]]></title>
		<primaryindexcondition><![CDATA[Pregnancy]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[337]]></modelsamplesize>
		<cohortsamplesize><![CDATA[562]]></cohortsamplesize>
		<numberofevents><![CDATA[48]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Calcification, Cyanosis, Heparin/Warfarin, Left Heart Obstruction, Multiple Gestation, NYHA Class, Prior Cardiac Event, Smoking, Lupus, Ventricular Dysfunction]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Blood Pressure/physiology; Electrocardiography; Female; Fetal Death; Follow-Up Studies; Heart Diseases/*physiopathology; Humans; Infant Mortality; Infant, Newborn; Multivariate Analysis; Pregnancy; Pregnancy Complications, Cardiovascular/*physiopathology; *Pregnancy Outcome; Prospective Studies]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-32]]></modelid>
		<pubmedid><![CDATA[24366060]]></pubmedid>
		<author><![CDATA[Brouwers]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[JAMA Neurology]]></journal>
		<title><![CDATA[Predicting hematoma expansion after primary intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[817]]></modelsamplesize>
		<cohortsamplesize><![CDATA[817]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ICH Volume, CT Angiography, Time to CT, Warfarin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-33]]></modelid>
		<pubmedid><![CDATA[24366060]]></pubmedid>
		<author><![CDATA[Brouwers]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[JAMA Neurology]]></journal>
		<title><![CDATA[Predicting hematoma expansion after primary intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[817]]></modelsamplesize>
		<cohortsamplesize><![CDATA[817]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ICH Volume, CT Angiography, Time to CT, Warfarin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-16]]></modelid>
		<pubmedid><![CDATA[11499737]]></pubmedid>
		<author><![CDATA[Krumholz]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[51851]]></modelsamplesize>
		<cohortsamplesize><![CDATA[103164]]></cohortsamplesize>
		<numberofevents><![CDATA[11227]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BUN/Creatinine, BMI, CHF/Edema, LVEF, PVD, Ability to Walk, Incontinence]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Female; Forecasting; Hospitalization; Humans; Male; Myocardial Infarction/*mortality; Prognosis; *Proportional Hazards Models; Retrospective Studies; Risk Factors; Survivors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-17]]></modelid>
		<pubmedid><![CDATA[11502646]]></pubmedid>
		<author><![CDATA[Daniel]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Assessment of Cardiac Stress From Massive Pulmonary Embolism With 12-Lead ECG]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Pulmonary Hypertension]]></outcome>
		<modelsamplesize><![CDATA[60]]></modelsamplesize>
		<cohortsamplesize><![CDATA[60]]></cohortsamplesize>
		<numberofevents><![CDATA[12]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.62]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[RBBB, Inverted T Wave, Q Wave, S Wave, T Wave Inversion, Tachycardia]]></covariates>
		<mh><![CDATA[Blood Pressure; *Electrocardiography; Heart/*physiopathology; Humans; Hypertension, Pulmonary/diagnosis/*etiology; Observer Variation; Pulmonary Embolism/complications/*physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-18]]></modelid>
		<pubmedid><![CDATA[11520656]]></pubmedid>
		<author><![CDATA[Dixon]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[Quality of life: an index for identifying high-risk cardiac patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[471]]></modelsamplesize>
		<cohortsamplesize><![CDATA[945]]></cohortsamplesize>
		<numberofevents><![CDATA[24]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.756]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, HF, Cerebrovascular Event, QOL]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Australia/epidemiology; Cardiovascular Diseases/*epidemiology; Female; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction/epidemiology; Predictive Value of Tests; *Quality of Life; Risk Assessment/standards; Risk Factors; Surveys and Questionnaires/*standards]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-19]]></modelid>
		<pubmedid><![CDATA[11556926]]></pubmedid>
		<author><![CDATA[Kumar]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of General Internal Medicine]]></journal>
		<title><![CDATA[Adverse cardiac events after surgery: assessing risk in a veteran population]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1121]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1121]]></cohortsamplesize>
		<numberofevents><![CDATA[91]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CHF, Emergency Surgery, MI, Arrhythmia]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiomyopathies/etiology; Cohort Studies; Female; Heart Diseases/*etiology; Humans; Logistic Models; Male; Postoperative Complications/*etiology; Prospective Studies; Risk Factors; Veterans]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-20]]></modelid>
		<pubmedid><![CDATA[11583866]]></pubmedid>
		<author><![CDATA[Solomon]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1473]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1473]]></cohortsamplesize>
		<numberofevents><![CDATA[101]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, CK-MB Fraction, S3 or Rales, ST Segment Depression]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable/*epidemiology/*therapy; *Angioplasty, Balloon, Coronary; C-Reactive Protein/analysis; Coronary Angiography; *Coronary Artery Bypass; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/*epidemiology/*therapy; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Troponin I/analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-21]]></modelid>
		<pubmedid><![CDATA[11686356]]></pubmedid>
		<author><![CDATA[Constans]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Thromb Haemost]]></journal>
		<title><![CDATA[Clinical Prediction of Lower Limb Deep Vein Thrombosis
in Symptomatic Hospitalized Patients]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[273]]></modelsamplesize>
		<cohortsamplesize><![CDATA[273]]></cohortsamplesize>
		<numberofevents><![CDATA[66]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cancer, Lower Limb Edema, Other Diagnosis, Paralysis, Superficial Venous Dilation, Warmth]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-22]]></modelid>
		<pubmedid><![CDATA[11686666]]></pubmedid>
		<author><![CDATA[Marchioli]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9601]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9601]]></cohortsamplesize>
		<numberofevents><![CDATA[904]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.774]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Diabetes, Electrical Instability, Fibrinogen, Heart Rate, HDL Cholesterol, Claudication, LV Dysfunction, Leukocytes, MI, Smoking, Residual Myocardial Ischemia]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Blood Pressure/physiology; Cholesterol/blood; Female; Follow-Up Studies; Heart Rate/physiology; Humans; Male; Middle Aged; Morbidity; Myocardial Infarction/complications/*mortality; Predictive Value of Tests; Prognosis; ROC Curve; Risk Factors; Sex Factors; Stroke Volume/physiology; Survival Analysis; Time Factors; Ventricular Dysfunction, Left/complications/diagnosis; beta-Thalassemia/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-23]]></modelid>
		<pubmedid><![CDATA[11686666]]></pubmedid>
		<author><![CDATA[Marchioli]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1647]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1647]]></cohortsamplesize>
		<numberofevents><![CDATA[167]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.791]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Diabetes, Electrical Instability, Fibrinogen, Heart Rate, HDL Cholesterol, Claudication, LV Dysfunction, Leukocytes, MI, Smoking, Residual Myocardial Ischemia]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Blood Pressure/physiology; Cholesterol/blood; Female; Follow-Up Studies; Heart Rate/physiology; Humans; Male; Middle Aged; Morbidity; Myocardial Infarction/complications/*mortality; Predictive Value of Tests; Prognosis; ROC Curve; Risk Factors; Sex Factors; Stroke Volume/physiology; Survival Analysis; Time Factors; Ventricular Dysfunction, Left/complications/diagnosis; beta-Thalassemia/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-24]]></modelid>
		<pubmedid><![CDATA[11716882]]></pubmedid>
		<author><![CDATA[Morrow]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[13253]]></modelsamplesize>
		<cohortsamplesize><![CDATA[13253]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, SBP]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Blood Pressure; Electrocardiography; Emergencies; Female; Humans; Male; Middle Aged; Myocardial Infarction/*classification/mortality; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Smoking; Triage]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-25]]></modelid>
		<pubmedid><![CDATA[11724655]]></pubmedid>
		<author><![CDATA[Stevens]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[Clinical Science]]></journal>
		<title><![CDATA[The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4540]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4540]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Ethnicity, Diabetes, Sex, HbA1c, Lipid Ratio, Age, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Blood Pressure; Coronary Disease/ethnology/*etiology; Diabetes Mellitus, Type 2/blood/*physiopathology; Diabetic Angiopathies/ethnology/*etiology; Female; Follow-Up Studies; Hemoglobin A, Glycosylated/analysis; Humans; Lipids/blood; Male; Middle Aged; *Models, Statistical; Risk Assessment/methods; Risk Factors; Smoking/adverse effects; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-26]]></modelid>
		<pubmedid><![CDATA[11728352]]></pubmedid>
		<author><![CDATA[Fortescue]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Development and validation of a clinical prediction rule for major adverse outcomes in coronary bypass grafting.]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[6237]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9498]]></cohortsamplesize>
		<numberofevents><![CDATA[408]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, LVEF, Priority, Sex, COPD, Liver Disease, Stroke/TIA, Hypertension, Creatinine, CABG]]></covariates>
		<mh><![CDATA[Aged; Confidence Intervals; Coronary Artery Bypass/*adverse effects/mortality; Female; Humans; Likelihood Functions; Male; Middle Aged; *Models, Statistical; Multivariate Analysis; Odds Ratio; ROC Curve; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-27]]></modelid>
		<pubmedid><![CDATA[11736969]]></pubmedid>
		<author><![CDATA[Kuhan]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[British Journal of Surgery]]></journal>
		<title><![CDATA[Risk modelling study for carotid endarterectomy]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[741]]></modelsamplesize>
		<cohortsamplesize><![CDATA[741]]></cohortsamplesize>
		<numberofevents><![CDATA[29]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Heart Disease, Stroke]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Diabetes Mellitus/mortality; Endarterectomy, Carotid/*mortality; Female; Heart Diseases/mortality; Humans; Logistic Models; Male; Medical Audit; Middle Aged; Prognosis; Prospective Studies; Regression Analysis; Retrospective Studies; Risk Assessment; Risk Factors; Stroke/mortality/*prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-28]]></modelid>
		<pubmedid><![CDATA[12086074]]></pubmedid>
		<author><![CDATA[Ciampi]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[European Journal of Epidemiology]]></journal>
		<title><![CDATA[Family history and the risk of coronary heart disease: comparing predictive models]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1147]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1147]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.886]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Family History, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Coronary Disease/epidemiology/*etiology/*genetics; Decision Trees; *Family Health; Female; Humans; Logistic Models; Male; Medical History Taking; Predictive Value of Tests; Quebec/epidemiology; ROC Curve; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-29]]></modelid>
		<pubmedid><![CDATA[21454299]]></pubmedid>
		<author><![CDATA[Manzano]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[Predictors of clinical outcomes in elderly patients with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1400]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2128]]></cohortsamplesize>
		<numberofevents><![CDATA[466]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.68]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, Diabetes, Left Atrial Size, NYHA Class, Orthopnea, PAD, MI, RBBB, Uric Acid, HF]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Bundle-Branch Block/epidemiology; Comorbidity; Creatinine/blood; Female; Heart Atria/pathology; Heart Failure/epidemiology/*mortality/pathology; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Prognosis; Risk Assessment; Treatment Outcome; Uric Acid/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[01-001-30]]></modelid>
		<pubmedid><![CDATA[21454299]]></pubmedid>
		<author><![CDATA[Manzano]]></author>
		<year><![CDATA[2001]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[Predictors of clinical outcomes in elderly patients with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1400]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2128]]></cohortsamplesize>
		<numberofevents><![CDATA[248]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Walk Distance, Age, BMI, CAD, Creatinine, Left Atrial Size, NYHA Class, MI, Uric Acid]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Bundle-Branch Block/epidemiology; Comorbidity; Creatinine/blood; Female; Heart Atria/pathology; Heart Failure/epidemiology/*mortality/pathology; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Prognosis; Risk Assessment; Treatment Outcome; Uric Acid/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-01]]></modelid>
		<pubmedid><![CDATA[11804985]]></pubmedid>
		<author><![CDATA[Assmann]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5389]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5389]]></cohortsamplesize>
		<numberofevents><![CDATA[325]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.829]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Family History, HDL Cholesterol, LDL Cholesterol, Smoking, SBP, Triglycerides]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Calibration; Cholesterol/analysis; Cohort Studies; Coronary Disease/*etiology; Disease-Free Survival; Follow-Up Studies; Forecasting; Humans; Male; Middle Aged; Myocardial Infarction/*etiology; Proportional Hazards Models; Prospective Studies; ROC Curve; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-02]]></modelid>
		<pubmedid><![CDATA[11809349]]></pubmedid>
		<author><![CDATA[Solomon]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[733]]></modelsamplesize>
		<cohortsamplesize><![CDATA[733]]></cohortsamplesize>
		<numberofevents><![CDATA[293]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.682]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Angina, Troponin, Nitrate Use, ST Segment Depression]]></covariates>
		<mh><![CDATA[Adult; Aged; Angina, Unstable/*drug therapy; *Cardiac Catheterization; Cardiotonic Agents/*therapeutic use; Decision Support Techniques; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/*drug therapy; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Factors; Treatment Failure]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-03]]></modelid>
		<pubmedid><![CDATA[11809350]]></pubmedid>
		<author><![CDATA[Lumley]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[A stroke prediction score in the elderly: validation and Web-based application]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[2495]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2495]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Walk Time, Age, AF, Creatinine, Diabetes, CVD, Glucose, LVH, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Blood Pressure; Female; Follow-Up Studies; Humans; Incidence; Male; Models, Cardiovascular; Predictive Value of Tests; ROC Curve; Risk Factors; Stroke/*epidemiology/etiology; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-04]]></modelid>
		<pubmedid><![CDATA[11809350]]></pubmedid>
		<author><![CDATA[Lumley]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[A stroke prediction score in the elderly: validation and Web-based application]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3393]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3393]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CVD]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Blood Pressure; Female; Follow-Up Studies; Humans; Incidence; Male; Models, Cardiovascular; Predictive Value of Tests; ROC Curve; Risk Factors; Stroke/*epidemiology/etiology; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-05]]></modelid>
		<pubmedid><![CDATA[11822347]]></pubmedid>
		<author><![CDATA[Russell]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[American Journal of Managed Care]]></journal>
		<title><![CDATA[Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1493497]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1493497]]></cohortsamplesize>
		<numberofevents><![CDATA[730]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal Respiration, Age, Anemia, Blood Disorder, Brain/Spinal Cord Injury, Cellulitis, COPD, Diabetes, IBS, IHD, Orthopedic Procedure, Neoplasm, Other Heart Disease, Pneumonia, Pregnancy, DVT/PE, Renal Failure, Arthritis, Corticosteroids, Hormone Replac]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; Disease Management; Female; Humans; Insurance Claim Review; Male; Managed Care Programs/*economics/utilization; Middle Aged; Outpatients; Prevalence; Risk Assessment/*methods; Risk Factors; Thromboembolism/epidemiology/prevention & control; United States/epidemiology; Venous Thrombosis/*epidemiology/prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-06]]></modelid>
		<pubmedid><![CDATA[11822347]]></pubmedid>
		<author><![CDATA[Russell]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[American Journal of Managed Care]]></journal>
		<title><![CDATA[Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1329856]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1329856]]></cohortsamplesize>
		<numberofevents><![CDATA[600]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal Respiration, Age, Anemia, Blood Disorder, Brain/Spinal Cord Injury, Cellulitis, COPD, Diabetes, IBS, IHD, Orthopedic Procedure, Neoplasm, Other Heart Disease, Pneumonia, Pregnancy, DVT/PE, Renal Failure, Arthritis, Corticosteroids, Hormone Replac]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; Disease Management; Female; Humans; Insurance Claim Review; Male; Managed Care Programs/*economics/utilization; Middle Aged; Outpatients; Prevalence; Risk Assessment/*methods; Risk Factors; Thromboembolism/epidemiology/prevention & control; United States/epidemiology; Venous Thrombosis/*epidemiology/prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-07]]></modelid>
		<pubmedid><![CDATA[11909572]]></pubmedid>
		<author><![CDATA[Lewis]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Validation of an algorithm for predicting cardiac events in renal transplant candidates]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[189]]></modelsamplesize>
		<cohortsamplesize><![CDATA[189]]></cohortsamplesize>
		<numberofevents><![CDATA[16]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Thallium Myocardial Perfusion Image, Revascularization]]></covariates>
		<mh><![CDATA[Adult; Algorithms; Female; Heart Diseases/mortality/*radionuclide imaging; Humans; *Kidney Transplantation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thallium Radioisotopes; *Tomography, Emission-Computed, Single-Photon/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-08]]></modelid>
		<pubmedid><![CDATA[11923032]]></pubmedid>
		<author><![CDATA[Shaw]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[50123]]></modelsamplesize>
		<cohortsamplesize><![CDATA[100253]]></cohortsamplesize>
		<numberofevents><![CDATA[707]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AMI, Age, Lung Disease, Diabetes, Emergency Status, IABP, Left Main Disease, LVEF, Shock, LAD Lesion, Renal Failure, SCAI LC, Non-Stent Device, Thrombolytic]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiology; Coronary Disease/*mortality/therapy; Data Collection; Databases, Factual/*statistics & numerical data; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries/*statistics & numerical data; Risk Adjustment; Risk Factors; Societies, Medical; Stents; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-09]]></modelid>
		<pubmedid><![CDATA[11923032]]></pubmedid>
		<author><![CDATA[Shaw]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8921]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8921]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Lung Disease, Diabetes, Emergency Status, IABP, Left Main Disease, LVEF, Shock, LAD Lesion, Renal Failure, SCAI LC, Non-Stent Device, Thrombolytic]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiology; Coronary Disease/*mortality/therapy; Data Collection; Databases, Factual/*statistics & numerical data; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries/*statistics & numerical data; Risk Adjustment; Risk Factors; Societies, Medical; Stents; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-10]]></modelid>
		<pubmedid><![CDATA[11923032]]></pubmedid>
		<author><![CDATA[Shaw]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[41202]]></modelsamplesize>
		<cohortsamplesize><![CDATA[41202]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Lung Disease, Diabetes, Emergency Status, IABP, Left Main Disease, LVEF, Shock, LAD Lesion, Renal Failure, SCAI LC, Non-Stent Device, Thrombolytic]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiology; Coronary Disease/*mortality/therapy; Data Collection; Databases, Factual/*statistics & numerical data; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries/*statistics & numerical data; Risk Adjustment; Risk Factors; Societies, Medical; Stents; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-11]]></modelid>
		<pubmedid><![CDATA[11935058]]></pubmedid>
		<author><![CDATA[Counsell]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting outcome after acute and subacute stroke: development and validation of new prognostic models]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[530]]></modelsamplesize>
		<cohortsamplesize><![CDATA[530]]></cohortsamplesize>
		<numberofevents><![CDATA[87]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Able to Lift Arms, Able to Walk, Age, Independence Before Stroke, Lives Alone, GCS Verbal Score]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Area Under Curve; Australia/epidemiology; Calibration; Cohort Studies; Female; Great Britain/epidemiology; Humans; Incidence; Italy/epidemiology; Male; *Models, Statistical; Outcome Assessment (Health Care)/*methods; Predictive Value of Tests; Prognosis; ROC Curve; Regression Analysis; Reproducibility of Results; Stroke/*diagnosis/mortality/*rehabilitation; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-12]]></modelid>
		<pubmedid><![CDATA[11935058]]></pubmedid>
		<author><![CDATA[Counsell]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting outcome after acute and subacute stroke: development and validation of new prognostic models]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[530]]></modelsamplesize>
		<cohortsamplesize><![CDATA[530]]></cohortsamplesize>
		<numberofevents><![CDATA[51]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Able to Lift Arms, Able to Walk, Age, Independence Before Stroke, Lives Alone, GCS Verbal Score]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Area Under Curve; Australia/epidemiology; Calibration; Cohort Studies; Female; Great Britain/epidemiology; Humans; Incidence; Italy/epidemiology; Male; *Models, Statistical; Outcome Assessment (Health Care)/*methods; Predictive Value of Tests; Prognosis; ROC Curve; Regression Analysis; Reproducibility of Results; Stroke/*diagnosis/mortality/*rehabilitation; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-13]]></modelid>
		<pubmedid><![CDATA[11996255]]></pubmedid>
		<author><![CDATA[Rodrigues Alves]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Endovascular treatment of thoracic disease: patient selection and a proposal of a risk score]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[47]]></modelsamplesize>
		<cohortsamplesize><![CDATA[47]]></cohortsamplesize>
		<numberofevents><![CDATA[6]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.831]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Renal Insufficiency, Arch-Aorta Angle, Anatomic Protocol, Distance Between Branches, Lesion Etiology, Instability, Stent, Aneurysm, Abdominal or Lower Limb Ischemia, Lesion Treatment]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm, Dissecting/classification/*therapy; *Aorta, Thoracic; Aortic Aneurysm, Thoracic/classification/*therapy; Catheterization, Peripheral; Female; Humans; Male; Middle Aged; *Patient Selection; ROC Curve; Radiography, Interventional; Retrospective Studies; Risk Factors; *Stents/adverse effects; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-14]]></modelid>
		<pubmedid><![CDATA[12048082]]></pubmedid>
		<author><![CDATA[van Eck]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[European Journal of Cardiothoracic Surgery]]></journal>
		<title><![CDATA[Preoperative prediction of early mortality in redocoronary artery surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[541]]></modelsamplesize>
		<cohortsamplesize><![CDATA[541]]></cohortsamplesize>
		<numberofevents><![CDATA[75]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Acute Operation, MI, Diabetes, Lung Disease, Time Period, Vascular Disease]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Analysis of Variance; Coronary Artery Bypass/*mortality; Diabetes Mellitus; Female; Humans; Logistic Models; Lung Diseases/mortality; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Myocardial Infarction/mortality; Probability; Prognosis; Reoperation; Risk Factors; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-63]]></modelid>
		<pubmedid><![CDATA[23522221]]></pubmedid>
		<author><![CDATA[Rankin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4510]]></modelsamplesize>
		<cohortsamplesize><![CDATA[50231]]></cohortsamplesize>
		<numberofevents><![CDATA[593]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.702]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, NYHA Class, Lung Disease, CABG, Creatinine, Diabetes, Cardiac Surgery, Status]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-15]]></modelid>
		<pubmedid><![CDATA[12088769]]></pubmedid>
		<author><![CDATA[Zaroff]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[71774]]></modelsamplesize>
		<cohortsamplesize><![CDATA[71774]]></cohortsamplesize>
		<numberofevents><![CDATA[3948]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, Diabetes, Killip Class, Previous AMI, Previous CABG, Q Wave AMI, Weight, Sex]]></covariates>
		<mh><![CDATA[Adult; Aged; Comorbidity; Coronary Artery Bypass/*mortality; Databases, Factual; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; *Models, Statistical; Myocardial Infarction/*surgery; Prospective Studies; *Registries; Risk Assessment/*methods; Shock, Cardiogenic/mortality; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-16]]></modelid>
		<pubmedid><![CDATA[12142101]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5463]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5463]]></cohortsamplesize>
		<numberofevents><![CDATA[220]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.782]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, Left Main CAD, Multivessel Disease, NYHA Class, Creatinine, Thrombus, Priority]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*adverse effects/mortality; Coronary Artery Bypass; Female; Follow-Up Studies; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Minnesota/epidemiology; Multivariate Analysis; Myocardial Ischemia/mortality/radiography/therapy; Postoperative Complications/*etiology/mortality/radiography; Prevalence; ROC Curve; Risk Factors; Statistics as Topic; Treatment Failure]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-17]]></modelid>
		<pubmedid><![CDATA[12470394]]></pubmedid>
		<author><![CDATA[Hintze]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Scandinavian Cardiovascular Journal]]></journal>
		<title><![CDATA[QT interval dynamics predict mortality in high-risk patients after myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[241]]></modelsamplesize>
		<cohortsamplesize><![CDATA[241]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Wall Motion Index]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Aged; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Anti-Arrhythmia Agents/therapeutic use; Arrhythmias, Cardiac/drug therapy/epidemiology/physiopathology; *Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate/drug effects/physiology; Humans; Male; Multivariate Analysis; Myocardial Infarction/drug therapy/*epidemiology/physiopathology; Observer Variation; Phenethylamines/therapeutic use; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides/therapeutic use; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left/drug therapy/epidemiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-18]]></modelid>
		<pubmedid><![CDATA[12470394]]></pubmedid>
		<author><![CDATA[Hintze]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Scandinavian Cardiovascular Journal]]></journal>
		<title><![CDATA[QT interval dynamics predict mortality in high-risk patients after myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[241]]></modelsamplesize>
		<cohortsamplesize><![CDATA[241]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Wall Motion Index, QT/RR Night]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Aged; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Anti-Arrhythmia Agents/therapeutic use; Arrhythmias, Cardiac/drug therapy/epidemiology/physiopathology; *Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate/drug effects/physiology; Humans; Male; Multivariate Analysis; Myocardial Infarction/drug therapy/*epidemiology/physiopathology; Observer Variation; Phenethylamines/therapeutic use; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides/therapeutic use; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left/drug therapy/epidemiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-19]]></modelid>
		<pubmedid><![CDATA[12470394]]></pubmedid>
		<author><![CDATA[Hintze]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Scandinavian Cardiovascular Journal]]></journal>
		<title><![CDATA[QT interval dynamics predict mortality in high-risk patients after myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[241]]></modelsamplesize>
		<cohortsamplesize><![CDATA[241]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Wall Motion Index, QRS, QT/RR Night]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Aged; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Anti-Arrhythmia Agents/therapeutic use; Arrhythmias, Cardiac/drug therapy/epidemiology/physiopathology; *Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate/drug effects/physiology; Humans; Male; Multivariate Analysis; Myocardial Infarction/drug therapy/*epidemiology/physiopathology; Observer Variation; Phenethylamines/therapeutic use; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides/therapeutic use; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left/drug therapy/epidemiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-20]]></modelid>
		<pubmedid><![CDATA[12470394]]></pubmedid>
		<author><![CDATA[Hintze]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Scandinavian Cardiovascular Journal]]></journal>
		<title><![CDATA[QT interval dynamics predict mortality in high-risk patients after myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[241]]></modelsamplesize>
		<cohortsamplesize><![CDATA[241]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Wall Motion Index, QRS, QT/RR Night, QTc]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Aged; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Anti-Arrhythmia Agents/therapeutic use; Arrhythmias, Cardiac/drug therapy/epidemiology/physiopathology; *Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate/drug effects/physiology; Humans; Male; Multivariate Analysis; Myocardial Infarction/drug therapy/*epidemiology/physiopathology; Observer Variation; Phenethylamines/therapeutic use; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides/therapeutic use; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left/drug therapy/epidemiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-21]]></modelid>
		<pubmedid><![CDATA[12473877]]></pubmedid>
		<author><![CDATA[West]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of Hypertension]]></journal>
		<title><![CDATA[Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[9014]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9014]]></cohortsamplesize>
		<numberofevents><![CDATA[388]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BMI, Creatinine, Smoking, HDL Cholesterol, Diabetes, Hypertension, Sex, Pravastatin, MI, Stroke, SBP, Total Cholesterol, Triglycerides, UA]]></covariates>
		<mh><![CDATA[Aged; Anticholesteremic Agents/*therapeutic use; Blood Pressure; Coronary Disease/*complications/*drug therapy/mortality/physiopathology; Double-Blind Method; Female; Humans; Male; Middle Aged; Pravastatin/*therapeutic use; Prognosis; Risk Factors; Stroke/*etiology/prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-22]]></modelid>
		<pubmedid><![CDATA[12529793]]></pubmedid>
		<author><![CDATA[Hallevy]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Journal of Neurology]]></journal>
		<title><![CDATA[Spontaneous supratentorial intracerebral hemorrhage. Criteria for short-term functional outcome prediction intracerebral hemorrhage Criteria for short-term functional outcome prediction]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[184]]></modelsamplesize>
		<cohortsamplesize><![CDATA[184]]></cohortsamplesize>
		<numberofevents><![CDATA[114]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Mental Status, Intraventricular Extension, Hematoma Size, Limb Paresis, Midline Shift on CT]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage/classification/diagnosis/physiopathology; Chi-Square Distribution; Confidence Intervals; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Prognosis; Retrospective Studies; Subarachnoid Hemorrhage/*classification/*diagnosis/physiopathology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-23]]></modelid>
		<pubmedid><![CDATA[12558083]]></pubmedid>
		<author><![CDATA[Hakala]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[Scandinavian Journal of Surgery: SJS]]></journal>
		<title><![CDATA[Feasibility of predicting the risk of atrial fibrillation after coronary artery bypass surgery with logistic regression model]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[3676]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3676]]></cohortsamplesize>
		<numberofevents><![CDATA[1141]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BSA, Digoxin, LVEF, IABP or Inotropes]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/*epidemiology; *Coronary Artery Bypass; Feasibility Studies; Female; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Patient Readmission; Postoperative Complications/*epidemiology; Predictive Value of Tests; ROC Curve]]></mh>
	</node>
	<node>
		<modelid><![CDATA[02-001-24]]></modelid>
		<pubmedid><![CDATA[15997450]]></pubmedid>
		<author><![CDATA[Hadjianastassiou]]></author>
		<year><![CDATA[2002]]></year>
		<journal><![CDATA[British Journal of Surgery]]></journal>
		<title><![CDATA[Quantification of mortality risk after abdominal aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1896]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1896]]></cohortsamplesize>
		<numberofevents><![CDATA[408]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.813]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Acute Physiology Score, Age, Chronic Health Dysfunction, Emergency Operation]]></covariates>
		<mh><![CDATA[APACHE; Adult; Aged; Aortic Aneurysm, Abdominal/mortality/*surgery; Hospital Mortality; Humans; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Regression Analysis; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-01]]></modelid>
		<pubmedid><![CDATA[12533358]]></pubmedid>
		<author><![CDATA[Cooper]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Emergency Medicine Journal]]></journal>
		<title><![CDATA[Resuscitation Predictor Scoring Scale for inhospital cardiac arrests]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[741]]></modelsamplesize>
		<cohortsamplesize><![CDATA[741]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[PEA/Asystole, Age, VT/VF]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cardiopulmonary Resuscitation/*mortality; England/epidemiology; Epidemiologic Methods; Female; Heart Arrest/mortality/*therapy; Hospital Mortality; Humans; Male; Middle Aged; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-02]]></modelid>
		<pubmedid><![CDATA[12533358]]></pubmedid>
		<author><![CDATA[Cooper]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Emergency Medicine Journal]]></journal>
		<title><![CDATA[Resuscitation Predictor Scoring Scale for inhospital cardiac arrests]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[707]]></modelsamplesize>
		<cohortsamplesize><![CDATA[707]]></cohortsamplesize>
		<numberofevents><![CDATA[65]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[PEA/Asystole, Cardiac vs Respiratory, VT/VF, Age]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cardiopulmonary Resuscitation/*mortality; England/epidemiology; Epidemiologic Methods; Female; Heart Arrest/mortality/*therapy; Hospital Mortality; Humans; Male; Middle Aged; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-03]]></modelid>
		<pubmedid><![CDATA[12618698]]></pubmedid>
		<author><![CDATA[Upchurch]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[158]]></modelsamplesize>
		<cohortsamplesize><![CDATA[158]]></cohortsamplesize>
		<numberofevents><![CDATA[25]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Inhaler, CAD]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/etiology/therapy; Aged; Aortic Aneurysm, Abdominal/complications/mortality/*surgery; Elective Surgical Procedures; Female; Humans; Length of Stay; Male; Multivariate Analysis; Myocardial Infarction/etiology; *Postoperative Complications; Pulmonary Disease, Chronic Obstructive/*complications/therapy; Renal Dialysis; Respiratory Insufficiency/etiology/therapy; Risk Factors; Survival Rate; Tracheostomy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-04]]></modelid>
		<pubmedid><![CDATA[12628725]]></pubmedid>
		<author><![CDATA[Koplan]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Pacemaker Placement]]></outcome>
		<modelsamplesize><![CDATA[3116]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4694]]></cohortsamplesize>
		<numberofevents><![CDATA[168]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Multivalve Surgery, Preoperative EKG, Prior Valve Surgery]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Female; Follow-Up Studies; Heart Valve Diseases/diagnosis/epidemiology/*surgery; *Heart Valve Prosthesis; Heart Valve Prosthesis Implantation/*adverse effects/methods; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; *Needs Assessment; Pacemaker, Artificial/*utilization; Postoperative Complications/epidemiology/*therapy; Predictive Value of Tests; Preoperative Care; Prevalence; Probability; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-05]]></modelid>
		<pubmedid><![CDATA[12637130]]></pubmedid>
		<author><![CDATA[Miniati]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[A structured clinical model for predicting the probability of pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1100]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1100]]></cohortsamplesize>
		<numberofevents><![CDATA[440]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.95]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Amputation of Hilar Artery, Chest Pain, Consolidation, Dyspnea, EKG, Fever, Hemoptysis, Sex, Oligemia, Pre-existing CVD, Pulmonary Edema, Thrombophlebitis]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Angiography; Female; Forecasting/*methods; Humans; Italy/epidemiology; Logistic Models; Male; Middle Aged; *Models, Statistical; Probability; Pulmonary Embolism/*epidemiology/radiography; ROC Curve; Reproducibility of Results; Risk Assessment/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-06]]></modelid>
		<pubmedid><![CDATA[12644346]]></pubmedid>
		<author><![CDATA[Sabatine]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1957]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1957]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CAD Risk Factors, Age, Cardiac Markers, Stenosis, Angina, ST Deviation, Aspirin]]></covariates>
		<mh><![CDATA[Acute Disease; Angina, Unstable/*diagnosis/drug therapy/mortality; Anticoagulants/*therapeutic use; Drug Therapy, Combination; Heparin/*therapeutic use; Humans; Logistic Models; Myocardial Infarction/*diagnosis/drug therapy/mortality; Platelet Aggregation Inhibitors/*therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors; Prognosis; Recurrence; Risk Assessment; *Thrombolytic Therapy; Troponin/blood; Tyrosine/analogs & derivatives/*therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-07]]></modelid>
		<pubmedid><![CDATA[12660671]]></pubmedid>
		<author><![CDATA[Villella]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Ergometric score systems after myocardial infarction: prognostic performance of the Duke Treadmill Score, Veterans Administration Medical Center Score, and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6251]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6251]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[LV Failure, ST Depression, Double Product, Work Capacity]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cohort Studies; Electrocardiography/statistics & numerical data; Ergometry/*statistics & numerical data; Exercise Test/*statistics & numerical data; Female; Fibrinolytic Agents/therapeutic use; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/*diagnosis/drug therapy/*mortality; Prognosis; Proportional Hazards Models; ROC Curve; Risk; Risk Factors; Survival Analysis; Survivors/*statistics & numerical data]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-08]]></modelid>
		<pubmedid><![CDATA[12690211]]></pubmedid>
		<author><![CDATA[Ricotta]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Modeling stroke risk after coronary artery bypass and combined coronary artery bypass and carotid endarterectomy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1987]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1987]]></cohortsamplesize>
		<numberofevents><![CDATA[34]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aortoiliac Disease, CPB Time, LVH, Calcified Aorta]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Aortic Diseases/epidemiology; Calcinosis/epidemiology; Carotid Stenosis/epidemiology/ultrasonography; *Coronary Artery Bypass; Diabetes Mellitus/epidemiology; *Endarterectomy, Carotid; Female; Hospitals, University/statistics & numerical data; Humans; Hypertension/epidemiology; Hypertrophy, Left Ventricular/epidemiology; Male; Middle Aged; *Models, Theoretical; New York/epidemiology; Patient Selection; Peripheral Vascular Diseases/epidemiology; Postoperative Complications/*etiology; Predictive Value of Tests; Preoperative Care; Prospective Studies; Pulmonary Disease, Chronic Obstructive/epidemiology; Recurrence; Risk Factors; Smoking/epidemiology; Stroke/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-09]]></modelid>
		<pubmedid><![CDATA[12712013]]></pubmedid>
		<author><![CDATA[Mazur]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American Society of Echocardiography]]></journal>
		<title><![CDATA[Prognostic value of exercise echocardiography: validation of a new risk index combining echocardiographic, treadmill, and exercise electrocardiographic parameters]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[388]]></modelsamplesize>
		<cohortsamplesize><![CDATA[493]]></cohortsamplesize>
		<numberofevents><![CDATA[38]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Exercise Duration, Wall Motion Score Index, ST Changes]]></covariates>
		<mh><![CDATA[Adult; Aged; Coronary Artery Disease/complications/mortality/*ultrasonography; Disease-Free Survival; *Echocardiography, Stress; Electrocardiography; *Exercise Test; Female; Follow-Up Studies; Health Status Indicators; Humans; Male; Middle Aged; Myocardial Infarction/etiology; Myocardial Revascularization; Prognosis; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-10]]></modelid>
		<pubmedid><![CDATA[12727148]]></pubmedid>
		<author><![CDATA[Colivicchi]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score]]></title>
		<primaryindexcondition><![CDATA[Syncope]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[270]]></modelsamplesize>
		<cohortsamplesize><![CDATA[270]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.897]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Age, CVD, Syncope]]></covariates>
		<mh><![CDATA[Cohort Studies; Electrocardiography; Emergencies; Emergency Service, Hospital/*standards; Female; Follow-Up Studies; Humans; Italy/epidemiology; Male; Medical History Taking; Middle Aged; Physical Examination; Risk Assessment/*standards; Risk Factors; Survival Analysis; Syncope/*etiology/mortality/therapy; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-11]]></modelid>
		<pubmedid><![CDATA[12748212]]></pubmedid>
		<author><![CDATA[Bouvy]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Predicting mortality in patients with heart failure: a pragmatic approach]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[152]]></modelsamplesize>
		<cohortsamplesize><![CDATA[152]]></cohortsamplesize>
		<numberofevents><![CDATA[51]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Edema, Diabetes, Renal Insufficiency, SBP/DBP, Sex, Beta Blockers, Weight]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Area Under Curve; Cardiac Output, Low/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Netherlands/epidemiology; Prospective Studies; Regression Analysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-12]]></modelid>
		<pubmedid><![CDATA[12788299]]></pubmedid>
		<author><![CDATA[Conroy]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9999999]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9999999]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cholesterol, Sex, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Aged, 80 and over; Cardiovascular Diseases/*mortality; Coronary Disease/mortality; Diabetic Angiopathies/mortality; Epidemiologic Methods; Europe/epidemiology; Humans; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-13]]></modelid>
		<pubmedid><![CDATA[12822622]]></pubmedid>
		<author><![CDATA[Lim]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[A simple model to predict coronary disease in patients undergoing operation for mitral regurgitation.]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[359]]></modelsamplesize>
		<cohortsamplesize><![CDATA[359]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.91]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Ischemia, Hypercholesterolemia, Sex]]></covariates>
		<mh><![CDATA[Aged; Cause of Death; Comorbidity; Coronary Angiography/statistics & numerical data; Coronary Disease/diagnosis/*epidemiology/surgery; Female; Heart Valve Diseases/diagnosis/*epidemiology/mortality; Humans; Logistic Models; Male; Middle Aged; *Mitral Valve/surgery; Patient Selection; Predictive Value of Tests; ROC Curve; Risk Factors; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-14]]></modelid>
		<pubmedid><![CDATA[12881825]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Archives of Physical Medicine & Rehabilitation]]></journal>
		<title><![CDATA[A prediction model of 1-year mortality for acute ischemic stroke patients]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[223]]></modelsamplesize>
		<cohortsamplesize><![CDATA[440]]></cohortsamplesize>
		<numberofevents><![CDATA[48]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabaetes, Dysphagia, Hyperthermia, IHD, PVD, Consciousness, Urinary Incontinence, Both Sides Affected]]></covariates>
		<mh><![CDATA[Aged; Analysis of Variance; Brain Ischemia/*complications; Cause of Death; Chi-Square Distribution; Comorbidity; Death Certificates; Feasibility Studies; Female; Hospitals, Teaching; Humans; Male; Middle Aged; New South Wales/epidemiology; Predictive Value of Tests; Prognosis; *Proportional Hazards Models; ROC Curve; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke/*etiology/*mortality; *Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-15]]></modelid>
		<pubmedid><![CDATA[12902078]]></pubmedid>
		<author><![CDATA[Likosky]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Intra- and postoperative predictors of stroke after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[11825]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11825]]></cohortsamplesize>
		<numberofevents><![CDATA[177]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, CPB Time, Preoperative Risk, Inotropes]]></covariates>
		<mh><![CDATA[Age Distribution; Aged; Aged, 80 and over; Cohort Studies; Confidence Intervals; Coronary Artery Bypass/*adverse effects/*methods; Coronary Disease/mortality/surgery; Female; Humans; Incidence; Intraoperative Complications/*epidemiology; Male; Middle Aged; Multivariate Analysis; New England/epidemiology; Odds Ratio; Postoperative Complications/*epidemiology; Predictive Value of Tests; Probability; Prospective Studies; Risk Factors; Sex Distribution; Stroke/*epidemiology; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-16]]></modelid>
		<pubmedid><![CDATA[12902080]]></pubmedid>
		<author><![CDATA[Charlesworth]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Development and validation of a prediction model for strokes after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[33062]]></modelsamplesize>
		<cohortsamplesize><![CDATA[33062]]></cohortsamplesize>
		<numberofevents><![CDATA[532]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, LVEF, Sex, Priority, Renal Failure/Creatinine, Vascular Disease]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Cohort Studies; Coronary Artery Bypass/*adverse effects/methods; Coronary Disease/epidemiology/*surgery; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; New England/epidemiology; Odds Ratio; Postoperative Complications/diagnosis/*epidemiology; Predictive Value of Tests; Probability; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Distribution; Stroke/diagnosis/*epidemiology; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-17]]></modelid>
		<pubmedid><![CDATA[12921810]]></pubmedid>
		<author><![CDATA[Kearney]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[553]]></cohortsamplesize>
		<numberofevents><![CDATA[201]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiothoracic Ratio, Creatinine, LVH, QT Interval, VT, QRS Dispersion, Sodium, R to R Interval]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Female; Heart Failure/drug therapy/*mortality; Humans; Male; Middle Aged; Models, Cardiovascular; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-18]]></modelid>
		<pubmedid><![CDATA[12930562]]></pubmedid>
		<author><![CDATA[Piombo]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[BMC Cardiovascular Disorders]]></journal>
		<title><![CDATA[A new scoring system to stratify risk in unstable angina]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[473]]></modelsamplesize>
		<cohortsamplesize><![CDATA[473]]></cohortsamplesize>
		<numberofevents><![CDATA[58]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Troponin, CABG, ST Segment Deviation]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Analysis of Variance; Angina, Unstable/blood/*complications/mortality; Biomarkers/blood; C-Reactive Protein/*analysis; Electrocardiography; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction/blood/*etiology/mortality; Odds Ratio; Prognosis; Prospective Studies; Reproducibility of Results; Risk Assessment; Troponin T/*blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-19]]></modelid>
		<pubmedid><![CDATA[12941677]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[868]]></modelsamplesize>
		<cohortsamplesize><![CDATA[868]]></cohortsamplesize>
		<numberofevents><![CDATA[111]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Stroke/TIA, SBP, Sex]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Anticoagulants/therapeutic use; Atrial Fibrillation/*complications/drug therapy; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Stroke/*epidemiology/*etiology/prevention & control; Survival Analysis; Warfarin/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-20]]></modelid>
		<pubmedid><![CDATA[12941677]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[868]]></modelsamplesize>
		<cohortsamplesize><![CDATA[868]]></cohortsamplesize>
		<numberofevents><![CDATA[485]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, CHF or MI, Stroke/TIA, Murmur, Smoking, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Anticoagulants/therapeutic use; Atrial Fibrillation/*complications/drug therapy; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Stroke/*epidemiology/*etiology/prevention & control; Survival Analysis; Warfarin/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-21]]></modelid>
		<pubmedid><![CDATA[14514579]]></pubmedid>
		<author><![CDATA[Folsom]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Prediction of coronary heart disease in middle-aged adults with diabetes]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[861]]></modelsamplesize>
		<cohortsamplesize><![CDATA[861]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.696]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Failure Time, HDL Cholesterol, Antihypertensive Medication, Race, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Coronary Disease/*epidemiology; Diabetes Mellitus, Type 2/*epidemiology; Female; Humans; Incidence; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Distribution]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-22]]></modelid>
		<pubmedid><![CDATA[14514579]]></pubmedid>
		<author><![CDATA[Folsom]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Prediction of coronary heart disease in middle-aged adults with diabetes]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[639]]></modelsamplesize>
		<cohortsamplesize><![CDATA[639]]></cohortsamplesize>
		<numberofevents><![CDATA[212]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.751]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Failure Time, HDL Cholesterol, Antihypertensive Medication, Race, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Coronary Disease/*epidemiology; Diabetes Mellitus, Type 2/*epidemiology; Female; Humans; Incidence; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Distribution]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-23]]></modelid>
		<pubmedid><![CDATA[14514579]]></pubmedid>
		<author><![CDATA[Folsom]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Prediction of coronary heart disease in middle-aged adults with diabetes]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[861]]></modelsamplesize>
		<cohortsamplesize><![CDATA[861]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.691]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Factor VIII, Failure Time, HDL Cholesterol, Antihypertensive Medication, Intima Media Thickness, Keys Score, LVH, Race, Albumin, Creatinine, Physical Activity, SBP, Total Cholesterol, Waist to Hip Ratio, WBC]]></covariates>
		<mh><![CDATA[Coronary Disease/*epidemiology; Diabetes Mellitus, Type 2/*epidemiology; Female; Humans; Incidence; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Distribution]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-24]]></modelid>
		<pubmedid><![CDATA[14514579]]></pubmedid>
		<author><![CDATA[Folsom]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Prediction of coronary heart disease in middle-aged adults with diabetes]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[639]]></modelsamplesize>
		<cohortsamplesize><![CDATA[639]]></cohortsamplesize>
		<numberofevents><![CDATA[212]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.779]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Factor VIII, Failure Time, HDL Cholesterol, Antihypertensive Medication, Intima Media Thickness, Keys Score, LVH, Race, Albumin, Creatinine, Physical Activity, SBP, Total Cholesterol, Waist to Hip Ratio, WBC]]></covariates>
		<mh><![CDATA[Coronary Disease/*epidemiology; Diabetes Mellitus, Type 2/*epidemiology; Female; Humans; Incidence; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Distribution]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-25]]></modelid>
		<pubmedid><![CDATA[14526040]]></pubmedid>
		<author><![CDATA[Tu]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6038]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6038]]></cohortsamplesize>
		<numberofevents><![CDATA[96]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, CHF, Carotid Occlusion, Diabetes, PVD]]></covariates>
		<mh><![CDATA[Adult; Aged; Cohort Studies; Comorbidity; Endarterectomy, Carotid/*adverse effects/*mortality; Female; Humans; Intraoperative Complications; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ontario/epidemiology; Postoperative Complications; Registries/*statistics & numerical data; Risk Assessment; Risk Factors; Stroke/epidemiology/*etiology; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-26]]></modelid>
		<pubmedid><![CDATA[14526040]]></pubmedid>
		<author><![CDATA[Tu]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[6038]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6038]]></cohortsamplesize>
		<numberofevents><![CDATA[265]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, CHF, Stroke/TIA]]></covariates>
		<mh><![CDATA[Adult; Aged; Cohort Studies; Comorbidity; Endarterectomy, Carotid/*adverse effects/*mortality; Female; Humans; Intraoperative Complications; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ontario/epidemiology; Postoperative Complications; Registries/*statistics & numerical data; Risk Assessment; Risk Factors; Stroke/epidemiology/*etiology; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-27]]></modelid>
		<pubmedid><![CDATA[14526040]]></pubmedid>
		<author><![CDATA[Tu]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[6038]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6038]]></cohortsamplesize>
		<numberofevents><![CDATA[361]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, CHF, Carotid Occlusion, Diabetes, Stroke/TIA]]></covariates>
		<mh><![CDATA[Adult; Aged; Cohort Studies; Comorbidity; Endarterectomy, Carotid/*adverse effects/*mortality; Female; Humans; Intraoperative Complications; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ontario/epidemiology; Postoperative Complications; Registries/*statistics & numerical data; Risk Assessment; Risk Factors; Stroke/epidemiology/*etiology; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-28]]></modelid>
		<pubmedid><![CDATA[14563499]]></pubmedid>
		<author><![CDATA[Constans]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[Comparison of four clinical prediction scores for the diagnosis of lower limb deep venous thrombosis in outpatients]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[444]]></modelsamplesize>
		<cohortsamplesize><![CDATA[444]]></cohortsamplesize>
		<numberofevents><![CDATA[126]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Confined to Bed, Lower Limb Enlargement, Paralysis/Immobilization, Sex, Other Diagnosis, Pain]]></covariates>
		<mh><![CDATA[Female; Humans; Leg/blood supply; Logistic Models; Male; Multivariate Analysis; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Venous Thrombosis/diagnosis/*ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-29]]></modelid>
		<pubmedid><![CDATA[14578751]]></pubmedid>
		<author><![CDATA[Smits]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Transplantation]]></journal>
		<title><![CDATA[A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[889]]></modelsamplesize>
		<cohortsamplesize><![CDATA[889]]></cohortsamplesize>
		<numberofevents><![CDATA[191]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Left Ventricular Score, Urgency Score]]></covariates>
		<mh><![CDATA[Adult; Cardiac Output, Low/etiology/*mortality/*surgery; Cohort Studies; Female; Germany; *Heart Transplantation; Humans; Male; Middle Aged; *Models, Theoretical; Patient Selection; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Ventricular Dysfunction, Left/complications; Ventricular Dysfunction, Right/complications; *Waiting Lists]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-30]]></modelid>
		<pubmedid><![CDATA[14581255]]></pubmedid>
		<author><![CDATA[Granger]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Predictors of hospital mortality in the global registry of acute coronary events]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[11389]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11389]]></cohortsamplesize>
		<numberofevents><![CDATA[509]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Q Wave, Cardiac Arrest, Diabetes, Heart Rate, Hypertension, Cardiac Enzymes, Creatinine, Killip Class, LBBB, EKG Changes, ST Segment Changes, SBP]]></covariates>
		<mh><![CDATA[Aged; Female; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia/*mortality; Prognosis; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-31]]></modelid>
		<pubmedid><![CDATA[14583307]]></pubmedid>
		<author><![CDATA[Huijskes]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Outcome prediction in coronary artery bypass grafting and valve surgery in the Netherlands: development of the Amphiascore and its comparison with the Euroscore]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4855]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7282]]></cohortsamplesize>
		<numberofevents><![CDATA[171]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CABG/Valve Surgery, Creatinine, Emergency Procedure, Sex, MI, LVEF, Prior Cardiac Surgery]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Analysis of Variance; Coronary Artery Bypass/*adverse effects/mortality; Female; *Health Status Indicators; Heart Valve Diseases/*surgery; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Netherlands/epidemiology; Postoperative Complications/epidemiology; Prognosis; ROC Curve; Risk Assessment/*methods; Risk Factors; Sensitivity and Specificity; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-32]]></modelid>
		<pubmedid><![CDATA[14583307]]></pubmedid>
		<author><![CDATA[Huijskes]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Outcome prediction in coronary artery bypass grafting and valve surgery in the Netherlands: development of the Amphiascore and its comparison with the Euroscore]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4855]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7282]]></cohortsamplesize>
		<numberofevents><![CDATA[1224]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CABG/Valve Surgery, Emergency Procedure, Extracardiac Arteriopathy, MI, Prior Cardiac Surgery, Hypertension]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Analysis of Variance; Coronary Artery Bypass/*adverse effects/mortality; Female; *Health Status Indicators; Heart Valve Diseases/*surgery; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Netherlands/epidemiology; Postoperative Complications/epidemiology; Prognosis; ROC Curve; Risk Assessment/*methods; Risk Factors; Sensitivity and Specificity; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-33]]></modelid>
		<pubmedid><![CDATA[14583307]]></pubmedid>
		<author><![CDATA[Huijskes]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Outcome prediction in coronary artery bypass grafting and valve surgery in the Netherlands: development of the Amphiascore and its comparison with the Euroscore]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[4855]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7282]]></cohortsamplesize>
		<numberofevents><![CDATA[1001]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CABG/Valve Surgery, Creatinine, Critical State, Emergency Procedure, Failed PCI, Sex, Hemoglobin, MI, Neurological Disease, LVEF, Prior Cardiac Surgery, Hypertension]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Analysis of Variance; Coronary Artery Bypass/*adverse effects/mortality; Female; *Health Status Indicators; Heart Valve Diseases/*surgery; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Netherlands/epidemiology; Postoperative Complications/epidemiology; Prognosis; ROC Curve; Risk Assessment/*methods; Risk Factors; Sensitivity and Specificity; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-34]]></modelid>
		<pubmedid><![CDATA[14625335]]></pubmedid>
		<author><![CDATA[Lee]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2624]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2624]]></cohortsamplesize>
		<numberofevents><![CDATA[281]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cancer, Cerebrovascular Disease, COPD, Dementia, Cirrhosis, Respiratory Rate, Sodium, Urea Nitrogen, SBP]]></covariates>
		<mh><![CDATA[Aged; Comorbidity; Female; Heart Failure/*mortality/therapy; Hospitalization; Humans; Male; *Models, Statistical; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Ventricular Dysfunction, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-35]]></modelid>
		<pubmedid><![CDATA[14625335]]></pubmedid>
		<author><![CDATA[Lee]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2624]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2624]]></cohortsamplesize>
		<numberofevents><![CDATA[863]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cancer, Cerebrovascular Disease, COPD, Dementia, Cirrhosis, Respiratory Rate, Sodium, Urea Nitrogen, SBP, Hemoglobin]]></covariates>
		<mh><![CDATA[Aged; Comorbidity; Female; Heart Failure/*mortality/therapy; Hospitalization; Humans; Male; *Models, Statistical; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Ventricular Dysfunction, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-36]]></modelid>
		<pubmedid><![CDATA[14644781]]></pubmedid>
		<author><![CDATA[Sarasin]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Academic Emergency Medicine]]></journal>
		<title><![CDATA[A risk score to predict arrhythmias in patients with unexplained syncope]]></title>
		<primaryindexcondition><![CDATA[Syncope]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[175]]></modelsamplesize>
		<cohortsamplesize><![CDATA[175]]></cohortsamplesize>
		<numberofevents><![CDATA[30]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.88]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Age, CHF]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Arrhythmias, Cardiac/complications/*diagnosis; Cohort Studies; Electrocardiography, Ambulatory; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Syncope/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[03-001-37]]></modelid>
		<pubmedid><![CDATA[14662247]]></pubmedid>
		<author><![CDATA[Qureshi]]></author>
		<year><![CDATA[2003]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Simplified scoring system for predicting mortality after percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9954]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9954]]></cohortsamplesize>
		<numberofevents><![CDATA[139]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.874]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Cholesterol, Creatinine, Sex, Multivessel Disease, MI, PVD]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Angioplasty, Balloon, Coronary/*mortality; Coronary Disease/mortality; Creatinine/blood; Female; Humans; Male; Middle Aged; Odds Ratio; Risk Factors; Stents; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-01]]></modelid>
		<pubmedid><![CDATA[14684776]]></pubmedid>
		<author><![CDATA[Weimar]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[1079]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1079]]></cohortsamplesize>
		<numberofevents><![CDATA[311]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.856]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Brain Ischemia/classification/*diagnosis/*mortality; Cohort Studies; Databases, Factual/statistics & numerical data; *Decision Support Systems, Clinical; Female; Follow-Up Studies; Germany/epidemiology; Humans; Likelihood Functions; Logistic Models; Male; *Models, Statistical; Predictive Value of Tests; Prognosis; ROC Curve; *Recovery of Function; *Severity of Illness Index; Survival Analysis; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-02]]></modelid>
		<pubmedid><![CDATA[14684776]]></pubmedid>
		<author><![CDATA[Weimar]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1079]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1079]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.832]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Brain Ischemia/classification/*diagnosis/*mortality; Cohort Studies; Databases, Factual/statistics & numerical data; *Decision Support Systems, Clinical; Female; Follow-Up Studies; Germany/epidemiology; Humans; Likelihood Functions; Logistic Models; Male; *Models, Statistical; Predictive Value of Tests; Prognosis; ROC Curve; *Recovery of Function; *Severity of Illness Index; Survival Analysis; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-03]]></modelid>
		<pubmedid><![CDATA[14752428]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Coronary artery bypass grafting: are risk models developed from on-pump surgery valid for off-pump surgery?]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[11063]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12845]]></cohortsamplesize>
		<numberofevents><![CDATA[255]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CCS Class, LVEF, Sex, Cerebrovascular Disease, Chronic Lung Disease, PVD, Renal Insufficiency, Stenosis, NYHA Class, Previous Cardiac Surgery, Age, Urgency]]></covariates>
		<mh><![CDATA[Aged; Cardiopulmonary Bypass/methods; Cohort Studies; Coronary Artery Bypass/*methods/*mortality; Coronary Disease/diagnosis/*surgery; Female; *Heart-Lung Machine; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Probability; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-04]]></modelid>
		<pubmedid><![CDATA[14752428]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Coronary artery bypass grafting: are risk models developed from on-pump surgery valid for off-pump surgery?]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[12845]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12845]]></cohortsamplesize>
		<numberofevents><![CDATA[300]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.806]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CCS Class, LVEF, Sex, Cerebrovascular Disease, Chronic Lung Disease, PVD, Renal Insufficiency, Stenosis, NYHA Class, Previous Cardiac Surgery, Age, Urgency]]></covariates>
		<mh><![CDATA[Aged; Cardiopulmonary Bypass/methods; Cohort Studies; Coronary Artery Bypass/*methods/*mortality; Coronary Disease/diagnosis/*surgery; Female; *Heart-Lung Machine; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Probability; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-05]]></modelid>
		<pubmedid><![CDATA[14980900]]></pubmedid>
		<author><![CDATA[Rohrig]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Anesthesia & Analgesia]]></journal>
		<title><![CDATA[The incidence and prediction of automatically detected intraoperative cardiovascular events in noncardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[29437]]></modelsamplesize>
		<cohortsamplesize><![CDATA[58458]]></cohortsamplesize>
		<numberofevents><![CDATA[5249]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.708]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Valve Disease, Arrhythmia, Hypertension, Stenosis, CRF, Emergency Surgery, Type of Surgery, Bypass or Angioplasty, Hypovolemia, Sex]]></covariates>
		<mh><![CDATA[Aged; Algorithms; Blood Pressure/physiology; Bradycardia/complications/diagnosis/epidemiology; Calibration; Cardiovascular Diseases/*diagnosis/*epidemiology; Female; Heart Rate/physiology; Humans; Hypertension/complications/diagnosis/epidemiology; Hypotension/complications/diagnosis/epidemiology; Intraoperative Complications/*diagnosis/*epidemiology; Logistic Models; Male; Middle Aged; Models, Statistical; *Monitoring, Intraoperative; Odds Ratio; Predictive Value of Tests; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sex Factors; *Surgical Procedures, Operative; Tachycardia/complications/diagnosis/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-06]]></modelid>
		<pubmedid><![CDATA[14980900]]></pubmedid>
		<author><![CDATA[Rohrig]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Anesthesia & Analgesia]]></journal>
		<title><![CDATA[The incidence and prediction of automatically detected intraoperative cardiovascular events in noncardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[29437]]></modelsamplesize>
		<cohortsamplesize><![CDATA[58458]]></cohortsamplesize>
		<numberofevents><![CDATA[5249]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.708]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ASA Classification, Type of Surgery]]></covariates>
		<mh><![CDATA[Aged; Algorithms; Blood Pressure/physiology; Bradycardia/complications/diagnosis/epidemiology; Calibration; Cardiovascular Diseases/*diagnosis/*epidemiology; Female; Heart Rate/physiology; Humans; Hypertension/complications/diagnosis/epidemiology; Hypotension/complications/diagnosis/epidemiology; Intraoperative Complications/*diagnosis/*epidemiology; Logistic Models; Male; Middle Aged; Models, Statistical; *Monitoring, Intraoperative; Odds Ratio; Predictive Value of Tests; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sex Factors; *Surgical Procedures, Operative; Tachycardia/complications/diagnosis/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-07]]></modelid>
		<pubmedid><![CDATA[14996596]]></pubmedid>
		<author><![CDATA[Addala]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score)]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3252]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3252]]></cohortsamplesize>
		<numberofevents><![CDATA[164]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.784]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anterior MI or LBB, Diabetes, Heart Rate, Killip Class]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; *Angioplasty, Balloon, Coronary; Electrocardiography; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction/*mortality/physiopathology/*therapy; Predictive Value of Tests; Retrospective Studies; Risk Assessment/*methods; Severity of Illness Index; Survival Rate; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-08]]></modelid>
		<pubmedid><![CDATA[15082699]]></pubmedid>
		<author><![CDATA[Mathew]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[A multicenter risk index for atrial fibrillation after cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[3093]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4657]]></cohortsamplesize>
		<numberofevents><![CDATA[976]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ACE Inhibitors, AF, Beta Blockers, COPD, Valve Surgery, Anti-inflammatory Drugs, Potassium Supplement]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/epidemiology/*etiology; Coronary Artery Bypass/*adverse effects; Female; Humans; Male; Middle Aged; Models, Statistical; Postoperative Complications/epidemiology; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-09]]></modelid>
		<pubmedid><![CDATA[15082699]]></pubmedid>
		<author><![CDATA[Mathew]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[A multicenter risk index for atrial fibrillation after cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[976]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3093]]></cohortsamplesize>
		<numberofevents><![CDATA[426]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Amiodarone, ACE Inhibitors, Beta Blockers, Bicaval Cannulation, CHF, Digoxin, LVH, Atherosclerosis]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/epidemiology/*etiology; Coronary Artery Bypass/*adverse effects; Female; Humans; Male; Middle Aged; Models, Statistical; Postoperative Complications/epidemiology; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-10]]></modelid>
		<pubmedid><![CDATA[15135693]]></pubmedid>
		<author><![CDATA[Elhendy]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Use of a scoring model combining clinical, exercise test, and echocardiographic data to predict mortality in patients with known or suspected coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2840]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5679]]></cohortsamplesize>
		<numberofevents><![CDATA[151]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Wall Motion Score Index, Sex, Metabolic Equivalents]]></covariates>
		<mh><![CDATA[Coronary Artery Disease/*diagnosis/*mortality/pathology/ultrasonography; *Decision Support Techniques; Echocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Minnesota/epidemiology; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-11]]></modelid>
		<pubmedid><![CDATA[15135693]]></pubmedid>
		<author><![CDATA[Elhendy]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Use of a scoring model combining clinical, exercise test, and echocardiographic data to predict mortality in patients with known or suspected coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2840]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5679]]></cohortsamplesize>
		<numberofevents><![CDATA[143]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Chest Pain, Wall Motion Score Index, Sex, Metabolic Equivalents]]></covariates>
		<mh><![CDATA[Coronary Artery Disease/*diagnosis/*mortality/pathology/ultrasonography; *Decision Support Techniques; Echocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Minnesota/epidemiology; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-12]]></modelid>
		<pubmedid><![CDATA[15159293]]></pubmedid>
		<author><![CDATA[De Luca]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1791]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1791]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.907]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Three Vessel Disease, Age, Anterior Infarction, Ischemia Time, Killip Class, TIMI Flow]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty; Costs and Cost Analysis; Feasibility Studies; Female; Humans; *Length of Stay/economics; Male; Middle Aged; Models, Statistical; Myocardial Infarction/mortality/*surgery; *Myocardial Revascularization; Prognosis; *Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-13]]></modelid>
		<pubmedid><![CDATA[15172248]]></pubmedid>
		<author><![CDATA[Nowicki]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5793]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5793]]></cohortsamplesize>
		<numberofevents><![CDATA[360]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BSA, CABG, Creatinine, Priority, CHF, Stroke, NYHA Class, Prior Cardiac Operation, Year]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Analysis of Variance; Aortic Valve/*surgery; Area Under Curve; Cardiac Surgical Procedures/*mortality; Coronary Artery Bypass; Female; Heart Valve Prosthesis Implantation/mortality; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Mitral Valve/*surgery; Models, Statistical; Multivariate Analysis; New England/epidemiology; ROC Curve; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-14]]></modelid>
		<pubmedid><![CDATA[15172248]]></pubmedid>
		<author><![CDATA[Nowicki]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3150]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3150]]></cohortsamplesize>
		<numberofevents><![CDATA[296]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Creatinine, Diabetes, Priority, CHF, NYHA Class, Stroke, Sex, Valve Replacement, Year]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Analysis of Variance; Aortic Valve/*surgery; Area Under Curve; Cardiac Surgical Procedures/*mortality; Coronary Artery Bypass; Female; Heart Valve Prosthesis Implantation/mortality; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Mitral Valve/*surgery; Models, Statistical; Multivariate Analysis; New England/epidemiology; ROC Curve; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-15]]></modelid>
		<pubmedid><![CDATA[15172420]]></pubmedid>
		<author><![CDATA[Marwick]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1456]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3156]]></cohortsamplesize>
		<numberofevents><![CDATA[160]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, HF, Ischemia, Low Workload, Scar]]></covariates>
		<mh><![CDATA[*Cardiotonic Agents; Coronary Artery Disease/pathology/*ultrasonography; Disease-Free Survival; *Dobutamine; Echocardiography/*methods; Female; Humans; Indiana; Male; Middle Aged; Myocardial Infarction/etiology/*mortality; Ohio; Predictive Value of Tests; Risk Factors; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-16]]></modelid>
		<pubmedid><![CDATA[15173150]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2439]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2439]]></cohortsamplesize>
		<numberofevents><![CDATA[195]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Diabetes, HDL Cholesterol, Smoking, Toal Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; China/epidemiology; Cohort Studies; Coronary Disease/*epidemiology/prevention & control; Female; Humans; Longitudinal Studies; Male; Mathematics; Middle Aged; Reproducibility of Results; *Risk Assessment/methods/statistics & numerical data; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-17]]></modelid>
		<pubmedid><![CDATA[15173150]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2812]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2812]]></cohortsamplesize>
		<numberofevents><![CDATA[78]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Diabetes, HDL Cholesterol, Smoking, Toal Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; China/epidemiology; Cohort Studies; Coronary Disease/*epidemiology/prevention & control; Female; Humans; Longitudinal Studies; Male; Mathematics; Middle Aged; Reproducibility of Results; *Risk Assessment/methods/statistics & numerical data; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-18]]></modelid>
		<pubmedid><![CDATA[15173150]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[16065]]></modelsamplesize>
		<cohortsamplesize><![CDATA[16065]]></cohortsamplesize>
		<numberofevents><![CDATA[137]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.736]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, HDL Cholesterol, Hypertension, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; China/epidemiology; Cohort Studies; Coronary Disease/*epidemiology/prevention & control; Female; Humans; Longitudinal Studies; Male; Mathematics; Middle Aged; Reproducibility of Results; *Risk Assessment/methods/statistics & numerical data; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-19]]></modelid>
		<pubmedid><![CDATA[15173150]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[14056]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14056]]></cohortsamplesize>
		<numberofevents><![CDATA[54]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.759]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, HDL Cholesterol, Hypertension, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; China/epidemiology; Cohort Studies; Coronary Disease/*epidemiology/prevention & control; Female; Humans; Longitudinal Studies; Male; Mathematics; Middle Aged; Reproducibility of Results; *Risk Assessment/methods/statistics & numerical data; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-20]]></modelid>
		<pubmedid><![CDATA[15175200]]></pubmedid>
		<author><![CDATA[Diercks]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Academic Emergency Medicine]]></journal>
		<title><![CDATA[Derivation and validation of a risk stratification model to identify coronary artery disease in women who present to the emergency department with potential acute coronary syndromes]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[733]]></modelsamplesize>
		<cohortsamplesize><![CDATA[733]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ACS, CAD, Hypercholesterolemia, Hypertension]]></covariates>
		<mh><![CDATA[California; Coronary Artery Disease/*epidemiology; Emergency Medical Services/*methods; Emergency Service, Hospital/*statistics & numerical data; Female; Humans; Logistic Models; Middle Aged; *Models, Theoretical; Multivariate Analysis; Outcome and Process Assessment (Health Care); ROC Curve; Retrospective Studies; Risk Adjustment/*methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-21]]></modelid>
		<pubmedid><![CDATA[15187054]]></pubmedid>
		<author><![CDATA[Eagle]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[15007]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15007]]></cohortsamplesize>
		<numberofevents><![CDATA[717]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, MI, Cardiac Enzymes, Creatinine, PCI, Pulse, ST Segment Depression, SBP]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable/*mortality; Cause of Death; *Decision Support Techniques; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia/*mortality; Registries; *Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-22]]></modelid>
		<pubmedid><![CDATA[15215808]]></pubmedid>
		<author><![CDATA[Wylie]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[4681]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4681]]></cohortsamplesize>
		<numberofevents><![CDATA[221]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, BNP, Diabetes, Heart Rate, EKG Changes]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable/*complications; Disease-Free Survival; Double-Blind Method; Electrocardiography; Heart Failure/*etiology; Humans; Incidence; Logistic Models; Middle Aged; Multivariate Analysis; Myocardial Infarction/*complications; Prognosis; *Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-23]]></modelid>
		<pubmedid><![CDATA[15246581]]></pubmedid>
		<author><![CDATA[Danciu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[A predictive model for survival after in-hospital cardiopulmonary arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[219]]></modelsamplesize>
		<cohortsamplesize><![CDATA[219]]></cohortsamplesize>
		<numberofevents><![CDATA[33]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, Renal Insufficiency, Time from Admission to Resuscitation, Respiratory Arrest, VF/VT]]></covariates>
		<mh><![CDATA[Aged; *Cardiopulmonary Resuscitation; Female; Heart Arrest/*mortality/therapy; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Retrospective Studies; Risk; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-24]]></modelid>
		<pubmedid><![CDATA[15246581]]></pubmedid>
		<author><![CDATA[Danciu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[A predictive model for survival after in-hospital cardiopulmonary arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[219]]></modelsamplesize>
		<cohortsamplesize><![CDATA[219]]></cohortsamplesize>
		<numberofevents><![CDATA[30]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, Renal Insufficiency, Time from Admission to Resuscitation, Respiratory Arrest, VF/VT]]></covariates>
		<mh><![CDATA[Aged; *Cardiopulmonary Resuscitation; Female; Heart Arrest/*mortality/therapy; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Retrospective Studies; Risk; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-25]]></modelid>
		<pubmedid><![CDATA[15246581]]></pubmedid>
		<author><![CDATA[Danciu]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[A predictive model for survival after in-hospital cardiopulmonary arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[219]]></modelsamplesize>
		<cohortsamplesize><![CDATA[219]]></cohortsamplesize>
		<numberofevents><![CDATA[25]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, Renal Insufficiency, Time from Admission to Resuscitation, Respiratory Arrest, VF/VT]]></covariates>
		<mh><![CDATA[Aged; *Cardiopulmonary Resuscitation; Female; Heart Arrest/*mortality/therapy; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Retrospective Studies; Risk; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-26]]></modelid>
		<pubmedid><![CDATA[15312862]]></pubmedid>
		<author><![CDATA[Sadanandan]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[2219]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2219]]></cohortsamplesize>
		<numberofevents><![CDATA[362]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CABG, PAD, Sex, Troponin, Angina, ST Deviation]]></covariates>
		<mh><![CDATA[Angina Pectoris/complications/pathology/*surgery; Cohort Studies; Coronary Artery Bypass/*utilization; Female; Hospitalization; Humans; Male; Massachusetts; Middle Aged; Myocardial Infarction/complications/pathology/*surgery; Oklahoma; Pennsylvania; Randomized Controlled Trials as Topic; Reproducibility of Results; *Risk Assessment; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-27]]></modelid>
		<pubmedid><![CDATA[15364327]]></pubmedid>
		<author><![CDATA[Amar]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[1553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1553]]></cohortsamplesize>
		<numberofevents><![CDATA[508]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Low Cardiac Output, P-Wave Duration]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Aged; Atrial Fibrillation/drug therapy/*etiology; Atrial Flutter/drug therapy/etiology; Cardiac Output, Low/drug therapy/etiology; Cardiopulmonary Bypass; *Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Multivariate Analysis; Postoperative Complications/drug therapy/*etiology; Predictive Value of Tests; ROC Curve; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-28]]></modelid>
		<pubmedid><![CDATA[15368799]]></pubmedid>
		<author><![CDATA[Panagiotakos]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Acta Cardiologica]]></journal>
		<title><![CDATA[An integrated assessment of family history on the risk of developing acute coronary syndromes (CARDIO2000 study)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[1926]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1926]]></cohortsamplesize>
		<numberofevents><![CDATA[848]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Family Size, Relatives with CAD, Relatives with Diabetes, Relatives with Hypercholesterolemia, Relatives with Hypertension]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Case-Control Studies; Coronary Disease/*epidemiology; Diabetes Mellitus/epidemiology; Family Health; Female; Humans; Hypercholesterolemia/epidemiology; Hypertension/epidemiology; Male; Middle Aged; Multivariate Analysis; Risk Assessment; Risk Factors; Syndrome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-29]]></modelid>
		<pubmedid><![CDATA[15459588]]></pubmedid>
		<author><![CDATA[Dunder]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[574]]></modelsamplesize>
		<cohortsamplesize><![CDATA[574]]></cohortsamplesize>
		<numberofevents><![CDATA[135]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Apolipoprotein B/A1 Ratio, Family History, Intact Proinsulin, Smoking, SBP]]></covariates>
		<mh><![CDATA[Apolipoprotein A-I/*blood; Apolipoproteins B/*blood; Biomarkers/*blood; Electrocardiography; Health Surveys; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction/*epidemiology/mortality; Prognosis; Proinsulin/*blood; Proportional Hazards Models; Reproducibility of Results; Risk Assessment/*methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-30]]></modelid>
		<pubmedid><![CDATA[15531065]]></pubmedid>
		<author><![CDATA[Haukoos]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction rules for estimating neurologic outcome following out-of-hospital cardiac arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[754]]></modelsamplesize>
		<cohortsamplesize><![CDATA[754]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Paramedic Response Time, Location of Arrest, Electrical Activity]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Decision Trees; Female; Heart Arrest/complications/*therapy; Humans; Male; Middle Aged; Nervous System Diseases/etiology; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-31]]></modelid>
		<pubmedid><![CDATA[15531065]]></pubmedid>
		<author><![CDATA[Haukoos]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction rules for estimating neurologic outcome following out-of-hospital cardiac arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[754]]></modelsamplesize>
		<cohortsamplesize><![CDATA[754]]></cohortsamplesize>
		<numberofevents><![CDATA[16]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Witnessed Arrest, Age, GCS]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Decision Trees; Female; Heart Arrest/complications/*therapy; Humans; Male; Middle Aged; Nervous System Diseases/etiology; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-32]]></modelid>
		<pubmedid><![CDATA[15531065]]></pubmedid>
		<author><![CDATA[Haukoos]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction rules for estimating neurologic outcome following out-of-hospital cardiac arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[754]]></modelsamplesize>
		<cohortsamplesize><![CDATA[754]]></cohortsamplesize>
		<numberofevents><![CDATA[15]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Asystolic  Rhythm, Witnessed Arrest, Age, GCS]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Decision Trees; Female; Heart Arrest/complications/*therapy; Humans; Male; Middle Aged; Nervous System Diseases/etiology; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-33]]></modelid>
		<pubmedid><![CDATA[15531065]]></pubmedid>
		<author><![CDATA[Haukoos]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction rules for estimating neurologic outcome following out-of-hospital cardiac arrest]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[754]]></modelsamplesize>
		<cohortsamplesize><![CDATA[754]]></cohortsamplesize>
		<numberofevents><![CDATA[5]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Patient Downtime, GCS]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Decision Trees; Female; Heart Arrest/complications/*therapy; Humans; Male; Middle Aged; Nervous System Diseases/etiology; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-34]]></modelid>
		<pubmedid><![CDATA[15534734]]></pubmedid>
		<author><![CDATA[Schmittling]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Annals of Vascular Surgery]]></journal>
		<title><![CDATA[Characterization and probability of upper extremity deep venous thrombosis]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[168]]></modelsamplesize>
		<cohortsamplesize><![CDATA[168]]></cohortsamplesize>
		<numberofevents><![CDATA[53]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Catheterization, Erythema, Malignancy, PE, Tenderness]]></covariates>
		<mh><![CDATA[Arm/*blood supply; Edema/diagnosis; Female; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Venous Thrombosis/*diagnosis/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-35]]></modelid>
		<pubmedid><![CDATA[15561024]]></pubmedid>
		<author><![CDATA[Garcia]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Development of a score to predict the need for coronary artery bypass graft surgery in patients with non-ST segment elevation acute coronary syndromes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[345]]></modelsamplesize>
		<cohortsamplesize><![CDATA[688]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CHF, PVD< CAD, Stroke, ST Deviation, Risk Factors]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable/*classification/complications/drug therapy/surgery; *Coronary Artery Bypass; Heart Failure/complications; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Myocardial Infarction/*classification/complications/drug therapy/surgery; Peripheral Vascular Diseases/complications; Platelet Aggregation Inhibitors/therapeutic use; ROC Curve; Retrospective Studies; Ticlopidine/*analogs & derivatives/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-36]]></modelid>
		<pubmedid><![CDATA[15650983]]></pubmedid>
		<author><![CDATA[Merle]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Journal of Cardiothoracic & Vascular Anesthesia]]></journal>
		<title><![CDATA[Surgery for mesenteric infarction: prognostic factors associated with early death within 72 hours]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[131]]></modelsamplesize>
		<cohortsamplesize><![CDATA[131]]></cohortsamplesize>
		<numberofevents><![CDATA[58]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AST, HF, Lactate, Procalcitonin, Cholesterol]]></covariates>
		<mh><![CDATA[Aged; Aspartate Aminotransferases/metabolism; Calcitonin/metabolism; Cholesterol/metabolism; Female; France; Heart Failure/complications; Humans; Infarction/*mortality/surgery; Ischemia/*diagnosis/*mortality/surgery; Lactic Acid/metabolism; Male; Mesentery/*blood supply/pathology/surgery; Postoperative Complications/diagnosis/metabolism/*mortality; Prognosis; Prospective Studies; Protein Precursors/metabolism; Risk Factors; Surgical Procedures, Operative/*mortality/statistics & numerical data; Survival Analysis; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-37]]></modelid>
		<pubmedid><![CDATA[15662552]]></pubmedid>
		<author><![CDATA[Balkau]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Diabetologia]]></journal>
		<title><![CDATA[Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[16506]]></modelsamplesize>
		<cohortsamplesize><![CDATA[16506]]></cohortsamplesize>
		<numberofevents><![CDATA[301]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, FPG, Impaired Glucose Regulation, Diabetes, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*mortality; Cohort Studies; Diabetic Angiopathies/mortality; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-38]]></modelid>
		<pubmedid><![CDATA[15662552]]></pubmedid>
		<author><![CDATA[Balkau]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Diabetologia]]></journal>
		<title><![CDATA[Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8907]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8907]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, FPG, Impaired Glucose Regulation, Diabetes, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*mortality; Cohort Studies; Diabetic Angiopathies/mortality; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-39]]></modelid>
		<pubmedid><![CDATA[15662552]]></pubmedid>
		<author><![CDATA[Balkau]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Diabetologia]]></journal>
		<title><![CDATA[Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[16506]]></modelsamplesize>
		<cohortsamplesize><![CDATA[16506]]></cohortsamplesize>
		<numberofevents><![CDATA[632]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, FPG, Impaired Glucose Regulation, Diabetes]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*mortality; Cohort Studies; Diabetic Angiopathies/mortality; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[04-001-40]]></modelid>
		<pubmedid><![CDATA[15662552]]></pubmedid>
		<author><![CDATA[Balkau]]></author>
		<year><![CDATA[2004]]></year>
		<journal><![CDATA[Diabetologia]]></journal>
		<title><![CDATA[Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8907]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8907]]></cohortsamplesize>
		<numberofevents><![CDATA[159]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, FPG, Impaired Glucose Regulation, Diabetes]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*mortality; Cohort Studies; Diabetic Angiopathies/mortality; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-01]]></modelid>
		<pubmedid><![CDATA[15659467]]></pubmedid>
		<author><![CDATA[Ferrario]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[International Journal of Epidemiology]]></journal>
		<title><![CDATA[Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[6865]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6865]]></cohortsamplesize>
		<numberofevents><![CDATA[312]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.742]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, Family History, HDL Cholesterol, Antihypertensive Medication, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Area Under Curve; Cholesterol/blood; Cholesterol, HDL/blood; Coronary Disease/*epidemiology/genetics; Diabetes Complications; Health Surveys; Humans; Hypertension/complications/drug therapy; Incidence; Italy/epidemiology; Male; Middle Aged; Prospective Studies; ROC Curve; Risk Assessment/methods; Smoking/adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-02]]></modelid>
		<pubmedid><![CDATA[15678041]]></pubmedid>
		<author><![CDATA[DeRose]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[360]]></modelsamplesize>
		<cohortsamplesize><![CDATA[544]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Calcified Aorta, COPD, CHF, Urgency Status, Immunodeficiency, OPCAB Surgery, CHF, PVD]]></covariates>
		<mh><![CDATA[Aged; *Coronary Artery Bypass; Coronary Artery Disease/*mortality/*physiopathology/surgery; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; New York/epidemiology; Postoperative Complications/etiology/mortality; Predictive Value of Tests; *Preoperative Care; Retrospective Studies; Stroke Volume/*physiology; Survival Analysis; Time Factors; Treatment Outcome; Ventricular Function, Left/*physiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-03]]></modelid>
		<pubmedid><![CDATA[15687312]]></pubmedid>
		<author><![CDATA[Fonarow]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[33046]]></modelsamplesize>
		<cohortsamplesize><![CDATA[33046]]></cohortsamplesize>
		<numberofevents><![CDATA[1383]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.759]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BUN, Heart Rate, SBP]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Female; Heart Failure/*mortality; *Hospital Mortality; Humans; Male; Middle Aged; Models, Statistical; Registries; *Risk Assessment; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-04]]></modelid>
		<pubmedid><![CDATA[15734617]]></pubmedid>
		<author><![CDATA[Hachamovitch]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2369]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5873]]></cohortsamplesize>
		<numberofevents><![CDATA[156]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Percent Myocardium Fixed or Ischemic, Abnormal EKG, Age, Dyspnea, Heart Rate]]></covariates>
		<mh><![CDATA[*Adenosine; Aged; Aged, 80 and over; Cause of Death; Coronary Circulation/*physiology; Coronary Disease/mortality/*radionuclide imaging; Electrocardiography/drug effects; *Exercise Test; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction/*mortality; Predictive Value of Tests; Prognosis; Risk Assessment; *Tomography, Emission-Computed, Single-Photon]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-05]]></modelid>
		<pubmedid><![CDATA[15734617]]></pubmedid>
		<author><![CDATA[Hachamovitch]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2369]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5873]]></cohortsamplesize>
		<numberofevents><![CDATA[156]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Percent Myocardium Fixed or Ischemic, Age, Diabetes, Dyspnea, Revascularization, Heart Rate]]></covariates>
		<mh><![CDATA[*Adenosine; Aged; Aged, 80 and over; Cause of Death; Coronary Circulation/*physiology; Coronary Disease/mortality/*radionuclide imaging; Electrocardiography/drug effects; *Exercise Test; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction/*mortality; Predictive Value of Tests; Prognosis; Risk Assessment; *Tomography, Emission-Computed, Single-Photon]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-06]]></modelid>
		<pubmedid><![CDATA[15758007]]></pubmedid>
		<author><![CDATA[Kucher]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[New England Journal of Medicine]]></journal>
		<title><![CDATA[Electronic alerts to prevent venous thromboembolism among hospitalized patients]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2506]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2506]]></cohortsamplesize>
		<numberofevents><![CDATA[164]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cancer, Sex, Surgery/Trauma, VTE, VTE Risk]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants/*therapeutic use; Bandages/*utilization; *Decision Support Systems, Clinical; Disease-Free Survival; Female; Follow-Up Studies; Hospital Information Systems; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Pulmonary Embolism/*prevention & control; Quality Assurance, Health Care; *Reminder Systems; Risk Assessment/methods; Risk Factors; *Software; Thromboembolism/prevention & control; Venous Thrombosis/*prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-07]]></modelid>
		<pubmedid><![CDATA[15769783]]></pubmedid>
		<author><![CDATA[Adlam]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Using BNP to develop a risk score for heart failure in primary care]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[528]]></modelsamplesize>
		<cohortsamplesize><![CDATA[528]]></cohortsamplesize>
		<numberofevents><![CDATA[190]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.752]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BNP, CVA, Diabetes, EKG, Sex]]></covariates>
		<mh><![CDATA[Aged; Biomarkers/blood; Female; Heart Failure/*diagnosis/mortality/physiopathology; Humans; Male; Multivariate Analysis; Natriuretic Peptide, Brain/*blood; Predictive Value of Tests; Prognosis; Risk Assessment/methods/standards; Risk Factors; Stroke Volume]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-08]]></modelid>
		<pubmedid><![CDATA[15820281]]></pubmedid>
		<author><![CDATA[Alehagen]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[510]]></modelsamplesize>
		<cohortsamplesize><![CDATA[510]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Sex, NYHA Class]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Area Under Curve; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure/*mortality; Humans; Male; Prognosis; Proportional Hazards Models; ROC Curve; Risk Assessment; Survival Analysis; Sweden/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-09]]></modelid>
		<pubmedid><![CDATA[15820281]]></pubmedid>
		<author><![CDATA[Alehagen]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[510]]></modelsamplesize>
		<cohortsamplesize><![CDATA[510]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, LVEF, Sex, NYHA Class]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Area Under Curve; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure/*mortality; Humans; Male; Prognosis; Proportional Hazards Models; ROC Curve; Risk Assessment; Survival Analysis; Sweden/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-10]]></modelid>
		<pubmedid><![CDATA[15854958]]></pubmedid>
		<author><![CDATA[Passman]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Prediction rule for atrial fibrillation after major noncardiac thoracic surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[856]]></modelsamplesize>
		<cohortsamplesize><![CDATA[856]]></cohortsamplesize>
		<numberofevents><![CDATA[147]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, Sex]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/epidemiology/*etiology; Cohort Studies; Confidence Intervals; Female; Humans; Male; Middle Aged; Regression Analysis; Retrospective Studies; Risk Assessment; Thoracic Surgical Procedures/*adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-11]]></modelid>
		<pubmedid><![CDATA[15862409]]></pubmedid>
		<author><![CDATA[Halkin]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2082]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2082]]></cohortsamplesize>
		<numberofevents><![CDATA[44]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, LVEF, TIMI Flow, Killip Class, Renal Insufficiency, Three Vessel Disease]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty, Balloon, Coronary; Female; Humans; Male; Multicenter Studies as Topic; Myocardial Infarction/*mortality/pathology/*therapy; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Survival Analysis; Ventricular Dysfunction, Left/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-12]]></modelid>
		<pubmedid><![CDATA[15911566]]></pubmedid>
		<author><![CDATA[Kostrubiec]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Biomarker-based risk assessment model in acute pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[100]]></modelsamplesize>
		<cohortsamplesize><![CDATA[100]]></cohortsamplesize>
		<numberofevents><![CDATA[15]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Troponin T]]></covariates>
		<mh><![CDATA[Acute Disease; Algorithms; Biomarkers/blood; Echocardiography/methods; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain/*blood; Peptide Fragments/*blood; Prognosis; Pulmonary Embolism/*blood/mortality; Regression Analysis; Risk Assessment/methods; Risk Factors; Sensitivity and Specificity; Troponin T/*blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-13]]></modelid>
		<pubmedid><![CDATA[15933390]]></pubmedid>
		<author><![CDATA[Porock]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journals of Gerontology Series A-Biological Sciences & Medical Sciences]]></journal>
		<title><![CDATA[Predicting death in the nursing home: development and validation of the 6-month Minimum Data Set mortality risk index]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[32599]]></modelsamplesize>
		<cohortsamplesize><![CDATA[43510]]></cohortsamplesize>
		<numberofevents><![CDATA[7473]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.762]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ADLs, Admission, Deterioration, Age, Dementia, Cancer, CHF, Cognitive Performance, Dehydration, Loss of Appetite, Renal Disease, Sex, Shortness of Breath, Weight]]></covariates>
		<mh><![CDATA[Activities of Daily Living; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease/epidemiology; Cognition Disorders/epidemiology; Cohort Studies; Death Certificates; Dyspnea/epidemiology; Feeding and Eating Disorders/epidemiology; Female; Forecasting; Heart Failure/epidemiology; Humans; Male; Missouri/epidemiology; *Mortality; Neoplasms/epidemiology; *Nursing Homes; Renal Insufficiency/epidemiology; Retrospective Studies; Risk Assessment; Sex Factors; Terminal Care]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-14]]></modelid>
		<pubmedid><![CDATA[15993230]]></pubmedid>
		<author><![CDATA[Rothwell]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[209]]></modelsamplesize>
		<cohortsamplesize><![CDATA[209]]></cohortsamplesize>
		<numberofevents><![CDATA[18]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Symptom Duration, Speech Disturbance, SBP, Weakness]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Early Diagnosis; Humans; Ischemic Attack, Transient/*complications; Middle Aged; Risk Factors; Stroke/complications/*diagnosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-15]]></modelid>
		<pubmedid><![CDATA[15998680]]></pubmedid>
		<author><![CDATA[Ambler]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Generic, simple risk stratification model for heart valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[16679]]></modelsamplesize>
		<cohortsamplesize><![CDATA[16679]]></cohortsamplesize>
		<numberofevents><![CDATA[1067]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CABG, Tricuspid Surgery, Diabetes, LVEF, Sex, Hypertension, Operation Sequence, Arrhythmia, Priority, Renal Failure, Valve Operation, Year]]></covariates>
		<mh><![CDATA[Cardiac Surgical Procedures/*mortality; Databases, Factual; Heart Valves/*surgery; Hospital Mortality; Humans; Knowledge Bases; *Models, Statistical; Prognosis; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-16]]></modelid>
		<pubmedid><![CDATA[16014347]]></pubmedid>
		<author><![CDATA[Armstrong]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Nephrology Dialysis Transplantation]]></journal>
		<title><![CDATA[Derivation and validation of a disease-specific risk score for cardiac risk stratification in chronic kidney disease]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[167]]></modelsamplesize>
		<cohortsamplesize><![CDATA[167]]></cohortsamplesize>
		<numberofevents><![CDATA[20]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, Dialysis, Phosphate, Previous Cardiac Event]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/*etiology; Diabetic Nephropathies/complications; Female; Humans; Kidney Failure, Chronic/*complications; Male; Middle Aged; Proportional Hazards Models; Risk; Risk Factors; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-17]]></modelid>
		<pubmedid><![CDATA[16020800]]></pubmedid>
		<author><![CDATA[Aujesky]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[American Journal of Respiratory and Critical Care Medicine]]></journal>
		<title><![CDATA[Derivation and validation of a prognostic model for pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10354]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15531]]></cohortsamplesize>
		<numberofevents><![CDATA[953]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Mental Status, O2 Saturation, Cancer, Lung Disease, HF, Sex, Pulse, Respiratory Rate, SBP, Temperature]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cause of Death; Comorbidity; Decision Support Techniques; Discriminant Analysis; Female; France/epidemiology; Hospitals, University; Humans; *Logistic Models; Male; Pennsylvania/epidemiology; Predictive Value of Tests; Prognosis; Pulmonary Embolism/*classification/complications/diagnosis/*mortality/therapy; ROC Curve; Risk Assessment/*organization & administration; Risk Factors; *Severity of Illness Index; Switzerland/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-18]]></modelid>
		<pubmedid><![CDATA[16039188]]></pubmedid>
		<author><![CDATA[Jin]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Validation and refinement of mortality risk models for heart valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1596]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1596]]></cohortsamplesize>
		<numberofevents><![CDATA[96]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BMI, COPD, CABG, Creatinine, Sex, Cardiac Surgery, NYHA Class, PVD, Priority of Operation, Hypertension]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Aortic Valve/surgery; Area Under Curve; Cardiac Surgical Procedures/mortality; Female; Heart Valve Diseases/*surgery; Heart Valve Prosthesis Implantation/*mortality; Humans; Male; Middle Aged; Mitral Valve/surgery; Models, Statistical; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-19]]></modelid>
		<pubmedid><![CDATA[16053956]]></pubmedid>
		<author><![CDATA[Sanchis]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[646]]></modelsamplesize>
		<cohortsamplesize><![CDATA[646]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Chest Pain, Age, Confounding EKG, Diabetes, Exercise, Killip Class, CABG, Stenosis, MI, Angioplasty, Aspirin]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable/blood/*diagnosis/*mortality/therapy; Angioplasty, Balloon, Coronary/methods; Chest Pain/diagnosis; Cohort Studies; *Electrocardiography; Emergency Service, Hospital; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction/blood/*diagnosis/*mortality/therapy; Probability; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Thrombolytic Therapy/methods; Troponin T/*blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-20]]></modelid>
		<pubmedid><![CDATA[16085199]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[A risk score predicted coronary heart disease and stroke in a Chinese cohort]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[3000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4400]]></cohortsamplesize>
		<numberofevents><![CDATA[55]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; China/epidemiology/ethnology; Coronary Disease/epidemiology/ethnology/*etiology; Epidemiologic Methods; European Continental Ancestry Group; Humans; Male; *Metallurgy; Middle Aged; Occupational Diseases/epidemiology/*etiology; Risk Assessment/*methods; Stroke/epidemiology/ethnology/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-21]]></modelid>
		<pubmedid><![CDATA[16085199]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[A risk score predicted coronary heart disease and stroke in a Chinese cohort]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4400]]></cohortsamplesize>
		<numberofevents><![CDATA[49]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; China/epidemiology/ethnology; Coronary Disease/epidemiology/ethnology/*etiology; Epidemiologic Methods; European Continental Ancestry Group; Humans; Male; *Metallurgy; Middle Aged; Occupational Diseases/epidemiology/*etiology; Risk Assessment/*methods; Stroke/epidemiology/ethnology/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-22]]></modelid>
		<pubmedid><![CDATA[16085199]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[A risk score predicted coronary heart disease and stroke in a Chinese cohort]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4400]]></cohortsamplesize>
		<numberofevents><![CDATA[33]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, DBP, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; China/epidemiology/ethnology; Coronary Disease/epidemiology/ethnology/*etiology; Epidemiologic Methods; European Continental Ancestry Group; Humans; Male; *Metallurgy; Middle Aged; Occupational Diseases/epidemiology/*etiology; Risk Assessment/*methods; Stroke/epidemiology/ethnology/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-23]]></modelid>
		<pubmedid><![CDATA[16098306]]></pubmedid>
		<author><![CDATA[Cortigiani]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[prognostic value of a multiparametric risk score in patients undergoing dipyridamole stress echocardiography]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3969]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3969]]></cohortsamplesize>
		<numberofevents><![CDATA[324]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Sex, Wall Motion Score Index]]></covariates>
		<mh><![CDATA[Aged; Coronary Disease/*diagnosis/mortality; *Dipyridamole; Echocardiography, Stress/*methods; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction/physiology; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; *Vasodilator Agents]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-24]]></modelid>
		<pubmedid><![CDATA[16128372]]></pubmedid>
		<author><![CDATA[Zaliunas]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Acta Cardiologica]]></journal>
		<title><![CDATA[Informative value of clinical markers for the risk of cardiovascular death in postinfarction chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[244]]></modelsamplesize>
		<cohortsamplesize><![CDATA[244]]></cohortsamplesize>
		<numberofevents><![CDATA[132]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Ventricular Arrhythmia, LVEF, NYHA Class, Thromboembolic Complications]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Heart Failure/etiology/*mortality; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/*complications; Proportional Hazards Models; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-25]]></modelid>
		<pubmedid><![CDATA[16146566]]></pubmedid>
		<author><![CDATA[Urbonavicius]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Current Controlled Trials in Cardiovascular Medicine]]></journal>
		<title><![CDATA[Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[69]]></modelsamplesize>
		<cohortsamplesize><![CDATA[69]]></cohortsamplesize>
		<numberofevents><![CDATA[8]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Previous MI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-26]]></modelid>
		<pubmedid><![CDATA[16146566]]></pubmedid>
		<author><![CDATA[Urbonavicius]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Current Controlled Trials in Cardiovascular Medicine]]></journal>
		<title><![CDATA[Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[69]]></modelsamplesize>
		<cohortsamplesize><![CDATA[69]]></cohortsamplesize>
		<numberofevents><![CDATA[8]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aneurysm, Sex, Previous MI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-27]]></modelid>
		<pubmedid><![CDATA[16158034]]></pubmedid>
		<author><![CDATA[Yale]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[International Angiology]]></journal>
		<title><![CDATA[Risk assessment model for venothromboembolism in post-hospitalized patients]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[380]]></modelsamplesize>
		<cohortsamplesize><![CDATA[380]]></cohortsamplesize>
		<numberofevents><![CDATA[160]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.829]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Cancer, Corticosteroids, Nursing Home, Other Medications, Paralysis, Diabetes, Varicose Veins]]></covariates>
		<mh><![CDATA[*Hospitalization; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Readmission; Postoperative Period; Risk Assessment; Risk Factors; Venous Thrombosis/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-28]]></modelid>
		<pubmedid><![CDATA[16159846]]></pubmedid>
		<author><![CDATA[Fowler]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Clinical predictors of major infections after cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Infection]]></outcome>
		<modelsamplesize><![CDATA[165715]]></modelsamplesize>
		<cohortsamplesize><![CDATA[331429]]></cohortsamplesize>
		<numberofevents><![CDATA[11633]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.697]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Anticoagulants, BMI, Shock, CVA, Cerebrovascular Disease, Lung Disease, CHF, Diabetes, Dialysis, LVEF, Cholesterol, Hypertension, Immunosuppressive Therapy, Sex, Valvular Insufficiency, NYHA Class, PVD, CABG, MI, Valve Surgery, Cardiac Device/Repair,]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cardiac Surgical Procedures/*statistics & numerical data; Databases, Factual; Female; Humans; Infection/*epidemiology; Intra-Aortic Balloon Pumping/statistics & numerical data; Intraoperative Period; Logistic Models; Male; Mediastinitis/epidemiology; Middle Aged; Models, Theoretical; Postoperative Complications/*epidemiology; Risk Factors; Sepsis/epidemiology; Surgical Wound Infection/epidemiology; Tissue and Organ Harvesting/adverse effects; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-29]]></modelid>
		<pubmedid><![CDATA[16159846]]></pubmedid>
		<author><![CDATA[Fowler]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Clinical predictors of major infections after cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Infection]]></outcome>
		<modelsamplesize><![CDATA[165715]]></modelsamplesize>
		<cohortsamplesize><![CDATA[331429]]></cohortsamplesize>
		<numberofevents><![CDATA[11633]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.711]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Anticoagulants, BMI, Shock, CVA, Cerebrovascular Disease, Lung Disease, CHF, Diabetes, Dialysis, LVEF, Cholesterol, Hypertension, Immunosuppressive Therapy, Sex, Valvular Insufficiency, NYHA Class, PVD, CABG, MI, Valve Surgery, Cardiac Device/Repair,]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cardiac Surgical Procedures/*statistics & numerical data; Databases, Factual; Female; Humans; Infection/*epidemiology; Intra-Aortic Balloon Pumping/statistics & numerical data; Intraoperative Period; Logistic Models; Male; Mediastinitis/epidemiology; Middle Aged; Models, Theoretical; Postoperative Complications/*epidemiology; Risk Factors; Sepsis/epidemiology; Surgical Wound Infection/epidemiology; Tissue and Organ Harvesting/adverse effects; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-30]]></modelid>
		<pubmedid><![CDATA[16188514]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Prediction of complications following nonemergency percutaneous coronary interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2894]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2894]]></cohortsamplesize>
		<numberofevents><![CDATA[232]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.641]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACA/AHA Type, Stenosis, Thrombus, Vein Graft]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*adverse effects/mortality; Biomarkers/analysis; Coronary Artery Bypass; Elective Surgical Procedures; Electrocardiography; Female; Hospital Mortality; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-31]]></modelid>
		<pubmedid><![CDATA[16210253]]></pubmedid>
		<author><![CDATA[Clayton]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[7311]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7311]]></cohortsamplesize>
		<numberofevents><![CDATA[1063]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Creatinine, Smoking, LVEF, Angina Medication, Glucose, Diabetes, Sex, Lipid Lowering Therapy, Angiography, MI, Stroke, QT Interval, SBP, WBC]]></covariates>
		<mh><![CDATA[Adult; Aged; Angina Pectoris/*mortality; Calcium Channel Blockers/therapeutic use; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction/*mortality; Nifedipine/therapeutic use; Quality of Life; Risk Assessment/methods; Risk Factors; Stroke/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-32]]></modelid>
		<pubmedid><![CDATA[16210253]]></pubmedid>
		<author><![CDATA[Clayton]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[7311]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7311]]></cohortsamplesize>
		<numberofevents><![CDATA[569]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Creatinine, Smoking, LVEF, Angina Medication, Glucose, Diabetes, Sex, Lipid Lowering Therapy, Angiography, MI, Stroke, QT Interval, SBP, WBC]]></covariates>
		<mh><![CDATA[Adult; Aged; Angina Pectoris/*mortality; Calcium Channel Blockers/therapeutic use; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction/*mortality; Nifedipine/therapeutic use; Quality of Life; Risk Assessment/methods; Risk Factors; Stroke/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-33]]></modelid>
		<pubmedid><![CDATA[16210253]]></pubmedid>
		<author><![CDATA[Clayton]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[7311]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7311]]></cohortsamplesize>
		<numberofevents><![CDATA[495]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Creatinine, Smoking, LVEF, Angina Medication, Glucose, Diabetes, Sex, Lipid Lowering Therapy, Angiography, MI, Stroke, QT Interval, SBP, WBC]]></covariates>
		<mh><![CDATA[Adult; Aged; Angina Pectoris/*mortality; Calcium Channel Blockers/therapeutic use; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction/*mortality; Nifedipine/therapeutic use; Quality of Life; Risk Assessment/methods; Risk Factors; Stroke/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-34]]></modelid>
		<pubmedid><![CDATA[16210253]]></pubmedid>
		<author><![CDATA[Clayton]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[7311]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7311]]></cohortsamplesize>
		<numberofevents><![CDATA[170]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Creatinine, Smoking, LVEF, Angina Medication, Glucose, Diabetes, Sex, Lipid Lowering Therapy, Angiography, MI, Stroke, QT Interval, SBP, WBC]]></covariates>
		<mh><![CDATA[Adult; Aged; Angina Pectoris/*mortality; Calcium Channel Blockers/therapeutic use; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction/*mortality; Nifedipine/therapeutic use; Quality of Life; Risk Assessment/methods; Risk Factors; Stroke/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-35]]></modelid>
		<pubmedid><![CDATA[16211206]]></pubmedid>
		<author><![CDATA[Heywood]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Cardiovascular Pharmacology and Therapuetics]]></journal>
		<title><![CDATA[Simple Clinical Criteria to Determine the prognosis of Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[680]]></modelsamplesize>
		<cohortsamplesize><![CDATA[680]]></cohortsamplesize>
		<numberofevents><![CDATA[75]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BUN, Diabetes, LVEF, Creatinine]]></covariates>
		<mh><![CDATA[Adult; Aged; Blood Urea Nitrogen; Female; Heart Failure/drug therapy/*mortality/physiopathology; Humans; Male; Middle Aged; Prognosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-36]]></modelid>
		<pubmedid><![CDATA[16211206]]></pubmedid>
		<author><![CDATA[Heywood]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Cardiovascular Pharmacology and Therapuetics]]></journal>
		<title><![CDATA[Simple Clinical Criteria to Determine the prognosis of Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[680]]></modelsamplesize>
		<cohortsamplesize><![CDATA[680]]></cohortsamplesize>
		<numberofevents><![CDATA[34]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BUN, Diabetes, LVEF, Creatinine]]></covariates>
		<mh><![CDATA[Adult; Aged; Blood Urea Nitrogen; Female; Heart Failure/drug therapy/*mortality/physiopathology; Humans; Male; Middle Aged; Prognosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-37]]></modelid>
		<pubmedid><![CDATA[16273581]]></pubmedid>
		<author><![CDATA[Eggebrecht]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Catheterization & Cardiovascular Interventions]]></journal>
		<title><![CDATA[Endovascular stent-graft placement for acute and contained rupture of the descending thoracic aorta]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.889]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Lesion Length, Aortic Diameter, Mediastinal Hematoma, Thoracic Aneurysm or AAD]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured/diagnosis/mortality/*surgery; Angiography; Aortic Aneurysm, Thoracic/diagnosis/mortality/*surgery; Blood Vessel Prosthesis Implantation/*instrumentation; Echocardiography, Transesophageal; Female; Follow-Up Studies; Hospital Mortality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; *Stents; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-38]]></modelid>
		<pubmedid><![CDATA[16307998]]></pubmedid>
		<author><![CDATA[Liang]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Prediction of cardiac function after weaning from ventricular assist devices]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[28]]></modelsamplesize>
		<cohortsamplesize><![CDATA[28]]></cohortsamplesize>
		<numberofevents><![CDATA[12]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[HF Duration, Left Ventricular Intracavitary Dimensions]]></covariates>
		<mh><![CDATA[Device Removal; Female; Heart/*physiology; Heart Failure/surgery; Heart Function Tests; *Heart-Assist Devices; Humans; Male; Multivariate Analysis; Prognosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[05-001-39]]></modelid>
		<pubmedid><![CDATA[16471120]]></pubmedid>
		<author><![CDATA[Wongchareon]]></author>
		<year><![CDATA[2005]]></year>
		<journal><![CDATA[Journal of the Medical Association of Thailand]]></journal>
		<title><![CDATA[A predictive model for distinguishing ischemic from non-ischemic cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[90]]></modelsamplesize>
		<cohortsamplesize><![CDATA[137]]></cohortsamplesize>
		<numberofevents><![CDATA[49]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.94]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Cardiomyopathy, EKG Leads with Q Waves]]></covariates>
		<mh><![CDATA[Cardiomyopathies/*diagnosis/ultrasonography; Diagnosis, Differential; Echocardiography; Electroencephalography; Female; Humans; Male; Middle Aged; Models, Theoretical; Myocardial Ischemia/*diagnosis/ultrasonography; Odds Ratio; ROC Curve; Ventricular Dysfunction, Left/*diagnosis/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-01]]></modelid>
		<pubmedid><![CDATA[16159983]]></pubmedid>
		<author><![CDATA[Grayson]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[9914]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9914]]></cohortsamplesize>
		<numberofevents><![CDATA[129]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, Cerebrovascular Disease, PCI, Sex, Lesion Treated]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*mortality; Cardiomyopathies/*mortality; England/epidemiology; Epidemiologic Methods; Female; Humans; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-02]]></modelid>
		<pubmedid><![CDATA[16219658]]></pubmedid>
		<author><![CDATA[Pocock]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predictors of mortality and morbidity in patients with chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[7599]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7599]]></cohortsamplesize>
		<numberofevents><![CDATA[1831]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BMI, BBB, Candesartan, Cardiomegaly, Smoking, Edema, Diabetes, CHF, DBP, LVEF, Sex, Heart Rate, Mitral Regurgitation, NYHA Class, Previous MI, HF Hospitalization, Pulmonary Crackles, Dyspnea]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Cause of Death; Chronic Disease; Heart Failure/*mortality; Hospitalization/statistics & numerical data; Humans; Middle Aged; Morbidity; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Sweden/epidemiology; Ventricular Dysfunction, Left/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-03]]></modelid>
		<pubmedid><![CDATA[16219658]]></pubmedid>
		<author><![CDATA[Pocock]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predictors of mortality and morbidity in patients with chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[7599]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7599]]></cohortsamplesize>
		<numberofevents><![CDATA[2460]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BMI, BBB, Candesartan, Cardiomegaly, Smoking, Edema, Diabetes, CHF, DBP, LVEF, Sex, Heart Rate, Mitral Regurgitation, NYHA Class, Previous MI, HF Hospitalization, Pulmonary Crackles, Dyspnea]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Cause of Death; Chronic Disease; Heart Failure/*mortality; Hospitalization/statistics & numerical data; Humans; Middle Aged; Morbidity; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Sweden/epidemiology; Ventricular Dysfunction, Left/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-04]]></modelid>
		<pubmedid><![CDATA[16354736]]></pubmedid>
		<author><![CDATA[Weimar]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery & Psychiatry]]></journal>
		<title><![CDATA[Development and validation of the Essen Intracerebral Haemorrhage Score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[340]]></modelsamplesize>
		<cohortsamplesize><![CDATA[340]]></cohortsamplesize>
		<numberofevents><![CDATA[126]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.851]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS, Level of Consciousness]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Cerebral Hemorrhage/classification/*diagnosis/mortality; Choline/metabolism; Cohort Studies; Female; Germany; Hospital Mortality; Humans; Male; Middle Aged; Neurologic Examination/*statistics & numerical data; Prognosis; Prospective Studies; Reproducibility of Results; Risk Factors; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-05]]></modelid>
		<pubmedid><![CDATA[16391380]]></pubmedid>
		<author><![CDATA[Gottschall]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Invasive Cardiology]]></journal>
		<title><![CDATA[Predictive score for target vessel revascularization after bare metal coronary stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[848]]></modelsamplesize>
		<cohortsamplesize><![CDATA[848]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACS, Age, Diabetes, Lesion Length, PTCA, Vessel Diameter, Sex]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cohort Studies; Coronary Disease/*therapy; Female; Humans; Male; *Metals; Middle Aged; Multivariate Analysis; *Myocardial Revascularization/statistics & numerical data; Odds Ratio; Prognosis; Prospective Studies; *Stents; Syndrome; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-06]]></modelid>
		<pubmedid><![CDATA[16391380]]></pubmedid>
		<author><![CDATA[Gottschall]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Invasive Cardiology]]></journal>
		<title><![CDATA[Predictive score for target vessel revascularization after bare metal coronary stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[848]]></modelsamplesize>
		<cohortsamplesize><![CDATA[848]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACS, Diabetes, Lesion Length, Vessel Diameter]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cohort Studies; Coronary Disease/*therapy; Female; Humans; Male; *Metals; Middle Aged; Multivariate Analysis; *Myocardial Revascularization/statistics & numerical data; Odds Ratio; Prognosis; Prospective Studies; *Stents; Syndrome; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-07]]></modelid>
		<pubmedid><![CDATA[16391380]]></pubmedid>
		<author><![CDATA[Gottschall]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Invasive Cardiology]]></journal>
		<title><![CDATA[Predictive score for target vessel revascularization after bare metal coronary stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[848]]></modelsamplesize>
		<cohortsamplesize><![CDATA[848]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACS, Lesion Length, Vessel Diameter]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cohort Studies; Coronary Disease/*therapy; Female; Humans; Male; *Metals; Middle Aged; Multivariate Analysis; *Myocardial Revascularization/statistics & numerical data; Odds Ratio; Prognosis; Prospective Studies; *Stents; Syndrome; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-64]]></modelid>
		<pubmedid><![CDATA[23522221]]></pubmedid>
		<author><![CDATA[Rankin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[27035]]></modelsamplesize>
		<cohortsamplesize><![CDATA[50231]]></cohortsamplesize>
		<numberofevents><![CDATA[2545]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.714]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Endocarditis, AF Ablation, Age, Reoperation, Aortic and Mitral Replacements, Aortic Insufficiency, Stenosis, BSA, CHF, NYHA Class, Lung Disease, CABG, Creatinine, Diabetes, Dialysis, Sex, Immunosuppressive Treatment, IABP or Inotrope, Cardiac Surgery, MI,]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-08]]></modelid>
		<pubmedid><![CDATA[16391380]]></pubmedid>
		<author><![CDATA[Gottschall]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Invasive Cardiology]]></journal>
		<title><![CDATA[Predictive score for target vessel revascularization after bare metal coronary stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[848]]></modelsamplesize>
		<cohortsamplesize><![CDATA[848]]></cohortsamplesize>
		<numberofevents><![CDATA[63]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Lesion Length, Vessel Diameter]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cohort Studies; Coronary Disease/*therapy; Female; Humans; Male; *Metals; Middle Aged; Multivariate Analysis; *Myocardial Revascularization/statistics & numerical data; Odds Ratio; Prognosis; Prospective Studies; *Stents; Syndrome; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-09]]></modelid>
		<pubmedid><![CDATA[16407373]]></pubmedid>
		<author><![CDATA[Chang]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6066]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6066]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Killip Class, Previous MI, Race, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Angioplasty, Balloon, Coronary/methods; Feasibility Studies; Female; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction/*mortality/therapy; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment/methods/standards; Thrombolytic Therapy/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-10]]></modelid>
		<pubmedid><![CDATA[16407373]]></pubmedid>
		<author><![CDATA[Chang]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6066]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6066]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Killip Class, Previous MI, Race, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Angioplasty, Balloon, Coronary/methods; Feasibility Studies; Female; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction/*mortality/therapy; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment/methods/standards; Thrombolytic Therapy/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-11]]></modelid>
		<pubmedid><![CDATA[16407373]]></pubmedid>
		<author><![CDATA[Chang]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6066]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6066]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Previous MI, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Angioplasty, Balloon, Coronary/methods; Feasibility Studies; Female; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction/*mortality/therapy; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment/methods/standards; Thrombolytic Therapy/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-12]]></modelid>
		<pubmedid><![CDATA[16407373]]></pubmedid>
		<author><![CDATA[Chang]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6066]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6066]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, Previous MI, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Angioplasty, Balloon, Coronary/methods; Feasibility Studies; Female; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction/*mortality/therapy; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment/methods/standards; Thrombolytic Therapy/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-13]]></modelid>
		<pubmedid><![CDATA[16427855]]></pubmedid>
		<author><![CDATA[Rexius]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[A simple score to assess mortality risk in patients waiting for coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5167]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5167]]></cohortsamplesize>
		<numberofevents><![CDATA[42]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Valve Disease, Stenosis, LVEF, Sex, Perioperative Risk, UA]]></covariates>
		<mh><![CDATA[Aged; Angina, Unstable; Aortic Valve Insufficiency; Coronary Artery Bypass/*mortality; Coronary Artery Disease/*mortality/*surgery; Female; Humans; Male; Middle Aged; Patient Selection; Prognosis; Retrospective Studies; Risk Assessment; *Severity of Illness Index; Sex Factors; *Triage; Ventricular Function, Left; *Waiting Lists]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-14]]></modelid>
		<pubmedid><![CDATA[16432084]]></pubmedid>
		<author><![CDATA[Aujesky]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[A prediction rule to identify low-risk patients with pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10354]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15531]]></cohortsamplesize>
		<numberofevents><![CDATA[945]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Mental Status, O2 Saturation, Cerebrovascular Disease, Lung Disease, Renal Disease, HF, Cancer, Pulse, SBP]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Cohort Studies; Decision Support Techniques; Discriminant Analysis; Female; Humans; Male; Middle Aged; Pennsylvania/epidemiology; *Predictive Value of Tests; Probability; Pulmonary Embolism/*classification/diagnosis/*epidemiology/therapy; Registries; Reproducibility of Results; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-15]]></modelid>
		<pubmedid><![CDATA[16442906]]></pubmedid>
		<author><![CDATA[Parkash]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[228]]></modelsamplesize>
		<cohortsamplesize><![CDATA[469]]></cohortsamplesize>
		<numberofevents><![CDATA[27]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, LVEF, AF, CAD, NYHA Class, Comorbidities, Creatinine, Sodium]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/mortality; Comorbidity; Death, Sudden, Cardiac/*prevention & control; *Defibrillators, Implantable; Epidemiologic Methods; Female; Heart Failure/mortality; Humans; Male; Patient Selection; Renal Insufficiency/mortality; Risk; Stroke Volume]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-16]]></modelid>
		<pubmedid><![CDATA[16458151]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A risk score to predict in-hospital mortality for percutaneous coronary interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[46090]]></modelsamplesize>
		<cohortsamplesize><![CDATA[46090]]></cohortsamplesize>
		<numberofevents><![CDATA[321]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.886]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, LVEF, Sex, Shock, Left Main CAD, MI, Stent Thrombosis, PAD, Creatinine, Dialysis]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; Female; *Hospital Mortality; Humans; Male; Middle Aged; *Models, Statistical; Myocardial Ischemia/complications/physiopathology/therapy; New York/epidemiology; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-17]]></modelid>
		<pubmedid><![CDATA[16458152]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Risk stratification of in-hospital mortality for coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[16120]]></modelsamplesize>
		<cohortsamplesize><![CDATA[16120]]></cohortsamplesize>
		<numberofevents><![CDATA[366]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.823]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, LVEF, Calcified Aorta, Sex, Hemodynamic State, MI, PAD, Previous Open Heart Operations, Dialysis]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Coronary Artery Bypass/*mortality; Coronary Disease/complications/physiopathology; Female; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; *Models, Statistical; New York/epidemiology; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-18]]></modelid>
		<pubmedid><![CDATA[16482367]]></pubmedid>
		<author><![CDATA[Kass-Hout]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Methods of Information in Medicine]]></journal>
		<title><![CDATA[A scoring system for ascertainment of incident stroke: the Risk Index Score (RISc)]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1718]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1718]]></cohortsamplesize>
		<numberofevents><![CDATA[374]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.975]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CVA, Fall, Stroke, TIA, ICH, Language, Motor Skill, Sensory Changes, SAH, Visual Changes]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Algorithms; Computers; Female; Forecasting; Humans; Inpatients; Male; Medical Audit; Prospective Studies; Risk Assessment/methods; Stroke/*epidemiology; Texas/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-19]]></modelid>
		<pubmedid><![CDATA[16498154]]></pubmedid>
		<author><![CDATA[Williams]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Emergency Medicine Journal]]></journal>
		<title><![CDATA[A new simplified immediate prognostic risk score for patients with acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[809]]></modelsamplesize>
		<cohortsamplesize><![CDATA[809]]></cohortsamplesize>
		<numberofevents><![CDATA[87]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, Killip Class, MI Location, QRS Duration, Sex, ST Depression, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Myocardial Infarction/*mortality/therapy; Prognosis; Risk Assessment; Risk Factors; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-20]]></modelid>
		<pubmedid><![CDATA[16504638]]></pubmedid>
		<author><![CDATA[Gage]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[3791]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3791]]></cohortsamplesize>
		<numberofevents><![CDATA[162]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Anemia, Alcohol Abuse, Fall Risk, Genetic Factors, Hepatic or Renal Disease, Hypertension, Malignancy, Age, Rebleed Risk, Platelets, Stroke]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Anticoagulants/*adverse effects/therapeutic use; Atrial Fibrillation/complications/*drug therapy; Cerebral Hemorrhage/epidemiology; Female; Gastrointestinal Hemorrhage/epidemiology; Hemorrhage/chemically induced/classification/*epidemiology; Humans; Male; Registries; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-21]]></modelid>
		<pubmedid><![CDATA[16520853]]></pubmedid>
		<author><![CDATA[Ivanov]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Canadian Journal of Cardiology]]></journal>
		<title><![CDATA[The Toronto Risk Score for adverse events following cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[12683]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12683]]></cohortsamplesize>
		<numberofevents><![CDATA[1243]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.744]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Complex Valve, CHF, Diabetes, Priority, Sex, Hypertension, Left Main Disease, LVEF, MI, PVD, CABG, Renal Insufficiency, Triple Vessel Disease]]></covariates>
		<mh><![CDATA[Aged; *Cardiac Surgical Procedures/adverse effects; Female; Heart Diseases/*surgery; Humans; Intensive Care Units; *Length of Stay; Linear Models; Logistic Models; Male; Middle Aged; Odds Ratio; Ontario; Postoperative Complications/*diagnosis/etiology/mortality; Prospective Studies; Reproducibility of Results; Risk Assessment; Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-22]]></modelid>
		<pubmedid><![CDATA[16525500]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Leukemia]]></journal>
		<title><![CDATA[Risk score model for fatal intracranial hemorrhage in acute leukemia]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[792]]></modelsamplesize>
		<cohortsamplesize><![CDATA[792]]></cohortsamplesize>
		<numberofevents><![CDATA[41]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[PTT, Leukemia, Age, Sex, Hemorrhage, Platelets, PT, WBC]]></covariates>
		<mh><![CDATA[Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Comorbidity; Female; Humans; Intracranial Hemorrhages/diagnosis/*epidemiology; Korea/epidemiology; Leukemia, Myeloid/diagnosis/*epidemiology; Leukemia, Promyelocytic, Acute/diagnosis/*epidemiology; Male; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/*epidemiology; Retrospective Studies; Risk Assessment; Risk Factors; *Severity of Illness Index; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-23]]></modelid>
		<pubmedid><![CDATA[16534009]]></pubmedid>
		<author><![CDATA[Levy]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[The Seattle Heart Failure Model: prediction of survival in heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1125]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1125]]></cohortsamplesize>
		<numberofevents><![CDATA[395]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.725]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Lymphocytes, Cholesterol, LVEF, Age, Allopurinol, Diuretic Dose, Sex, Hemoglobin, Ischemic Etiology, NYHA Class, Sodium, Statin, SBP, Uric Acid]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Area Under Curve; Cardiac Pacing, Artificial/utilization; Cardiovascular Agents/therapeutic use; Cohort Studies; Combined Modality Therapy; Comorbidity; Defibrillators, Implantable/utilization; Diuretics/adverse effects/therapeutic use; Female; Follow-Up Studies; Forecasting; Heart Failure/drug therapy/etiology/*mortality/surgery; Heart-Assist Devices/utilization; Hemoglobins/analysis; Humans; Life Expectancy; Lymphocyte Count; Male; Middle Aged; *Models, Cardiovascular; Multivariate Analysis; *Proportional Hazards Models; Prospective Studies; ROC Curve; Randomized Controlled Trials as Topic/statistics & numerical data; *Survival Analysis; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left/complications/drug therapy/surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-24]]></modelid>
		<pubmedid><![CDATA[16581261]]></pubmedid>
		<author><![CDATA[McGuirk]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk assessment and early outcome following the Norwood procedure for hypoplastic left heart syndrome]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Congenital]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[332]]></modelsamplesize>
		<cohortsamplesize><![CDATA[332]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Aortic Size, BSA, RV Function, Source of Clot]]></covariates>
		<mh><![CDATA[Aorta/pathology/surgery; Body Surface Area; Epidemiologic Methods; Female; Humans; Hypoplastic Left Heart Syndrome/pathology/physiopathology/*surgery; Infant; Infant, Newborn; Infant, Premature; Male; Pulmonary Artery/surgery; Pulmonary Circulation; Treatment Outcome; Ventricular Function, Right]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-25]]></modelid>
		<pubmedid><![CDATA[16581261]]></pubmedid>
		<author><![CDATA[McGuirk]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk assessment and early outcome following the Norwood procedure for hypoplastic left heart syndrome]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Congenital]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[332]]></modelsamplesize>
		<cohortsamplesize><![CDATA[332]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Aortic Size, Duration of Cardiopulmonary Support, Source of Clot, Weight]]></covariates>
		<mh><![CDATA[Aorta/pathology/surgery; Body Surface Area; Epidemiologic Methods; Female; Humans; Hypoplastic Left Heart Syndrome/pathology/physiopathology/*surgery; Infant; Infant, Newborn; Infant, Premature; Male; Pulmonary Artery/surgery; Pulmonary Circulation; Treatment Outcome; Ventricular Function, Right]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-26]]></modelid>
		<pubmedid><![CDATA[16607053]]></pubmedid>
		<author><![CDATA[Chen]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[International Heart Journal]]></journal>
		<title><![CDATA[A simplified clinical model to predict pulmonary embolism in patients with acute dyspnea]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[148]]></modelsamplesize>
		<cohortsamplesize><![CDATA[148]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Chest Pain, Roentgenogram, Cough, EKG, Oxygen Gradient, Sex, Breath Sounds, Leg Edema]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Blood Gas Analysis; Dyspnea/*complications; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Electrocardiography; Female; Forecasting; Humans; Male; Middle Aged; *Models, Statistical; Predictive Value of Tests; Probability; Pulmonary Embolism/*diagnosis; Radiography, Thoracic; Regression Analysis; Retrospective Studies]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-27]]></modelid>
		<pubmedid><![CDATA[16607904]]></pubmedid>
		<author><![CDATA[Xu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Heart Valve Disease]]></journal>
		<title><![CDATA[A preoperative and intraoperative predictive model of prolonged intensive care unit stay for valvular surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[507]]></modelsamplesize>
		<cohortsamplesize><![CDATA[507]]></cohortsamplesize>
		<numberofevents><![CDATA[75]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiothoracic Ratio, LVEF, Ventilation, Previous Cardiac Surgery, CPB]]></covariates>
		<mh><![CDATA[*Cardiac Surgical Procedures; Female; Heart Valve Diseases/physiopathology/*surgery; Humans; *Intensive Care Units; Intraoperative Period; Length of Stay/*statistics & numerical data; Male; Middle Aged; Preoperative Care; Prognosis; ROC Curve; Retrospective Studies; Risk Factors; Stroke Volume/physiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-28]]></modelid>
		<pubmedid><![CDATA[16675235]]></pubmedid>
		<author><![CDATA[Chaudhuri]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Intestinal ischaemia following cardiac surgery: a multivariate risk model]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Intestinal Ischemia]]></outcome>
		<modelsamplesize><![CDATA[10976]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10976]]></cohortsamplesize>
		<numberofevents><![CDATA[50]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.93]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Blood Loss, AF, Inotrope/Dialysis, Ventilation]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cardiac Surgical Procedures/*adverse effects; Cardiopulmonary Bypass; England/epidemiology; Epidemiologic Methods; Female; Humans; Intestines/*blood supply; Ischemia/epidemiology/*etiology; Male; Middle Aged; Postoperative Care/methods; Prognosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-29]]></modelid>
		<pubmedid><![CDATA[16732001]]></pubmedid>
		<author><![CDATA[Donnan]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4569]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4569]]></cohortsamplesize>
		<numberofevents><![CDATA[243]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Height, Diabetes, HbA1c, Sex, SBP, Antihypertensive Therapy, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Blood Pressure; Cohort Studies; Coronary Disease/*epidemiology/mortality; Diabetes Mellitus, Type 2/*epidemiology; Diabetic Angiopathies/*epidemiology; Female; Great Britain/epidemiology; Hemoglobin A, Glycosylated; Humans; Hypertension/epidemiology; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction/epidemiology/mortality; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Smoking/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-30]]></modelid>
		<pubmedid><![CDATA[16765268]]></pubmedid>
		<author><![CDATA[Martins]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Clinical Epidemiology]]></journal>
		<title><![CDATA[Evaluation of comorbidity indices for inpatient mortality prediction models]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[54680]]></modelsamplesize>
		<cohortsamplesize><![CDATA[54680]]></cohortsamplesize>
		<numberofevents><![CDATA[3882]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AIDS, Alcoholism, Arrhythmia, Cardiomyopathy, Cerebrovascular Disease, Coagulopathy, CHF, Fluid Disorders, GI Hemorrhage, General Symptoms, Leukemia, Cancer, Liver Disease, Pulmonary Disease, Renal Disease, MI, Endocrine Disease, PVD, Pneumonia]]></covariates>
		<mh><![CDATA[Brazil; Cardiovascular Diseases/epidemiology; *Comorbidity; Databases, Factual; *Health Status Indicators; *Hospital Mortality; Humans; Lung Diseases/epidemiology; Models, Statistical; Predictive Value of Tests; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-31]]></modelid>
		<pubmedid><![CDATA[16775593]]></pubmedid>
		<author><![CDATA[Schwaiger]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Kidney International]]></journal>
		<title><![CDATA[A simple score predicts future cardiovascular events in an inception cohort of dialysis patients]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[154]]></modelsamplesize>
		<cohortsamplesize><![CDATA[154]]></cohortsamplesize>
		<numberofevents><![CDATA[46]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Smoking, Vascular Risk]]></covariates>
		<mh><![CDATA[Adult; Aged; Blood Vessels/pathology; Calcinosis/epidemiology/*radiography; Cardiovascular Diseases/epidemiology/*radiography; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic/epidemiology/*radiography/therapy; Leg/radiography; Male; Middle Aged; Pelvis/radiography; Predictive Value of Tests; Prevalence; Proportional Hazards Models; *Renal Dialysis; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-32]]></modelid>
		<pubmedid><![CDATA[16824205]]></pubmedid>
		<author><![CDATA[Bjork]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[BMC Medical Informatics & Decision Making]]></journal>
		<title><![CDATA[A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Acute Coronary Syndrome (ACS)]]></outcome>
		<modelsamplesize><![CDATA[627]]></modelsamplesize>
		<cohortsamplesize><![CDATA[627]]></cohortsamplesize>
		<numberofevents><![CDATA[126]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.806]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EKG Results, Age, Angina, Risk of ACS, Chest Pain, CHF, Hypertension, CABG, Previous MI, Symptom Duration]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Aged, 80 and over; Chest Pain/*diagnosis/etiology; Diagnostic Tests, Routine; Electrocardiography; *Emergency Service, Hospital; Female; Forecasting; Humans; Logistic Models; Male; Middle Aged; *Models, Statistical; Myocardial Infarction/*diagnosis/physiopathology/radiography; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-33]]></modelid>
		<pubmedid><![CDATA[16824205]]></pubmedid>
		<author><![CDATA[Bjork]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[BMC Medical Informatics & Decision Making]]></journal>
		<title><![CDATA[A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Acute Coronary Syndrome (ACS)]]></outcome>
		<modelsamplesize><![CDATA[605]]></modelsamplesize>
		<cohortsamplesize><![CDATA[605]]></cohortsamplesize>
		<numberofevents><![CDATA[129]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.88]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EKG Results, ACS, Age, Angina, Chest Pain, CHF, Hypertension, Previous MI, CABG, Symptom Duration]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Aged, 80 and over; Chest Pain/*diagnosis/etiology; Diagnostic Tests, Routine; Electrocardiography; *Emergency Service, Hospital; Female; Forecasting; Humans; Logistic Models; Male; Middle Aged; *Models, Statistical; Myocardial Infarction/*diagnosis/physiopathology/radiography; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-34]]></modelid>
		<pubmedid><![CDATA[16926081]]></pubmedid>
		<author><![CDATA[Trujillo-Santos]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Predicting adverse outcome in outpatients with acute deep vein thrombosis. findings from the RIETE Registry]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[2947]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4405]]></cohortsamplesize>
		<numberofevents><![CDATA[83]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[DVT, Weight, Cancer, CHF, Creatinine, Immobilization]]></covariates>
		<mh><![CDATA[Aged; Angiography; Female; Fibrinolytic Agents/adverse effects/*therapeutic use; Follow-Up Studies; Hemorrhage/epidemiology/*etiology; Humans; Incidence; Male; Outpatients; Prognosis; Pulmonary Embolism/epidemiology/*etiology; *Registries; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Venous Thrombosis/complications/diagnosis/*drug therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-35]]></modelid>
		<pubmedid><![CDATA[16928995]]></pubmedid>
		<author><![CDATA[Rassi]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[New England Journal of Medicine]]></journal>
		<title><![CDATA[Development and validation of a risk score for predicting death in Chagas' heart disease]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[424]]></modelsamplesize>
		<cohortsamplesize><![CDATA[424]]></cohortsamplesize>
		<numberofevents><![CDATA[130]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiomegaly, Low QRS Voltage, Sex, NYHA Class, VT, Wall Motion Abnormality]]></covariates>
		<mh><![CDATA[Adult; Analysis of Variance; Animals; Arrhythmias, Cardiac/etiology; Brazil/epidemiology; Bundle-Branch Block/etiology; Chagas Cardiomyopathy/*mortality; Chagas Disease/complications/mortality; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; *Risk Assessment; Risk Factors; Survival Analysis; Trypanosoma cruzi]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-36]]></modelid>
		<pubmedid><![CDATA[16955034]]></pubmedid>
		<author><![CDATA[Mocco]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Neurosurgery]]></journal>
		<title><![CDATA[Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[98]]></modelsamplesize>
		<cohortsamplesize><![CDATA[98]]></cohortsamplesize>
		<numberofevents><![CDATA[60]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aneurysm Size, Hyperglycemia]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Follow-Up Studies; Humans; Intracranial Aneurysm/diagnosis/*epidemiology/therapy; Male; Middle Aged; Predictive Value of Tests; *Preoperative Care; Subarachnoid Hemorrhage/diagnosis/*epidemiology/therapy; Survival Analysis; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-37]]></modelid>
		<pubmedid><![CDATA[16990579]]></pubmedid>
		<author><![CDATA[Hofmann]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk score for peri-interventional complications of carotid artery stenting]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[606]]></modelsamplesize>
		<cohortsamplesize><![CDATA[606]]></cohortsamplesize>
		<numberofevents><![CDATA[26]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Stenosis, HbA1c, Ulceration]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Carotid Arteries/surgery; Carotid Stenosis/*surgery; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction/epidemiology/etiology; Postoperative Complications/*epidemiology/mortality; Risk Assessment; Risk Factors; *Stents; Stroke/epidemiology/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-38]]></modelid>
		<pubmedid><![CDATA[17000947]]></pubmedid>
		<author><![CDATA[Huynh]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Archives of Internal Medicine]]></journal>
		<title><![CDATA[Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[282]]></modelsamplesize>
		<cohortsamplesize><![CDATA[282]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Dementia, PVD, Serum Urea Nitrogen, Sodium, SBP]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Blood Pressure; Blood Urea Nitrogen; Coronary Artery Disease/complications; Dementia/complications; Female; Follow-Up Studies; Heart Failure/complications/diagnosis/*mortality; Humans; Male; Peripheral Vascular Diseases/complications; Prognosis; Risk Factors; Sodium/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-39]]></modelid>
		<pubmedid><![CDATA[17027575]]></pubmedid>
		<author><![CDATA[Senni]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[292]]></modelsamplesize>
		<cohortsamplesize><![CDATA[807]]></cohortsamplesize>
		<numberofevents><![CDATA[61]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.844]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, AF, COPD, Diabetes, Hypertension, LVEF, Cancer, Kidney Dysfunction, NYHA Class, ACE Inhibitors, Beta Blockers, Valve Disease]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Comorbidity; Female; Heart Failure/*diagnosis/*epidemiology/mortality; Hospitalization; Humans; Logistic Models; Male; Prognosis; ROC Curve; Reproducibility of Results; Risk Factors; Survival Analysis; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-40]]></modelid>
		<pubmedid><![CDATA[17032691]]></pubmedid>
		<author><![CDATA[Fox]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[21688]]></modelsamplesize>
		<cohortsamplesize><![CDATA[21688]]></cohortsamplesize>
		<numberofevents><![CDATA[1757]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Arrest, CHF, Hypertension, Cardiac Markers, Creatinine, Killip Class, LBBB, ST Segment Changes, PCI, PVD, Pulse, SBP]]></covariates>
		<mh><![CDATA[Epidemiologic Methods; Female; Humans; Male; Myocardial Infarction/mortality; Myocardial Ischemia/diagnosis/*mortality; Prognosis; Severity of Illness Index; Syndrome; Triage/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-41]]></modelid>
		<pubmedid><![CDATA[17068305]]></pubmedid>
		<author><![CDATA[Kent]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[2131]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2131]]></cohortsamplesize>
		<numberofevents><![CDATA[773]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.793]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS, Diabetes, Sex, Prior Stroke, rt-PA Treatment, Time to Treatment, SBP]]></covariates>
		<mh><![CDATA[Aged; Brain Ischemia/*diagnosis/*drug therapy/epidemiology; Female; Fibrinolytic Agents/administration & dosage; Humans; Infusions, Intravenous; Male; Middle Aged; Predictive Value of Tests; Stroke/*diagnosis/*drug therapy/epidemiology; Thrombolytic Therapy/methods; Tissue Plasminogen Activator/administration & dosage; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-42]]></modelid>
		<pubmedid><![CDATA[17068305]]></pubmedid>
		<author><![CDATA[Kent]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[2131]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2131]]></cohortsamplesize>
		<numberofevents><![CDATA[464]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.775]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS, Glucose]]></covariates>
		<mh><![CDATA[Aged; Brain Ischemia/*diagnosis/*drug therapy/epidemiology; Female; Fibrinolytic Agents/administration & dosage; Humans; Infusions, Intravenous; Male; Middle Aged; Predictive Value of Tests; Stroke/*diagnosis/*drug therapy/epidemiology; Thrombolytic Therapy/methods; Tissue Plasminogen Activator/administration & dosage; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-43]]></modelid>
		<pubmedid><![CDATA[17082207]]></pubmedid>
		<author><![CDATA[Adrie]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[130]]></modelsamplesize>
		<cohortsamplesize><![CDATA[130]]></cohortsamplesize>
		<numberofevents><![CDATA[102]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Lactate, Flow Interval, VF/VT]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiopulmonary Resuscitation/*mortality; Cohort Studies; Critical Care/statistics & numerical data; Emergency Medical Services/*statistics & numerical data; Female; France; Heart Arrest/mortality/*therapy; Hospitalization/statistics & numerical data; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Recovery of Function; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-44]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[4890]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4890]]></cohortsamplesize>
		<numberofevents><![CDATA[224]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-45]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[5013]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5013]]></cohortsamplesize>
		<numberofevents><![CDATA[147]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-46]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[4890]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4890]]></cohortsamplesize>
		<numberofevents><![CDATA[224]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-47]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[5013]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5013]]></cohortsamplesize>
		<numberofevents><![CDATA[147]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-48]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4890]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4890]]></cohortsamplesize>
		<numberofevents><![CDATA[66]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-49]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[5013]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5013]]></cohortsamplesize>
		<numberofevents><![CDATA[39]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-50]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[4890]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4890]]></cohortsamplesize>
		<numberofevents><![CDATA[158]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-51]]></modelid>
		<pubmedid><![CDATA[17088464]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[5013]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5013]]></cohortsamplesize>
		<numberofevents><![CDATA[108]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; *Asian Continental Ancestry Group/statistics & numerical data; Brain Ischemia/*complications; Cohort Studies; Coronary Disease/epidemiology/ethnology/*etiology/*mortality; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Models, Statistical; Prognosis; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Sex Distribution; Stroke/epidemiology/ethnology/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-52]]></modelid>
		<pubmedid><![CDATA[17099015]]></pubmedid>
		<author><![CDATA[Shireman]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Development of a contemporary bleeding risk model for elderly warfarin recipients.]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[19875]]></modelsamplesize>
		<cohortsamplesize><![CDATA[26345]]></cohortsamplesize>
		<numberofevents><![CDATA[318]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Substance Abuse, Anemia, Antiplatelet Medication, Diabetes, Sex, Bleeding]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Anticoagulants/*adverse effects/*therapeutic use; Atrial Fibrillation/*drug therapy/physiopathology; Cohort Studies; Decision Support Techniques; Female; Hemorrhage/*chemically induced/physiopathology; Humans; Male; *Models, Theoretical; Practice Guidelines as Topic; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stroke/drug therapy/prevention & control; Warfarin/*adverse effects/*therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[06-001-53]]></modelid>
		<pubmedid><![CDATA[17718249]]></pubmedid>
		<author><![CDATA[Poungvarin]]></author>
		<year><![CDATA[2006]]></year>
		<journal><![CDATA[Journal of the Medical Association of Thailand]]></journal>
		<title><![CDATA[Grave prognosis on spontaneous intracerebral haemorrhage: GP on Stage score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[995]]></modelsamplesize>
		<cohortsamplesize><![CDATA[995]]></cohortsamplesize>
		<numberofevents><![CDATA[402]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Fever, GCS Score, Hematoma, Intraventicular Hemorrhage]]></covariates>
		<mh><![CDATA[Cerebral Hemorrhage/*diagnosis/drug therapy/mortality; Cerebrovascular Disorders; Female; Health Status Indicators; Humans; Male; Mannitol/therapeutic use; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Time Factors; *Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-01]]></modelid>
		<pubmedid><![CDATA[17090561]]></pubmedid>
		<author><![CDATA[Woodward]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[6540]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6540]]></cohortsamplesize>
		<numberofevents><![CDATA[743]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.727]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, Family History, HDL Cholesterol, SIMD Score, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Cardiovascular Diseases/*etiology/genetics; Cohort Studies; Female; Genetic Predisposition to Disease; *Health Status Indicators; Humans; Male; Middle Aged; Models, Biological; *Models, Statistical; *Psychosocial Deprivation; Risk Factors; Scotland; Sensitivity and Specificity; Sex Factors; Smoking/adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-02]]></modelid>
		<pubmedid><![CDATA[17090561]]></pubmedid>
		<author><![CDATA[Woodward]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[6757]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6757]]></cohortsamplesize>
		<numberofevents><![CDATA[422]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.765]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, Family History, HDL Cholesterol, SIMD Score, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Cardiovascular Diseases/*etiology/genetics; Cohort Studies; Female; Genetic Predisposition to Disease; *Health Status Indicators; Humans; Male; Middle Aged; Models, Biological; *Models, Statistical; *Psychosocial Deprivation; Risk Factors; Scotland; Sensitivity and Specificity; Sex Factors; Smoking/adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-03]]></modelid>
		<pubmedid><![CDATA[17184630]]></pubmedid>
		<author><![CDATA[Rampoldi]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[682]]></modelsamplesize>
		<cohortsamplesize><![CDATA[682]]></cohortsamplesize>
		<numberofevents><![CDATA[163]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Pulse, EKG Findings, AVR, Chest Pain, Tamponade, Hypotension or Shock]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Aneurysm, Dissecting/mortality/*surgery; Aortic Aneurysm/mortality/*surgery; Female; *Hospital Mortality; Humans; Male; Middle Aged; Models, Theoretical; Registries; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-04]]></modelid>
		<pubmedid><![CDATA[17184630]]></pubmedid>
		<author><![CDATA[Rampoldi]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[682]]></modelsamplesize>
		<cohortsamplesize><![CDATA[682]]></cohortsamplesize>
		<numberofevents><![CDATA[163]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Pulse, AVR, CABG, Hypotension or Shock, Partial Arch, RV Dysfunction, Chest Pain]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Aneurysm, Dissecting/mortality/*surgery; Aortic Aneurysm/mortality/*surgery; Female; *Hospital Mortality; Humans; Male; Middle Aged; Models, Theoretical; Registries; Risk]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-05]]></modelid>
		<pubmedid><![CDATA[17192335]]></pubmedid>
		<author><![CDATA[Yang]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3668]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3668]]></cohortsamplesize>
		<numberofevents><![CDATA[190]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.749]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin to Creatinine Ratio, HbA1c, CAD]]></covariates>
		<mh><![CDATA[*Asian Continental Ancestry Group; Coronary Disease/epidemiology; Diabetes Mellitus, Type 2/*complications; Diabetic Angiopathies/*epidemiology; Female; Follow-Up Studies; Hong Kong/epidemiology; Humans; Incidence; Male; Patient Selection; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Stroke/*epidemiology; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-06]]></modelid>
		<pubmedid><![CDATA[17223413]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17787]]></modelsamplesize>
		<cohortsamplesize><![CDATA[29526]]></cohortsamplesize>
		<numberofevents><![CDATA[709]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hematocrit, Sex, MCH, MCV, Platelets, RBC, WBC]]></covariates>
		<mh><![CDATA[Age Factors; Blood Cell Count; Cardiovascular Diseases/*blood/*mortality; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment/methods; Sex Factors; Survival Rate/trends; Time Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-07]]></modelid>
		<pubmedid><![CDATA[17223413]]></pubmedid>
		<author><![CDATA[Anderson]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17787]]></modelsamplesize>
		<cohortsamplesize><![CDATA[29526]]></cohortsamplesize>
		<numberofevents><![CDATA[709]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.711]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hematocrit, Sex, MCH, MCV, Platelets, RBC, WBC]]></covariates>
		<mh><![CDATA[Age Factors; Blood Cell Count; Cardiovascular Diseases/*blood/*mortality; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment/methods; Sex Factors; Survival Rate/trends; Time Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-08]]></modelid>
		<pubmedid><![CDATA[17270062]]></pubmedid>
		<author><![CDATA[Bae]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Health Services Management Research]]></journal>
		<title><![CDATA[Managing and analysing a large health-care system database for predicting in-hospital mortality among acute myocardial infarction patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3758]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3758]]></cohortsamplesize>
		<numberofevents><![CDATA[353]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ACE Inhibitor, Age, Cardiac Rehabilitation, Beta Blockers, CPR, Comorbidities, Complication, Killip Class, Angioplasty, Plavix]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Databases as Topic/*organization & administration; Delivery of Health Care; Female; Forecasting; Health Services Research; *Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction/*mortality; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-09]]></modelid>
		<pubmedid><![CDATA[17287128]]></pubmedid>
		<author><![CDATA[Kuduvalli]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4550]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4550]]></cohortsamplesize>
		<numberofevents><![CDATA[207]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Shock, CABG, LVEF, Hypertension, NYHA Class, Non-Elective Surgery, Prior Cardiac Surgery, Renal Dysfunction]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Valve/*surgery; Coronary Artery Bypass/mortality; England/epidemiology; Female; Heart Valve Diseases/complications/surgery; Heart Valve Prosthesis Implantation/*mortality; *Hospital Mortality; Humans; Kidney Diseases/complications; Logistic Models; Male; Models, Statistical; Retrospective Studies; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-10]]></modelid>
		<pubmedid><![CDATA[17299196]]></pubmedid>
		<author><![CDATA[Ridker]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.[Erratum appears in JAMA. 2007 Apr 4;297(13):1433]]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[16400]]></modelsamplesize>
		<cohortsamplesize><![CDATA[24558]]></cohortsamplesize>
		<numberofevents><![CDATA[504]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.809]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Apolipoprotein A/B, Smoking, Hemoglobin, Diabetes, CRP, SBP, Family History]]></covariates>
		<mh><![CDATA[*Algorithms; Cardiovascular Diseases/*epidemiology; Female; Humans; Middle Aged; Models, Statistical; *Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-11]]></modelid>
		<pubmedid><![CDATA[17299196]]></pubmedid>
		<author><![CDATA[Ridker]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of the American Medical Association]]></journal>
		<title><![CDATA[Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[16400]]></modelsamplesize>
		<cohortsamplesize><![CDATA[24558]]></cohortsamplesize>
		<numberofevents><![CDATA[504]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.808]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Hemoglobin, Diabetes, HDL Cholesterol, CRP, SBP, Family History, Total Cholesterol]]></covariates>
		<mh><![CDATA[*Algorithms; Cardiovascular Diseases/*epidemiology; Female; Humans; Middle Aged; Models, Statistical; *Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-12]]></modelid>
		<pubmedid><![CDATA[17307434]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Risk index for predicting in-hospital mortality for cardiac valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10702]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10702]]></cohortsamplesize>
		<numberofevents><![CDATA[472]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.794]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, Creatinine, Endocarditis, Sex, Hepatic Failure, MVR, PAD, MI, Previous Open Heart Operations, Dialysis, Shock, Hemodynamic State]]></covariates>
		<mh><![CDATA[Aged; Cardiac Surgical Procedures/*mortality; Coronary Artery Bypass/mortality; Female; Heart Valves/*surgery; *Hospital Mortality; Humans; Male; Middle Aged; *Models, Cardiovascular; Prognosis; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-13]]></modelid>
		<pubmedid><![CDATA[17307434]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Risk index for predicting in-hospital mortality for cardiac valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8823]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8823]]></cohortsamplesize>
		<numberofevents><![CDATA[784]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cerebrovascular Disease, Creatinine, Diabetes, LVEF, Endocarditis, Calcified Aorta, Sex, MVR/CABG, MI, Previous Open Heart Operations, Dialysis, Shock, Hemodynamic State]]></covariates>
		<mh><![CDATA[Aged; Cardiac Surgical Procedures/*mortality; Coronary Artery Bypass/mortality; Female; Heart Valves/*surgery; *Hospital Mortality; Humans; Male; Middle Aged; *Models, Cardiovascular; Prognosis; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-14]]></modelid>
		<pubmedid><![CDATA[17379820]]></pubmedid>
		<author><![CDATA[Ruiz-Sandoval]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Grading scale for prediction of outcome in primary intracerebral hemorrhages]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[378]]></modelsamplesize>
		<cohortsamplesize><![CDATA[378]]></cohortsamplesize>
		<numberofevents><![CDATA[174]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.831]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Extension into Ventricles, GCS Score, ICH Location, ICH Volume]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cerebral Hemorrhage/*mortality; Female; Hospital Mortality; Humans; Male; Middle Aged; Outcome Assessment (Health Care); Predictive Value of Tests; Prognosis; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-15]]></modelid>
		<pubmedid><![CDATA[17380222]]></pubmedid>
		<author><![CDATA[McDonald]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Canadian Journal of Cardiology]]></journal>
		<title><![CDATA[Clinical risk scoring beyond initial troponin values: results from a large, prospective, unselected acute chest pain population]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1054]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1054]]></cohortsamplesize>
		<numberofevents><![CDATA[141]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CAD Risk Factors, Aspirin, Sex, CHF, ST Deviation]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Analysis of Variance; Chest Pain/*blood/etiology; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Ischemia/blood/*diagnosis; Predictive Value of Tests; Prospective Studies; Research Design; Risk Assessment; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires; Troponin I/*blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-16]]></modelid>
		<pubmedid><![CDATA[17443658]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Clinical Cardiology]]></journal>
		<title><![CDATA[A risk-predictive score for cardiogenic shock after acute myocardial infarction in Chinese patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Cardiogenic Shock]]></outcome>
		<modelsamplesize><![CDATA[2077]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2077]]></cohortsamplesize>
		<numberofevents><![CDATA[184]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Family History, Sex, Killip Class, Multivessel Disease, MI Location, Previous MI, Thrombolytic Therapy]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Blood Pressure; Case-Control Studies; China/epidemiology; Female; Heart Rate; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/*complications/physiopathology; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Sex Factors; Shock, Cardiogenic/*epidemiology/*etiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-17]]></modelid>
		<pubmedid><![CDATA[17478150]]></pubmedid>
		<author><![CDATA[Mainous]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A coronary heart disease risk score based on patient-reported information]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[6239]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6239]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.649]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CHD Risk, Age, Family History, Diabetes, Hypercholesterolemia, Hypertension, Physical Activity, Smoking]]></covariates>
		<mh><![CDATA[Body Mass Index; Cohort Studies; Coronary Disease/*etiology; Diabetes Complications/complications; Female; *Health Status Indicators; Humans; Hypercholesterolemia/complications; Hypertension/complications; Life Style; Male; Middle Aged; ROC Curve; Risk Assessment; *Self-Assessment; Smoking/adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-18]]></modelid>
		<pubmedid><![CDATA[17478150]]></pubmedid>
		<author><![CDATA[Mainous]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A coronary heart disease risk score based on patient-reported information]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[8104]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8104]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.788]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CHD Risk, Age, BMI, Diabetes, Hypercholesterolemia, Hypertension, Smoking]]></covariates>
		<mh><![CDATA[Body Mass Index; Cohort Studies; Coronary Disease/*etiology; Diabetes Complications/complications; Female; *Health Status Indicators; Humans; Hypercholesterolemia/complications; Hypertension/complications; Life Style; Male; Middle Aged; ROC Curve; Risk Assessment; *Self-Assessment; Smoking/adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-19]]></modelid>
		<pubmedid><![CDATA[17484455]]></pubmedid>
		<author><![CDATA[Xu]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Heart Valve Disease]]></journal>
		<title><![CDATA[A simple predictive model of prolonged intensive care unit stay after surgery for acquired heart valve disease]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[2193]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2193]]></cohortsamplesize>
		<numberofevents><![CDATA[345]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiothoracic Ratio, LVEF, Age, CPB Time, CABG, Valve Surgery, Stroke, Ischemic MR, Cardiac Surgery, Pulmonary Dysfunction, Hypertension, Repeat CPB]]></covariates>
		<mh><![CDATA[Adult; Analysis of Variance; Aortic Valve/*surgery; China; Female; Heart Valve Diseases/epidemiology/*surgery; *Heart Valve Prosthesis Implantation/mortality; Humans; *Intensive Care Units; *Length of Stay; Logistic Models; Male; Middle Aged; Predictive Value of Tests; ROC Curve; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-20]]></modelid>
		<pubmedid><![CDATA[17484455]]></pubmedid>
		<author><![CDATA[Xu]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Heart Valve Disease]]></journal>
		<title><![CDATA[A simple predictive model of prolonged intensive care unit stay after surgery for acquired heart valve disease]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[2193]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2193]]></cohortsamplesize>
		<numberofevents><![CDATA[345]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiothoracic Ratio, LVEF, Age, CPB Time, CABG, Valve Surgery, Stroke, Ischemic MR, Cardiac Surgery, Pulmonary Dysfunction, Hypertension, Repeat CPB]]></covariates>
		<mh><![CDATA[Adult; Analysis of Variance; Aortic Valve/*surgery; China; Female; Heart Valve Diseases/epidemiology/*surgery; *Heart Valve Prosthesis Implantation/mortality; Humans; *Intensive Care Units; *Length of Stay; Logistic Models; Male; Middle Aged; Predictive Value of Tests; ROC Curve; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-21]]></modelid>
		<pubmedid><![CDATA[17499658]]></pubmedid>
		<author><![CDATA[Chen]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[A risk score to predict silent myocardial ischemia in patients with coronary artery disease under aspirin therapy presenting with upper gastrointestinal hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[224]]></modelsamplesize>
		<cohortsamplesize><![CDATA[224]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.93]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BUN/Creatinine, DBP, Hematocrit, CAD Severity, SBP]]></covariates>
		<mh><![CDATA[Aged; Aspirin/*adverse effects/therapeutic use; Coronary Artery Disease/*complications/*drug therapy; Female; Fibrinolytic Agents/*therapeutic use; Gastrointestinal Hemorrhage/*chemically induced; Humans; Logistic Models; Male; Multivariate Analysis; Myocardial Ischemia/*diagnosis/*etiology; Prospective Studies; Risk Assessment/methods; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-22]]></modelid>
		<pubmedid><![CDATA[17540848]]></pubmedid>
		<author><![CDATA[Richardson]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[813]]></modelsamplesize>
		<cohortsamplesize><![CDATA[813]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Ischemic Etiology, Cardiac Resynchronization Therapy, Mechanical Delay, Mitral Regurgitation, NT-proBNP, SBP]]></covariates>
		<mh><![CDATA[Aged; Blood Pressure; *Cardiac Pacing, Artificial; Heart Failure/mortality/*therapy/ultrasonography; Humans; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Systole; Time Factors; *Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-23]]></modelid>
		<pubmedid><![CDATA[17544078]]></pubmedid>
		<author><![CDATA[Davenport]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of the American College of Surgeons]]></journal>
		<title><![CDATA[Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the patient safety in surgery study]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[91403]]></modelsamplesize>
		<cohortsamplesize><![CDATA[183069]]></cohortsamplesize>
		<numberofevents><![CDATA[1181]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.856]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ASA Status, Ascites, Bleeding, CHF, CVA, Dyspnea, Emergency, Sex, Impaired Senses, Albumin, Creatinine, Platelets, Sepsis, Specialty, Operation Type, WBC, Weight, Work RVU, Wound Class]]></covariates>
		<mh><![CDATA[Academic Medical Centers; Female; Heart Arrest/*etiology; Hospitals, Veterans; Humans; Male; Middle Aged; *Models, Statistical; Myocardial Infarction/*etiology; *Postoperative Complications; Private Sector; Regression Analysis; Safety; *Surgical Procedures, Operative; United States; *Vascular Surgical Procedures]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-24]]></modelid>
		<pubmedid><![CDATA[17544079]]></pubmedid>
		<author><![CDATA[Rogers]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of the American College of Surgeons]]></journal>
		<title><![CDATA[Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[182783]]></modelsamplesize>
		<cohortsamplesize><![CDATA[183069]]></cohortsamplesize>
		<numberofevents><![CDATA[1162]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.765]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ASA Class, Aneurysm, Chemotherapy, Cancer, Dyspnea, Emergency, Sex, Hernia, Albumin, Bilirubin, Hematocrit, Sodium, Transfusion, Ventilator, Work RVU, Wound Class]]></covariates>
		<mh><![CDATA[Academic Medical Centers; Female; Hospitals, Veterans; Humans; Logistic Models; Male; Middle Aged; *Models, Statistical; Postoperative Complications/*etiology; Private Sector; Risk Factors; Safety; *Surgical Procedures, Operative; Thromboembolism/*etiology; United States; Vascular Surgical Procedures; Venous Thrombosis/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-25]]></modelid>
		<pubmedid><![CDATA[17550750]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Mayo Clinic Proceedings]]></journal>
		<title><![CDATA[Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[7457]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7457]]></cohortsamplesize>
		<numberofevents><![CDATA[136]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.902]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, MI/Shock, Diabetes, LVEF, Sex, PAD, Shock, Creatinine]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*adverse effects/statistics & numerical data; Cardiovascular Diseases/mortality/*therapy; Creatinine/blood; Female; Health Status; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Point-of-Care Systems; Prognosis; Registries; *Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-26]]></modelid>
		<pubmedid><![CDATA[17550750]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Mayo Clinic Proceedings]]></journal>
		<title><![CDATA[Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[7457]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7457]]></cohortsamplesize>
		<numberofevents><![CDATA[291]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.758]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, Diabetes, LVEF, Sex, MI, PAD, Shock, Creatinine]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*adverse effects/statistics & numerical data; Cardiovascular Diseases/mortality/*therapy; Creatinine/blood; Female; Health Status; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Point-of-Care Systems; Prognosis; Registries; *Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-27]]></modelid>
		<pubmedid><![CDATA[17569877]]></pubmedid>
		<author><![CDATA[Prosser]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predictors of early cardiac morbidity and mortality after ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[846]]></modelsamplesize>
		<cohortsamplesize><![CDATA[846]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, Creatinine, Diabetes, Hypertension, QTc Duration, Stroke Severity, SBP, Ventricular Premature Beats]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Brain Ischemia/*mortality/physiopathology; Causality; Comorbidity; Creatinine/blood; *Death; Diabetes Complications/epidemiology; Female; Heart Diseases/*mortality/*physiopathology; Heart Failure/epidemiology/physiopathology; Humans; Male; Predictive Value of Tests; Risk Factors; Stroke/*mortality/physiopathology; Survival Analysis; Time Factors; Ventricular Premature Complexes/epidemiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-28]]></modelid>
		<pubmedid><![CDATA[17615182]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[646421]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1283174]]></cohortsamplesize>
		<numberofevents><![CDATA[27828]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, Family History, Age, Cholesterol, Antihypertensive Medication, Smoking, SBP, Townsend Score]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; Cardiovascular Diseases/*etiology/mortality/prevention & control; Cohort Studies; Female; Great Britain/epidemiology; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-29]]></modelid>
		<pubmedid><![CDATA[17615182]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[636753]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1283174]]></cohortsamplesize>
		<numberofevents><![CDATA[37843]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, Family History, Age, Cholesterol, Antihypertensive Medication, Smoking, SBP, Townsend Score]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; Cardiovascular Diseases/*etiology/mortality/prevention & control; Cohort Studies; Female; Great Britain/epidemiology; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-30]]></modelid>
		<pubmedid><![CDATA[17638928]]></pubmedid>
		<author><![CDATA[Lietz]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[222]]></modelsamplesize>
		<cohortsamplesize><![CDATA[222]]></cohortsamplesize>
		<numberofevents><![CDATA[76]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AST, BUN, Hematocrit, INR, Pulmonary Artery Pressure, Inotropes, Platelets, Albumin, Vasodilator Therapy]]></covariates>
		<mh><![CDATA[Aged; Cardiovascular Agents/therapeutic use; Cause of Death; Equipment Failure/statistics & numerical data; Female; Follow-Up Studies; Heart Failure/drug therapy/mortality/*surgery; Heart Transplantation; *Heart-Assist Devices/statistics & numerical data; Hematologic Diseases/complications; Hospital Mortality; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Malnutrition/complications; Middle Aged; Multiple Organ Failure/etiology/mortality; Quality of Life; Registries/statistics & numerical data; Retrospective Studies; Risk; Sepsis/etiology/mortality; Survival Analysis; Survival Rate; Treatment Outcome; United States/epidemiology; Ventricular Dysfunction, Right/etiology/mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-65]]></modelid>
		<pubmedid><![CDATA[23522221]]></pubmedid>
		<author><![CDATA[Rankin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[18686]]></modelsamplesize>
		<cohortsamplesize><![CDATA[50231]]></cohortsamplesize>
		<numberofevents><![CDATA[1424]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.727]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Insufficiency, BSA, Shock, CHF, NYHA Class, Lung Disease, CABG, Creatinine, CVD, Diabetes, Dialysis, LVEF, Immunosuppressive Treatment, Mitral Insufficiency, Mitral Replacement, Cardiac Surgery, MI, PVD, Status, Tricuspid Replacement]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-31]]></modelid>
		<pubmedid><![CDATA[17643583]]></pubmedid>
		<author><![CDATA[Negassa]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Tree-structured risk stratification of in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction: a report from the New York State percutaneous coronary intervention database]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5385]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5385]]></cohortsamplesize>
		<numberofevents><![CDATA[196]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, CHF]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; Female; Hospital Mortality; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction/mortality/*therapy; New York; *Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-32]]></modelid>
		<pubmedid><![CDATA[17643630]]></pubmedid>
		<author><![CDATA[Reddy]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Logistic risk model for prolonged ventilation after adult cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Ventilation]]></outcome>
		<modelsamplesize><![CDATA[6000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12662]]></cohortsamplesize>
		<numberofevents><![CDATA[330]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Surgery, Smoking, LVEF, Emergency Surgery, FEV1, Mitral Valve Surgery, MI, PVD, Ventilation, Prior Cardiac Surgery, Creatinine, CPB]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Body Mass Index; Cardiac Surgical Procedures/adverse effects/*statistics & numerical data; Female; Heart Diseases/classification/physiopathology; Humans; Male; Middle Aged; Models, Statistical; Organization and Administration; Postoperative Complications/classification/therapy; Respiration, Artificial/*adverse effects; Retrospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-33]]></modelid>
		<pubmedid><![CDATA[17721802]]></pubmedid>
		<author><![CDATA[Tambyraja]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[World Journal of Surgery]]></journal>
		<title><![CDATA[Predictors of outcome after abdominal aortic aneurysm rupture: Edinburgh Ruptured Aneurysm Score]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[105]]></modelsamplesize>
		<cohortsamplesize><![CDATA[105]]></cohortsamplesize>
		<numberofevents><![CDATA[39]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BP, GCS Score, Hemoglobin]]></covariates>
		<mh><![CDATA[Aged; Aortic Aneurysm, Abdominal/*mortality/surgery; Aortic Rupture/*mortality/surgery; Female; *Glasgow Coma Scale; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; *Outcome Assessment (Health Care); Patient Selection; Prognosis; Risk Assessment/*methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-34]]></modelid>
		<pubmedid><![CDATA[17824292]]></pubmedid>
		<author><![CDATA[Zaliunas]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Acta Cardiologica]]></journal>
		<title><![CDATA[The risk of cardiovascular death following the first acute ischaemic syndrome: experience in Kaunas between 1997 and 2001]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[732]]></modelsamplesize>
		<cohortsamplesize><![CDATA[732]]></cohortsamplesize>
		<numberofevents><![CDATA[84]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Killip Class, LVEF, Revascularization, Q Wave, Stenosis]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/*mortality/physiopathology; Aged; Analysis of Variance; Angina, Unstable/mortality; Coronary Stenosis/mortality; *Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Lithuania/epidemiology; Male; Middle Aged; Myocardial Infarction/mortality; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Research Design; Risk Factors; Stroke Volume; Survival Analysis; Survival Rate; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-35]]></modelid>
		<pubmedid><![CDATA[17934885]]></pubmedid>
		<author><![CDATA[Solberg]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Neurology]]></journal>
		<title><![CDATA[Derivation and validation of a simple risk score for predicting 1-year mortality in stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[442]]></modelsamplesize>
		<cohortsamplesize><![CDATA[737]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.747]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Canadian Neurological Scale]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Predictive Value of Tests; *Proportional Hazards Models; Random Allocation; Reproducibility of Results; Retrospective Studies; *Risk Factors; Severity of Illness Index; Stroke/epidemiology/*mortality; *Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-36]]></modelid>
		<pubmedid><![CDATA[17934885]]></pubmedid>
		<author><![CDATA[Solberg]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Neurology]]></journal>
		<title><![CDATA[Derivation and validation of a simple risk score for predicting 1-year mortality in stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[442]]></modelsamplesize>
		<cohortsamplesize><![CDATA[737]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.758]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Canadian Neurological Scale, Charlson Comorbidity Index]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Predictive Value of Tests; *Proportional Hazards Models; Random Allocation; Reproducibility of Results; Retrospective Studies; *Risk Factors; Severity of Illness Index; Stroke/epidemiology/*mortality; *Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-37]]></modelid>
		<pubmedid><![CDATA[17934885]]></pubmedid>
		<author><![CDATA[Solberg]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Neurology]]></journal>
		<title><![CDATA[Derivation and validation of a simple risk score for predicting 1-year mortality in stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[442]]></modelsamplesize>
		<cohortsamplesize><![CDATA[737]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.777]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Canadian Neurological Scale, Charlson Comorbidity Index, Stroke Type]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Predictive Value of Tests; *Proportional Hazards Models; Random Allocation; Reproducibility of Results; Retrospective Studies; *Risk Factors; Severity of Illness Index; Stroke/epidemiology/*mortality; *Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-38]]></modelid>
		<pubmedid><![CDATA[18004645]]></pubmedid>
		<author><![CDATA[Roquer]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Neurology]]></journal>
		<title><![CDATA[Clustering of vascular risk factors and in-hospital death after acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1527]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1527]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.649]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Glycemia, Complications, Sex, NIHSS]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Atrial Fibrillation/complications; Brain Ischemia/complications; Cluster Analysis; Diabetes Mellitus; Disease Progression; Female; *Hospital Mortality; Humans; Hypertension/complications; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; ROC Curve; Retrospective Studies; Risk Factors; Stroke/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-39]]></modelid>
		<pubmedid><![CDATA[18004645]]></pubmedid>
		<author><![CDATA[Roquer]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Neurology]]></journal>
		<title><![CDATA[Clustering of vascular risk factors and in-hospital death after acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1527]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1527]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.711]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Glycemia, Sex, NIHSS]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Atrial Fibrillation/complications; Brain Ischemia/complications; Cluster Analysis; Diabetes Mellitus; Disease Progression; Female; *Hospital Mortality; Humans; Hypertension/complications; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; ROC Curve; Retrospective Studies; Risk Factors; Stroke/*etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-40]]></modelid>
		<pubmedid><![CDATA[18035241]]></pubmedid>
		<author><![CDATA[Okamoto]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[Journal of Stroke & Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Prediction of subarachnoid hemorrhage from a ruptured cerebral aneurysm by discriminant analysis in women]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[124]]></modelsamplesize>
		<cohortsamplesize><![CDATA[124]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Antioxidant Intake, Family History, Hypertension, Pregnancy, Smoking]]></covariates>
		<mh><![CDATA[Adult; Aged; Antioxidants/metabolism; Asian Continental Ancestry Group; Case-Control Studies; Discriminant Analysis; Female; Gravidity; Humans; Hypertension/complications; Intracranial Aneurysm/*complications; Japan; Mass Screening/*methods; Middle Aged; Models, Statistical; Odds Ratio; Pedigree; Predictive Value of Tests; Pregnancy; Risk Assessment; Risk Factors; Rupture; Smoking/adverse effects; Subarachnoid Hemorrhage/*diagnosis/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-41]]></modelid>
		<pubmedid><![CDATA[18036028]]></pubmedid>
		<author><![CDATA[Assmann]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[European Journal of Clinical Investigation]]></journal>
		<title><![CDATA[Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[26975]]></modelsamplesize>
		<cohortsamplesize><![CDATA[26975]]></cohortsamplesize>
		<numberofevents><![CDATA[511]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Family History, Glucose or Diabetes, HDL Cholesterol, LDL Cholesterol, Smoking, SBP, Triglycerides]]></covariates>
		<mh><![CDATA[Adult; Aged; Death, Sudden, Cardiac/*epidemiology; Female; Germany/epidemiology; Humans; Ischemic Attack, Transient/*epidemiology; Male; Middle Aged; Myocardial Infarction/*epidemiology; Prospective Studies; Risk Factors; Stroke/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-42]]></modelid>
		<pubmedid><![CDATA[18036028]]></pubmedid>
		<author><![CDATA[Assmann]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[European Journal of Clinical Investigation]]></journal>
		<title><![CDATA[Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[26975]]></modelsamplesize>
		<cohortsamplesize><![CDATA[26975]]></cohortsamplesize>
		<numberofevents><![CDATA[85]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.817]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Sex, Smoking, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Death, Sudden, Cardiac/*epidemiology; Female; Germany/epidemiology; Humans; Ischemic Attack, Transient/*epidemiology; Male; Middle Aged; Myocardial Infarction/*epidemiology; Prospective Studies; Risk Factors; Stroke/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[07-001-43]]></modelid>
		<pubmedid><![CDATA[18062902]]></pubmedid>
		<author><![CDATA[Nielsen]]></author>
		<year><![CDATA[2007]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[459]]></modelsamplesize>
		<cohortsamplesize><![CDATA[459]]></cohortsamplesize>
		<numberofevents><![CDATA[98]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, AF, BNP, Q Wave, MI]]></covariates>
		<mh><![CDATA[Aged; Angiotensin-Converting Enzyme Inhibitors/*therapeutic use; Biomarkers/blood; Cardiotonic Agents/*therapeutic use; Diuretics/*therapeutic use; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure/*blood/diagnosis/drug therapy; Humans; Immunoradiometric Assay; Male; Natriuretic Peptide, Brain/*blood; Primary Health Care/*methods; Prognosis; Reproducibility of Results; Risk Factors; Severity of Illness Index; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-01]]></modelid>
		<pubmedid><![CDATA[17499864]]></pubmedid>
		<author><![CDATA[Yap]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2707]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2707]]></cohortsamplesize>
		<numberofevents><![CDATA[480]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Heart Rate, Hypertension, Sex, NYHA Class, Non Q Wave Infarct, Previous MI or Angina, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; *Defibrillators, Implantable/statistics & numerical data/trends; *Demography; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic/methods/statistics & numerical data/trends; Myocardial Infarction/*diagnosis/*mortality/therapy; Prognosis; Randomized Controlled Trials as Topic/methods/statistics & numerical data/trends; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-02]]></modelid>
		<pubmedid><![CDATA[17499864]]></pubmedid>
		<author><![CDATA[Yap]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2707]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2707]]></cohortsamplesize>
		<numberofevents><![CDATA[213]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Heart Rate, Hypertension, Sex, NYHA Class, Non Q Wave Infarct, Previous MI or Angina, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; *Defibrillators, Implantable/statistics & numerical data/trends; *Demography; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic/methods/statistics & numerical data/trends; Myocardial Infarction/*diagnosis/*mortality/therapy; Prognosis; Randomized Controlled Trials as Topic/methods/statistics & numerical data/trends; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-03]]></modelid>
		<pubmedid><![CDATA[17499864]]></pubmedid>
		<author><![CDATA[Yap]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2707]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2707]]></cohortsamplesize>
		<numberofevents><![CDATA[171]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Heart Rate, Hypertension, Sex, NYHA Class, Non Q Wave Infarct, Previous MI or Angina, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; *Defibrillators, Implantable/statistics & numerical data/trends; *Demography; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic/methods/statistics & numerical data/trends; Myocardial Infarction/*diagnosis/*mortality/therapy; Prognosis; Randomized Controlled Trials as Topic/methods/statistics & numerical data/trends; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-04]]></modelid>
		<pubmedid><![CDATA[17586511]]></pubmedid>
		<author><![CDATA[Jee]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Atherosclerosis]]></journal>
		<title><![CDATA[Stroke risk prediction model: a risk profile from the Korean study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[777502]]></modelsamplesize>
		<cohortsamplesize><![CDATA[777502]]></cohortsamplesize>
		<numberofevents><![CDATA[29216]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8165]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Alcohol Use, BMI, Diabetes, Physical Activity, Smoking, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Incidence; Korea/epidemiology; Male; Middle Aged; National Health Programs/statistics & numerical data; Predictive Value of Tests; *Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Distribution; Stroke/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-05]]></modelid>
		<pubmedid><![CDATA[17586511]]></pubmedid>
		<author><![CDATA[Jee]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Atherosclerosis]]></journal>
		<title><![CDATA[Stroke risk prediction model: a risk profile from the Korean study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[446238]]></modelsamplesize>
		<cohortsamplesize><![CDATA[446238]]></cohortsamplesize>
		<numberofevents><![CDATA[18017]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8095]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Alcohol Use, BMI, Diabetes, Physical Activity, Smoking, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Incidence; Korea/epidemiology; Male; Middle Aged; National Health Programs/statistics & numerical data; Predictive Value of Tests; *Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Distribution; Stroke/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-06]]></modelid>
		<pubmedid><![CDATA[18028368]]></pubmedid>
		<author><![CDATA[Huang]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Internal Medicine Journal]]></journal>
		<title><![CDATA[prognostic factors of spontaneous intracerebral haemorrhage in haemodialysis patients and predictors of 30-day mortality]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[107]]></modelsamplesize>
		<cohortsamplesize><![CDATA[107]]></cohortsamplesize>
		<numberofevents><![CDATA[72]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, GCS Score, Intraventricular Hemorrhage, Glucose, SBP, Volume]]></covariates>
		<mh><![CDATA[Adult; Aged; Cerebral Hemorrhage/*diagnosis/*mortality; Cohort Studies; Female; Hospital Mortality/*trends; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Renal Dialysis/*mortality/*trends; Retrospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-07]]></modelid>
		<pubmedid><![CDATA[18063146]]></pubmedid>
		<author><![CDATA[Atsma]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[No added value of age at menopause and the lifetime cumulative number of menstrual cycles for cardiovascular risk prediction in postmenopausal women.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Peripheral Vascular Disease (PVD)]]></outcome>
		<modelsamplesize><![CDATA[960]]></modelsamplesize>
		<cohortsamplesize><![CDATA[960]]></cohortsamplesize>
		<numberofevents><![CDATA[152]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Glucose, SBP, Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aging/physiology; Cardiovascular Diseases/*etiology/physiopathology/*prevention & control; Cohort Studies; Female; Humans; Menopause/physiology; Menstrual Cycle/*physiology; Middle Aged; Postmenopause/*physiology; Predictive Value of Tests; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-08]]></modelid>
		<pubmedid><![CDATA[18063146]]></pubmedid>
		<author><![CDATA[Atsma]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[No added value of age at menopause and the lifetime cumulative number of menstrual cycles for cardiovascular risk prediction in postmenopausal women.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Peripheral Vascular Disease (PVD)]]></outcome>
		<modelsamplesize><![CDATA[952]]></modelsamplesize>
		<cohortsamplesize><![CDATA[952]]></cohortsamplesize>
		<numberofevents><![CDATA[152]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Age at Menopause, BMI, Smoking, Glucose, SBP, Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aging/physiology; Cardiovascular Diseases/*etiology/physiopathology/*prevention & control; Cohort Studies; Female; Humans; Menopause/physiology; Menstrual Cycle/*physiology; Middle Aged; Postmenopause/*physiology; Predictive Value of Tests; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-09]]></modelid>
		<pubmedid><![CDATA[18063146]]></pubmedid>
		<author><![CDATA[Atsma]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[No added value of age at menopause and the lifetime cumulative number of menstrual cycles for cardiovascular risk prediction in postmenopausal women.]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Peripheral Vascular Disease (PVD)]]></outcome>
		<modelsamplesize><![CDATA[928]]></modelsamplesize>
		<cohortsamplesize><![CDATA[928]]></cohortsamplesize>
		<numberofevents><![CDATA[152]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.68]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Glucose, Lifetime Menstrual Cycles, SBP, Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aging/physiology; Cardiovascular Diseases/*etiology/physiopathology/*prevention & control; Cohort Studies; Female; Humans; Menopause/physiology; Menstrual Cycle/*physiology; Middle Aged; Postmenopause/*physiology; Predictive Value of Tests; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-10]]></modelid>
		<pubmedid><![CDATA[18206526]]></pubmedid>
		<author><![CDATA[Fiutowski]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Heart & Lung]]></journal>
		<title><![CDATA[Pulmonary edema prognostic score predicts in-hospital mortality risk in patients with acute cardiogenic pulmonary edema]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[276]]></modelsamplesize>
		<cohortsamplesize><![CDATA[276]]></cohortsamplesize>
		<numberofevents><![CDATA[58]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AMI, Heart Rate, SBP, WBC]]></covariates>
		<mh><![CDATA[Acute Disease; Adult; Aged; Aged, 80 and over; Diastole; Female; Health Status Indicators; *Hospital Mortality; Humans; Male; Middle Aged; Prognosis; Pulmonary Edema/*mortality; Retrospective Studies; Risk Factors; Shock, Cardiogenic/*etiology/mortality; Systole; Ventricular Dysfunction, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-11]]></modelid>
		<pubmedid><![CDATA[18206738]]></pubmedid>
		<author><![CDATA[Goldenberg]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[445]]></modelsamplesize>
		<cohortsamplesize><![CDATA[445]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, BUN, NYHA Class, QRS]]></covariates>
		<mh><![CDATA[Aged; Death, Sudden, Cardiac/epidemiology/prevention & control; *Defibrillators, Implantable; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction/complications/*therapy; Outcome Assessment (Health Care); Proportional Hazards Models; Risk Assessment/*methods; Ventricular Dysfunction, Left/etiology/mortality/*therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-12]]></modelid>
		<pubmedid><![CDATA[18212285]]></pubmedid>
		<author><![CDATA[D'Agostino]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[General cardiovascular risk profile for use in primary care: the Framingham Heart Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[3969]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3969]]></cohortsamplesize>
		<numberofevents><![CDATA[718]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.763]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Age, HDL Cholesterol, SBP, Antihypertensive Medication, Total Cholesterol, Smoking]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; *Cardiovascular Diseases; Female; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Primary Health Care; Proportional Hazards Models; Risk Assessment/*methods; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-13]]></modelid>
		<pubmedid><![CDATA[18212285]]></pubmedid>
		<author><![CDATA[D'Agostino]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[General cardiovascular risk profile for use in primary care: the Framingham Heart Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4522]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4522]]></cohortsamplesize>
		<numberofevents><![CDATA[456]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.793]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Age, HDL Cholesterol, SBP, Antihypertensive Medication, Total Cholesterol, Smoking]]></covariates>
		<mh><![CDATA[Adult; Aged; Algorithms; *Cardiovascular Diseases; Female; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Primary Health Care; Proportional Hazards Models; Risk Assessment/*methods; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-14]]></modelid>
		<pubmedid><![CDATA[18216292]]></pubmedid>
		<author><![CDATA[Khorana]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Blood]]></journal>
		<title><![CDATA[Development and validation of a predictive model for chemotherapy-associated thrombosis]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2701]]></cohortsamplesize>
		<numberofevents><![CDATA[60]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, Hemoglobin, Leukocytes, Platelet, Site of Cancer]]></covariates>
		<mh><![CDATA[Aged; Antineoplastic Agents/*adverse effects; Cohort Studies; Diagnosis, Computer-Assisted/methods; Female; Humans; Logistic Models; Male; Middle Aged; *Models, Biological; Neoplasms/complications; Predictive Value of Tests; Risk Assessment; Thrombosis/*chemically induced]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-15]]></modelid>
		<pubmedid><![CDATA[18217155]]></pubmedid>
		<author><![CDATA[Constans]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Thrombosis & Haemostasis]]></journal>
		<title><![CDATA[A clinical prediction score for upper extremity deep venous thrombosis]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[140]]></modelsamplesize>
		<cohortsamplesize><![CDATA[140]]></cohortsamplesize>
		<numberofevents><![CDATA[50]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Pain, Other Diagnosis Plausible, Edema, Venous Material]]></covariates>
		<mh><![CDATA[Adult; Aged; *Decision Support Techniques; Diagnosis, Differential; Edema/etiology; Female; France/epidemiology; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Pain/etiology; Pain Measurement; Predictive Value of Tests; Prevalence; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Upper Extremity/*blood supply; Venous Thrombosis/complications/*diagnosis/epidemiology/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-16]]></modelid>
		<pubmedid><![CDATA[18250266]]></pubmedid>
		<author><![CDATA[Mehta]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[708593]]></modelsamplesize>
		<cohortsamplesize><![CDATA[708593]]></cohortsamplesize>
		<numberofevents><![CDATA[24092]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.726]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CABG/Valve, Sex, Immunosuppressive Therapy, IABP, LVEF, MI, Operative Status, Creatinine, Resuscitation, Prior Cardiac Surgery]]></covariates>
		<mh><![CDATA[Aged; Canada/epidemiology; Coronary Artery Bypass/mortality/*statistics & numerical data; Databases, Factual; Female; Heart Rupture, Post-Infarction/epidemiology/surgery; Heart Valve Prosthesis Implantation/mortality/statistics & numerical data; Hospital Mortality; Humans; Male; Middle Aged; Point-of-Care Systems; Postoperative Complications/mortality; Retrospective Studies; Risk; Risk Factors; *Severity of Illness Index; Shock, Cardiogenic/etiology/mortality/*surgery; Treatment Outcome; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-17]]></modelid>
		<pubmedid><![CDATA[18255324]]></pubmedid>
		<author><![CDATA[Barnes]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[European Journal of Vascular & Endovascular Surgery]]></journal>
		<title><![CDATA[A model to predict outcomes for endovascular aneurysm repair using preoperative variables]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[961]]></modelsamplesize>
		<cohortsamplesize><![CDATA[961]]></cohortsamplesize>
		<numberofevents><![CDATA[890]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Aneurysm Diameter, Aortic Neck Angle, Atrial Septal Aneurysm, Creatinine, Sex, Infrarenal Neck Diameter/Length]]></covariates>
		<mh><![CDATA[Aneurysm/*therapy; Australia; Humans; Logistic Models; Medical Audit; *Models, Cardiovascular; Predictive Value of Tests; Prognosis; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-18]]></modelid>
		<pubmedid><![CDATA[18267231]]></pubmedid>
		<author><![CDATA[Stempfle]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of Heart & Lung Transplantation]]></journal>
		<title><![CDATA[The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[178]]></modelsamplesize>
		<cohortsamplesize><![CDATA[178]]></cohortsamplesize>
		<numberofevents><![CDATA[86]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Fractional Shortening, Cardiomyopathy Etiology, LV End Diastolic Diameter, Maximum Workload, SBP]]></covariates>
		<mh><![CDATA[Adult; Ambulatory Care/*methods; Analysis of Variance; Chronic Disease; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Echocardiography, Transesophageal; *Exercise Test; Female; Heart Failure/*diagnosis/*mortality/surgery; Heart Function Tests; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Multivariate Analysis; Patient Selection; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Sensitivity and Specificity; *Severity of Illness Index; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-19]]></modelid>
		<pubmedid><![CDATA[18280547]]></pubmedid>
		<author><![CDATA[Chauleur]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Thrombosis Research]]></journal>
		<title><![CDATA[Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women]]></title>
		<primaryindexcondition><![CDATA[Pregnancy]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2736]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2736]]></cohortsamplesize>
		<numberofevents><![CDATA[9]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Antithrombin Deficiency, Protein Deficiency, Family History, Obstetric Complications, VTE, Anticoagulant, Lupus]]></covariates>
		<mh><![CDATA[Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Anticoagulants/therapeutic use; Aspirin/therapeutic use; Cohort Studies; Enoxaparin/therapeutic use; Female; Humans; Placenta/*blood supply; Pregnancy; Pregnancy Complications, Cardiovascular/*diagnosis/*prevention & control; Pregnancy Outcome; Prospective Studies; Risk; Risk Factors; Venous Thromboembolism/*diagnosis/*prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-20]]></modelid>
		<pubmedid><![CDATA[18296827]]></pubmedid>
		<author><![CDATA[Miura]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation Journal]]></journal>
		<title><![CDATA[prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1554]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1554]]></cohortsamplesize>
		<numberofevents><![CDATA[420]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, LVDI, LVEF, NYHA Class, Sex]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Cardiomyopathy, Dilated/*mortality/*physiopathology; Female; Follow-Up Studies; Health Surveys; Heart Ventricles/pathology/physiopathology; Humans; Japan; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Sex Factors; Stroke Volume/physiology; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-21]]></modelid>
		<pubmedid><![CDATA[18358941]]></pubmedid>
		<author><![CDATA[Xanthos]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[A prognostic index for the successful use of adenosine in patients with paroxysmal supraventricular tachycardia in emergency settings: a retrospective study]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[321]]></modelsamplesize>
		<cohortsamplesize><![CDATA[321]]></cohortsamplesize>
		<numberofevents><![CDATA[26]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, PSVT Episodes]]></covariates>
		<mh><![CDATA[Adenosine/*therapeutic use; Algorithms; Anti-Arrhythmia Agents/*therapeutic use; Electrocardiography; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tachycardia, Supraventricular/*drug therapy; Treatment Outcome; Valsalva Maneuver]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-22]]></modelid>
		<pubmedid><![CDATA[18403738]]></pubmedid>
		<author><![CDATA[Konig]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[4441]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4441]]></cohortsamplesize>
		<numberofevents><![CDATA[1970]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Brain Ischemia/*epidemiology/rehabilitation; Controlled Clinical Trials as Topic/*statistics & numerical data; Data Interpretation, Statistical; Databases, Factual; Female; Humans; Male; Middle Aged; *Models, Statistical; Predictive Value of Tests; Prognosis; *Severity of Illness Index; Stroke/*epidemiology/rehabilitation; Survival]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-23]]></modelid>
		<pubmedid><![CDATA[18403738]]></pubmedid>
		<author><![CDATA[Konig]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5419]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5419]]></cohortsamplesize>
		<numberofevents><![CDATA[4441]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Brain Ischemia/*epidemiology/rehabilitation; Controlled Clinical Trials as Topic/*statistics & numerical data; Data Interpretation, Statistical; Databases, Factual; Female; Humans; Male; Middle Aged; *Models, Statistical; Predictive Value of Tests; Prognosis; *Severity of Illness Index; Stroke/*epidemiology/rehabilitation; Survival]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-24]]></modelid>
		<pubmedid><![CDATA[18410812]]></pubmedid>
		<author><![CDATA[Garcia-Almagro]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[prognostic value of the Thrombolysis in Myocardial Infarction risk score in a unselected population with chest pain. Construction of a new predictive model]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[711]]></modelsamplesize>
		<cohortsamplesize><![CDATA[711]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aspirin, LVEF, Cardiac Markers, Diabetes, CAD Risk Factors, CAD, ST Segment Deviation]]></covariates>
		<mh><![CDATA[Aged; Angina Pectoris/*diagnosis; Chest Pain/*etiology; Female; *Health Status Indicators; Humans; Male; Middle Aged; Models, Cardiovascular; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-25]]></modelid>
		<pubmedid><![CDATA[18430204]]></pubmedid>
		<author><![CDATA[Yang]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Cardiovascular Diabetology]]></journal>
		<title><![CDATA[Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[3456]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7067]]></cohortsamplesize>
		<numberofevents><![CDATA[131]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hemoglobin, BMI, CHD, HbA1c, Albumin to Creatinine Ratio]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Diabetes Mellitus, Type 2/*epidemiology; Female; Follow-Up Studies; Heart Failure/*epidemiology; Hong Kong/epidemiology; Hospitalization/*statistics & numerical data; Humans; Male; Middle Aged; Predictive Value of Tests; Registries/standards; Reproducibility of Results; Risk Factors; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-26]]></modelid>
		<pubmedid><![CDATA[18436792]]></pubmedid>
		<author><![CDATA[Miniati]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[American Journal of Respiratory & Critical Care Medicine]]></journal>
		<title><![CDATA[Simple and accurate prediction of the clinical probability of pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1100]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1100]]></cohortsamplesize>
		<numberofevents><![CDATA[440]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.9]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Acute Cor Pulmonale, Age, CVD, Chest Pain, Crackles, DVT, Dyspnea, Syncope, Fever, Hemoptysis, Immobilization, Leg Swelling, Sex, Orthopnea, Pulmonary Disease, Wheezing]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; *Diagnosis, Computer-Assisted; Electrocardiography; Female; Humans; Male; Middle Aged; Odds Ratio; Physical Examination; Pulmonary Embolism/*diagnosis; ROC Curve; *Severity of Illness Index; Software]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-27]]></modelid>
		<pubmedid><![CDATA[18482294]]></pubmedid>
		<author><![CDATA[Huynh]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of the American Geriatrics Society]]></journal>
		<title><![CDATA[Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score.]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[282]]></modelsamplesize>
		<cohortsamplesize><![CDATA[282]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[PAD, Sodium, Serum Urea Nitrogen, SBP]]></covariates>
		<mh><![CDATA[Aged; Female; Heart Failure/*diagnosis/mortality; *Hospice Care; Humans; Logistic Models; Male; Multivariate Analysis; *Patient Selection; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; *Severity of Illness Index; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-28]]></modelid>
		<pubmedid><![CDATA[18510965]]></pubmedid>
		<author><![CDATA[Matthews]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Right Ventricular Failure]]></outcome>
		<modelsamplesize><![CDATA[197]]></modelsamplesize>
		<cohortsamplesize><![CDATA[197]]></cohortsamplesize>
		<numberofevents><![CDATA[68]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AST, Bilirubin, Creatinine, Vasopressor Requirement]]></covariates>
		<mh><![CDATA[Databases as Topic; Female; Health Status Indicators; Heart Failure/complications/*diagnosis/mortality; Heart Ventricles/*physiopathology; Heart-Assist Devices/*adverse effects; Hemodynamics; Humans; Male; Middle Aged; Odds Ratio; Phenylephrine; *Preoperative Care; Prospective Studies; ROC Curve; Risk Assessment; Risk Factors; Vasopressins]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-29]]></modelid>
		<pubmedid><![CDATA[18513521]]></pubmedid>
		<author><![CDATA[Madan]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[9494]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9494]]></cohortsamplesize>
		<numberofevents><![CDATA[264]]></numberofevents>
		<followupduration><![CDATA[NR]]></followupduration>
		<auroc><![CDATA[0.701]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stents, AMI, CHF, PCI, Hypertension, PVD, Renal Insufficiency, Thrombus, Type C Lesion, UA]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*adverse effects; Coronary Artery Bypass; Female; Forecasting; Humans; Male; Middle Aged; Postoperative Complications/*etiology; Risk Assessment; Risk Factors; Texas]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-30]]></modelid>
		<pubmedid><![CDATA[18573589]]></pubmedid>
		<author><![CDATA[Nishiuchi]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Survival rate and factors associated with 1-month survival of witnessed out-of-hospital cardiac arrest of cardiac origin with ventricular fibrillation and pulseless ventricular tachycardia: the Utstein Osaka project]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1028]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1028]]></cohortsamplesize>
		<numberofevents><![CDATA[202]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Time to Defibrillation, Time to CPR, Time to Arrival, Sex, Witnessed Arrest]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Electrocardiography; Emergency Medical Services; Female; Heart Arrest/etiology/*mortality/*physiopathology; Humans; Japan; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Survival Rate; Tachycardia, Ventricular/*complications/*mortality/physiopathology; Ventricular Fibrillation/*complications/*mortality/physiopathology; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-31]]></modelid>
		<pubmedid><![CDATA[18591403]]></pubmedid>
		<author><![CDATA[Cederholm]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Diabetes Care]]></journal>
		<title><![CDATA[Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[11646]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11646]]></cohortsamplesize>
		<numberofevents><![CDATA[990]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[HbA1c, SBP, BMI, Diabetes, Age, Antihypertensive Therapy, Lipid Lowering Therapy, Sex, Smoking]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Diabetes Mellitus, Type 2/*complications; Diabetic Angiopathies/*epidemiology/mortality; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Probability; Registries; Risk Assessment; Survival Analysis; Sweden/epidemiology; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-32]]></modelid>
		<pubmedid><![CDATA[18591432]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of first events of coronary heart disease and stroke with consideration of adiposity]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4780]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4780]]></cohortsamplesize>
		<numberofevents><![CDATA[492]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.813]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cholesterol, Smoking, Diabetes, Sex, SBP]]></covariates>
		<mh><![CDATA[*Adiposity; Adult; Body Mass Index; Cholesterol/blood; Coronary Disease/diagnosis/*epidemiology; Diabetes Mellitus; Humans; Hypertension; Male; Middle Aged; *Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke/diagnosis/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-33]]></modelid>
		<pubmedid><![CDATA[18591432]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Prediction of first events of coronary heart disease and stroke with consideration of adiposity]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[4780]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4780]]></cohortsamplesize>
		<numberofevents><![CDATA[492]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.804]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholesterol, Smoking, SBP]]></covariates>
		<mh><![CDATA[*Adiposity; Adult; Body Mass Index; Cholesterol/blood; Coronary Disease/diagnosis/*epidemiology; Diabetes Mellitus; Humans; Hypertension; Male; Middle Aged; *Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke/diagnosis/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-34]]></modelid>
		<pubmedid><![CDATA[18612534]]></pubmedid>
		<author><![CDATA[Ruiz-Gimenez]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Thrombosis & Haemostasis]]></journal>
		<title><![CDATA[Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[13057]]></modelsamplesize>
		<cohortsamplesize><![CDATA[19274]]></cohortsamplesize>
		<numberofevents><![CDATA[314]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, Cancer, PE, Creatinine, Major Bleed]]></covariates>
		<mh><![CDATA[Acute Disease; Age Factors; Aged; Aged, 80 and over; Anemia/complications; Anticoagulants/*adverse effects; Argentina/epidemiology; Creatinine/blood; Europe/epidemiology; Female; Hemorrhage/blood/*chemically induced/epidemiology; Humans; Incidence; Israel/epidemiology; Likelihood Functions; Logistic Models; Male; Middle Aged; Patient Selection; Prospective Studies; Pulmonary Embolism/complications; Registries; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Venous Thromboembolism/blood/*drug therapy/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-35]]></modelid>
		<pubmedid><![CDATA[18616825]]></pubmedid>
		<author><![CDATA[Reddy]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[BMC Medical Informatics & Decision Making]]></journal>
		<title><![CDATA[Logical Analysis of Data (LAD) model for the early diagnosis of acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[80]]></modelsamplesize>
		<cohortsamplesize><![CDATA[80]]></cohortsamplesize>
		<numberofevents><![CDATA[48]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.826]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Peptide Types]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Algorithms; Biomarkers/*blood; Brain Ischemia/blood/*diagnosis; Case-Control Studies; Early Diagnosis; Female; Humans; Logistic Models; Male; *Models, Theoretical; Observer Variation; Predictive Value of Tests; Proteomics; Reference Values; Reproducibility of Results; Severity of Illness Index; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stroke/blood/classification/*diagnosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-36]]></modelid>
		<pubmedid><![CDATA[18652942]]></pubmedid>
		<author><![CDATA[Abraham]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[48612]]></modelsamplesize>
		<cohortsamplesize><![CDATA[48612]]></cohortsamplesize>
		<numberofevents><![CDATA[1834]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Race, Age, ACE Inhibitor, Beta Blocker, COPD, DBP, HF, Heart Rate, Hyperlipidemia, LVSD, Liver Disease, PVD, CVA, Creatinine, Smoking, Sodium, SBP]]></covariates>
		<mh><![CDATA[Aged; Analysis of Variance; Blood Pressure; Creatinine/blood; Female; Heart Failure/*mortality; *Hospital Mortality; Hospitalization; Humans; Male; Nomograms; Regression Analysis; *Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-37]]></modelid>
		<pubmedid><![CDATA[18721509]]></pubmedid>
		<author><![CDATA[Baran]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A clinical risk score for prediction of stent thrombosis]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stent Thrombosis]]></outcome>
		<modelsamplesize><![CDATA[2487]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2487]]></cohortsamplesize>
		<numberofevents><![CDATA[53]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.819]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Stent, Lesion Length, Calcification, Vessel Diameter, Smoking, Thienopyridine]]></covariates>
		<mh><![CDATA[*Blood Vessel Prosthesis; *Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis/*epidemiology/radiography; Follow-Up Studies; Graft Occlusion, Vascular/*epidemiology/radiography; Humans; Incidence; Male; Middle Aged; Prosthesis Failure; ROC Curve; Risk Factors; Severity of Illness Index; *Stents; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-38]]></modelid>
		<pubmedid><![CDATA[18762707]]></pubmedid>
		<author><![CDATA[Teramoto]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation Journal]]></journal>
		<title><![CDATA[Practical risk prediction tools for coronary heart disease in mild to moderate hypercholesterolemia in Japan: originated from the MEGA study data]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hyperlipidemia]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[7832]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7832]]></cohortsamplesize>
		<numberofevents><![CDATA[138]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diet, Glucose, Hypertension, HDL Cholesterol, LDL Cholesterol, Sex]]></covariates>
		<mh><![CDATA[Adult; Aged; Blood Glucose/metabolism; Blood Pressure; Cholesterol, HDL/blood; Coronary Disease/*epidemiology; Female; *Health Status Indicators; Humans; Hypercholesterolemia/complications/*epidemiology; Hypertension/epidemiology; Japan/epidemiology; Male; Postmenopause; Prospective Studies; Smoking/epidemiology; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-39]]></modelid>
		<pubmedid><![CDATA[18926148]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4402]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4402]]></cohortsamplesize>
		<numberofevents><![CDATA[358]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.723]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Sodium, SBP, Age, Beta Blocker, Depression, Liver Disease, LE Edema, Reactive Airway Disease, Statin, Weight]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Aged; Aged, 80 and over; Blood Pressure; Female; Heart Failure/drug therapy/*mortality/physiopathology; Hospitalization; Humans; Hypolipidemic Agents/therapeutic use; Male; Middle Aged; Nomograms; Patient Readmission; Prognosis; Proportional Hazards Models; Registries; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-40]]></modelid>
		<pubmedid><![CDATA[18955684]]></pubmedid>
		<author><![CDATA[Lou]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[302]]></modelsamplesize>
		<cohortsamplesize><![CDATA[302]]></cohortsamplesize>
		<numberofevents><![CDATA[46]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes or Glucose, Hypodensity on CT, NIHSS]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cerebral Hemorrhage/*chemically induced/*diagnosis; Cohort Studies; Disability Evaluation; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; ROC Curve; Reproducibility of Results; Risk; *Severity of Illness Index; Stroke/drug therapy; Tissue Plasminogen Activator/*adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-41]]></modelid>
		<pubmedid><![CDATA[18980456]]></pubmedid>
		<author><![CDATA[Schonwetter]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of Palliative Medicine]]></journal>
		<title><![CDATA[Predicting emergency room visits and hospitalizations among hospice patients with cardiac disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[145]]></modelsamplesize>
		<cohortsamplesize><![CDATA[145]]></cohortsamplesize>
		<numberofevents><![CDATA[65]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.877]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Diabetes, Medication Compliance, Morphine, Nursing Visits, PVD, Caregiver Presence, Hospice Kit, Race]]></covariates>
		<mh><![CDATA[Attitude to Health; *Emergency Service, Hospital; Heart Diseases/*therapy; Hospice Care/*methods/standards; *Hospitalization; Humans; Logistic Models; *Models, Statistical; Palliative Care/*methods/standards; Probability; Quality-Adjusted Life Years; Retrospective Studies]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-42]]></modelid>
		<pubmedid><![CDATA[18997194]]></pubmedid>
		<author><![CDATA[Ridker]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[10724]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10724]]></cohortsamplesize>
		<numberofevents><![CDATA[1294]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.699]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, HDL Cholesterol, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Biomarkers/blood; C-Reactive Protein/*metabolism; Cardiovascular Diseases/blood/*epidemiology/*genetics; Female; Follow-Up Studies; Humans; Inflammation/blood/physiopathology; Life Style; Likelihood Functions; Male; Predictive Value of Tests; Prospective Studies; Risk Assessment; Sex Characteristics]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-43]]></modelid>
		<pubmedid><![CDATA[18997194]]></pubmedid>
		<author><![CDATA[Ridker]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[10724]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10724]]></cohortsamplesize>
		<numberofevents><![CDATA[1294]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.708]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, HDL Cholesterol, CRP, Family History, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Biomarkers/blood; C-Reactive Protein/*metabolism; Cardiovascular Diseases/blood/*epidemiology/*genetics; Female; Follow-Up Studies; Humans; Inflammation/blood/physiopathology; Life Style; Likelihood Functions; Male; Predictive Value of Tests; Prospective Studies; Risk Assessment; Sex Characteristics]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-44]]></modelid>
		<pubmedid><![CDATA[19059108]]></pubmedid>
		<author><![CDATA[Fitzpatrick]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Journal of Heart & Lung Transplantation]]></journal>
		<title><![CDATA[A risk score derived from preoperative data analysis predicts the need for biventricular mechanical circulatory support]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Right Ventricular Failure]]></outcome>
		<modelsamplesize><![CDATA[266]]></modelsamplesize>
		<cohortsamplesize><![CDATA[266]]></cohortsamplesize>
		<numberofevents><![CDATA[99]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Index, Creatinine, Previous Cardiac Surgery, RV Stroke Work Index, VAD RV Dysfunction, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Blood Pressure; Diabetes Complications/epidemiology; Equipment Design; Female; Heart Failure/*physiopathology/surgery; *Heart Transplantation; *Heart-Assist Devices/adverse effects; Hemodynamics; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive/epidemiology; Retrospective Studies; Risk Assessment; Risk Factors; Ventricular Dysfunction, Left/epidemiology/physiopathology/*surgery; Ventricular Dysfunction, Right/physiopathology/*surgery; Ventricular Function, Right]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-45]]></modelid>
		<pubmedid><![CDATA[19157168]]></pubmedid>
		<author><![CDATA[Maracy]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Acta Cardiologica]]></journal>
		<title><![CDATA[Risk scores in ischaemic heart disease patients with type 2 diabetes, Isfahan, Iran]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[2101]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2101]]></cohortsamplesize>
		<numberofevents><![CDATA[773]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Duration, BP, Sex]]></covariates>
		<mh><![CDATA[Aged; Cross-Sectional Studies; Diabetic Angiopathies/*epidemiology; Female; Humans; Iran/epidemiology; Logistic Models; Male; Middle Aged; Myocardial Ischemia/*epidemiology; Odds Ratio; ROC Curve; Risk Assessment; Sensitivity and Specificity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-66]]></modelid>
		<pubmedid><![CDATA[23522221]]></pubmedid>
		<author><![CDATA[Rankin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4510]]></modelsamplesize>
		<cohortsamplesize><![CDATA[50231]]></cohortsamplesize>
		<numberofevents><![CDATA[593]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.706]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF Ablation, Age, CHF, NYHA Class, Lung Disease, CABG, Creatinine, Diabetes, Mitral Replacement, Cardiac Surgery, Status]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-46]]></modelid>
		<pubmedid><![CDATA[19229423]]></pubmedid>
		<author><![CDATA[Gabriel]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular]]></journal>
		<title><![CDATA[First inflammatory risk score for aortic endoprostheses]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[25]]></modelsamplesize>
		<cohortsamplesize><![CDATA[25]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Preoperative IL-8, Crystalloid Volume]]></covariates>
		<mh><![CDATA[Aortic Aneurysm/blood/physiopathology/*surgery; Blood Vessel Prosthesis Implantation/*adverse effects; Blood Volume/physiology; Cell Adhesion Molecules/blood; Female; Follow-Up Studies; Humans; Inflammation Mediators/*blood; Interleukin-8/blood; Logistic Models; Male; Postoperative Care; Preoperative Care; ROC Curve; Risk Assessment; Systemic Inflammatory Response Syndrome/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-47]]></modelid>
		<pubmedid><![CDATA[19284086]]></pubmedid>
		<author><![CDATA[Mocan]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Romanian Journal of Internal Medicine]]></journal>
		<title><![CDATA[A new prediction score for myocardial infarction: MINF SCORE]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[208]]></modelsamplesize>
		<cohortsamplesize><![CDATA[208]]></cohortsamplesize>
		<numberofevents><![CDATA[104]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.745]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CRP, Lipoprotein A, LDL Cholesterol, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; C-Reactive Protein/metabolism; Cross-Sectional Studies; Female; *Health Status Indicators; Humans; Lipids/blood; Male; Middle Aged; Myocardial Infarction/blood/*diagnosis/*etiology; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[08-001-48]]></modelid>
		<pubmedid><![CDATA[19777072]]></pubmedid>
		<author><![CDATA[Butler]]></author>
		<year><![CDATA[2008]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Incident heart failure prediction in the elderly: the health ABC heart failure score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[2935]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2935]]></cohortsamplesize>
		<numberofevents><![CDATA[258]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, CHD, Creatinine, Glucose, Heart Rate, LVH, Smoking, SBP]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Female; Follow-Up Studies; *Health Status; Heart Failure/*epidemiology; Humans; Incidence; Male; *Models, Statistical; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Rate/trends; Time Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-01]]></modelid>
		<pubmedid><![CDATA[18823637]]></pubmedid>
		<author><![CDATA[Koopman]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of the Neurological Sciences]]></journal>
		<title><![CDATA[Development and validation of a predictive outcome score of cerebral venous thrombosis]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Central Venous Thrombosis (CVT)]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[90]]></modelsamplesize>
		<cohortsamplesize><![CDATA[90]]></cohortsamplesize>
		<numberofevents><![CDATA[16]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CNS Infection, DVT, GCS Score, ICH, Sex, Malignancy, Mental Status]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Follow-Up Studies; Humans; Intracranial Thrombosis/complications/*epidemiology; Male; Middle Aged; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Venous Thrombosis/complications/*epidemiology; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-02]]></modelid>
		<pubmedid><![CDATA[18922710]]></pubmedid>
		<author><![CDATA[Yamaki]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Vascular & Endovascular Surgery]]></journal>
		<title><![CDATA[Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: preliminary report]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[203]]></modelsamplesize>
		<cohortsamplesize><![CDATA[203]]></cohortsamplesize>
		<numberofevents><![CDATA[118]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cancer, Anticoagulation, Leg Symptoms, Sex, DVT]]></covariates>
		<mh><![CDATA[Aged; Female; *Health Status Indicators; Humans; Lower Extremity/*blood supply; Male; Middle Aged; Odds Ratio; Pilot Projects; Predictive Value of Tests; Pressure; Prognosis; Prospective Studies; Pulmonary Embolism/etiology/mortality/*ultrasonography; ROC Curve; Risk Assessment; Risk Factors; Time Factors; *Ultrasonography, Doppler, Color; Venous Thromboembolism/complications/mortality/*ultrasonography; Venous Thrombosis/complications/mortality/*ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-03]]></modelid>
		<pubmedid><![CDATA[19081413]]></pubmedid>
		<author><![CDATA[Chowdhary]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[The Toronto score for in-hospital mortality after percutaneous coronary interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10694]]></modelsamplesize>
		<cohortsamplesize><![CDATA[16041]]></cohortsamplesize>
		<numberofevents><![CDATA[139]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.933]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Left Main Disease, LVEF, Multivessel Disease, NYHA Class, Thrombolysis, PCI, MI, Renal Insufficiency, Shock]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/*mortality; Female; *Hospital Mortality; Humans; Male; Middle Aged; Multivariate Analysis; Ontario; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-04]]></modelid>
		<pubmedid><![CDATA[19219391]]></pubmedid>
		<author><![CDATA[Capodanno]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stent Thrombosis]]></outcome>
		<modelsamplesize><![CDATA[1377]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1377]]></cohortsamplesize>
		<numberofevents><![CDATA[39]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACS, LVEF, Bifurcation Lesion, Left Anterior Descending Artery as Treated Vessel, Number of Stents]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/therapy; Aged; Angioplasty, Balloon, Coronary/*methods; Coronary Angiography; Databases, Factual; *Drug-Eluting Stents; Female; Follow-Up Studies; Forecasting/methods; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors/administration & dosage; Prognosis; Prospective Studies; Risk; Thrombosis/epidemiology/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-05]]></modelid>
		<pubmedid><![CDATA[19238132]]></pubmedid>
		<author><![CDATA[Oto]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Physical & Rehabilitation Medicine]]></journal>
		<title><![CDATA[Predicting the chance of weaning dysphagic stroke patients from enteral nutrition: a multivariate logistic modelling study]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[30]]></modelsamplesize>
		<cohortsamplesize><![CDATA[30]]></cohortsamplesize>
		<numberofevents><![CDATA[12]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.926]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Time from Onset, FIM-Cognition, FIM-Motor]]></covariates>
		<mh><![CDATA[Activities of Daily Living; Aged; Aged, 80 and over; Deglutition Disorders/etiology/*rehabilitation; Enteral Nutrition/adverse effects/*methods; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Recovery of Function; Stroke/complications/*rehabilitation]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-06]]></modelid>
		<pubmedid><![CDATA[19240065]]></pubmedid>
		<author><![CDATA[Vazquez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[992]]></modelsamplesize>
		<cohortsamplesize><![CDATA[992]]></cohortsamplesize>
		<numberofevents><![CDATA[267]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, eGFR, Hyponatremia, Left Atrial Size, LVEF, VT, NT-proBNP, Atherosclerotic Event, Troponin]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Bundle-Branch Block/*mortality; Chronic Disease; Female; Heart Failure/*mortality; Humans; Male; Middle Aged; Models, Cardiovascular; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-07]]></modelid>
		<pubmedid><![CDATA[19240065]]></pubmedid>
		<author><![CDATA[Vazquez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[992]]></modelsamplesize>
		<cohortsamplesize><![CDATA[992]]></cohortsamplesize>
		<numberofevents><![CDATA[213]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[eGFR, Hyponatremia, Left Atrial Size, LVEF, VT, NT-proBNP, Atherosclerotic Event, Troponin]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Bundle-Branch Block/*mortality; Chronic Disease; Female; Heart Failure/*mortality; Humans; Male; Middle Aged; Models, Cardiovascular; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-08]]></modelid>
		<pubmedid><![CDATA[19240065]]></pubmedid>
		<author><![CDATA[Vazquez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[992]]></modelsamplesize>
		<cohortsamplesize><![CDATA[992]]></cohortsamplesize>
		<numberofevents><![CDATA[123]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[eGFR, Hyponatremia, Left Atrial Size, LVEF, NT-proBNP, Troponin]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Bundle-Branch Block/*mortality; Chronic Disease; Female; Heart Failure/*mortality; Humans; Male; Middle Aged; Models, Cardiovascular; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-09]]></modelid>
		<pubmedid><![CDATA[19240065]]></pubmedid>
		<author><![CDATA[Vazquez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[992]]></modelsamplesize>
		<cohortsamplesize><![CDATA[992]]></cohortsamplesize>
		<numberofevents><![CDATA[90]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[LBBB or IVCD, Left Atrial Size, VT, NT-proBNP, Atherosclerotic Event]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Bundle-Branch Block/*mortality; Chronic Disease; Female; Heart Failure/*mortality; Humans; Male; Middle Aged; Models, Cardiovascular; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-10]]></modelid>
		<pubmedid><![CDATA[19243970]]></pubmedid>
		<author><![CDATA[Antunes]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk-prediction for postoperative major morbidity in coronary surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[4567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4567]]></cohortsamplesize>
		<numberofevents><![CDATA[114]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.715]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cerebrovascular Disease, Sex, LV Dysfunction, Non-Elective Surgery, PVD]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/epidemiology/etiology; Aged; Coronary Artery Bypass/*adverse effects/methods; Epidemiologic Methods; Female; Heart Failure/epidemiology/etiology; Humans; Male; Mediastinitis/epidemiology/etiology; Middle Aged; Portugal/epidemiology; Prognosis; Respiratory Insufficiency/epidemiology/etiology; Stroke/epidemiology/etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-11]]></modelid>
		<pubmedid><![CDATA[19243970]]></pubmedid>
		<author><![CDATA[Antunes]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk-prediction for postoperative major morbidity in coronary surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mediastinitis]]></outcome>
		<modelsamplesize><![CDATA[4567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4567]]></cohortsamplesize>
		<numberofevents><![CDATA[55]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.696]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BSA, Cardiomegaly, Diabetes, Smoking]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/epidemiology/etiology; Aged; Coronary Artery Bypass/*adverse effects/methods; Epidemiologic Methods; Female; Heart Failure/epidemiology/etiology; Humans; Male; Mediastinitis/epidemiology/etiology; Middle Aged; Portugal/epidemiology; Prognosis; Respiratory Insufficiency/epidemiology/etiology; Stroke/epidemiology/etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-12]]></modelid>
		<pubmedid><![CDATA[19243970]]></pubmedid>
		<author><![CDATA[Antunes]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk-prediction for postoperative major morbidity in coronary surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[4567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4567]]></cohortsamplesize>
		<numberofevents><![CDATA[256]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.778]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/epidemiology/etiology; Aged; Coronary Artery Bypass/*adverse effects/methods; Epidemiologic Methods; Female; Heart Failure/epidemiology/etiology; Humans; Male; Mediastinitis/epidemiology/etiology; Middle Aged; Portugal/epidemiology; Prognosis; Respiratory Insufficiency/epidemiology/etiology; Stroke/epidemiology/etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-13]]></modelid>
		<pubmedid><![CDATA[19243970]]></pubmedid>
		<author><![CDATA[Antunes]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk-prediction for postoperative major morbidity in coronary surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Respiratory Failure]]></outcome>
		<modelsamplesize><![CDATA[4567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4567]]></cohortsamplesize>
		<numberofevents><![CDATA[41]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.787]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, COPD, PVD, Smoking]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/epidemiology/etiology; Aged; Coronary Artery Bypass/*adverse effects/methods; Epidemiologic Methods; Female; Heart Failure/epidemiology/etiology; Humans; Male; Mediastinitis/epidemiology/etiology; Middle Aged; Portugal/epidemiology; Prognosis; Respiratory Insufficiency/epidemiology/etiology; Stroke/epidemiology/etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-14]]></modelid>
		<pubmedid><![CDATA[19243970]]></pubmedid>
		<author><![CDATA[Antunes]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk-prediction for postoperative major morbidity in coronary surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[4567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4567]]></cohortsamplesize>
		<numberofevents><![CDATA[256]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Angina CCS Class, LV Dysfunction, Non-Elective Surgery, Previous Cardiac Surgery]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/epidemiology/etiology; Aged; Coronary Artery Bypass/*adverse effects/methods; Epidemiologic Methods; Female; Heart Failure/epidemiology/etiology; Humans; Male; Mediastinitis/epidemiology/etiology; Middle Aged; Portugal/epidemiology; Prognosis; Respiratory Insufficiency/epidemiology/etiology; Stroke/epidemiology/etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-15]]></modelid>
		<pubmedid><![CDATA[19243970]]></pubmedid>
		<author><![CDATA[Antunes]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Risk-prediction for postoperative major morbidity in coronary surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[4567]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4567]]></cohortsamplesize>
		<numberofevents><![CDATA[411]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.701]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Angina CCS Class, Cerebrovascular Disease, COPD, LV Dysfunction, Non-Elective Surgery, PVD, Previous Cardiac Surgery]]></covariates>
		<mh><![CDATA[Acute Kidney Injury/epidemiology/etiology; Aged; Coronary Artery Bypass/*adverse effects/methods; Epidemiologic Methods; Female; Heart Failure/epidemiology/etiology; Humans; Male; Mediastinitis/epidemiology/etiology; Middle Aged; Portugal/epidemiology; Prognosis; Respiratory Insufficiency/epidemiology/etiology; Stroke/epidemiology/etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-16]]></modelid>
		<pubmedid><![CDATA[19249184]]></pubmedid>
		<author><![CDATA[Giles]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Risk prediction for perioperative mortality of endovascular vs open repair of abdominal aortic aneurysms using the Medicare population]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[22830]]></modelsamplesize>
		<cohortsamplesize><![CDATA[45660]]></cohortsamplesize>
		<numberofevents><![CDATA[1621]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.726]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Renal Insufficiency, CHF, ESRD, Sex, Open Repair, Vascular Disease]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/*mortality/*surgery; Chi-Square Distribution; Comorbidity; Female; *Hospital Mortality; Humans; Logistic Models; Male; *Medicare; Predictive Value of Tests; ROC Curve; Risk Assessment; Risk Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-17]]></modelid>
		<pubmedid><![CDATA[19249423]]></pubmedid>
		<author><![CDATA[Giraldez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[14519]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14519]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.738]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Hemoglobin]]></covariates>
		<mh><![CDATA[Aged; Creatinine/*blood; Female; Hemoglobins/*analysis; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/*blood/epidemiology/mortality; Odds Ratio; Risk Assessment/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-18]]></modelid>
		<pubmedid><![CDATA[19249635]]></pubmedid>
		<author><![CDATA[Schnabel]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Lancet]]></journal>
		<title><![CDATA[Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[4764]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4764]]></cohortsamplesize>
		<numberofevents><![CDATA[457]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, HF, Murmur, BMI, Sex, SBP, Antihypertensive Medication]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aging/*physiology; Atrial Fibrillation/*etiology/prevention & control/ultrasonography; Consumer Participation; Female; Heart Murmurs/*complications; Humans; Hypertension/*complications/drug therapy; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-19]]></modelid>
		<pubmedid><![CDATA[19289663]]></pubmedid>
		<author><![CDATA[Russo]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Archives of Surgery]]></journal>
		<title><![CDATA[Pretransplantation patient characteristics and survival following combined heart and kidney transplantation: an analysis of the United Network for Organ Sharing Database]]></title>
		<primaryindexcondition><![CDATA[Heart Transplant]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[19383]]></modelsamplesize>
		<cohortsamplesize><![CDATA[19383]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[VAD, Dialysis, PVD, Nonischemic Etiology, Age]]></covariates>
		<mh><![CDATA[Adult; Databases as Topic; Female; Glomerular Filtration Rate; Heart Failure/*surgery; Heart Transplantation/*mortality; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic/*surgery; Kidney Transplantation/*mortality; Male; Middle Aged; Proportional Hazards Models; Risk Factors; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-20]]></modelid>
		<pubmedid><![CDATA[19327419]]></pubmedid>
		<author><![CDATA[Negassa]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A simple prognostic classification model for postprocedural complications after percutaneous coronary intervention for acute myocardial infarction (from the New York State percutaneous coronary intervention database)]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[5385]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5385]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, CHF, Diabetes]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*methods/*statistics & numerical data; Female; Follow-Up Studies; Hospital Mortality/trends; Humans; Incidence; Male; Middle Aged; Myocardial Infarction/radiography/*surgery; New York/epidemiology; Postoperative Complications/*classification/epidemiology; Prognosis; Registries/*statistics & numerical data; Retrospective Studies; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-21]]></modelid>
		<pubmedid><![CDATA[19327431]]></pubmedid>
		<author><![CDATA[Cygankiewicz]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[294]]></modelsamplesize>
		<cohortsamplesize><![CDATA[294]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, QT/RR, Heart Rate, VT, MI, QRS, SDNN, Turbulence, Ventricular Premature Beats]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Electrocardiography, Ambulatory/methods; Female; Follow-Up Studies; Heart Failure/*mortality/physiopathology; Heart Rate/physiology; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment/*methods; Risk Factors; Spain/epidemiology; Stroke Volume/*physiology; Survival Rate/trends; Ventricular Function, Left/*physiology; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-22]]></modelid>
		<pubmedid><![CDATA[19332461]]></pubmedid>
		<author><![CDATA[Subherwal]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[71277]]></modelsamplesize>
		<cohortsamplesize><![CDATA[89134]]></cohortsamplesize>
		<numberofevents><![CDATA[6700]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Hematocrit, Creatinine, Diabetes, Sex, Heart Rate, Vascular Disease, CHF, SBP]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/*complications/mortality/physiopathology; Aged; Algorithms; Angina, Unstable/*complications; Blood Pressure; Creatinine; Diabetic Angiopathies/physiopathology; Female; Heart Rate; Hematocrit; Hemorrhage/classification/*epidemiology; Humans; Male; Middle Aged; Myocardial Infarction/*complications/mortality/physiopathology; Predictive Value of Tests; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-23]]></modelid>
		<pubmedid><![CDATA[19341875]]></pubmedid>
		<author><![CDATA[Beck]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Predicting 1-year mortality after elective abdominal aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[748]]></modelsamplesize>
		<cohortsamplesize><![CDATA[748]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Chronic Renal Insufficiency, COPD, Suprarenal Aortic Clamp Site]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aortic Aneurysm, Abdominal/complications/*mortality/pathology/*surgery; Constriction; Decision Support Techniques; Elective Surgical Procedures/mortality; Female; Heart Failure/complications/mortality; Humans; Male; New England/epidemiology; Patient Selection; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive/complications/mortality; Registries; Renal Insufficiency, Chronic/complications/mortality; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vascular Surgical Procedures/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-24]]></modelid>
		<pubmedid><![CDATA[19341875]]></pubmedid>
		<author><![CDATA[Beck]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Predicting 1-year mortality after elective abdominal aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[639]]></modelsamplesize>
		<cohortsamplesize><![CDATA[639]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Aneurysm Size, CHF]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aortic Aneurysm, Abdominal/complications/*mortality/pathology/*surgery; Constriction; Decision Support Techniques; Elective Surgical Procedures/mortality; Female; Heart Failure/complications/mortality; Humans; Male; New England/epidemiology; Patient Selection; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive/complications/mortality; Registries; Renal Insufficiency, Chronic/complications/mortality; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vascular Surgical Procedures/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-25]]></modelid>
		<pubmedid><![CDATA[19356527]]></pubmedid>
		<author><![CDATA[Stevens]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[JACC: Cardiovascular Imaging]]></journal>
		<title><![CDATA[Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[1015]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1015]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Left Atrial Volume Index, LVEF, Left Ventricular Mass Index, Left Ventricular Outflow, Mitral Regurgitation, NT-proBNP, Diastolic Function]]></covariates>
		<mh><![CDATA[Aged; California; Coronary Artery Disease/complications/physiopathology/*ultrasonography; Disease Progression; *Echocardiography, Doppler; Female; Follow-Up Studies; Heart Atria/ultrasonography; Heart Failure/*etiology/physiopathology/ultrasonography; Heart Ventricles/ultrasonography; Humans; Length of Stay; Male; Middle Aged; Mitral Valve Insufficiency/complications/ultrasonography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Left/complications/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-26]]></modelid>
		<pubmedid><![CDATA[19359652]]></pubmedid>
		<author><![CDATA[Hallevi]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[190]]></modelsamplesize>
		<cohortsamplesize><![CDATA[190]]></cohortsamplesize>
		<numberofevents><![CDATA[126]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Glucose, Age, CAD, Diabetes, NIHSS, Stroke]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Analysis of Variance; Blood Glucose/metabolism; Brain Ischemia/complications/*surgery; *Cerebral Revascularization; Cohort Studies; Female; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; ROC Curve; Reproducibility of Results; Risk Factors; Stroke/etiology/mortality/*surgery; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-27]]></modelid>
		<pubmedid><![CDATA[19361592]]></pubmedid>
		<author><![CDATA[Garcia-Alvarez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[74]]></modelsamplesize>
		<cohortsamplesize><![CDATA[74]]></cohortsamplesize>
		<numberofevents><![CDATA[41]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, TIMI Grade, Left Main Coronary Artery Occlusion, LVEF, Multivessel CAD, Symptoms to Revascularization Interval]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*adverse effects; Female; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardial Infarction/complications/*therapy; Risk Assessment; Shock, Cardiogenic/etiology/mortality/*therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-28]]></modelid>
		<pubmedid><![CDATA[19420921]]></pubmedid>
		<author><![CDATA[Ferro]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Central Venous Thrombosis (CVT)]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[624]]></modelsamplesize>
		<cohortsamplesize><![CDATA[624]]></cohortsamplesize>
		<numberofevents><![CDATA[19]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Coma, ICH, Sex, Malignancy, Mental Status, DVT]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; *Cerebral Veins; Coma/complications; Female; Follow-Up Studies; Humans; International Cooperation; Intracranial Hemorrhages/complications; Intracranial Thrombosis/complications/*diagnosis; Male; Middle Aged; Outcome Assessment (Health Care); Predictive Value of Tests; Prognosis; *Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; *Severity of Illness Index; Sex Factors; Sinus Thrombosis, Intracranial/complications/*diagnosis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-29]]></modelid>
		<pubmedid><![CDATA[19437507]]></pubmedid>
		<author><![CDATA[Vemulapalli]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Hematology]]></journal>
		<title><![CDATA[Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[220]]></modelsamplesize>
		<cohortsamplesize><![CDATA[220]]></cohortsamplesize>
		<numberofevents><![CDATA[40]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[VTE, Cancer, Platelets]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Clinical Trials, Phase I as Topic; Disease Progression; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Multivariate Analysis; Neoplasms/*complications/mortality/*physiopathology; Pancreatic Neoplasms/blood/complications; Platelet Count; Prognosis; Pulmonary Embolism/complications; Retrospective Studies; Time Factors; Treatment Outcome; Venous Thromboembolism/epidemiology/*etiology; Venous Thrombosis/complications; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-30]]></modelid>
		<pubmedid><![CDATA[19443431]]></pubmedid>
		<author><![CDATA[Mazza]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Europace]]></journal>
		<title><![CDATA[Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[158]]></modelsamplesize>
		<cohortsamplesize><![CDATA[158]]></cohortsamplesize>
		<numberofevents><![CDATA[81]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AAD Therapy, Apnoea/Hypopnoea Index, CRP]]></covariates>
		<mh><![CDATA[Adult; Aged; Atrial Fibrillation/blood/*diagnosis/*prevention & control; C-Reactive Protein/*analysis; Cardiac Pacing, Artificial/*methods; Female; Humans; Male; Outcome Assessment (Health Care)/*methods; *Proportional Hazards Models; Recurrence; Reproducibility of Results; Risk Assessment/methods; Risk Factors; Sensitivity and Specificity; Sleep Apnea, Obstructive/*diagnosis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-31]]></modelid>
		<pubmedid><![CDATA[19478232]]></pubmedid>
		<author><![CDATA[Starke]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[202]]></modelsamplesize>
		<cohortsamplesize><![CDATA[202]]></cohortsamplesize>
		<numberofevents><![CDATA[29]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Embolization, Deep Venous Drainage, Eloquent Location, Diameter]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Child; Child, Preschool; Embolization, Therapeutic/*methods; Enbucrilate/*administration & dosage; Female; Follow-Up Studies; Humans; Intracranial Arteriovenous Malformations/*drug therapy/surgery; Male; Middle Aged; Nervous System Diseases/*etiology/prevention & control; Postoperative Complications/*etiology/prevention & control; Predictive Value of Tests; Retrospective Studies; Treatment Outcome; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-32]]></modelid>
		<pubmedid><![CDATA[19486721]]></pubmedid>
		<author><![CDATA[Cruz-Gonzalez]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[Predicting success and long-term outcomes of percutaneous mitral valvuloplasty: a multifactorial score]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[800]]></modelsamplesize>
		<cohortsamplesize><![CDATA[800]]></cohortsamplesize>
		<numberofevents><![CDATA[544]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Echo Score, Sex, NYHA Class, Mitral Regurgitation, Mitral Valve Area]]></covariates>
		<mh><![CDATA[Age Distribution; *Catheterization; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Stenosis/pathology/*therapy/ultrasonography; Predictive Value of Tests; Regression Analysis; Retrospective Studies; Risk Assessment; Sex Distribution; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-33]]></modelid>
		<pubmedid><![CDATA[19506110]]></pubmedid>
		<author><![CDATA[Ranucci]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4557]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4557]]></cohortsamplesize>
		<numberofevents><![CDATA[150]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.744]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, LVEF, Creatinine]]></covariates>
		<mh><![CDATA[Adult; Age Factors; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*mortality; Cohort Studies; Creatinine/*blood; Elective Surgical Procedures/*mortality; Female; *Heart Diseases/blood/mortality/physiopathology/surgery; Humans; Male; Middle Aged; *Models, Theoretical; Predictive Value of Tests; Risk Assessment/methods; Risk Factors; *Stroke Volume]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-34]]></modelid>
		<pubmedid><![CDATA[19507312]]></pubmedid>
		<author><![CDATA[Bernardi]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of Cardiovascular Medicine]]></journal>
		<title><![CDATA[The acute myocardial infarction with ST segment elevation Udine registry (Come-to-Udine): predictors of 3 years mortality]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[514]]></modelsamplesize>
		<cohortsamplesize><![CDATA[514]]></cohortsamplesize>
		<numberofevents><![CDATA[120]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, LVEF, Killip Class, Pre-Hospital Delay, Procedural Strategy]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; Combined Modality Therapy; Female; Health Care Rationing/organization & administration; Health Services Accessibility/*organization & administration; Hospitals, Community/*organization & administration; Humans; Italy/epidemiology; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction/*mortality/*therapy; Patient Selection; Patient Transfer/*organization & administration; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Thrombolytic Therapy/*mortality; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-35]]></modelid>
		<pubmedid><![CDATA[19523840]]></pubmedid>
		<author><![CDATA[Nissinen]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Is it possible to improve the accuracy of EuroSCORE?]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3613]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3613]]></cohortsamplesize>
		<numberofevents><![CDATA[90]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.873]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CKD, Critical Status, Arteriopathy, Sex, LVEF, Neurological Dysfunction, Number of Procedures, Pulmonary Disease, Reoperation, Aortic Surgery, Ventricular Septal Defect]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Algorithms; Cardiac Surgical Procedures/*adverse effects/mortality; Epidemiologic Methods; Female; Finland/epidemiology; Humans; Male; Middle Aged; Prognosis; *Severity of Illness Index; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-36]]></modelid>
		<pubmedid><![CDATA[19543085]]></pubmedid>
		<author><![CDATA[Michaelides]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Coronary Artery Disease]]></journal>
		<title><![CDATA[Duration of treadmill exercise testing combined with QRS score predicts adverse cardiac outcome at long-term follow-up]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[628]]></modelsamplesize>
		<cohortsamplesize><![CDATA[628]]></cohortsamplesize>
		<numberofevents><![CDATA[82]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hypertension, LVEF, ST Segment Deviation]]></covariates>
		<mh><![CDATA[Aged; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease/complications/*diagnosis/mortality/physiopathology; *Electrocardiography; *Exercise Test; Female; Follow-Up Studies; Heart Conduction System/*physiopathology; Humans; Male; Middle Aged; Myocardial Infarction/*etiology/mortality/physiopathology; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-37]]></modelid>
		<pubmedid><![CDATA[19546391]]></pubmedid>
		<author><![CDATA[Monin]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk score for predicting outcome in patients with asymptomatic aortic stenosis]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[107]]></modelsamplesize>
		<cohortsamplesize><![CDATA[107]]></cohortsamplesize>
		<numberofevents><![CDATA[62]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.9]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Valve Area, Calcification, Sex, Peak Velocity, BNP, Three-Leaflet Valve, Transaortic Mean Pressure Gradient]]></covariates>
		<mh><![CDATA[Aged; Aortic Valve/surgery; Aortic Valve Stenosis/*mortality/surgery/*ultrasonography; *Echocardiography, Doppler; Exercise Test; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Prognosis; Prospective Studies; Risk Assessment/methods/standards; Risk Factors; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-38]]></modelid>
		<pubmedid><![CDATA[19559823]]></pubmedid>
		<author><![CDATA[O'Brien]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[65855]]></modelsamplesize>
		<cohortsamplesize><![CDATA[109759]]></cohortsamplesize>
		<numberofevents><![CDATA[3706]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.805]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, MVR, Reoperation, Status, AF, BSA, CHF, NYHA Class, CLD, Creatinine, CVA, Diabetes, Dialysis, LVEF, Endocarditis, Sex, Hypertension, IABP, Immunosuppressive Treatment, Mitral or Tricuspid Insufficiency, Left Main Disease, MI, Number of Diseased Vesse]]></covariates>
		<mh><![CDATA[Advisory Committees; Age Factors; Aged; *Cause of Death; Databases, Factual; Female; Heart Valve Diseases/mortality/surgery; Heart Valve Prosthesis Implantation/methods/*mortality; Humans; Male; Middle Aged; *Models, Cardiovascular; *Models, Statistical; Postoperative Complications/*mortality; Reproducibility of Results; Risk Adjustment; Sensitivity and Specificity; Sex Factors; Societies, Medical; Survival Analysis; Thoracic Surgery/standards/trends; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-39]]></modelid>
		<pubmedid><![CDATA[19559824]]></pubmedid>
		<author><![CDATA[Shahian]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cardiac Surgery]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[101661]]></modelsamplesize>
		<cohortsamplesize><![CDATA[101661]]></cohortsamplesize>
		<numberofevents><![CDATA[6919]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.754]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, MVR, Reoperation, Status, AF, BSA, CHF, NYHA Class, CLD, Creatinine, CVA, Diabetes, Dialysis, LVEF, Endocarditis, Sex, Hypertension, IABP, Immunosuppressive Treatment, Mitral or Tricuspid Insufficiency, Left Main Disease, MI, Number of Diseased Vesse]]></covariates>
		<mh><![CDATA[Advisory Committees; Age Factors; Aged; Aged, 80 and over; Aortic Valve/surgery; Cause of Death; Combined Modality Therapy; Coronary Artery Bypass/methods/*mortality; Databases, Factual; Female; Heart Valve Diseases/mortality/*surgery; Heart Valve Prosthesis Implantation/methods/*mortality; Humans; Male; Middle Aged; Mitral Valve/surgery; *Models, Cardiovascular; *Models, Statistical; Postoperative Complications/*mortality; Predictive Value of Tests; Prognosis; Risk Adjustment; Sensitivity and Specificity; Sex Factors; Societies, Medical; Survival Analysis; Thoracic Surgery/standards/trends]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-40]]></modelid>
		<pubmedid><![CDATA[19592389]]></pubmedid>
		<author><![CDATA[Levya]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[148]]></modelsamplesize>
		<cohortsamplesize><![CDATA[148]]></cohortsamplesize>
		<numberofevents><![CDATA[37]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.92]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CV Magnetic Resonance-Tissue Synchronization Index, Creatinine, Scar Location]]></covariates>
		<mh><![CDATA[Aged; Cardiac Pacing, Artificial/*mortality; Female; Heart Failure/*mortality/pathology/therapy; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Risk Assessment; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-67]]></modelid>
		<pubmedid><![CDATA[23522527]]></pubmedid>
		<author><![CDATA[Fujii]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the Neurological Sciences]]></journal>
		<title><![CDATA[A simple score for predicting paroxysmal atrial fibrillation in acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[215]]></modelsamplesize>
		<cohortsamplesize><![CDATA[215]]></cohortsamplesize>
		<numberofevents><![CDATA[32]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BNP, Left Atrial Size, Mitral Valvular Disease, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-41]]></modelid>
		<pubmedid><![CDATA[19640868]]></pubmedid>
		<author><![CDATA[Herman]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Interactive Cardiovascular and Thoracic Surgery]]></journal>
		<title><![CDATA[Predicting prolonged intensive care unit length of stay in patients undergoing coronary artery bypass surgery--development of an entirely preoperative scorecard]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[3483]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3483]]></cohortsamplesize>
		<numberofevents><![CDATA[411]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cerebrovascular Disease/PAD, COPD, LVEF, Left Main or Three Vessel Disease, NYHA Class, Renal Failure, CABG, MI, Clinical Status]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Coronary Artery Bypass/*adverse effects; Female; *Health Status Indicators; Humans; Intensive Care Units/*statistics & numerical data; *Length of Stay; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Registries; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-42]]></modelid>
		<pubmedid><![CDATA[19681116]]></pubmedid>
		<author><![CDATA[Hamburger]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Catheterization and Cardiovascular Interventions]]></journal>
		<title><![CDATA[Percutaneous coronary intervention and 30-day mortality: the British Columbia PCI risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[26350]]></modelsamplesize>
		<cohortsamplesize><![CDATA[26350]]></cohortsamplesize>
		<numberofevents><![CDATA[500]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.902]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Critical State, Creatinine or Dialysis, Urgency, Sex, Left main Disease, LVEF, NYHA Class, Other ACS, STEMI, Three Vessel Disease]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; British Columbia/epidemiology; Coronary Angiography; Coronary Artery Disease/mortality/physiopathology/radiography/*therapy; Female; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Population Surveillance; Predictive Value of Tests; Prospective Studies; ROC Curve; Registries; Reproducibility of Results; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-43]]></modelid>
		<pubmedid><![CDATA[19751624]]></pubmedid>
		<author><![CDATA[Ngako]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Prediction of myocardial infarction risk in older patients with acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[399]]></modelsamplesize>
		<cohortsamplesize><![CDATA[399]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Dyspnea, Epigastric Pain, CAD, Sex, Chest Pain, Arm/Jaw/Neck Pain]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/*epidemiology; Aged; Aged, 80 and over; Area Under Curve; Electrocardiography; Humans; Multivariate Analysis; Myocardial Infarction/*epidemiology; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Triage; Troponin I/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-44]]></modelid>
		<pubmedid><![CDATA[19751624]]></pubmedid>
		<author><![CDATA[Ngako]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Prediction of myocardial infarction risk in older patients with acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[399]]></modelsamplesize>
		<cohortsamplesize><![CDATA[399]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.6]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Q Wave, ST Changes]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/*epidemiology; Aged; Aged, 80 and over; Area Under Curve; Electrocardiography; Humans; Multivariate Analysis; Myocardial Infarction/*epidemiology; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Triage; Troponin I/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-45]]></modelid>
		<pubmedid><![CDATA[19751624]]></pubmedid>
		<author><![CDATA[Ngako]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Prediction of myocardial infarction risk in older patients with acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[399]]></modelsamplesize>
		<cohortsamplesize><![CDATA[399]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Dyspnea, Epigastric Pain, CAD, Sex, Q Wave, ST Changes, Chest Pain, Arm/Jaw/Neck Pain]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/*epidemiology; Aged; Aged, 80 and over; Area Under Curve; Electrocardiography; Humans; Multivariate Analysis; Myocardial Infarction/*epidemiology; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Triage; Troponin I/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-46]]></modelid>
		<pubmedid><![CDATA[19751624]]></pubmedid>
		<author><![CDATA[Ngako]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Prediction of myocardial infarction risk in older patients with acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[399]]></modelsamplesize>
		<cohortsamplesize><![CDATA[399]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Troponin I, Dyspnea, Epigastric Pain, CAD, Sex, Q Wave, Chest Pain, Arm/Jaw/Neck Pain]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/*epidemiology; Aged; Aged, 80 and over; Area Under Curve; Electrocardiography; Humans; Multivariate Analysis; Myocardial Infarction/*epidemiology; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Triage; Troponin I/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-47]]></modelid>
		<pubmedid><![CDATA[19752011]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Europace]]></journal>
		<title><![CDATA[Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[436]]></modelsamplesize>
		<cohortsamplesize><![CDATA[436]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.678]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Activity, Footprint, Heart Rate, SDANN]]></covariates>
		<mh><![CDATA[Aged; Cardiac Pacing, Artificial/*mortality; *Decision Support Systems, Clinical; Electrocardiography/*methods/*statistics & numerical data; Female; Heart Failure/*diagnosis/*mortality; Humans; Incidence; Male; Prognosis; *Proportional Hazards Models; Reproducibility of Results; Risk Assessment/methods; Risk Factors; Sensitivity and Specificity; *Survival Analysis; Survival Rate; Treatment Outcome; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-48]]></modelid>
		<pubmedid><![CDATA[19763133]]></pubmedid>
		<author><![CDATA[Arima]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Hypertension Research - Clinical & Experimental]]></journal>
		<title><![CDATA[Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1756]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2634]]></cohortsamplesize>
		<numberofevents><![CDATA[216]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, HDL Cholesterol, LDL Cholesterol, Sex, SBP]]></covariates>
		<mh><![CDATA[Adult; Aged; Asian Continental Ancestry Group/*statistics & numerical data; Cardiovascular Diseases/*ethnology; Cohort Studies; Female; Humans; Japan/epidemiology; Male; Middle Aged; *Models, Statistical; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; *Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-49]]></modelid>
		<pubmedid><![CDATA[19766355]]></pubmedid>
		<author><![CDATA[Sun]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Annals of Emergency Medicine]]></journal>
		<title><![CDATA[Predictors of 30-day serious events in older patients with syncope]]></title>
		<primaryindexcondition><![CDATA[Syncope]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2584]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2584]]></cohortsamplesize>
		<numberofevents><![CDATA[173]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Troponin I, Age, Shortness of Breath, Chest Pain, LVEF, Arrhythmia, Traumatic Injury, Sex, Syncope, Pulse, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; California/epidemiology; Cardiovascular Diseases/epidemiology; Female; *Health Status Indicators; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Syncope/*diagnosis/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-50]]></modelid>
		<pubmedid><![CDATA[19766355]]></pubmedid>
		<author><![CDATA[Sun]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Annals of Emergency Medicine]]></journal>
		<title><![CDATA[Predictors of 30-day serious events in older patients with syncope]]></title>
		<primaryindexcondition><![CDATA[Syncope]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2584]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2584]]></cohortsamplesize>
		<numberofevents><![CDATA[173]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.61]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Troponin I, Age, Arrhythmia, Sex, Syncope, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; California/epidemiology; Cardiovascular Diseases/epidemiology; Female; *Health Status Indicators; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Syncope/*diagnosis/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-51]]></modelid>
		<pubmedid><![CDATA[19782526]]></pubmedid>
		<author><![CDATA[Egorova]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Defining high-risk patients for endovascular aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[44630]]></modelsamplesize>
		<cohortsamplesize><![CDATA[66943]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.735]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, CHF, Sex, Hospital Volume, Liver Disease, LE Ischemia, Neurological Risk Factors, Renal Failure, Dialysis, Surgeon Volume]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/*mortality/*surgery; Blood Vessel Prosthesis Implantation/adverse effects/*mortality; Female; *Health Status Indicators; Humans; Logistic Models; Male; Medicare; Odds Ratio; *Patient Selection; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-52]]></modelid>
		<pubmedid><![CDATA[19808342]]></pubmedid>
		<author><![CDATA[Lewis]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Predictors of heart failure in patients with stable coronary artery disease: a PEACE study]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[8211]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8211]]></cohortsamplesize>
		<numberofevents><![CDATA[268]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Antiarrhythmic Medicine, Diuretic, BMI, Calcium Channel Blocker, Smoking, Digitalis, eGFR, Angina, CABG, Diabetes, Hypertension, MI, Stroke/TIA, LVEF, Lipid Lowering Medicine, Trandolapril]]></covariates>
		<mh><![CDATA[Aged; Angiotensin-Converting Enzyme Inhibitors/*therapeutic use; Coronary Artery Disease/*complications/drug therapy/mortality/physiopathology; Female; Heart Failure/*etiology/mortality/physiopathology/prevention & control; Humans; Indoles/*therapeutic use; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke Volume/drug effects; Time Factors; Treatment Outcome; Ventricular Function, Left/drug effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-53]]></modelid>
		<pubmedid><![CDATA[19822976]]></pubmedid>
		<author><![CDATA[Kinugasa]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Circulation Journal]]></journal>
		<title><![CDATA[A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure--hypoalbuminemia as an additional prognostic factor]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[349]]></modelsamplesize>
		<cohortsamplesize><![CDATA[349]]></cohortsamplesize>
		<numberofevents><![CDATA[34]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Albumin, BUN, BNP, HF Hospitalization, Sodium]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Biomarkers/blood; Female; *Health Status Indicators; Heart Failure/blood/diagnosis/*mortality; Hospital Mortality; Humans; Hypoalbuminemia/blood/diagnosis/*mortality; Logistic Models; Male; Odds Ratio; Predictive Value of Tests; Prognosis; ROC Curve; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin/*analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-54]]></modelid>
		<pubmedid><![CDATA[19828550]]></pubmedid>
		<author><![CDATA[Chuang]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[International Journal for Quality in Health Care]]></journal>
		<title><![CDATA[Risk stratification for predicting 30-day mortality of intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[293]]></modelsamplesize>
		<cohortsamplesize><![CDATA[293]]></cohortsamplesize>
		<numberofevents><![CDATA[40]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Dialysis, GCS Score, Hypertension, Glucose]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Cerebral Hemorrhage/*mortality; Female; Humans; Logistic Models; Male; Middle Aged; *Models, Statistical; Prognosis; ROC Curve; Risk Assessment; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-55]]></modelid>
		<pubmedid><![CDATA[19837547]]></pubmedid>
		<author><![CDATA[Sprengers]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[800]]></modelsamplesize>
		<cohortsamplesize><![CDATA[800]]></cohortsamplesize>
		<numberofevents><![CDATA[120]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ABI, Creatinine, Smoking, HDL Cholesterol, Symptomatic CVD, SBP]]></covariates>
		<mh><![CDATA[Aged; Cardiovascular Diseases/*etiology/*mortality; Female; *Health Status Indicators; Humans; Incidence; Male; Middle Aged; *Models, Cardiovascular; Netherlands/epidemiology; Patient Selection; Peripheral Vascular Diseases/*complications/*mortality/prevention &; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Assessment; Risk Factors; Surveys and Questionnaires; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-56]]></modelid>
		<pubmedid><![CDATA[19838490]]></pubmedid>
		<author><![CDATA[Volschan]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Arquivos Brasileiros de Cardiologia]]></journal>
		<title><![CDATA[Predictors of hospital mortality in hemodynamically stable patients with pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[582]]></modelsamplesize>
		<cohortsamplesize><![CDATA[582]]></cohortsamplesize>
		<numberofevents><![CDATA[82]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Bed Rest, Cor Pulmonale, Tachycardia, Tachypnea]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bed Rest/adverse effects; Chronic Disease; Epidemiologic Methods; Female; Hemodynamics; *Hospital Mortality; Humans; Male; Middle Aged; Pulmonary Embolism/diagnosis/*mortality; Pulmonary Heart Disease/complications; Sleep Wake Disorders/complications; Tachycardia, Sinus/complications; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-57]]></modelid>
		<pubmedid><![CDATA[19936453]]></pubmedid>
		<author><![CDATA[Santos]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Arquivos Brasileiros de Cardiologia]]></journal>
		<title><![CDATA[Dante Pazzanese risk score for non-st-segment elevation acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1027]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1027]]></cohortsamplesize>
		<numberofevents><![CDATA[54]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Diabetes, Age, Sex, ACE Inhibitor, Stroke, Troponin I, ST-Segment Depression]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/*mortality; Aged; Brazil; Emergency Service, Hospital; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Infarction/etiology; Recurrence; Risk Assessment/methods/standards]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-58]]></modelid>
		<pubmedid><![CDATA[19938731]]></pubmedid>
		<author><![CDATA[Poungvarin]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of the Medical Association of Thailand]]></journal>
		<title><![CDATA[Thai venous stroke prognostic score: TV-SPSS]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Central Venous Thrombosis (CVT)]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[194]]></modelsamplesize>
		<cohortsamplesize><![CDATA[194]]></cohortsamplesize>
		<numberofevents><![CDATA[51]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[GCS Score, Hemorrhagic Infarction, Lateral Sinus Involvement, Malignancy]]></covariates>
		<mh><![CDATA[Adult; Cerebral Veins/*physiopathology; Female; Humans; Logistic Models; Male; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Sinus Thrombosis, Intracranial/diagnosis/*physiopathology/therapy; Statistics, Nonparametric; Thailand; Treatment Outcome; Veins]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-59]]></modelid>
		<pubmedid><![CDATA[19958966]]></pubmedid>
		<author><![CDATA[Sacco]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2737]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2737]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.747]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Race, Smoking, DBP, Antihypertensive Medication, FPG, Sex, Alcohol Use, Physical Activity, PVD, SBP, Cholesterol, Waist Size]]></covariates>
		<mh><![CDATA[Aged; *Anthropometry; *Behavior; Cardiovascular Diseases/*epidemiology; Female; Humans; Male; Models, Statistical; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-60]]></modelid>
		<pubmedid><![CDATA[19962465]]></pubmedid>
		<author><![CDATA[Atwater]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[37258]]></modelsamplesize>
		<cohortsamplesize><![CDATA[37258]]></cohortsamplesize>
		<numberofevents><![CDATA[1568]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Diabetes, LVEF, Cerebrovascular Disease, HF, Smoking, Hypertension, Number of Diseased Arteries]]></covariates>
		<mh><![CDATA[Aged; Coronary Angiography; Coronary Artery Disease/*mortality/*radiography; *Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-61]]></modelid>
		<pubmedid><![CDATA[20001655]]></pubmedid>
		<author><![CDATA[Kjeldsen]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Blood Pressure]]></journal>
		<title><![CDATA[Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[9193]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9193]]></cohortsamplesize>
		<numberofevents><![CDATA[1096]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.733]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Exercise, AF, Diabetes, IHD, Stroke/TIA, LVH, Albumin to Creatinine Ratio, Sex, Total Cholesterol]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Antihypertensive Agents/*therapeutic use; Atenolol/*therapeutic use; Blood Pressure/drug effects; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension/complications/*drug therapy/physiopathology; Hypertrophy, Left Ventricular/complications/*drug therapy/physiopathology; Losartan/*therapeutic use; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-62]]></modelid>
		<pubmedid><![CDATA[20001655]]></pubmedid>
		<author><![CDATA[Kjeldsen]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Blood Pressure]]></journal>
		<title><![CDATA[Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9193]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9193]]></cohortsamplesize>
		<numberofevents><![CDATA[438]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.795]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Exercise, AF, Stroke/TIA, LVH, Albumin to Creatinine Ratio, Sex, IHD, Creatinine, Glucose]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Antihypertensive Agents/*therapeutic use; Atenolol/*therapeutic use; Blood Pressure/drug effects; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension/complications/*drug therapy/physiopathology; Hypertrophy, Left Ventricular/complications/*drug therapy/physiopathology; Losartan/*therapeutic use; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-63]]></modelid>
		<pubmedid><![CDATA[20001655]]></pubmedid>
		<author><![CDATA[Kjeldsen]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Blood Pressure]]></journal>
		<title><![CDATA[Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[8465]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8465]]></cohortsamplesize>
		<numberofevents><![CDATA[443]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.704]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, AF, Diabetes, LVH, Albumin to Creatinine Ratio, Uric Acid]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Antihypertensive Agents/*therapeutic use; Atenolol/*therapeutic use; Blood Pressure/drug effects; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension/complications/*drug therapy/physiopathology; Hypertrophy, Left Ventricular/complications/*drug therapy/physiopathology; Losartan/*therapeutic use; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-64]]></modelid>
		<pubmedid><![CDATA[20001655]]></pubmedid>
		<author><![CDATA[Kjeldsen]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Blood Pressure]]></journal>
		<title><![CDATA[Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[8624]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8624]]></cohortsamplesize>
		<numberofevents><![CDATA[331]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.677]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Angina, Diabetes, Albumin to Creatinine Ratio, Sex, Pulse Pressure, Total Cholesterol]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Antihypertensive Agents/*therapeutic use; Atenolol/*therapeutic use; Blood Pressure/drug effects; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension/complications/*drug therapy/physiopathology; Hypertrophy, Left Ventricular/complications/*drug therapy/physiopathology; Losartan/*therapeutic use; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-65]]></modelid>
		<pubmedid><![CDATA[20031896]]></pubmedid>
		<author><![CDATA[Mehta]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Reoperation for Bleeding]]></outcome>
		<modelsamplesize><![CDATA[422949]]></modelsamplesize>
		<cohortsamplesize><![CDATA[528686]]></cohortsamplesize>
		<numberofevents><![CDATA[10122]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.6]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Three Vessel CAD, Age, BSA, Shock, Cerebrovascular Disease, Lung Disease, CHF, Urgency, Immunosuppressive Therapy, IABP or Inotropes, Sex, Diabetes, Race, PCI, PVD, Dialysis, Creatinine, Thienopyridine]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Body Mass Index; Comorbidity; Coronary Artery Bypass/*adverse effects/methods; Databases, Factual; Female; Heart Diseases/etiology/*surgery; Hemorrhage/etiology/*surgery; Humans; Incidence; Logistic Models; Male; Middle Aged; *Outcome Assessment (Health Care); Platelet Aggregation Inhibitors/administration & dosage/adverse effects; Pneumonia/epidemiology; Reoperation/*statistics & numerical data; Respiration, Artificial/utilization; Risk Assessment; Risk Factors; Sepsis/epidemiology; Sex Factors; Stroke/epidemiology; Time Factors; United States]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-66]]></modelid>
		<pubmedid><![CDATA[20368195]]></pubmedid>
		<author><![CDATA[Anselmino]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Diabetes & Vascular Disease Research]]></journal>
		<title><![CDATA[A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1283]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1283]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Beta Blockers, Clinical Status, Interventions, OGTT, Previous MI/HF]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Blood Glucose/*metabolism; Cholesterol, HDL/blood; Coronary Artery Disease/*blood/complications/mortality; Disease-Free Survival; Fasting/blood; Female; Glucose Tolerance Test; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metabolic Syndrome X/*blood/complications/mortality; Middle Aged; Myocardial Infarction/blood/*etiology/mortality; Neural Networks (Computer); Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke/blood/*etiology/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-67]]></modelid>
		<pubmedid><![CDATA[20368195]]></pubmedid>
		<author><![CDATA[Anselmino]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Diabetes & Vascular Disease Research]]></journal>
		<title><![CDATA[A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1283]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1283]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Beta Blockers, Clinical Status, Interventions, OLR, Previous MI/HF]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Blood Glucose/*metabolism; Cholesterol, HDL/blood; Coronary Artery Disease/*blood/complications/mortality; Disease-Free Survival; Fasting/blood; Female; Glucose Tolerance Test; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metabolic Syndrome X/*blood/complications/mortality; Middle Aged; Myocardial Infarction/blood/*etiology/mortality; Neural Networks (Computer); Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke/blood/*etiology/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[09-001-68]]></modelid>
		<pubmedid><![CDATA[20368195]]></pubmedid>
		<author><![CDATA[Anselmino]]></author>
		<year><![CDATA[2009]]></year>
		<journal><![CDATA[Diabetes & Vascular Disease Research]]></journal>
		<title><![CDATA[A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1283]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1283]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ANN, Beta Blockers, Clinical Status, Interventions, Previous MI/HF]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Blood Glucose/*metabolism; Cholesterol, HDL/blood; Coronary Artery Disease/*blood/complications/mortality; Disease-Free Survival; Fasting/blood; Female; Glucose Tolerance Test; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metabolic Syndrome X/*blood/complications/mortality; Middle Aged; Myocardial Infarction/blood/*etiology/mortality; Neural Networks (Computer); Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke/blood/*etiology/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-01]]></modelid>
		<pubmedid><![CDATA[18789548]]></pubmedid>
		<author><![CDATA[Velavan]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Predictors of short term mortality in heart failure - insights from the Euro Heart Failure survey]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10701]]></cohortsamplesize>
		<numberofevents><![CDATA[1401]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ACE Inhibitors, Angiotensin Receptor Blockers, Aspirin, Beta Blockers, Calcium Channel Blockers, Creatinine, Hemoglobin, Heparin, Lipid Lowering Therapy, Inotropes, LVSD, Sodium, Warfarin]]></covariates>
		<mh><![CDATA[Adrenergic beta-Antagonists/therapeutic use; Age Distribution; Aged; Aged, 80 and over; Calcium Channel Blockers/therapeutic use; Cardiotonic Agents/therapeutic use; Cholesterol/blood; Comorbidity; Europe/epidemiology; Female; Fibrinolytic Agents/therapeutic use; *Health Surveys; Heart Failure/drug therapy/*mortality; Hospitalization/*statistics & numerical data; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-02]]></modelid>
		<pubmedid><![CDATA[19541376]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2148]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2148]]></cohortsamplesize>
		<numberofevents><![CDATA[184]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Killip Class, Creatinine, TIMI Risk Index]]></covariates>
		<mh><![CDATA[Aged; *Electrocardiography; Female; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction/*diagnosis/*mortality; Predictive Value of Tests; Prognosis; ROC Curve; Registries; Republic of Korea/epidemiology; Risk Assessment/methods; Risk Factors; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-03]]></modelid>
		<pubmedid><![CDATA[19687023]]></pubmedid>
		<author><![CDATA[Lovelock]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery & Psychiatry]]></journal>
		<title><![CDATA[The SCAN rule: a clinical rule to reduce CT misdiagnosis of intracerebral haemorrhage in minor stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Transient Ischemic Attack (TIA)/Minor Stroke]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[334]]></modelsamplesize>
		<cohortsamplesize><![CDATA[334]]></cohortsamplesize>
		<numberofevents><![CDATA[17]]></numberofevents>
		<followupduration><![CDATA[diagnosis]]></followupduration>
		<auroc><![CDATA[0.92]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Anticoagulation, Confusion, Nausea/Vomiting, Hypertension]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Anticoagulants/adverse effects/therapeutic use; Cerebral Hemorrhage/*diagnosis; Cerebral Infarction/*diagnosis; Cohort Studies; Confusion/diagnosis/etiology; Decision Support Techniques; *Diagnostic Errors/prevention & control; Female; Headache/etiology; Humans; Hypertension/complications/diagnosis; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nausea/diagnosis/etiology; Neurologic Examination/*methods; Platelet Aggregation Inhibitors/adverse effects/therapeutic use; Prognosis; Referral and Consultation; *Tomography, X-Ray Computed; Vomiting/diagnosis/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-04]]></modelid>
		<pubmedid><![CDATA[19736213]]></pubmedid>
		<author><![CDATA[Ergelen]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Clinical & Applied Thrombosis/Hemostasis]]></journal>
		<title><![CDATA[Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Stent Thrombosis]]></outcome>
		<modelsamplesize><![CDATA[1960]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1960]]></cohortsamplesize>
		<numberofevents><![CDATA[89]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, Clopidogrel, Stent Diameter]]></covariates>
		<mh><![CDATA[Adult; Aged; Angioplasty, Balloon, Coronary/adverse effects/*mortality; Coronary Thrombosis/*mortality; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/*mortality/*therapy; Platelet Aggregation Inhibitors/therapeutic use; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Shock, Cardiogenic/mortality/therapy; Stents/adverse effects/*statistics & numerical data; Ticlopidine/analogs & derivatives/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-05]]></modelid>
		<pubmedid><![CDATA[19762550]]></pubmedid>
		<author><![CDATA[Lip]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Systemic Embolization]]></outcome>
		<modelsamplesize><![CDATA[5333]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5333]]></cohortsamplesize>
		<numberofevents><![CDATA[25]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.606]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHF/LV Dysfunction, Diabetes, Sex, Hypertension, Stroke/TIA, Vascular Disease]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/*complications/epidemiology; Europe/epidemiology; Female; Follow-Up Studies; Humans; Incidence; Male; Population Surveillance/*methods; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment/*methods; Risk Factors; Stroke/*epidemiology/etiology; Thromboembolism/*epidemiology/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-06]]></modelid>
		<pubmedid><![CDATA[19782586]]></pubmedid>
		<author><![CDATA[Klotz]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Heart & Lung Transplantation]]></journal>
		<title><![CDATA[Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[241]]></modelsamplesize>
		<cohortsamplesize><![CDATA[241]]></cohortsamplesize>
		<numberofevents><![CDATA[77]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Labs, Emergency Implant, Heart Rate, ICU, Inotropes, Lactate, Mechanical Support, Platelets, CPR, Renal Impairment, Re-Sternotomy, Transfusion, Ventilation]]></covariates>
		<mh><![CDATA[Adult; Blood Urea Nitrogen; C-Reactive Protein/metabolism; Creatinine/blood; Female; *Heart-Assist Devices; Hospital Mortality; Humans; Intensive Care Units/statistics & numerical data; Lactates/blood; Logistic Models; Male; Middle Aged; Predictive Value of Tests; *Preoperative Period; Retrospective Studies; Ventricular Dysfunction/blood/*mortality/*surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-07]]></modelid>
		<pubmedid><![CDATA[19809351]]></pubmedid>
		<author><![CDATA[Martinez-Selles]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Cardiovascular Medicine]]></journal>
		<title><![CDATA[Determinants of long-term survival in patients hospitalized for heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[701]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Stenosis, COPD, LVEF, Creatinine, Stroke]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Aortic Valve Stenosis/mortality; Female; Follow-Up Studies; *Health Status Indicators; Heart Failure/*mortality/physiopathology/ultrasonography; Hospitalization/*statistics & numerical data; Humans; Kaplan-Meier Estimate; Kidney Diseases/mortality; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive/mortality; Registries; Risk Assessment; Risk Factors; Stroke/mortality; Stroke Volume; Survivors/*statistics & numerical data; Time Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-08]]></modelid>
		<pubmedid><![CDATA[19897498]]></pubmedid>
		<author><![CDATA[Ostman-Smith]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congenital Heart Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[87]]></modelsamplesize>
		<cohortsamplesize><![CDATA[87]]></cohortsamplesize>
		<numberofevents><![CDATA[18]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[12-Lead Amplitude Duration, QRS Axis Deviation, QT Interval, Limb-Lead QRS Amplitude, T Wave Inversion, ST Segment Depression]]></covariates>
		<mh><![CDATA[Adult; Cardiomyopathy, Hypertrophic/*ultrasonography; Case-Control Studies; Death, Sudden, Cardiac/*prevention & control; Early Diagnosis; Electrocardiography/*methods; Female; Heart Arrest/etiology; Humans; Male; Retrospective Studies; Risk Assessment; Risk Factors; *Running; *Swimming]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-09]]></modelid>
		<pubmedid><![CDATA[19910608]]></pubmedid>
		<author><![CDATA[Sanchez]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[American Journal of Respiratory and Critical Care Medicine]]></journal>
		<title><![CDATA[prognostic factors for pulmonary embolism: the PREP study, a prospective multicenter cohort study]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[570]]></modelsamplesize>
		<cohortsamplesize><![CDATA[570]]></cohortsamplesize>
		<numberofevents><![CDATA[42]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Mental Status, BNP, Cancer, Shock, Right/Left Ventricle Ratio]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Cause of Death; Cohort Studies; Echocardiography; Female; Hospital Mortality; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Natriuretic Peptide, Brain/blood; Peptide Fragments/blood; Prognosis; Prospective Studies; Pulmonary Embolism/*genetics/*physiopathology; Recurrence; Risk Assessment; Shock, Cardiogenic/mortality/physiopathology; Survival Rate; Troponin I/blood; Venous Thromboembolism/mortality/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-10]]></modelid>
		<pubmedid><![CDATA[19933693]]></pubmedid>
		<author><![CDATA[Borleffs]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[332]]></modelsamplesize>
		<cohortsamplesize><![CDATA[332]]></cohortsamplesize>
		<numberofevents><![CDATA[88]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, LVEF, Renal Clearance]]></covariates>
		<mh><![CDATA[Aged; Cause of Death; *Defibrillators, Implantable; Echocardiography; Female; Heart Diseases/*mortality; Humans; Male; Middle Aged; Myocardial Ischemia/mortality; Primary Prevention; Prospective Studies; Risk Assessment; Risk Factors; Tachycardia, Ventricular/etiology/mortality/*prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-11]]></modelid>
		<pubmedid><![CDATA[19933693]]></pubmedid>
		<author><![CDATA[Borleffs]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[704]]></modelsamplesize>
		<cohortsamplesize><![CDATA[704]]></cohortsamplesize>
		<numberofevents><![CDATA[188]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Smoking, LVEF, QRS Duration, Renal Clearance]]></covariates>
		<mh><![CDATA[Aged; Cause of Death; *Defibrillators, Implantable; Echocardiography; Female; Heart Diseases/*mortality; Humans; Male; Middle Aged; Myocardial Ischemia/mortality; Primary Prevention; Prospective Studies; Risk Assessment; Risk Factors; Tachycardia, Ventricular/etiology/mortality/*prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-12]]></modelid>
		<pubmedid><![CDATA[20018608]]></pubmedid>
		<author><![CDATA[Ay]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[A score to predict early risk of recurrence after ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1458]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1458]]></cohortsamplesize>
		<numberofevents><![CDATA[54]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CCS Stroke Type, Prior Stroke/TIA]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Algorithms; Brain Ischemia/*diagnosis/*epidemiology; Cohort Studies; Female; Humans; Internet/trends; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Regression Analysis; Reproducibility of Results; Retrospective Studies; Risk Assessment/methods; Software; Stroke/*diagnosis/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-13]]></modelid>
		<pubmedid><![CDATA[20018608]]></pubmedid>
		<author><![CDATA[Ay]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[A score to predict early risk of recurrence after ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[1458]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1458]]></cohortsamplesize>
		<numberofevents><![CDATA[54]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CCS Stroke Type, Prior Stroke/TIA, Infarct]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Algorithms; Brain Ischemia/*diagnosis/*epidemiology; Cohort Studies; Female; Humans; Internet/trends; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Regression Analysis; Reproducibility of Results; Retrospective Studies; Risk Assessment/methods; Software; Stroke/*diagnosis/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-14]]></modelid>
		<pubmedid><![CDATA[20092615]]></pubmedid>
		<author><![CDATA[Gencer]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[BMC Medicine]]></journal>
		<title><![CDATA[Ruling out coronary heart disease in primary care patients with chest pain: a clinical prediction score]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[661]]></modelsamplesize>
		<cohortsamplesize><![CDATA[661]]></cohortsamplesize>
		<numberofevents><![CDATA[85]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.946]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CV Risk Factors, Tenderness, Area of Pain, Duration of Pain, History of CVD, Sex, Age, Precipitating with Exertion]]></covariates>
		<mh><![CDATA[Adult; Aged; Area Under Curve; Chest Pain/*diagnosis/etiology; Cohort Studies; Coronary Disease/*diagnosis; Diagnosis, Differential; Electrocardiography; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Primary Health Care/methods; ROC Curve; Reproducibility of Results; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-15]]></modelid>
		<pubmedid><![CDATA[20102874]]></pubmedid>
		<author><![CDATA[Capodanno]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[255]]></modelsamplesize>
		<cohortsamplesize><![CDATA[255]]></cohortsamplesize>
		<numberofevents><![CDATA[17]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.756]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Angioplasty, Balloon, Coronary/*methods/mortality; Cohort Studies; Confidence Intervals; Coronary Angiography/methods; Coronary Disease/classification/*mortality/radiography/*therapy; Coronary Vessels/*pathology; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Probability; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; *Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-16]]></modelid>
		<pubmedid><![CDATA[20106391]]></pubmedid>
		<author><![CDATA[Yoon]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Decision support in surgical management of ischemic cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[309]]></modelsamplesize>
		<cohortsamplesize><![CDATA[309]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Regurgitation, Bilirubin, BUN, Canadian Angina Class, Cholesterol, COPD, Complete Heart Block, Hematocrit, Diabetes, Time from MI to Operation, CAD, Stenosis, LVEF, NYHA Class, PVD, Popliteal Disease, Stroke, Renal Disease, Ventricular Arrhythmia]]></covariates>
		<mh><![CDATA[Comorbidity; Coronary Artery Bypass; *Decision Support Techniques; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mitral Valve/surgery; Myocardial Ischemia/epidemiology/*mortality/physiopathology/*surgery; Prognosis; Risk Management; Ventricular Dysfunction, Left/surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-17]]></modelid>
		<pubmedid><![CDATA[20106391]]></pubmedid>
		<author><![CDATA[Yoon]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Decision support in surgical management of ischemic cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[170]]></modelsamplesize>
		<cohortsamplesize><![CDATA[170]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Regurgitation, Bilirubin, BUN, Canadian Angina Class, Cholesterol, COPD, Complete Heart Block, Hematocrit, Diabetes, Time from MI to Operation, CAD, Stenosis, LVEF, NYHA Class, PVD, Popliteal Disease, Stroke, Renal Disease, Ventricular Arrhythmia]]></covariates>
		<mh><![CDATA[Comorbidity; Coronary Artery Bypass; *Decision Support Techniques; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mitral Valve/surgery; Myocardial Ischemia/epidemiology/*mortality/physiopathology/*surgery; Prognosis; Risk Management; Ventricular Dysfunction, Left/surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-18]]></modelid>
		<pubmedid><![CDATA[20106391]]></pubmedid>
		<author><![CDATA[Yoon]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Decision support in surgical management of ischemic cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[288]]></modelsamplesize>
		<cohortsamplesize><![CDATA[288]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Regurgitation, Bilirubin, BUN, Canadian Angina Class, Cholesterol, COPD, Complete Heart Block, Hematocrit, Diabetes, Time from MI to Operation, CAD, Stenosis, LVEF, NYHA Class, PVD, Popliteal Disease, Stroke, Renal Disease, Ventricular Arrhythmia]]></covariates>
		<mh><![CDATA[Comorbidity; Coronary Artery Bypass; *Decision Support Techniques; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mitral Valve/surgery; Myocardial Ischemia/epidemiology/*mortality/physiopathology/*surgery; Prognosis; Risk Management; Ventricular Dysfunction, Left/surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-19]]></modelid>
		<pubmedid><![CDATA[20106391]]></pubmedid>
		<author><![CDATA[Yoon]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Thoracic & Cardiovascular Surgery]]></journal>
		<title><![CDATA[Decision support in surgical management of ischemic cardiomyopathy]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[408]]></modelsamplesize>
		<cohortsamplesize><![CDATA[408]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Regurgitation, Bilirubin, BUN, Canadian Angina Class, Cholesterol, COPD, Complete Heart Block, Hematocrit, Diabetes, Time from MI to Operation, CAD, Stenosis, LVEF, NYHA Class, PVD, Popliteal Disease, Stroke, Renal Disease, Ventricular Arrhythmia]]></covariates>
		<mh><![CDATA[Comorbidity; Coronary Artery Bypass; *Decision Support Techniques; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mitral Valve/surgery; Myocardial Ischemia/epidemiology/*mortality/physiopathology/*surgery; Prognosis; Risk Management; Ventricular Dysfunction, Left/surgery]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-20]]></modelid>
		<pubmedid><![CDATA[20123668]]></pubmedid>
		<author><![CDATA[Peterson]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[27850]]></modelsamplesize>
		<cohortsamplesize><![CDATA[39783]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Race, BUN, COPD, Heart Rate, Sodium, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; *American Heart Association; Chi-Square Distribution; Cohort Studies; Female; Guideline Adherence; *Health Status Indicators; Heart Failure/*mortality/physiopathology; Hospital Mortality; Humans; Inpatients/*statistics & numerical data; Logistic Models; Male; Middle Aged; Practice Guidelines as Topic; Predictive Value of Tests; ROC Curve; Registries; Reproducibility of Results; Risk Assessment; Risk Factors; Systole; Time Factors; United States/epidemiology; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-21]]></modelid>
		<pubmedid><![CDATA[20155439]]></pubmedid>
		<author><![CDATA[Risselada]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[European Journal of Epidemiology]]></journal>
		<title><![CDATA[Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2128]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2128]]></cohortsamplesize>
		<numberofevents><![CDATA[153]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Fisher Grade, Lumen Size, WFNS Grade]]></covariates>
		<mh><![CDATA[Female; Follow-Up Studies; Humans; Logistic Models; Male; *Models, Statistical; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Subarachnoid Hemorrhage/diagnosis/*mortality/radiography; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-22]]></modelid>
		<pubmedid><![CDATA[20170808]]></pubmedid>
		<author><![CDATA[de Vos]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[1219]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1219]]></cohortsamplesize>
		<numberofevents><![CDATA[178]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.675]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, HF, Stroke/TIA, Hypertension]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/diagnosis/*pathology; *Disease Progression; Female; Humans; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-23]]></modelid>
		<pubmedid><![CDATA[20181681]]></pubmedid>
		<author><![CDATA[Ducrocq]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis]]></title>
		<primaryindexcondition><![CDATA[Cardiovascular Disease (CVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[56616]]></modelsamplesize>
		<cohortsamplesize><![CDATA[56616]]></cohortsamplesize>
		<numberofevents><![CDATA[903]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.64]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Employment, Incapacity, Lives Alone, Sex, Weight]]></covariates>
		<mh><![CDATA[Aged; Ambulatory Care; Atherosclerosis/etiology/*prevention & control; Early Diagnosis; Female; Fibrinolytic Agents/*adverse effects; Hemorrhage/chemically induced/*prevention & control; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombosis/etiology/*prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-24]]></modelid>
		<pubmedid><![CDATA[20185037]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[423]]></modelsamplesize>
		<cohortsamplesize><![CDATA[423]]></cohortsamplesize>
		<numberofevents><![CDATA[83]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Walk Distance, Age, BUN, CPR/Mechanical Ventilation, BNP, Diuretic Dose, Beta Blockers, Sodium]]></covariates>
		<mh><![CDATA[Aged; Canada/epidemiology; Catheterization, Swan-Ganz/*methods; Female; Follow-Up Studies; Heart Failure/*diagnosis/mortality/therapy; Hospital Mortality/trends; Hospitalization/*statistics & numerical data; Humans; Male; Middle Aged; *Models, Organizational; Patient Discharge/*statistics & numerical data; Prognosis; Retrospective Studies; Risk Factors; Triage/*organization & administration; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-25]]></modelid>
		<pubmedid><![CDATA[20197631]]></pubmedid>
		<author><![CDATA[Noda]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Atherosclerosis & Thrombosis]]></journal>
		<title><![CDATA[Prediction of myocardial infarction using coronary risk scores among Japanese male workers: 3M Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[612]]></modelsamplesize>
		<cohortsamplesize><![CDATA[612]]></cohortsamplesize>
		<numberofevents><![CDATA[204]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.773]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Hypertension, Glucose, LDL Cholesterol, Triglycerides, HDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Female; Humans; Japan/epidemiology; Male; Middle Aged; Myocardial Infarction/*epidemiology; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-26]]></modelid>
		<pubmedid><![CDATA[20197631]]></pubmedid>
		<author><![CDATA[Noda]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Atherosclerosis & Thrombosis]]></journal>
		<title><![CDATA[Prediction of myocardial infarction using coronary risk scores among Japanese male workers: 3M Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[612]]></modelsamplesize>
		<cohortsamplesize><![CDATA[612]]></cohortsamplesize>
		<numberofevents><![CDATA[204]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Hypertension, Glucose, Triglycerides, LDL Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Female; Humans; Japan/epidemiology; Male; Middle Aged; Myocardial Infarction/*epidemiology; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-27]]></modelid>
		<pubmedid><![CDATA[20197631]]></pubmedid>
		<author><![CDATA[Noda]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Atherosclerosis & Thrombosis]]></journal>
		<title><![CDATA[Prediction of myocardial infarction using coronary risk scores among Japanese male workers: 3M Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[612]]></modelsamplesize>
		<cohortsamplesize><![CDATA[612]]></cohortsamplesize>
		<numberofevents><![CDATA[204]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Hypertension, Glucose, Triglycerides]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Female; Humans; Japan/epidemiology; Male; Middle Aged; Myocardial Infarction/*epidemiology; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-28]]></modelid>
		<pubmedid><![CDATA[20223889]]></pubmedid>
		<author><![CDATA[Flint]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[American Journal of Neuroradiology]]></journal>
		<title><![CDATA[Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[305]]></modelsamplesize>
		<cohortsamplesize><![CDATA[305]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.683]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Brain Ischemia/*mortality/*surgery; Chronic Disease; Clinical Trials as Topic/statistics & numerical data; Humans; Logistic Models; Multicenter Studies as Topic/statistics & numerical data; Multivariate Analysis; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Stroke/*mortality/*surgery; Thrombectomy/*mortality; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-29]]></modelid>
		<pubmedid><![CDATA[20223889]]></pubmedid>
		<author><![CDATA[Flint]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[American Journal of Neuroradiology]]></journal>
		<title><![CDATA[Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[305]]></modelsamplesize>
		<cohortsamplesize><![CDATA[305]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.709]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Diabetes, Hypertension, NIHSS]]></covariates>
		<mh><![CDATA[Adult; Age Distribution; Aged; Brain Ischemia/*mortality/*surgery; Chronic Disease; Clinical Trials as Topic/statistics & numerical data; Humans; Logistic Models; Multicenter Studies as Topic/statistics & numerical data; Multivariate Analysis; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Stroke/*mortality/*surgery; Thrombectomy/*mortality; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-30]]></modelid>
		<pubmedid><![CDATA[20233732]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Age & Ageing]]></journal>
		<title><![CDATA[Predicting functional outcome after stroke by modelling baseline clinical and CT variables]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[310]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.882]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Arm Power, Pre-Stroke Independence, Stroke Severity]]></covariates>
		<mh><![CDATA[Activities of Daily Living; Acute Disease; Aged; Aged, 80 and over; Area Under Curve; Female; Humans; Male; Middle Aged; *Models, Statistical; Outcome Assessment (Health Care)/*methods; Predictive Value of Tests; Prognosis; ROC Curve; Severity of Illness Index; Stroke/mortality/*radiography/*rehabilitation; Survival Rate; *Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-31]]></modelid>
		<pubmedid><![CDATA[20233732]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Age & Ageing]]></journal>
		<title><![CDATA[Predicting functional outcome after stroke by modelling baseline clinical and CT variables]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[CVA]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[310]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.876]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Arm Power, Pre-Stroke Independence, Verbal GCS Score]]></covariates>
		<mh><![CDATA[Activities of Daily Living; Acute Disease; Aged; Aged, 80 and over; Area Under Curve; Female; Humans; Male; Middle Aged; *Models, Statistical; Outcome Assessment (Health Care)/*methods; Predictive Value of Tests; Prognosis; ROC Curve; Severity of Illness Index; Stroke/mortality/*radiography/*rehabilitation; Survival Rate; *Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-33]]></modelid>
		<pubmedid><![CDATA[20236721]]></pubmedid>
		<author><![CDATA[Zgibor]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Diabetes Research & Clinical Practice]]></journal>
		<title><![CDATA[Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[304]]></modelsamplesize>
		<cohortsamplesize><![CDATA[304]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[HDL Cholesterol, WBC, Albumin, Diabetes]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Body Mass Index; Child; Cohort Studies; Coronary Disease/*etiology; Diabetes Mellitus, Type 1/*complications; Female; Humans; Male; Middle Aged; *Models, Statistical; Prognosis; Prospective Studies; Risk Factors; United States; Waist-Hip Ratio; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-34]]></modelid>
		<pubmedid><![CDATA[20236721]]></pubmedid>
		<author><![CDATA[Zgibor]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Diabetes Research & Clinical Practice]]></journal>
		<title><![CDATA[Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[299]]></modelsamplesize>
		<cohortsamplesize><![CDATA[299]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[LDL Cholesterol, Diabetes, SBP, Antihypertensive Medication, Waist to Hip Ratio]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Body Mass Index; Child; Cohort Studies; Coronary Disease/*etiology; Diabetes Mellitus, Type 1/*complications; Female; Humans; Male; Middle Aged; *Models, Statistical; Prognosis; Prospective Studies; Risk Factors; United States; Waist-Hip Ratio; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-35]]></modelid>
		<pubmedid><![CDATA[20299623]]></pubmedid>
		<author><![CDATA[Pisters]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[3978]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3978]]></cohortsamplesize>
		<numberofevents><![CDATA[53]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[]]></calibrationreported>
		<covariates><![CDATA[Renal/Liver Dysfunction, Age, Substance Use, Bleeding, Hypertension, INR, Stroke]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/*complications/epidemiology; Europe/epidemiology; Female; Fibrinolytic Agents/*adverse effects/therapeutic use; Follow-Up Studies; Hemorrhage/*epidemiology/etiology; Humans; Incidence; Male; Platelet Aggregation Inhibitors/*adverse effects/therapeutic use; Population Surveillance/*methods; Prognosis; Prospective Studies; Risk Assessment/*methods; Risk Factors; Stroke/etiology/prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-36]]></modelid>
		<pubmedid><![CDATA[20351233]]></pubmedid>
		<author><![CDATA[Eichinger]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[929]]></modelsamplesize>
		<cohortsamplesize><![CDATA[929]]></cohortsamplesize>
		<numberofevents><![CDATA[176]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.651]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[D-dimer, Sex, Thrombosis, PE]]></covariates>
		<mh><![CDATA[Austria/epidemiology; Body Mass Index; Cohort Studies; Factor V/analysis; Female; Follow-Up Studies; Humans; Male; Polymorphism, Single Nucleotide; Probability; Proportional Hazards Models; Prospective Studies; Prothrombin/genetics; Pulmonary Embolism/*epidemiology/mortality; Recurrence; Risk Assessment; Thrombin/genetics; Time Factors; Venous Thrombosis/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-37]]></modelid>
		<pubmedid><![CDATA[20354440]]></pubmedid>
		<author><![CDATA[Ergelen]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Coronary Artery Disease]]></journal>
		<title><![CDATA[Prediction of cardiovascular mortality in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2529]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2529]]></cohortsamplesize>
		<numberofevents><![CDATA[76]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Nephropathy, Diabetes, Killip Class, Procedural Failure]]></covariates>
		<mh><![CDATA[Age Factors; Aged; *Angioplasty, Balloon, Coronary; Contrast Media/adverse effects; Coronary Angiography; Diabetes Mellitus; *Electrocardiography; Female; Hospital Mortality; Humans; Kidney Diseases/chemically induced/complications; Male; Middle Aged; Myocardial Infarction/complications/mortality/*surgery; Odds Ratio; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; *Severity of Illness Index; *Stents; Turkey]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-38]]></modelid>
		<pubmedid><![CDATA[20418056]]></pubmedid>
		<author><![CDATA[Wei]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American Society of Echocardiography]]></journal>
		<title><![CDATA[A predictive instrument using contrast echocardiography in patients presenting to the emergency department with chest pain and without ST-segment elevation]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1166]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1166]]></cohortsamplesize>
		<numberofevents><![CDATA[142]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Abnormal Regional Function, Myocardial Perfusion, ST-T Changes]]></covariates>
		<mh><![CDATA[Aged; Angina Pectoris/*ultrasonography; *Echocardiography; Electrocardiography; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Myocardial Ischemia/*diagnosis; Predictive Value of Tests; Prospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-39]]></modelid>
		<pubmedid><![CDATA[20430263]]></pubmedid>
		<author><![CDATA[Peterson]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[181775]]></modelsamplesize>
		<cohortsamplesize><![CDATA[181775]]></cohortsamplesize>
		<numberofevents><![CDATA[2254]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.911]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Shock, Lung Disease, GFR, NYHA Class, PCI Status, STEMI/NSTEMI, PVD, CHF]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality/statistics & numerical data; Female; *Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction/*mortality/therapy; Prognosis; Registries/statistics & numerical data; Reproducibility of Results; Risk Adjustment/statistics & numerical data; Risk Assessment/*statistics & numerical data; Risk Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-40]]></modelid>
		<pubmedid><![CDATA[20431079]]></pubmedid>
		<author><![CDATA[Setacci]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Siena carotid artery stenting score: a risk modelling study for individual patients]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[2124]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2124]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Lesion Size, Calcification, Ulceration, Stenosis, Lesion Type, Operator Experience, Cardiac Disease, Diabetes, Neurological Symptoms, Procedural Details]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Brain Ischemia/*etiology/mortality; Carotid Stenosis/mortality/*therapy; Female; Humans; Male; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Stents/*adverse effects; Stroke/*etiology/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-41]]></modelid>
		<pubmedid><![CDATA[20447530]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multimarker prediction of coronary heart disease risk: the Women's Health Initiative]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1064]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1064]]></cohortsamplesize>
		<numberofevents><![CDATA[321]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.699]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes, HDL Cholesterol, SBP, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Case-Control Studies; Cohort Studies; Coronary Disease/*blood/diagnosis/*etiology; Female; Humans; Logistic Models; Middle Aged; Postmenopause/blood; Predictive Value of Tests; Prognosis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-42]]></modelid>
		<pubmedid><![CDATA[20447530]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multimarker prediction of coronary heart disease risk: the Women's Health Initiative]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1064]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1064]]></cohortsamplesize>
		<numberofevents><![CDATA[321]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.729]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Estrogen Treatment, CVD History, Diabetes, HDL Cholesterol, SBP, Smoking, Statin, Total Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Case-Control Studies; Cohort Studies; Coronary Disease/*blood/diagnosis/*etiology; Female; Humans; Logistic Models; Middle Aged; Postmenopause/blood; Predictive Value of Tests; Prognosis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-43]]></modelid>
		<pubmedid><![CDATA[20447530]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multimarker prediction of coronary heart disease risk: the Women's Health Initiative]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1064]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1064]]></cohortsamplesize>
		<numberofevents><![CDATA[321]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.751]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Estrogen Treatment, Diabetes, HDL Cholesterol, Interleukin 6, D-dimer, Factor VIII, Homocysteine, SBP, Smoking, Statin, Total Cholesterol, von Willebrand Factor]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Case-Control Studies; Cohort Studies; Coronary Disease/*blood/diagnosis/*etiology; Female; Humans; Logistic Models; Middle Aged; Postmenopause/blood; Predictive Value of Tests; Prognosis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-44]]></modelid>
		<pubmedid><![CDATA[20447530]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multimarker prediction of coronary heart disease risk: the Women's Health Initiative]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[864]]></modelsamplesize>
		<cohortsamplesize><![CDATA[864]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.707]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Diabetes, HDL Cholesterol, SBP, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Case-Control Studies; Cohort Studies; Coronary Disease/*blood/diagnosis/*etiology; Female; Humans; Logistic Models; Middle Aged; Postmenopause/blood; Predictive Value of Tests; Prognosis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-45]]></modelid>
		<pubmedid><![CDATA[20447530]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multimarker prediction of coronary heart disease risk: the Women's Health Initiative]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[864]]></modelsamplesize>
		<cohortsamplesize><![CDATA[864]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.715]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Estrogen Treatment, CVD History, Diabetes, HDL Cholesterol, SBP, Smoking, Statin, Total Cholesterol]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Case-Control Studies; Cohort Studies; Coronary Disease/*blood/diagnosis/*etiology; Female; Humans; Logistic Models; Middle Aged; Postmenopause/blood; Predictive Value of Tests; Prognosis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-46]]></modelid>
		<pubmedid><![CDATA[20447530]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multimarker prediction of coronary heart disease risk: the Women's Health Initiative]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[864]]></modelsamplesize>
		<cohortsamplesize><![CDATA[864]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.731]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Estrogen Treatment, Diabetes, HDL Cholesterol, Interleukin 6, D-dimer, Factor VIII, Homocysteine, SBP, Smoking, Statin, Total Cholesterol, von Willebrand Factor]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Biomarkers/blood; Case-Control Studies; Cohort Studies; Coronary Disease/*blood/diagnosis/*etiology; Female; Humans; Logistic Models; Middle Aged; Postmenopause/blood; Predictive Value of Tests; Prognosis; Risk Factors; Sex Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-13]]></modelid>
		<pubmedid><![CDATA[24032701]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurosurgery]]></journal>
		<title><![CDATA[Predicting inpatient complications from cerebral aneurysm clipping: the Nationwide Inpatient Sample 2005-2009]]></title>
		<primaryindexcondition><![CDATA[Unruptured Cerebral Aneurysm]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Unfavorable Discharge]]></outcome>
		<modelsamplesize><![CDATA[3682]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3682]]></cohortsamplesize>
		<numberofevents><![CDATA[563]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stroke, CHF, Coagulopathy]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-14]]></modelid>
		<pubmedid><![CDATA[24032701]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurosurgery]]></journal>
		<title><![CDATA[Predicting inpatient complications from cerebral aneurysm clipping: the Nationwide Inpatient Sample 2005-2009]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Unfavorable Discharge]]></outcome>
		<modelsamplesize><![CDATA[3969]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3969]]></cohortsamplesize>
		<numberofevents><![CDATA[2097]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stroke, CRF, Coagulopathy]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-15]]></modelid>
		<pubmedid><![CDATA[24032701]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurosurgery]]></journal>
		<title><![CDATA[Predicting inpatient complications from cerebral aneurysm clipping: the Nationwide Inpatient Sample 2005-2009]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3969]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3969]]></cohortsamplesize>
		<numberofevents><![CDATA[456]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stroke, Coagulopathy, COPD]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-16]]></modelid>
		<pubmedid><![CDATA[24032701]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurosurgery]]></journal>
		<title><![CDATA[Predicting inpatient complications from cerebral aneurysm clipping: the Nationwide Inpatient Sample 2005-2009]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[3969]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3969]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CAD, Coagulopathy, CHF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-17]]></modelid>
		<pubmedid><![CDATA[24091567]]></pubmedid>
		<author><![CDATA[Pannucci]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients]]></title>
		<primaryindexcondition><![CDATA[Post-Operative]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[6768]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10344]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cancer, Family History, Sex, VTE, Sepsis/Shock/SIRS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-18]]></modelid>
		<pubmedid><![CDATA[24179162]]></pubmedid>
		<author><![CDATA[Salah]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1301]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1301]]></cohortsamplesize>
		<numberofevents><![CDATA[195]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hyponatremia, NT-proBNP, NYHA Class, Peripheral Edema, SBP, Serum Urea]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-19]]></modelid>
		<pubmedid><![CDATA[24200547]]></pubmedid>
		<author><![CDATA[Guijarro]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[European Journal of Internal Medicine]]></journal>
		<title><![CDATA[Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients: Findings from the Spanish national discharge database]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1148301]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1148301]]></cohortsamplesize>
		<numberofevents><![CDATA[13848]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[HF, Respiratory Insufficiency, Anemia, Cancer, Coagulation Disorder or Thrombocytopenia, Sex, Infection, IBD, IHD, Liver Disease, Obesity, Upper GI Disease]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-20]]></modelid>
		<pubmedid><![CDATA[24200547]]></pubmedid>
		<author><![CDATA[Guijarro]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[European Journal of Internal Medicine]]></journal>
		<title><![CDATA[Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients: Findings from the Spanish national discharge database]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[1148301]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1148301]]></cohortsamplesize>
		<numberofevents><![CDATA[35567]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[HF, Respiratory Insufficiency, Anemia, Cancer, Coagulation Disorder or Thrombocytopenia, Sex, Infection, IBD, IHD, Liver Disease, Obesity, Upper GI Disease]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-21]]></modelid>
		<pubmedid><![CDATA[24203840]]></pubmedid>
		<author><![CDATA[Calvet]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting asymptomatic coronary artery disease in patients with ischemic stroke and transient ischemic attack: the PRECORIS score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[300]]></modelsamplesize>
		<cohortsamplesize><![CDATA[300]]></cohortsamplesize>
		<numberofevents><![CDATA[50]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Atherosclerosis/Left Main or 3-Vessel Disease, Framingham Risk Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-22]]></modelid>
		<pubmedid><![CDATA[24262323]]></pubmedid>
		<author><![CDATA[Perry]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3906]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3906]]></cohortsamplesize>
		<numberofevents><![CDATA[86]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Antiplatelet Medication, AF, Dysarthria or Aphasia, First TIA, Glucose, Carotid Stenosis, Gait Disturbance, Unilateral Weakness, Vertigo, Infarction on CT, DBP, Platelets, Symptom Duration]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-23]]></modelid>
		<pubmedid><![CDATA[24281135]]></pubmedid>
		<author><![CDATA[Chyu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Four-variable risk model in men and women with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1569]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1569]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.787]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, BNP, NYHA Class, Peak VO2]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-24]]></modelid>
		<pubmedid><![CDATA[24281135]]></pubmedid>
		<author><![CDATA[Chyu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Four-variable risk model in men and women with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1096]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1096]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.791]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, BNP, NYHA Class, Peak VO2]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-25]]></modelid>
		<pubmedid><![CDATA[24281135]]></pubmedid>
		<author><![CDATA[Chyu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Four-variable risk model in men and women with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[473]]></modelsamplesize>
		<cohortsamplesize><![CDATA[473]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.796]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, BNP, NYHA Class, Peak VO2]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-26]]></modelid>
		<pubmedid><![CDATA[24333491]]></pubmedid>
		<author><![CDATA[Dodson]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Developing a Risk Model for In-Hospital Adverse Events Following Implantable Cardioverter-Defibrillator Implantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[168442]]></modelsamplesize>
		<cohortsamplesize><![CDATA[240632]]></cohortsamplesize>
		<numberofevents><![CDATA[4388]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.724]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal Conduction, BUN, Lung Disease, Dialysis, Hemoglobin, ICD Type, Prior CABG, NYHA Class, Procedure Type, Reason for Admission, Sex, Sodium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-27]]></modelid>
		<pubmedid><![CDATA[24333602]]></pubmedid>
		<author><![CDATA[Kretz]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Annals of Vascular Surgery]]></journal>
		<title><![CDATA[Risk index for predicting shunt in carotid endarterectomy]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Shunt for Cerebral Perfusion]]></outcome>
		<modelsamplesize><![CDATA[1223]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1223]]></cohortsamplesize>
		<numberofevents><![CDATA[88]]></numberofevents>
		<followupduration><![CDATA[N/A (Case-Control)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Carotid Flow, Carotid Occlusion, Carotid Surgery, Hypertension, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-28]]></modelid>
		<pubmedid><![CDATA[24353280]]></pubmedid>
		<author><![CDATA[Rapsomaniki]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[102023]]></modelsamplesize>
		<cohortsamplesize><![CDATA[102023]]></cohortsamplesize>
		<numberofevents><![CDATA[20817]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Anxiety, CHD, AF, Cancer, COPD, Creatinine, Smoking, Depression, Diabetes, HDL Cholesterol, HF, Heart Rate, Hemoglobin, Liver Disease, PCI/CABG, PAD, MI, Renal Disease, Stroke, Total Cholesterol, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-29]]></modelid>
		<pubmedid><![CDATA[24353280]]></pubmedid>
		<author><![CDATA[Rapsomaniki]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[102023]]></modelsamplesize>
		<cohortsamplesize><![CDATA[102023]]></cohortsamplesize>
		<numberofevents><![CDATA[9896]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, Anxiety, CHD, AF, Cancer, COPD, Creatinine, Smoking, Depression, Diabetes, HDL Cholesterol, HF, Heart Rate, Hemoglobin, Liver Disease, PCI/CABG, PAD, MI, Renal Disease, Stroke, Total Cholesterol, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-30]]></modelid>
		<pubmedid><![CDATA[24366060]]></pubmedid>
		<author><![CDATA[Brouwers]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[JAMA Neurology]]></journal>
		<title><![CDATA[Predicting hematoma expansion after primary intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[817]]></modelsamplesize>
		<cohortsamplesize><![CDATA[817]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ICH Volume, CT Angiography, Time to CT, Warfarin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-31]]></modelid>
		<pubmedid><![CDATA[24366060]]></pubmedid>
		<author><![CDATA[Brouwers]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[JAMA Neurology]]></journal>
		<title><![CDATA[Predicting hematoma expansion after primary intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Hematoma Expansion]]></outcome>
		<modelsamplesize><![CDATA[817]]></modelsamplesize>
		<cohortsamplesize><![CDATA[817]]></cohortsamplesize>
		<numberofevents><![CDATA[156]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ICH Volume, CT Angiography, Time to CT, Warfarin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-34]]></modelid>
		<pubmedid><![CDATA[24373542]]></pubmedid>
		<author><![CDATA[Cuschieri]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Digestive Diseases]]></journal>
		<title><![CDATA[Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[3218]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3218]]></cohortsamplesize>
		<numberofevents><![CDATA[107]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CKD, Liver Disease, Diabetes, Warfarin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-35]]></modelid>
		<pubmedid><![CDATA[24378806]]></pubmedid>
		<author><![CDATA[Aaronson]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Archives of Physical Medicine and Rehabilitation]]></journal>
		<title><![CDATA[Can a Prediction Model Combining Self-Reported Symptoms, Sociodemographic and Clinical Features Serve as a Reliable First Screening Method for Sleep Apnea Syndrome in Patients with Stroke?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Sleep Apnea]]></outcome>
		<modelsamplesize><![CDATA[438]]></modelsamplesize>
		<cohortsamplesize><![CDATA[438]]></cohortsamplesize>
		<numberofevents><![CDATA[135]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Apneas, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-36]]></modelid>
		<pubmedid><![CDATA[24385451]]></pubmedid>
		<author><![CDATA[Eichinger]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[D-Dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna Prediction Model]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[553]]></cohortsamplesize>
		<numberofevents><![CDATA[150]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[D-dimer, VTE Location, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-37]]></modelid>
		<pubmedid><![CDATA[24385451]]></pubmedid>
		<author><![CDATA[Eichinger]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[D-Dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna Prediction Model]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[553]]></cohortsamplesize>
		<numberofevents><![CDATA[150]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[D-dimer, VTE Location, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-38]]></modelid>
		<pubmedid><![CDATA[24385451]]></pubmedid>
		<author><![CDATA[Eichinger]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[D-Dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna Prediction Model]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[553]]></cohortsamplesize>
		<numberofevents><![CDATA[150]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[D-dimer, VTE Location, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-39]]></modelid>
		<pubmedid><![CDATA[24385451]]></pubmedid>
		<author><![CDATA[Eichinger]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[D-Dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna Prediction Model]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[553]]></cohortsamplesize>
		<numberofevents><![CDATA[150]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[D-dimer, VTE Location, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-40]]></modelid>
		<pubmedid><![CDATA[24388023]]></pubmedid>
		<author><![CDATA[Corrales-Medina]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Mayo Clinic Proceedings]]></journal>
		<title><![CDATA[Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1343]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1343]]></cohortsamplesize>
		<numberofevents><![CDATA[358]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Arterial pH, CXR Results, Arrhythmia, CAD, HF, Hematocrit, Platelets, Pulse, SBP, Glucose, Serum Urea Nitrogen, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-41]]></modelid>
		<pubmedid><![CDATA[24390521]]></pubmedid>
		<author><![CDATA[Imai]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Internal Medicine]]></journal>
		<title><![CDATA[Prediction of Congestive Heart Failure in Patients with Non Valvular Atrial Fibrillation]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[347]]></modelsamplesize>
		<cohortsamplesize><![CDATA[347]]></cohortsamplesize>
		<numberofevents><![CDATA[41]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, CHF, Hypertension]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-42]]></modelid>
		<pubmedid><![CDATA[24423583]]></pubmedid>
		<author><![CDATA[Shimoyama]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the Neurological Sciences]]></journal>
		<title><![CDATA[The DASH score: a simple score to assess risk for development of malignant middle cerebral artery infarction]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Malignant MCA Infarction (MMI)]]></outcome>
		<modelsamplesize><![CDATA[119]]></modelsamplesize>
		<cohortsamplesize><![CDATA[119]]></cohortsamplesize>
		<numberofevents><![CDATA[57]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.88]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ACA Territory Involvement, DWI ASPECTS, Glucose, M1 Susceptibility Vessel Sign]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-43]]></modelid>
		<pubmedid><![CDATA[24424334]]></pubmedid>
		<author><![CDATA[Boehme]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Stroke and Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Systemic Inflammatory Response Syndrome (SIRS)]]></outcome>
		<modelsamplesize><![CDATA[212]]></modelsamplesize>
		<cohortsamplesize><![CDATA[212]]></cohortsamplesize>
		<numberofevents><![CDATA[44]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.743]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Stroke, Hypertension, Race, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-44]]></modelid>
		<pubmedid><![CDATA[24425588]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Risk stratification for long-term mortality after percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5948]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11897]]></cohortsamplesize>
		<numberofevents><![CDATA[237]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.809]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, COPD, CHF, Diabetes, LVEF, Hemodynamic State, Number of Diseased Vessels, PAD, CABG, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-45]]></modelid>
		<pubmedid><![CDATA[24425588]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Risk stratification for long-term mortality after percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5948]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11897]]></cohortsamplesize>
		<numberofevents><![CDATA[582]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.786]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, COPD, CHF, Diabetes, LVEF, Hemodynamic State, Number of Diseased Vessels, PAD, CABG, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-46]]></modelid>
		<pubmedid><![CDATA[24425588]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Risk stratification for long-term mortality after percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5948]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11897]]></cohortsamplesize>
		<numberofevents><![CDATA[957]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.782]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, COPD, CHF, Diabetes, LVEF, Hemodynamic State, Number of Diseased Vessels, PAD, CABG, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-47]]></modelid>
		<pubmedid><![CDATA[24428678]]></pubmedid>
		<author><![CDATA[Than]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Emergency Medicine Australasia]]></journal>
		<title><![CDATA[Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1974]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1974]]></cohortsamplesize>
		<numberofevents><![CDATA[305]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Risk Factors, Diaphoresis, Sex, Pain]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-48]]></modelid>
		<pubmedid><![CDATA[24484224]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurosurgery]]></journal>
		<title><![CDATA[Increased risk of acute kidney injury associated with higher infusion rate of mannitol in patients with intracranial hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[153]]></modelsamplesize>
		<cohortsamplesize><![CDATA[153]]></cohortsamplesize>
		<numberofevents><![CDATA[16]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.917]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, DBP, GFR, Rate of Mannitol Infusion]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-49]]></modelid>
		<pubmedid><![CDATA[24508827]]></pubmedid>
		<author><![CDATA[Pezzini]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1867]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1867]]></cohortsamplesize>
		<numberofevents><![CDATA[67]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.62]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Antiphospholipid Antibodies, Cumulative Index, Family History, Medications, Migraine]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-50]]></modelid>
		<pubmedid><![CDATA[24508827]]></pubmedid>
		<author><![CDATA[Pezzini]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1867]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1867]]></cohortsamplesize>
		<numberofevents><![CDATA[214]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Antiphospholipid Antibodies, Cumulative Index, Family History, Medications, Migraine]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-51]]></modelid>
		<pubmedid><![CDATA[24560394]]></pubmedid>
		<author><![CDATA[Chung-Esaki]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Validation of a prediction rule for endocarditis in febrile injection drug users]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[IVDU]]></secondaryindexcondition>
		<outcome><![CDATA[Endocarditis]]></outcome>
		<modelsamplesize><![CDATA[249]]></modelsamplesize>
		<cohortsamplesize><![CDATA[249]]></cohortsamplesize>
		<numberofevents><![CDATA[18]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Murmur, Skin Infection, Tachycardia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-52]]></modelid>
		<pubmedid><![CDATA[24562803]]></pubmedid>
		<author><![CDATA[Ketchum]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[European Heart Journal: Acute Cardiovascular Care]]></journal>
		<title><![CDATA[The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6632]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6632]]></cohortsamplesize>
		<numberofevents><![CDATA[1253]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Medications, Creatinine, Heart Rate, Hemoglobin, Killip Class, Race, Risk Factors, Reperfusion Therapy, Sodium, SBP, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-53]]></modelid>
		<pubmedid><![CDATA[24567314]]></pubmedid>
		<author><![CDATA[Ingle]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[387]]></modelsamplesize>
		<cohortsamplesize><![CDATA[387]]></cohortsamplesize>
		<numberofevents><![CDATA[107]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Exertional Oscillatory Ventilation, Oxygen Uptake Efficiency Slope, Ventilation and Carbon Dioxide Production, VEqCO2]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-54]]></modelid>
		<pubmedid><![CDATA[24578036]]></pubmedid>
		<author><![CDATA[Kötting]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Thoracic and Cardiovascular Surgeon]]></journal>
		<title><![CDATA[German CABG score: a specific risk model for patients undergoing isolated coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[43145]]></modelsamplesize>
		<cohortsamplesize><![CDATA[43145]]></cohortsamplesize>
		<numberofevents><![CDATA[1294]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.826]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Reoperation, Critical State, Diabetes, Dialysis or Renal Failure, Extracardiac Arteriopathy, NYHA Class, Arrhythmia, Lung Disease, LVEF, MI, Neurological Dysfunction, Pulmonary Hypertension, Sex, Three-Vessel Disease]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-55]]></modelid>
		<pubmedid><![CDATA[24581409]]></pubmedid>
		<author><![CDATA[Barco]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[American Journal of Occupational Therapy]]></journal>
		<title><![CDATA[Predicting road test performance in drivers with stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[72]]></modelsamplesize>
		<cohortsamplesize><![CDATA[72]]></cohortsamplesize>
		<numberofevents><![CDATA[27]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Snellgrove Maze Task, Trail Making Test]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-56]]></modelid>
		<pubmedid><![CDATA[24603072]]></pubmedid>
		<author><![CDATA[Whiteley]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[1515]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1515]]></cohortsamplesize>
		<numberofevents><![CDATA[104]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Antiplatelet Medication, AF, Diabetes, Glucose, Leukoaraiosis, NIHSS, Hypertension, Infarct on CT]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-57]]></modelid>
		<pubmedid><![CDATA[24612485]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[CNS Neuroscience and Therapeutics]]></journal>
		<title><![CDATA[Risk assessment of deep-vein thrombosis after acute stroke: a prospective study using clinical factors]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[575]]></modelsamplesize>
		<cohortsamplesize><![CDATA[862]]></cohortsamplesize>
		<numberofevents><![CDATA[76]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cancer, Sex, NIHSS, BMI, Age, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-58]]></modelid>
		<pubmedid><![CDATA[24636588]]></pubmedid>
		<author><![CDATA[Murthy]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[International Journal of Stroke]]></journal>
		<title><![CDATA[Factors associated with adverse long-term outcomes in ischemic stroke: development of a prediction model and its validation]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[325]]></modelsamplesize>
		<cohortsamplesize><![CDATA[325]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Root Sclerosis, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-59]]></modelid>
		<pubmedid><![CDATA[24663335]]></pubmedid>
		<author><![CDATA[Mariscalco]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[12938]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17262]]></cohortsamplesize>
		<numberofevents><![CDATA[3423]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, eGFR, Emergency, LVEF, IABP, Valve Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-60]]></modelid>
		<pubmedid><![CDATA[24663335]]></pubmedid>
		<author><![CDATA[Mariscalco]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[12938]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17262]]></cohortsamplesize>
		<numberofevents><![CDATA[214]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, eGFR, Emergency, LVEF, IABP, Valve Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-61]]></modelid>
		<pubmedid><![CDATA[24663335]]></pubmedid>
		<author><![CDATA[Mariscalco]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[12938]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17262]]></cohortsamplesize>
		<numberofevents><![CDATA[325]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, eGFR, Emergency, LVEF, IABP, Valve Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-62]]></modelid>
		<pubmedid><![CDATA[24663335]]></pubmedid>
		<author><![CDATA[Mariscalco]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[12938]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17262]]></cohortsamplesize>
		<numberofevents><![CDATA[682]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, eGFR, Emergency, LVEF, IABP, Valve Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-63]]></modelid>
		<pubmedid><![CDATA[24663335]]></pubmedid>
		<author><![CDATA[Mariscalco]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[12938]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17262]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, eGFR, Emergency, LVEF, IABP, Valve Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-64]]></modelid>
		<pubmedid><![CDATA[24714416]]></pubmedid>
		<author><![CDATA[Chen]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[PLoS One]]></journal>
		<title><![CDATA[Validation of a novel clinical prediction score for severe coronary artery diseases before elective coronary angiography]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[347]]></modelsamplesize>
		<cohortsamplesize><![CDATA[551]]></cohortsamplesize>
		<numberofevents><![CDATA[202]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.744]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, Age, Aortic Valve Calcification, Diabetes, HDL Cholesterol, Hyperlipidemia, LDL Cholesterol, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-65]]></modelid>
		<pubmedid><![CDATA[24714793]]></pubmedid>
		<author><![CDATA[Romano]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Arquivos Brasileiros de Cardiologia]]></journal>
		<title><![CDATA[Prognostic score for acute coronary syndrome in a private terciary hospital]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[760]]></modelsamplesize>
		<cohortsamplesize><![CDATA[760]]></cohortsamplesize>
		<numberofevents><![CDATA[52]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cancer, LVEF, Troponin, Thrombolysis]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-66]]></modelid>
		<pubmedid><![CDATA[24714793]]></pubmedid>
		<author><![CDATA[Romano]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Arquivos Brasileiros de Cardiologia]]></journal>
		<title><![CDATA[Prognostic score for acute coronary syndrome in a private terciary hospital]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[760]]></modelsamplesize>
		<cohortsamplesize><![CDATA[760]]></cohortsamplesize>
		<numberofevents><![CDATA[79]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cancer, Thrombolysis, COPD, Creatinine, Hemoglobin, LVEF, Troponin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-67]]></modelid>
		<pubmedid><![CDATA[24714831]]></pubmedid>
		<author><![CDATA[Figueiredo]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Clinics (Sao Paulo, Brazil)]]></journal>
		<title><![CDATA[Score for atrial fibrillation detection in acute stroke and transient ischemic attack patients in a Brazilian population: the acute stroke atrial fibrillation scoring system]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[257]]></modelsamplesize>
		<cohortsamplesize><![CDATA[257]]></cohortsamplesize>
		<numberofevents><![CDATA[44]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Left Atrial Enlargement, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-35]]></modelid>
		<pubmedid><![CDATA[22308287]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Risk prediction for early in-hospital mortality following heart transplantation in the United States]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4248]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4248]]></cohortsamplesize>
		<numberofevents><![CDATA[201]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.722]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diagnosis, Dialysis, GFR, Mechanical Support, Albumin, Ventilator]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-68]]></modelid>
		<pubmedid><![CDATA[24738120]]></pubmedid>
		<author><![CDATA[Cohen]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Thrombosis and Haemostasis]]></journal>
		<title><![CDATA[Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Thrombophilia]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1201]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1201]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Family History, FGG Allele, Thrombophilia, Von Willebrand Factor Antigen]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-69]]></modelid>
		<pubmedid><![CDATA[24740804]]></pubmedid>
		<author><![CDATA[Iung]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2552]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3833]]></cohortsamplesize>
		<numberofevents><![CDATA[253]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Surgical Approach, BMI, Critical State, Dialysis, NYHA Class, Pulmonary Hypertension, Pulmonary Edema, Respiratory Insufficiency]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-70]]></modelid>
		<pubmedid><![CDATA[24772034]]></pubmedid>
		<author><![CDATA[Sladojevic]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Scientific World Journal]]></journal>
		<title><![CDATA[Echocardiographic Parameters as Predictors of In-Hospital Mortality in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2030]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2030]]></cohortsamplesize>
		<numberofevents><![CDATA[156]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aortic Leaflet Separation Diameter, LVEF, Right Ventricular Diameter, Right Ventricular Systolic Pressure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-71]]></modelid>
		<pubmedid><![CDATA[24779617]]></pubmedid>
		<author><![CDATA[Rizzi]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[BMC Infectious Diseases]]></journal>
		<title><![CDATA[Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI)]]></title>
		<primaryindexcondition><![CDATA[Endocarditis]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1456]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1456]]></cohortsamplesize>
		<numberofevents><![CDATA[499]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.6019]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Staphylococcus Aureus Etiology, Vegetation Size]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-72]]></modelid>
		<pubmedid><![CDATA[24818129]]></pubmedid>
		<author><![CDATA[Tribuddharat]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[BioMed Research International]]></journal>
		<title><![CDATA[Development of an Open-Heart Intraoperative Risk Scoring Model for Predicting a Prolonged Intensive Care Unit Stay]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[168]]></modelsamplesize>
		<cohortsamplesize><![CDATA[168]]></cohortsamplesize>
		<numberofevents><![CDATA[66]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.818]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Inotrope/Vasopressors, P/F Ratio, Platelets, Potassium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-73]]></modelid>
		<pubmedid><![CDATA[24852838]]></pubmedid>
		<author><![CDATA[Martínez-Sellés]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Endocarditis]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[437]]></modelsamplesize>
		<cohortsamplesize><![CDATA[437]]></cohortsamplesize>
		<numberofevents><![CDATA[106]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, EuroSCORE, Large Intracardiac Destruction, Prosthetic Valve IE, Sex, Staphylococcus, Urgent Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-74]]></modelid>
		<pubmedid><![CDATA[24865309]]></pubmedid>
		<author><![CDATA[Jairam]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Radiology]]></journal>
		<title><![CDATA[Incidental imaging findings from routine chest CT used to identify subjects at high risk of future cardiovascular events]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[10410]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10410]]></cohortsamplesize>
		<numberofevents><![CDATA[1148]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Diameter, Calcification, Indication, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-75]]></modelid>
		<pubmedid><![CDATA[24865309]]></pubmedid>
		<author><![CDATA[Jairam]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Radiology]]></journal>
		<title><![CDATA[Incidental imaging findings from routine chest CT used to identify subjects at high risk of future cardiovascular events]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[10410]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10410]]></cohortsamplesize>
		<numberofevents><![CDATA[1148]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Diameter, Calcification, Indication, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-76]]></modelid>
		<pubmedid><![CDATA[24876089]]></pubmedid>
		<author><![CDATA[Haapaniemi]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[The CAVE score for predicting late seizures after intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Seizure]]></outcome>
		<modelsamplesize><![CDATA[764]]></modelsamplesize>
		<cohortsamplesize><![CDATA[993]]></cohortsamplesize>
		<numberofevents><![CDATA[70]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cortical Involvement of ICH, Seizure, Volume]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-77]]></modelid>
		<pubmedid><![CDATA[25005445]]></pubmedid>
		<author><![CDATA[Rangaraju]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Pittsburgh outcomes after stroke thrombectomy score predicts outcomes after endovascular therapy for anterior circulation large vessel occlusions]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[247]]></modelsamplesize>
		<cohortsamplesize><![CDATA[247]]></cohortsamplesize>
		<numberofevents><![CDATA[98]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Final Infarct Volume, Hemorrhage]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-78]]></modelid>
		<pubmedid><![CDATA[25028448]]></pubmedid>
		<author><![CDATA[Ji]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk Score to Predict Hospital-Acquired Pneumonia After Spontaneous Intracerebral Hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Pneumonia]]></outcome>
		<modelsamplesize><![CDATA[2998]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4998]]></cohortsamplesize>
		<numberofevents><![CDATA[510]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[GCS Score, NIHSS, Age, COPD, Smoking, Dysphagia, Alcohol, Extension into Ventricles, Infratentorial Location, mRS Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-79]]></modelid>
		<pubmedid><![CDATA[25028448]]></pubmedid>
		<author><![CDATA[Ji]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk Score to Predict Hospital-Acquired Pneumonia After Spontaneous Intracerebral Hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Pneumonia]]></outcome>
		<modelsamplesize><![CDATA[2507]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4215]]></cohortsamplesize>
		<numberofevents><![CDATA[400]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[NIHSS, Age, COPD, Smoking, Dysphagia, Alcohol, Hematoma Volume, Infratentorial Location, mRS Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-80]]></modelid>
		<pubmedid><![CDATA[25034061]]></pubmedid>
		<author><![CDATA[Hsu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Inadequate Defibrillation Safety Margin]]></outcome>
		<modelsamplesize><![CDATA[132477]]></modelsamplesize>
		<cohortsamplesize><![CDATA[132477]]></cohortsamplesize>
		<numberofevents><![CDATA[12397]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.597]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ICD Type, Sex, Ischemic Heart Disease, NYHA Class, Race, Renal Dialysis, Secondary Prevention Indication]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-81]]></modelid>
		<pubmedid><![CDATA[25043863]]></pubmedid>
		<author><![CDATA[Ad]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Thoracic and Cardiovascular Surgery]]></journal>
		<title><![CDATA[Prediction of sinus rhythm in patients undergoing concomitant Cox maze procedure through a median sternotomy]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Sinus Rhythm]]></outcome>
		<modelsamplesize><![CDATA[303]]></modelsamplesize>
		<cohortsamplesize><![CDATA[303]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.858]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF Duration, AF Type, Age, Sex, Left Atrial Size, Surgeon Experience, Concomitant Procedures]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-82]]></modelid>
		<pubmedid><![CDATA[25043863]]></pubmedid>
		<author><![CDATA[Ad]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Thoracic and Cardiovascular Surgery]]></journal>
		<title><![CDATA[Prediction of sinus rhythm in patients undergoing concomitant Cox maze procedure through a median sternotomy]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Sinus Rhythm]]></outcome>
		<modelsamplesize><![CDATA[195]]></modelsamplesize>
		<cohortsamplesize><![CDATA[195]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.859]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF Duration, AF Type, Age, Sex, Left Atrial Size, Surgeon Experience, Concomitant Procedures]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-83]]></modelid>
		<pubmedid><![CDATA[25052544]]></pubmedid>
		<author><![CDATA[Dhoble]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting Long-Term Cardiovascular Risk Using the Mayo Clinic Cardiovascular Risk Score in a Referral Population]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[6546]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6546]]></cohortsamplesize>
		<numberofevents><![CDATA[448]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.768]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Functional Aerobic Capacity, Age, Chronotropic Incompetence, Family History of CAD, HDL Cholesterol, Hypertension Therapy, Sex, EKG Changes, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-84]]></modelid>
		<pubmedid><![CDATA[25076543]]></pubmedid>
		<author><![CDATA[Iosifescu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Heart Valve Disease]]></journal>
		<title><![CDATA[Aortic prosthesis-patient mismatch strongly affects early results of double valve replacement]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[196]]></modelsamplesize>
		<cohortsamplesize><![CDATA[196]]></cohortsamplesize>
		<numberofevents><![CDATA[13]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.846]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Prosthesis-Patient Mismatch]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-85]]></modelid>
		<pubmedid><![CDATA[25076543]]></pubmedid>
		<author><![CDATA[Iosifescu]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Heart Valve Disease]]></journal>
		<title><![CDATA[Aortic prosthesis-patient mismatch strongly affects early results of double valve replacement]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Procedural Complications]]></outcome>
		<modelsamplesize><![CDATA[196]]></modelsamplesize>
		<cohortsamplesize><![CDATA[196]]></cohortsamplesize>
		<numberofevents><![CDATA[97]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.735]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CPB Time, Prosthesis-Patient Mismatch]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-86]]></modelid>
		<pubmedid><![CDATA[25169175]]></pubmedid>
		<author><![CDATA[Jørgensen]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Electrocardiographic changes improve risk prediction in asymptomatic persons age 65 years or above without cardiovascular disease]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality - CVD]]></outcome>
		<modelsamplesize><![CDATA[6991]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6991]]></cohortsamplesize>
		<numberofevents><![CDATA[2236]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, EKG Changes, Sex, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-87]]></modelid>
		<pubmedid><![CDATA[25169175]]></pubmedid>
		<author><![CDATA[Jørgensen]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Electrocardiographic changes improve risk prediction in asymptomatic persons age 65 years or above without cardiovascular disease]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[6991]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6991]]></cohortsamplesize>
		<numberofevents><![CDATA[3849]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, EKG Changes, Sex, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-88]]></modelid>
		<pubmedid><![CDATA[25184160]]></pubmedid>
		<author><![CDATA[Kleber]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Internal Medicine]]></journal>
		<title><![CDATA[Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1275]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1275]]></cohortsamplesize>
		<numberofevents><![CDATA[449]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[25-OH Vitamin D3, Age, Cystatin C, HbA1c, Heart Rate, LVEF, Sex, NT-proBNP, Renin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-89]]></modelid>
		<pubmedid><![CDATA[25184160]]></pubmedid>
		<author><![CDATA[Kleber]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Internal Medicine]]></journal>
		<title><![CDATA[Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1275]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1275]]></cohortsamplesize>
		<numberofevents><![CDATA[449]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[25-OH Vitamin D3, Age, Cystatin C, HbA1c, Heart Rate, Sex, NT-proBNP, Renin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-90]]></modelid>
		<pubmedid><![CDATA[25200055]]></pubmedid>
		<author><![CDATA[Tolenaar]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predicting In-Hospital Mortality in Acute Type B Aortic Dissection]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1034]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1034]]></cohortsamplesize>
		<numberofevents><![CDATA[110]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Acute Renal Failure, Age, Diameter, Sex, Hypotension or Shock, Limb Ischemia, Mesenteric Ischemia, Periaortic Hematoma]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-91]]></modelid>
		<pubmedid><![CDATA[25293667]]></pubmedid>
		<author><![CDATA[Bray]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Derivation and external validation of a case mix model for the standardized reporting of 30-day stroke mortality rates]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[27169]]></cohortsamplesize>
		<numberofevents><![CDATA[1188]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS, AF, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-92]]></modelid>
		<pubmedid><![CDATA[25293667]]></pubmedid>
		<author><![CDATA[Bray]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Derivation and external validation of a case mix model for the standardized reporting of 30-day stroke mortality rates]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[27169]]></cohortsamplesize>
		<numberofevents><![CDATA[1188]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS Consciousness, AF, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-93]]></modelid>
		<pubmedid><![CDATA[25444486]]></pubmedid>
		<author><![CDATA[Brunner]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Mayo Clinic Proceedings]]></journal>
		<title><![CDATA[Clinical Predictors of Risk for Atrial Fibrillation: Implications for Diagnosis and Monitoring]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[97909]]></modelsamplesize>
		<cohortsamplesize><![CDATA[97909]]></cohortsamplesize>
		<numberofevents><![CDATA[3431]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.812]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Diabetes, HF, Hypertension, Sex, Valve Disease]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-01]]></modelid>
		<pubmedid><![CDATA[25242230]]></pubmedid>
		<author><![CDATA[Trujillo-Santos]]></author>
		<year><![CDATA[2015]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[15280]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15280]]></cohortsamplesize>
		<numberofevents><![CDATA[359]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cancer, CHF, Creatinine Clearance, Immobility, Platelets, Major Bleeding]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[15-001-02]]></modelid>
		<pubmedid><![CDATA[25432413]]></pubmedid>
		<author><![CDATA[Debonnaire]]></author>
		<year><![CDATA[2015]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Value of the "TAVI2-SCORe" Versus Surgical Risk Scores for Prediction of One Year Mortality in 511 Patients Who Underwent Transcatheter Aortic Valve Implantation]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[471]]></modelsamplesize>
		<cohortsamplesize><![CDATA[511]]></cohortsamplesize>
		<numberofevents><![CDATA[80]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.715]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Anemia, Aortic Valve Stenosis, Sex, Age, Porcelain Thoracic Aorta, MI, Creatinine Clearance, LVEF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-47]]></modelid>
		<pubmedid><![CDATA[20479658]]></pubmedid>
		<author><![CDATA[Chiostri]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Cardiovascular Medicine]]></journal>
		<title><![CDATA[A new post-PCI scoring system for in-hospital mortality in STEMI patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[558]]></modelsamplesize>
		<cohortsamplesize><![CDATA[558]]></cohortsamplesize>
		<numberofevents><![CDATA[24]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[LVEF, Hemoglobin, CRF, Killip Class, Lactic Acid, ST Elevation, SBP, Troponin I]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; Biomarkers/blood; Coronary Angiography; Coronary Care Units; Discriminant Analysis; Female; *Health Status Indicators; *Hospital Mortality; Humans; Italy; Kidney Failure, Chronic/mortality; Male; Middle Aged; Myocardial Infarction/diagnosis/*mortality/*therapy; Myocardium/pathology; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; Ventricular Function]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-48]]></modelid>
		<pubmedid><![CDATA[20487120]]></pubmedid>
		<author><![CDATA[Jons]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Cardiovascular Electrophysiology]]></journal>
		<title><![CDATA[Autonomic dysfunction and new-onset atrial fibrillation in patients with left ventricular systolic dysfunction after acute myocardial infarction: a CARISMA substudy]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[271]]></modelsamplesize>
		<cohortsamplesize><![CDATA[271]]></cohortsamplesize>
		<numberofevents><![CDATA[101]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Detrended Fluctuation, Heart Rate, Heart Rate Variability, NYHA Class]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/diagnosis/*etiology/physiopathology; Autonomic Nervous System/*physiopathology; Chi-Square Distribution; Echocardiography; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Exercise Test; Female; Heart/*innervation; Heart Rate; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction/*complications/physiopathology; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Systole; Time Factors; Ventricular Dysfunction, Left/*etiology/physiopathology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-49]]></modelid>
		<pubmedid><![CDATA[20513595]]></pubmedid>
		<author><![CDATA[Mehran]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A risk score to predict bleeding in patients with acute coronary syndromes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[17421]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17421]]></cohortsamplesize>
		<numberofevents><![CDATA[744]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, Glycoprotein Inhibitor, Sex, STEMI or NSTEMI, Creatinine, Heparin, WBC]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/*drug therapy/mortality/therapy; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/methods; *Cause of Death; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass/methods; Electrocardiography; Female; Fibrinolytic Agents/*adverse effects/therapeutic use; Hemorrhage/*chemically induced/*mortality; Heparin/adverse effects/therapeutic use; Hospital Mortality/trends; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors/*adverse effects/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/adverse effects/therapeutic use; Predictive Value of Tests; Probability; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-50]]></modelid>
		<pubmedid><![CDATA[20513595]]></pubmedid>
		<author><![CDATA[Mehran]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A risk score to predict bleeding in patients with acute coronary syndromes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17421]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17421]]></cohortsamplesize>
		<numberofevents><![CDATA[660]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Glycoprotein Inhibitor, Smoking, Sex, Hemoglobin, Diabetes, Sex, MI, Biomarkers, Creatinine, STEMI, Heparin, WBC]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/*drug therapy/mortality/therapy; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/methods; *Cause of Death; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass/methods; Electrocardiography; Female; Fibrinolytic Agents/*adverse effects/therapeutic use; Hemorrhage/*chemically induced/*mortality; Heparin/adverse effects/therapeutic use; Hospital Mortality/trends; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors/*adverse effects/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/adverse effects/therapeutic use; Predictive Value of Tests; Probability; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-51]]></modelid>
		<pubmedid><![CDATA[20570467]]></pubmedid>
		<author><![CDATA[Bertges]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[8208]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8208]]></cohortsamplesize>
		<numberofevents><![CDATA[517]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Beta Blockers, CAD, Stress Test, COPD, CHF, CABG/PCI, Creatinine, Diabetes, Smoking]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/surgery; Arrhythmias, Cardiac/etiology; Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Decision Support Techniques; Endarterectomy, Carotid/adverse effects; Female; *Health Status Indicators; Heart Diseases/epidemiology/*etiology; Heart Failure/etiology; Humans; Incidence; Logistic Models; Lower Extremity/blood supply; Male; Middle Aged; Myocardial Infarction/etiology; New England; Odds Ratio; Patient Selection; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Vascular Surgical Procedures/*adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-52]]></modelid>
		<pubmedid><![CDATA[20584777]]></pubmedid>
		<author><![CDATA[Drenthen]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predictors of pregnancy complications in women with congenital heart disease]]></title>
		<primaryindexcondition><![CDATA[Pregnancy]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Procedural Complications]]></outcome>
		<modelsamplesize><![CDATA[714]]></modelsamplesize>
		<cohortsamplesize><![CDATA[714]]></cohortsamplesize>
		<numberofevents><![CDATA[436]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.762]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cyanotic Heart Disease, Arrhythmia, Left Heart Obstruction, Mechanical Valve Prosthesis, NYHA Class, Cardiac Medication, Valve Regurgitation]]></covariates>
		<mh><![CDATA[Adult; Arrhythmias, Cardiac/etiology; Female; Heart Defects, Congenital/*complications; Heart Failure/etiology; Humans; Maternal Age; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular/*etiology; Pregnancy Outcome; Retrospective Studies; Risk Assessment; Risk Factors; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-53]]></modelid>
		<pubmedid><![CDATA[20603345]]></pubmedid>
		<author><![CDATA[Bosner]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[CMAJ Canadian Medical Association Journal]]></journal>
		<title><![CDATA[Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[1249]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1249]]></cohortsamplesize>
		<numberofevents><![CDATA[180]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Cough, CVD, Diabetes, HF, Muscle Tension, Pain]]></covariates>
		<mh><![CDATA[Adolescent; Age Factors; Aged; Aged, 80 and over; Chest Pain/diagnosis/etiology; Child; Confidence Intervals; Coronary Artery Disease/complications/*diagnosis; Cross-Sectional Studies; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Primary Health Care/*methods; ROC Curve; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-54]]></modelid>
		<pubmedid><![CDATA[20627521]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[110]]></modelsamplesize>
		<cohortsamplesize><![CDATA[110]]></cohortsamplesize>
		<numberofevents><![CDATA[64]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hemofiltration, Life Support, Bilirubin]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiac Surgical Procedures/*adverse effects; *Extracorporeal Membrane Oxygenation; Female; Heart Failure/mortality/physiopathology; Hemodynamics; Hospital Mortality; Humans; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Resuscitation/*methods; Retrospective Studies; Risk Factors; Shock, Cardiogenic/*etiology/mortality/physiopathology/*therapy; Stroke Volume; Survival Rate; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-55]]></modelid>
		<pubmedid><![CDATA[20630456]]></pubmedid>
		<author><![CDATA[Chen]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[JACC: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[337]]></modelsamplesize>
		<cohortsamplesize><![CDATA[337]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Stent, AMI, Age, Shock, Biomarkers, Culotte, Diabetes, GI Bleed, Hypertension, Revascularization, LVEF, LDL Cholesterol, IABP, Total Occlusion Failure, Statin, PVD, Previous MI, Creatinine, Sex, Smoking, Ultrasound Guidance]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/adverse effects/*instrumentation/mortality; Cardiovascular Agents/*administration & dosage; Chi-Square Distribution; China; Coronary Angiography; *Coronary Artery Bypass/adverse effects/mortality; Coronary Stenosis/mortality/radiography/surgery/*therapy; *Drug-Eluting Stents; Female; *Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction/etiology; Odds Ratio; Paclitaxel/*administration & dosage; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; ROC Curve; Registries; Risk Assessment; Risk Factors; Thrombosis/etiology; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-56]]></modelid>
		<pubmedid><![CDATA[20661138]]></pubmedid>
		<author><![CDATA[Wong]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Coronary Artery Disease]]></journal>
		<title><![CDATA[Validation of a prediction score model to distinguish acute coronary syndromes from other conditions causing raised cardiac troponin T levels]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Acute Coronary Syndrome (ACS)]]></outcome>
		<modelsamplesize><![CDATA[313]]></modelsamplesize>
		<cohortsamplesize><![CDATA[313]]></cohortsamplesize>
		<numberofevents><![CDATA[195]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.9]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Acute Renal Failure, Respiratory Disease, Stroke, AF, Charlson Score, Chest Pain, ST Depression, Troponin T]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/blood/complications/*diagnosis/mortality; Aged; Aged, 80 and over; Angina Pectoris/etiology; Area Under Curve; Atrial Fibrillation/epidemiology; Atrial Flutter/epidemiology; Biomarkers/blood; Chi-Square Distribution; Comorbidity; Diagnosis, Differential; Electrocardiography; England; Female; Hospital Mortality; Hospitals, University; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Time Factors; Troponin T/*blood; Up-Regulation]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-57]]></modelid>
		<pubmedid><![CDATA[20667343]]></pubmedid>
		<author><![CDATA[Miceli]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[A clinical score to predict the need for intraaortic balloon pump in patients undergoing coronary artery bypass grafting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[IABP Placement]]></outcome>
		<modelsamplesize><![CDATA[4575]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8872]]></cohortsamplesize>
		<numberofevents><![CDATA[116]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CCS Angina Class, Emergency Surgery, Interval Between MI and Surgery, Left Main Disease, LVEF, Previous Cardiac Surgery]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; *Coronary Artery Bypass; Female; Forecasting; Humans; Intra-Aortic Balloon Pumping/*utilization; Male; *Models, Statistical; Retrospective Studies; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-58]]></modelid>
		<pubmedid><![CDATA[20671251]]></pubmedid>
		<author><![CDATA[Chien]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Constructing the prediction model for the risk of stroke in a Chinese population: report from a cohort study in Taiwan]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3513]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3513]]></cohortsamplesize>
		<numberofevents><![CDATA[240]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.778]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Diabetes, DBP, Family History, Sex, SBP]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Area Under Curve; Asian Continental Ancestry Group/statistics & numerical data; Blood Pressure; Humans; Incidence; Life Style; Middle Aged; Models, Statistical; Proportional Hazards Models; Risk; *Risk Assessment; Risk Factors; Stroke/*epidemiology; Taiwan/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-59]]></modelid>
		<pubmedid><![CDATA[20671251]]></pubmedid>
		<author><![CDATA[Chien]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Constructing the prediction model for the risk of stroke in a Chinese population: report from a cohort study in Taiwan]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3513]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3513]]></cohortsamplesize>
		<numberofevents><![CDATA[240]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.779]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, DBP, Family History, Glucose, Sex, SBP, Total Cholesterol, WBC]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Area Under Curve; Asian Continental Ancestry Group/statistics & numerical data; Blood Pressure; Humans; Incidence; Life Style; Middle Aged; Models, Statistical; Proportional Hazards Models; Risk; *Risk Assessment; Risk Factors; Stroke/*epidemiology; Taiwan/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-60]]></modelid>
		<pubmedid><![CDATA[20723638]]></pubmedid>
		<author><![CDATA[Maluenda]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A novel percutaneous coronary intervention risk score to predict one-year mortality]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6932]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6932]]></cohortsamplesize>
		<numberofevents><![CDATA[383]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.818]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CRF, Diabetes, Heart Rate, Hematocrit, Left Main CAD, TIMI Flow]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; *Angioplasty, Balloon, Coronary; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Ischemia/diagnosis/*mortality/*therapy; Predictive Value of Tests; ROC Curve; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-61]]></modelid>
		<pubmedid><![CDATA[20802909]]></pubmedid>
		<author><![CDATA[Silva]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular]]></journal>
		<title><![CDATA[Risk index proposal to predict atrial fibrillation after cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[452]]></modelsamplesize>
		<cohortsamplesize><![CDATA[452]]></cohortsamplesize>
		<numberofevents><![CDATA[99]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Valve Disease, Beta Blockers, Water Balance]]></covariates>
		<mh><![CDATA[Aged; Atrial Fibrillation/diagnosis/epidemiology/*etiology; Cardiac Surgical Procedures/*adverse effects; Female; Humans; Incidence; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-62]]></modelid>
		<pubmedid><![CDATA[20808904]]></pubmedid>
		<author><![CDATA[Novack]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[PLoS ONE [Electronic Resource]]]></journal>
		<title><![CDATA[Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8246]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8246]]></cohortsamplesize>
		<numberofevents><![CDATA[701]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Albumin, Blood Urea, Comorbidities, Demographics, Sodium, Uric Acid, WBC]]></covariates>
		<mh><![CDATA[Aged; Calibration; *Clinical Laboratory Techniques; *Diagnostic Tests, Routine; Echocardiography; Female; Heart Failure/blood/*diagnosis/*mortality/ultrasonography; *Hospitalization; Humans; Male; Multivariate Analysis; Prognosis; Reproducibility of Results; Retrospective Studies; Risk; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-63]]></modelid>
		<pubmedid><![CDATA[20876438]]></pubmedid>
		<author><![CDATA[Smith]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[164993]]></modelsamplesize>
		<cohortsamplesize><![CDATA[274988]]></cohortsamplesize>
		<numberofevents><![CDATA[9075]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Time of Arrival, AF, CAD, Diabetes, Dyslipidemia, Hypertension, Stenosis, Mode of Arrival, PVD, Stroke, Smoking, Age]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Female; *Hospital Mortality; Humans; Internet; Logistic Models; Male; Middle Aged; *Models, Statistical; *Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke/*epidemiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-64]]></modelid>
		<pubmedid><![CDATA[20923988]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9165]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9165]]></cohortsamplesize>
		<numberofevents><![CDATA[1243]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.786]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Medications, CHF, BMI, Comorbidities, Shock, Smoking, Glycoprotein, Cholesterol, MI, LVEF, Sex, CABG, PCI, Procedural Failure, Angina, Stent, Three Vessel Disease, Troponin T, Arrhythmia]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty, Balloon, Coronary; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction/*diagnosis/mortality/physiopathology/*therapy; Prognosis; Proportional Hazards Models; Risk Adjustment; Risk Factors; Sensitivity and Specificity; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-65]]></modelid>
		<pubmedid><![CDATA[20923988]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[9165]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9165]]></cohortsamplesize>
		<numberofevents><![CDATA[1939]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.737]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Comorbidities, Shock, Smoking, Gycoprotein, Cholesterol, CHF, MI, LVEF, Sex, CABG, PCI, Procedural Failure, Angina, Stent, Three Vessel Disease, Troponin T, Arrhythmia]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty, Balloon, Coronary; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction/*diagnosis/mortality/physiopathology/*therapy; Prognosis; Proportional Hazards Models; Risk Adjustment; Risk Factors; Sensitivity and Specificity; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-66]]></modelid>
		<pubmedid><![CDATA[20932461]]></pubmedid>
		<author><![CDATA[Guazzi]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Journal of Cardiac Failure]]></journal>
		<title><![CDATA[Development of a cardiopulmonary exercise prognostic score for optimizing risk stratification in heart failure: the (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[695]]></modelsamplesize>
		<cohortsamplesize><![CDATA[695]]></cohortsamplesize>
		<numberofevents><![CDATA[134]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Exercise Periodic Breathing, Peak O2 Consumption, Ventilation to CO2]]></covariates>
		<mh><![CDATA[Adult; Aged; Carbon Dioxide/blood; Cardiovascular Agents/therapeutic use; *Exercise Test/instrumentation/methods; Female; *Heart Failure/blood/diagnosis/epidemiology/physiopathology/therapy; Humans; Kaplan-Meier Estimate; Life Expectancy; Male; Middle Aged; *Oxygen Consumption/physiology; Prognosis; Proportional Hazards Models; *Pulmonary Ventilation/physiology; Risk Assessment/methods; *Test Taking Skills/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-67]]></modelid>
		<pubmedid><![CDATA[21051669]]></pubmedid>
		<author><![CDATA[Calvillo-King]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting risk of perioperative death and stroke after carotid endarterectomy in asymptomatic patients: derivation and validation of a clinical risk score]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[6553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6553]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.64]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CHF, CAD, Stroke/TIA, Sex, Stenosis, Race, Disability, VHD]]></covariates>
		<mh><![CDATA[Adult; Aged; Analysis of Variance; Cardiomyopathy, Dilated/complications/epidemiology; Carotid Stenosis/complications/epidemiology; Cohort Studies; Disabled Persons; Endarterectomy, Carotid/*adverse effects/*mortality; Ethnic Groups; Female; Heart Valve Diseases/complications/epidemiology; Humans; Ischemic Attack, Transient/complications/epidemiology; Male; Middle Aged; Models, Statistical; New York/epidemiology; Perioperative Period/*statistics & numerical data; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Sex Factors; Stroke/*epidemiology/*etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-68]]></modelid>
		<pubmedid><![CDATA[21051669]]></pubmedid>
		<author><![CDATA[Calvillo-King]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting risk of perioperative death and stroke after carotid endarterectomy in asymptomatic patients: derivation and validation of a clinical risk score]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[6553]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6553]]></cohortsamplesize>
		<numberofevents><![CDATA[165]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CAD, Stroke/TIA, Sex, Stenosis, Race, Disability, VHD]]></covariates>
		<mh><![CDATA[Adult; Aged; Analysis of Variance; Cardiomyopathy, Dilated/complications/epidemiology; Carotid Stenosis/complications/epidemiology; Cohort Studies; Disabled Persons; Endarterectomy, Carotid/*adverse effects/*mortality; Ethnic Groups; Female; Heart Valve Diseases/complications/epidemiology; Humans; Ischemic Attack, Transient/complications/epidemiology; Male; Middle Aged; Models, Statistical; New York/epidemiology; Perioperative Period/*statistics & numerical data; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Sex Factors; Stroke/*epidemiology/*etiology; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-69]]></modelid>
		<pubmedid><![CDATA[21067001]]></pubmedid>
		<author><![CDATA[Shi]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[International Surgery]]></journal>
		<title><![CDATA[A mortality risk assessment model for cardiac valve replacement surgery and its application in the use of prophylactic extracorporeal membrane oxygenation]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Valve]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[158]]></modelsamplesize>
		<cohortsamplesize><![CDATA[158]]></cohortsamplesize>
		<numberofevents><![CDATA[8]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.736]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, LVEF, Sex, CAD, LV End Diastolic Diameter, Pulmonary Artery Pressure, Renal Function]]></covariates>
		<mh><![CDATA[Extracorporeal Membrane Oxygenation/*mortality; Female; Heart Valve Diseases/mortality/*surgery; Hospital Mortality; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Retrospective Studies; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-70]]></modelid>
		<pubmedid><![CDATA[21071878]]></pubmedid>
		<author><![CDATA[Filipiak]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Circulation Journal]]></journal>
		<title><![CDATA[Prospective comparison of the 5 most popular risk scores in clinical use for unselected patients with acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[924]]></modelsamplesize>
		<cohortsamplesize><![CDATA[924]]></cohortsamplesize>
		<numberofevents><![CDATA[125]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aborted Sudden Cardiac Death, Age, Angina, Cardiac Markers, HF, Bundle Block, Heart Rate, Killip Class, Q Wave, SBP, ST Depression/Elevation]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/*etiology/mortality; Adult; Aged; Aged, 80 and over; Area Under Curve; Chi-Square Distribution; Female; *Health Status Indicators; Humans; Logistic Models; Male; Middle Aged; Poland/epidemiology; Predictive Value of Tests; Prognosis; Prospective Studies; ROC Curve; Registries; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[10-001-71]]></modelid>
		<pubmedid><![CDATA[21114132]]></pubmedid>
		<author><![CDATA[Kasim]]></author>
		<year><![CDATA[2010]]></year>
		<journal><![CDATA[Acta Neurologica Belgica]]></journal>
		<title><![CDATA[Combined clinical and radiological prognostic model in acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[127]]></modelsamplesize>
		<cohortsamplesize><![CDATA[127]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Early Ischemic Change, NIHSS]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Brain Ischemia/*radiography; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Severity of Illness Index; Stroke/*radiography; *Tomography, X-Ray Computed]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-01]]></modelid>
		<pubmedid><![CDATA[19329801]]></pubmedid>
		<author><![CDATA[Sy]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis]]></title>
		<primaryindexcondition><![CDATA[Endocarditis]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[192]]></modelsamplesize>
		<cohortsamplesize><![CDATA[192]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Charlson Score, CHF, Creatinine, Platelets, Pulse]]></covariates>
		<mh><![CDATA[Adult; Aged; Embolism/mortality; Endocarditis, Bacterial/*mortality/surgery; Epidemiologic Methods; Female; Heart Failure/mortality; Hospitalization/statistics & numerical data; Humans; Kidney Diseases/mortality; Male; Middle Aged; Prognosis; Tachycardia/mortality; Thrombocytopenia/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-02]]></modelid>
		<pubmedid><![CDATA[19329801]]></pubmedid>
		<author><![CDATA[Sy]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis]]></title>
		<primaryindexcondition><![CDATA[Endocarditis]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[192]]></modelsamplesize>
		<cohortsamplesize><![CDATA[192]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Charlson Score, CHF, Creatinine, Platelets, Severe Embolic Event]]></covariates>
		<mh><![CDATA[Adult; Aged; Embolism/mortality; Endocarditis, Bacterial/*mortality/surgery; Epidemiologic Methods; Female; Heart Failure/mortality; Hospitalization/statistics & numerical data; Humans; Kidney Diseases/mortality; Male; Middle Aged; Prognosis; Tachycardia/mortality; Thrombocytopenia/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-03]]></modelid>
		<pubmedid><![CDATA[19329801]]></pubmedid>
		<author><![CDATA[Sy]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis]]></title>
		<primaryindexcondition><![CDATA[Endocarditis]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[192]]></modelsamplesize>
		<cohortsamplesize><![CDATA[192]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Charlson Score, CHF, Platelets]]></covariates>
		<mh><![CDATA[Adult; Aged; Embolism/mortality; Endocarditis, Bacterial/*mortality/surgery; Epidemiologic Methods; Female; Heart Failure/mortality; Hospitalization/statistics & numerical data; Humans; Kidney Diseases/mortality; Male; Middle Aged; Prognosis; Tachycardia/mortality; Thrombocytopenia/mortality; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-04]]></modelid>
		<pubmedid><![CDATA[20453069]]></pubmedid>
		<author><![CDATA[Decousus]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[9388]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9388]]></cohortsamplesize>
		<numberofevents><![CDATA[198]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Ulcer, Age, Bleeding, Cancer, Catheter, hepatic Failure, ICU, Sex, GFR, Platelets, Rheumatic Disease]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Female; Fibrinolytic Agents/adverse effects; Hemorrhage/chemically induced/*epidemiology; Humans; Incidence; *Inpatients; Length of Stay; Male; Middle Aged; Patient Admission/*standards; Prognosis; Retrospective Studies; Risk Assessment/*methods; Risk Factors; Survival Rate/trends; Thromboembolism/drug therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-05]]></modelid>
		<pubmedid><![CDATA[20535515]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Neurological Sciences]]></journal>
		<title><![CDATA[Quantifying links between stroke and risk factors: a study on individual health risk appraisal of stroke in a community of Chongqing]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHD, Diabetes, DBP, Education, Family History, Diet, Hyperlipidemia, Hypertension, Exercise]]></covariates>
		<mh><![CDATA[Age Distribution; Age Factors; China/epidemiology; Female; *Health Status Indicators; Humans; Logistic Models; Male; Prevalence; Residence Characteristics; Risk Factors; Sex Factors; Stroke/*epidemiology/*etiology; Surveys and Questionnaires]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-06]]></modelid>
		<pubmedid><![CDATA[20535515]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Neurological Sciences]]></journal>
		<title><![CDATA[Quantifying links between stroke and risk factors: a study on individual health risk appraisal of stroke in a community of Chongqing]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Diabetes, DBP, Alcohol Use, Education, Family History, Diet, Hyperlipidemia, Hypertension]]></covariates>
		<mh><![CDATA[Age Distribution; Age Factors; China/epidemiology; Female; *Health Status Indicators; Humans; Logistic Models; Male; Prevalence; Residence Characteristics; Risk Factors; Sex Factors; Stroke/*epidemiology/*etiology; Surveys and Questionnaires]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-07]]></modelid>
		<pubmedid><![CDATA[20655699]]></pubmedid>
		<author><![CDATA[Sladjana]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of Critical Care]]></journal>
		<title><![CDATA[A prediction survival model for out-of-hospital cardiopulmonary resuscitations]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[591]]></modelsamplesize>
		<cohortsamplesize><![CDATA[591]]></cohortsamplesize>
		<numberofevents><![CDATA[469]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.833]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Bystander CPR, Time to CPR, Cardiac Arrest Mode, Shockable Rhythm, Witnessed Arrest]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cardiopulmonary Resuscitation/*mortality; Female; Humans; Male; Middle Aged; Out-of-Hospital Cardiac Arrest/*mortality; Prospective Studies; Quality of Life; Risk Factors; Serbia/epidemiology; Survival Rate; Time Factors; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-08]]></modelid>
		<pubmedid><![CDATA[20655699]]></pubmedid>
		<author><![CDATA[Sladjana]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of Critical Care]]></journal>
		<title><![CDATA[A prediction survival model for out-of-hospital cardiopulmonary resuscitations]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[591]]></modelsamplesize>
		<cohortsamplesize><![CDATA[591]]></cohortsamplesize>
		<numberofevents><![CDATA[517]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.882]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Bystander CPR, Time to CPR, Cardiac Arrest Mode, Shockable Rhythm, Witnessed Arrest]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cardiopulmonary Resuscitation/*mortality; Female; Humans; Male; Middle Aged; Out-of-Hospital Cardiac Arrest/*mortality; Prospective Studies; Quality of Life; Risk Factors; Serbia/epidemiology; Survival Rate; Time Factors; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-09]]></modelid>
		<pubmedid><![CDATA[20655699]]></pubmedid>
		<author><![CDATA[Sladjana]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of Critical Care]]></journal>
		<title><![CDATA[A prediction survival model for out-of-hospital cardiopulmonary resuscitations]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[591]]></modelsamplesize>
		<cohortsamplesize><![CDATA[591]]></cohortsamplesize>
		<numberofevents><![CDATA[534]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.913]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Bystander CPR, Time to CPR, Cardiac Arrest Mode, Shockable Rhythm, Witnessed Arrest]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cardiopulmonary Resuscitation/*mortality; Female; Humans; Male; Middle Aged; Out-of-Hospital Cardiac Arrest/*mortality; Prospective Studies; Quality of Life; Risk Factors; Serbia/epidemiology; Survival Rate; Time Factors; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-10]]></modelid>
		<pubmedid><![CDATA[20728962]]></pubmedid>
		<author><![CDATA[Barrett]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Annals of Emergency Medicine]]></journal>
		<title><![CDATA[A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[832]]></modelsamplesize>
		<cohortsamplesize><![CDATA[832]]></cohortsamplesize>
		<numberofevents><![CDATA[651]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, Dyspnea, Edema, Sex, HF, Beta Blockers, Diuretics, Hypertension, Inadequate Ventricular Rate Control, Palpitations, Smoking]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Atrial Fibrillation/*complications/diagnosis/therapy; Emergency Service, Hospital/*statistics & numerical data; Female; Humans; Logistic Models; Male; Middle Aged; Models, Theoretical; Probability; Retrospective Studies; Risk Factors; Sex Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-11]]></modelid>
		<pubmedid><![CDATA[21037471]]></pubmedid>
		<author><![CDATA[Creutzfeldt]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Critical Care Medicine]]></journal>
		<title><![CDATA[Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[424]]></modelsamplesize>
		<cohortsamplesize><![CDATA[424]]></cohortsamplesize>
		<numberofevents><![CDATA[187]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.93]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, GCS Score, Heart Rate, Mass Effect, Intraventricular Extension, Functional Status, SBP]]></covariates>
		<mh><![CDATA[Academic Medical Centers; Aged; Aged, 80 and over; Cerebral Hemorrhage/*diagnosis/*mortality/therapy; Cohort Studies; Critical Care/methods; Critical Illness/mortality/therapy; Decision Support Techniques; Female; Humans; Logistic Models; Male; Middle Aged; *Models, Theoretical; Multivariate Analysis; Predictive Value of Tests; Prognosis; ROC Curve; Resuscitation Orders/*ethics; Retrospective Studies; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-12]]></modelid>
		<pubmedid><![CDATA[21037471]]></pubmedid>
		<author><![CDATA[Creutzfeldt]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Critical Care Medicine]]></journal>
		<title><![CDATA[Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[242]]></modelsamplesize>
		<cohortsamplesize><![CDATA[242]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[GCS Score, Mass Effect, Functional Status, SBP]]></covariates>
		<mh><![CDATA[Academic Medical Centers; Aged; Aged, 80 and over; Cerebral Hemorrhage/*diagnosis/*mortality/therapy; Cohort Studies; Critical Care/methods; Critical Illness/mortality/therapy; Decision Support Techniques; Female; Humans; Logistic Models; Male; Middle Aged; *Models, Theoretical; Multivariate Analysis; Predictive Value of Tests; Prognosis; ROC Curve; Resuscitation Orders/*ethics; Retrospective Studies; Survival Analysis]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-13]]></modelid>
		<pubmedid><![CDATA[21068341]]></pubmedid>
		<author><![CDATA[Komajda]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE)]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2563]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2563]]></cohortsamplesize>
		<numberofevents><![CDATA[1505]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.711]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, Diabetes, LVEF, GFR, Heart Rate, Hospitalization for HF, Ischemic Etiology, MI, Neutrophils, NT-proBNP, QOL]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers/pharmacology/*therapeutic use; Biphenyl Compounds/pharmacology/*therapeutic use; Female; Heart Failure/diagnosis/*drug therapy/*physiopathology; Heart Rate/drug effects/physiology; Humans; Kaplan-Meier Estimate; Male; Natriuretic Peptide, Brain/blood; Neutrophils/drug effects/pathology; Peptide Fragments/blood; Prognosis; Proportional Hazards Models; Retrospective Studies; Stroke Volume/drug effects/*physiology; Tetrazoles/pharmacology/*therapeutic use; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-14]]></modelid>
		<pubmedid><![CDATA[21146692]]></pubmedid>
		<author><![CDATA[Chamberlain]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[14546]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14546]]></cohortsamplesize>
		<numberofevents><![CDATA[515]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Race, CAD, Diabetes, HF, Height, Left Atrial Enlargement, LVH, Medications, Murmur, Smoking, SBP]]></covariates>
		<mh><![CDATA[Atrial Fibrillation/*epidemiology; Cohort Studies; Female; Follow-Up Studies; Forecasting; Humans; Incidence; Male; Middle Aged; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-15]]></modelid>
		<pubmedid><![CDATA[21167342]]></pubmedid>
		<author><![CDATA[Chin]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality mode]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[65668]]></modelsamplesize>
		<cohortsamplesize><![CDATA[82004]]></cohortsamplesize>
		<numberofevents><![CDATA[3218]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, Troponin, HF, Heart Rate, PAD, Shock, ST Segment Changes, SBP]]></covariates>
		<mh><![CDATA[Aged; Female; Follow-Up Studies; Hospital Mortality/trends; Humans; Male; Middle Aged; *Models, Statistical; Myocardial Infarction/*mortality/therapy; Myocardial Revascularization/*methods; *Registries; Retrospective Studies; Risk Assessment/*methods; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-16]]></modelid>
		<pubmedid><![CDATA[21167488]]></pubmedid>
		<author><![CDATA[Ramos]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Atherosclerosis]]></journal>
		<title><![CDATA[Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Peripheral Vascular Disease (PVD)]]></outcome>
		<modelsamplesize><![CDATA[4046]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4046]]></cohortsamplesize>
		<numberofevents><![CDATA[235]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, Pulse Pressure, Sex]]></covariates>
		<mh><![CDATA[Aged; *Ankle Brachial Index; Asymptomatic Diseases; Chi-Square Distribution; Female; Humans; Logistic Models; Male; Mass Screening/*methods; Middle Aged; Patient Selection; Peripheral Arterial Disease/*diagnosis/etiology/physiopathology/prevention &; Practice Guidelines as Topic; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Spain]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-17]]></modelid>
		<pubmedid><![CDATA[21167488]]></pubmedid>
		<author><![CDATA[Ramos]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Atherosclerosis]]></journal>
		<title><![CDATA[Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Peripheral Vascular Disease (PVD)]]></outcome>
		<modelsamplesize><![CDATA[3285]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3285]]></cohortsamplesize>
		<numberofevents><![CDATA[230]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, Pulse Pressure, Sex]]></covariates>
		<mh><![CDATA[Aged; *Ankle Brachial Index; Asymptomatic Diseases; Chi-Square Distribution; Female; Humans; Logistic Models; Male; Mass Screening/*methods; Middle Aged; Patient Selection; Peripheral Arterial Disease/*diagnosis/etiology/physiopathology/prevention &; Practice Guidelines as Topic; Predictive Value of Tests; ROC Curve; Reproducibility of Results; Risk Assessment; Risk Factors; Spain]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-18]]></modelid>
		<pubmedid><![CDATA[21177699]]></pubmedid>
		<author><![CDATA[McGorrian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[12772]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12772]]></cohortsamplesize>
		<numberofevents><![CDATA[5349]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Apoliprotein A/B, Smoking, Secondhand Smoke, Diabetes, Hypertension, Waist to Hip Ratio, Stress, Depression, Diet, Physical Activity]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Coronary Disease/*epidemiology; Female; Global Health/statistics & numerical data; Humans; Male; Middle Aged; Myocardial Infarction/*epidemiology; Residence Characteristics; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-19]]></modelid>
		<pubmedid><![CDATA[21177699]]></pubmedid>
		<author><![CDATA[McGorrian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[12772]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12772]]></cohortsamplesize>
		<numberofevents><![CDATA[5349]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Smoking, Secondhand Smoke, Diabetes, Hypertension, Family History, Waist to Hip Ratio, Stress, Depression, Diet, Physical Activity]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Coronary Disease/*epidemiology; Female; Global Health/statistics & numerical data; Humans; Male; Middle Aged; Myocardial Infarction/*epidemiology; Residence Characteristics; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-20]]></modelid>
		<pubmedid><![CDATA[21177699]]></pubmedid>
		<author><![CDATA[McGorrian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[12772]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12772]]></cohortsamplesize>
		<numberofevents><![CDATA[5349]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, LDL Cholesterol, HDL Cholesterol, Smoking, Secondhand Smoke, Diabetes, Hypertension]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Coronary Disease/*epidemiology; Female; Global Health/statistics & numerical data; Humans; Male; Middle Aged; Myocardial Infarction/*epidemiology; Residence Characteristics; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-21]]></modelid>
		<pubmedid><![CDATA[21177699]]></pubmedid>
		<author><![CDATA[McGorrian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[12772]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12772]]></cohortsamplesize>
		<numberofevents><![CDATA[5349]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Apoliprotein A/B, Smoking, Diabetes, Hypertension]]></covariates>
		<mh><![CDATA[Adult; Aged; Case-Control Studies; Coronary Disease/*epidemiology; Female; Global Health/statistics & numerical data; Humans; Male; Middle Aged; Myocardial Infarction/*epidemiology; Residence Characteristics; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-22]]></modelid>
		<pubmedid><![CDATA[21185497]]></pubmedid>
		<author><![CDATA[Damman]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.[Erratum appears in J Am Coll Cardiol. 2011 Apr 19;57]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1034]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1034]]></cohortsamplesize>
		<numberofevents><![CDATA[120]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anterior MI, BMI, eGFR, Glucose, Diabetes or Hypertension, NT-proBNP, SBP/Pulse, Time to Treatment]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary/*methods; Biomarkers/*blood; C-Reactive Protein/metabolism; *Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction/blood/*mortality/therapy; Natriuretic Peptide, Brain/blood; Netherlands/epidemiology; *Patient Admission; Peptide Fragments/blood; Prognosis; Proportional Hazards Models; Protein Precursors; Receptor, Epidermal Growth Factor/blood; Retrospective Studies; Risk Factors; Survival Rate/trends; Troponin T/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-23]]></modelid>
		<pubmedid><![CDATA[21217144]]></pubmedid>
		<author><![CDATA[Verheugt]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population]]></title>
		<primaryindexcondition><![CDATA[Congenital Heart Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Endocarditis]]></outcome>
		<modelsamplesize><![CDATA[10210]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10210]]></cohortsamplesize>
		<numberofevents><![CDATA[233]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aortic Coarctation, Stenosis, Septal Defect, Bicuspic Aortic Valve, CVA, Endocarditis, Congenitally Corrected Transposition of Great Arteries, Ebstein Malformation, Sex, Marfan Syndrome, Congenital Heart Defects, Pulmonary Atresia, Arrhythmia, Tetralogy o]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Endocarditis/epidemiology/*etiology; Epidemiologic Methods; Female; Health Transition; Heart Defects, Congenital/*complications/epidemiology; Humans; Male; Middle Aged; Netherlands/epidemiology; Young Adult]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-36]]></modelid>
		<pubmedid><![CDATA[22308287]]></pubmedid>
		<author><![CDATA[Singh]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Risk prediction for early in-hospital mortality following heart transplantation in the United States]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4248]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4248]]></cohortsamplesize>
		<numberofevents><![CDATA[201]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.742]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diagnosis, Dialysis, Donor Age, GFR, Ischemic Time, Mechanical Support, Albumin, Ventilator]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-24]]></modelid>
		<pubmedid><![CDATA[21256468]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score)]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3997]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3997]]></cohortsamplesize>
		<numberofevents><![CDATA[228]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Glucose, Age, Killip Class, LVEF, PCI, Creatinine]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/mortality; Blood Glucose/metabolism; Blood Pressure; Cause of Death; Cohort Studies; Creatinine/blood; Death, Sudden, Cardiac/epidemiology; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Korea; Male; Multivariate Analysis; Myocardial Infarction/blood/*mortality/therapy; Patient Discharge/*statistics & numerical data; Proportional Hazards Models; Prospective Studies; Registries/*statistics & numerical data; Risk Assessment/*statistics & numerical data; Survival Rate; Ventricular Dysfunction, Left/blood/mortality/therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-25]]></modelid>
		<pubmedid><![CDATA[21300951]]></pubmedid>
		<author><![CDATA[Saposnik]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8223]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12262]]></cohortsamplesize>
		<numberofevents><![CDATA[1004]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Cancer, CHF, Glucose, Sex, Disability, Dialysis, Stroke Severity, Stroke Subtype]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Brain Ischemia/diagnosis/*mortality; Female; Hospitalization/statistics & numerical data; Humans; Male; Middle Aged; *Models, Statistical; Ontario/epidemiology; Patient Discharge/*statistics & numerical data; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Risk Adjustment/methods; Risk Factors; *Severity of Illness Index; Stroke/diagnosis/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-26]]></modelid>
		<pubmedid><![CDATA[21300951]]></pubmedid>
		<author><![CDATA[Saposnik]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8223]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12262]]></cohortsamplesize>
		<numberofevents><![CDATA[1853]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.823]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Cancer, CHF, Smoking, Glucose, Sex, Disability, Previous MI, Dialysis, Stroke Severity, Stroke Subtype]]></covariates>
		<mh><![CDATA[Acute Disease; Aged; Aged, 80 and over; Brain Ischemia/diagnosis/*mortality; Female; Hospitalization/statistics & numerical data; Humans; Male; Middle Aged; *Models, Statistical; Ontario/epidemiology; Patient Discharge/*statistics & numerical data; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Risk Adjustment/methods; Risk Factors; *Severity of Illness Index; Stroke/diagnosis/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-27]]></modelid>
		<pubmedid><![CDATA[21311063]]></pubmedid>
		<author><![CDATA[Beer]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Traditional risk factors for incident cardiovascular events have limited importance in later life compared with the health in men study cardiovascular risk score]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[4382]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4382]]></cohortsamplesize>
		<numberofevents><![CDATA[686]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, DBP, Self-Reported Health, CRP, Homocysteine, Waist to Hip Ratio]]></covariates>
		<mh><![CDATA[Age Distribution; Age Factors; Aged; Aged, 80 and over; Cohort Studies; Comorbidity/trends; Humans; Incidence; Male; Myocardial Infarction/complications/*epidemiology; Prospective Studies; Risk Factors; Stroke/complications/*epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-28]]></modelid>
		<pubmedid><![CDATA[21319356]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Yonsei Medical Journal]]></journal>
		<title><![CDATA[Risk factors for postoperative complications after open infrarenal abdominal aortic aneurysm repair in Koreans]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Procedural Complications]]></outcome>
		<modelsamplesize><![CDATA[162]]></modelsamplesize>
		<cohortsamplesize><![CDATA[162]]></cohortsamplesize>
		<numberofevents><![CDATA[55]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Dopamine, Clamp Duration, Emergency Operation, Transfusion]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aortic Aneurysm, Abdominal/*surgery; Blood Loss, Surgical; Chi-Square Distribution; Female; Humans; Logistic Models; Male; Odds Ratio; Postoperative Complications/*etiology; Republic of Korea; Retrospective Studies; Risk Factors; Statistics, Nonparametric]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-29]]></modelid>
		<pubmedid><![CDATA[21324428]]></pubmedid>
		<author><![CDATA[Mathews]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry[REGISTERED]-GWTGTM]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[72313]]></modelsamplesize>
		<cohortsamplesize><![CDATA[90273]]></cohortsamplesize>
		<numberofevents><![CDATA[7810]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hemoglobin, Creatinine, Diabetes, Sex, Heart Rate, Warfarin Use, PAD, HF Symptoms, ST Segment Changes, SBP, Weight]]></covariates>
		<mh><![CDATA[Aged; *Electrocardiography; Female; Fibrinolytic Agents/*adverse effects/therapeutic use; Follow-Up Studies; Hemorrhage/*chemically induced/epidemiology; Humans; Incidence; *Inpatients; Male; Middle Aged; Myocardial Infarction/*complications/drug therapy; *Registries; Retrospective Studies; Risk Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-30]]></modelid>
		<pubmedid><![CDATA[21330241]]></pubmedid>
		<author><![CDATA[Ito]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Eurointervention]]></journal>
		<title><![CDATA[An integer based risk score for predicting 30-day major adverse cardiac or cerebrovascular events after percutaneous coronary intervention with drug-eluting stents: results from a large prospective multicentre registry, the STENT Group]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[10679]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10679]]></cohortsamplesize>
		<numberofevents><![CDATA[443]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.646]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Statin Use, Type C Lesion, CHF, Shock, Thrombosis, Hemoglobin, Left Anterior Descending Lesion, Left Main Disease, Ostial Lesion]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*adverse effects/mortality/statistics & numerical ; Coronary Artery Disease/*mortality/*therapy; Drug-Eluting Stents/*adverse effects/statistics & numerical data; Female; Humans; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge/statistics & numerical data; Predictive Value of Tests; Prospective Studies; Registries/*statistics & numerical data; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-31]]></modelid>
		<pubmedid><![CDATA[21330242]]></pubmedid>
		<author><![CDATA[Baran]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Eurointervention]]></journal>
		<title><![CDATA[A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stent Thrombosis]]></outcome>
		<modelsamplesize><![CDATA[7459]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7459]]></cohortsamplesize>
		<numberofevents><![CDATA[56]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Bifurcation Lesion, Stent, CABG, MI, Renal Disease, Smoking]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary/*adverse effects/statistics & numerical data; Coronary Artery Disease/*epidemiology; Coronary Thrombosis/diagnosis/*epidemiology; Drug-Eluting Stents/*adverse effects/statistics & numerical data; Follow-Up Studies; Humans; Predictive Value of Tests; Proportional Hazards Models; ROC Curve; Registries/statistics & numerical data; Risk Assessment; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-32]]></modelid>
		<pubmedid><![CDATA[21334918]]></pubmedid>
		<author><![CDATA[Rahmanian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[Logistic risk model predicting postoperative renal failure requiring dialysis in cardiac surgery patients.]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[2511]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2511]]></cohortsamplesize>
		<numberofevents><![CDATA[98]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.829]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CPB Time, Diabetes, NYHA Class, MI, PVD, Creatinine, Hypertension]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Cardiopulmonary Bypass/adverse effects; Epidemiologic Methods; Female; Germany/epidemiology; Humans; Hypertension, Pulmonary/complications/epidemiology; Kidney/physiopathology; Male; Middle Aged; Prognosis; Renal Dialysis; Renal Insufficiency/epidemiology/*etiology/therapy; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-33]]></modelid>
		<pubmedid><![CDATA[21345854]]></pubmedid>
		<author><![CDATA[De Mulder]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[23032]]></modelsamplesize>
		<cohortsamplesize><![CDATA[46064]]></cohortsamplesize>
		<numberofevents><![CDATA[339]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.91]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Bifurcation Lesion, BMI, Diabetes, Smoking, Sex, Hemodynamic Instability, PCI Indication, Left Main Disease, Diseased Vessels, CABG, Stroke, Proximal Left Anterior Descending Diseased, TIMI Score, Type-C Lesion, VHD]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; Europe; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction/mortality/*therapy; Risk Assessment; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-34]]></modelid>
		<pubmedid><![CDATA[21345854]]></pubmedid>
		<author><![CDATA[De Mulder]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4091]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8060]]></cohortsamplesize>
		<numberofevents><![CDATA[220]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Bifurcation Lesion, BMI, Diabetes, Smoking, Sex, Hemodynamic Instability, Ischemic Time, Left Anterior Descending is Target Vessel, Left Main Disease, Diseased Vessels, CABG, Stroke, Proximal Left Anterior Descending Diseased, TIMI Score, Type-C Lesi]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*mortality; Europe; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction/mortality/*therapy; Risk Assessment; *Severity of Illness Index]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-35]]></modelid>
		<pubmedid><![CDATA[21376618]]></pubmedid>
		<author><![CDATA[Ariyaratne]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Journal of Cardio-Thoracic Surgery]]></journal>
		<title><![CDATA[An Australian risk prediction model for determining early mortality following aortic valve replacement]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[3544]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3544]]></cohortsamplesize>
		<numberofevents><![CDATA[147]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Endocarditis, Coma, CVA, Left Main Disease, LVEF, NYHA Class, CABG, Valve Surgery, Renal Dysfunction, TIA]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Valve/*surgery; Australia/epidemiology; Female; Heart Valve Diseases/mortality/*surgery; Heart Valve Prosthesis Implantation/adverse effects/*mortality; Humans; Male; Middle Aged; *Models, Statistical; Preoperative Care/methods; Prognosis; Risk Assessment/methods; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-36]]></modelid>
		<pubmedid><![CDATA[21392604]]></pubmedid>
		<author><![CDATA[de Boer]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5421]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5421]]></cohortsamplesize>
		<numberofevents><![CDATA[363]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Infarct Location, Diabetes, Heart Rate, Prior MI, SBP, Time to Treatment, Sex]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary; Humans; Myocardial Infarction/*mortality/*therapy; Patient Selection; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; *Thrombolytic Therapy; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-37]]></modelid>
		<pubmedid><![CDATA[21412997]]></pubmedid>
		<author><![CDATA[Grant]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[British Journal of Surgery]]></journal>
		<title><![CDATA[Logistic risk model for mortality following elective abdominal aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1936]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2765]]></cohortsamplesize>
		<numberofevents><![CDATA[31]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Antiplatelet Medication, Creatinine, Diabetes, Sex, Open Surgery, Respiratory Disease]]></covariates>
		<mh><![CDATA[Adult; Aged; Aortic Aneurysm, Abdominal/mortality/*surgery; Elective Surgical Procedures/*mortality; England/epidemiology; Epidemiologic Methods; Female; Humans; Male; Middle Aged]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-38]]></modelid>
		<pubmedid><![CDATA[21413131]]></pubmedid>
		<author><![CDATA[Elmariah]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Catheterization and Cardiovascular Interventions]]></journal>
		<title><![CDATA[A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: the CRRAC the AV score]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[281]]></modelsamplesize>
		<cohortsamplesize><![CDATA[281]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.754]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiac Output, Critical Status, RA Pressure, Renal Dysfunction]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Valve Stenosis/diagnosis/mortality/physiopathology/*therapy; Atrial Function, Right; Cardiac Output; Catheterization/*mortality; Female; *Health Status Indicators; Humans; Kaplan-Meier Estimate; Kidney/physiopathology; Kidney Diseases/mortality/physiopathology; Logistic Models; Male; New York City/epidemiology; Predictive Value of Tests; Pressure; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-39]]></modelid>
		<pubmedid><![CDATA[21436241]]></pubmedid>
		<author><![CDATA[Spyropoulos]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Predictive and associative models to identify hospitalized medical patients at risk for VTE]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[13172]]></modelsamplesize>
		<cohortsamplesize><![CDATA[13172]]></cohortsamplesize>
		<numberofevents><![CDATA[184]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cancer, Thrombophilia, VTE]]></covariates>
		<mh><![CDATA[Aged; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Models, Statistical; Pulmonary Embolism/*epidemiology/prevention & control; Risk Assessment; Risk Factors; Venous Thrombosis/*epidemiology/prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-40]]></modelid>
		<pubmedid><![CDATA[21436241]]></pubmedid>
		<author><![CDATA[Spyropoulos]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[Predictive and associative models to identify hospitalized medical patients at risk for VTE]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diagnosis]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[13172]]></modelsamplesize>
		<cohortsamplesize><![CDATA[13172]]></cohortsamplesize>
		<numberofevents><![CDATA[184]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cancer, Paralysis, ICU Stay, Immobilization, Thrombophilia, VTE]]></covariates>
		<mh><![CDATA[Aged; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Models, Statistical; Pulmonary Embolism/*epidemiology/prevention & control; Risk Assessment; Risk Factors; Venous Thrombosis/*epidemiology/prevention & control]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-41]]></modelid>
		<pubmedid><![CDATA[21478735]]></pubmedid>
		<author><![CDATA[Mashour]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Anesthesiology]]></journal>
		<title><![CDATA[Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[350031]]></modelsamplesize>
		<cohortsamplesize><![CDATA[350031]]></cohortsamplesize>
		<numberofevents><![CDATA[485]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Acute Renal Failure, Age, BMI, COPD, Smoking, Stroke, TIA, Hypertension, MI, Dialysis]]></covariates>
		<mh><![CDATA[Cohort Studies; Databases, Factual/trends; Female; Humans; Male; Middle Aged; *Perioperative Period/trends; Postoperative Complications/etiology/*mortality; Prospective Studies; Risk Factors; Stroke/etiology/*mortality]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-42]]></modelid>
		<pubmedid><![CDATA[21482007]]></pubmedid>
		<author><![CDATA[Hayakawa]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: the Utstein Osaka Project]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[285]]></modelsamplesize>
		<cohortsamplesize><![CDATA[285]]></cohortsamplesize>
		<numberofevents><![CDATA[91]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.851]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ROSC, Time to ROSC]]></covariates>
		<mh><![CDATA[Aged; Cardiopulmonary Resuscitation/*methods; Emergency Medical Services; Female; Follow-Up Studies; Heart Arrest/epidemiology/physiopathology/*therapy; Hemodynamics/*physiology; Humans; Incidence; Japan/epidemiology; Male; Middle Aged; Prognosis; Prospective Studies; ROC Curve; Recovery of Function/*physiology; Survival Rate/trends]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-43]]></modelid>
		<pubmedid><![CDATA[21489563]]></pubmedid>
		<author><![CDATA[Gan]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of the Neurological Sciences]]></journal>
		<title><![CDATA[Predicting the incidence risk of ischemic stroke in a hospital population of southern China: a classification tree analysis]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[618]]></modelsamplesize>
		<cohortsamplesize><![CDATA[618]]></cohortsamplesize>
		<numberofevents><![CDATA[309]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Education Level, HDL Cholesterol, Hypertension, Exercise, Smoking, Diet]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Brain Ischemia/complications/*epidemiology; China/epidemiology; *Decision Trees; Female; Hospitals/statistics & numerical data; Humans; Incidence; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stroke/*epidemiology/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-44]]></modelid>
		<pubmedid><![CDATA[21489563]]></pubmedid>
		<author><![CDATA[Gan]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of the Neurological Sciences]]></journal>
		<title><![CDATA[Predicting the incidence risk of ischemic stroke in a hospital population of southern China: a classification tree analysis]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[618]]></modelsamplesize>
		<cohortsamplesize><![CDATA[618]]></cohortsamplesize>
		<numberofevents><![CDATA[309]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Education Level, HDL Cholesterol, Hypertension, Exercise, Smoking, Diet]]></covariates>
		<mh><![CDATA[Adult; Aged; Aged, 80 and over; Brain Ischemia/complications/*epidemiology; China/epidemiology; *Decision Trees; Female; Hospitals/statistics & numerical data; Humans; Incidence; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stroke/*epidemiology/etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-45]]></modelid>
		<pubmedid><![CDATA[21494889]]></pubmedid>
		<author><![CDATA[Swinkels]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Netherlands Heart Journal]]></journal>
		<title><![CDATA[Predicting 30-day mortality of aortic valve replacement by the AVR score]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[673]]></modelsamplesize>
		<cohortsamplesize><![CDATA[673]]></cohortsamplesize>
		<numberofevents><![CDATA[19]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, CABG, MI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-46]]></modelid>
		<pubmedid><![CDATA[21537001]]></pubmedid>
		<author><![CDATA[Haines]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[134069]]></modelsamplesize>
		<cohortsamplesize><![CDATA[268701]]></cohortsamplesize>
		<numberofevents><![CDATA[8589]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.677]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Admission, Age, AF, BUN, Lung Disease, Sex, ICD Type, NYHA Class, Valve Surgery]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Death, Sudden, Cardiac/*epidemiology; Defibrillators, Implantable/*adverse effects; Female; Humans; Logistic Models; Male; *Models, Statistical; Postoperative Complications/*epidemiology; Prevalence; Registries; Retrospective Studies; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-47]]></modelid>
		<pubmedid><![CDATA[21537001]]></pubmedid>
		<author><![CDATA[Haines]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[134069]]></modelsamplesize>
		<cohortsamplesize><![CDATA[268701]]></cohortsamplesize>
		<numberofevents><![CDATA[1021]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.842]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Admission, AF, BUN, Cardiac Arrest, Creatinine, NYHA Class, SBP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Death, Sudden, Cardiac/*epidemiology; Defibrillators, Implantable/*adverse effects; Female; Humans; Logistic Models; Male; *Models, Statistical; Postoperative Complications/*epidemiology; Prevalence; Registries; Retrospective Studies; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-48]]></modelid>
		<pubmedid><![CDATA[21562057]]></pubmedid>
		<author><![CDATA[Subramanian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[New predictive models of heart failure mortality using time-series measurements and ensemble models]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[963]]></modelsamplesize>
		<cohortsamplesize><![CDATA[963]]></cohortsamplesize>
		<numberofevents><![CDATA[172]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BUN, Cardiothoracic Ratio, LVEF, Lymphocytes]]></covariates>
		<mh><![CDATA[Aged; Algorithms; Biomarkers/blood; Cytokines/blood; Female; Heart Failure/blood/*mortality; Humans; Interleukin-6/blood; *Logistic Models; Male; Middle Aged; *Models, Cardiovascular; *ROC Curve; Receptors, Cytokine/blood; Retrospective Studies; Tumor Necrosis Factor-alpha/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-49]]></modelid>
		<pubmedid><![CDATA[21562057]]></pubmedid>
		<author><![CDATA[Subramanian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[New predictive models of heart failure mortality using time-series measurements and ensemble models]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[963]]></modelsamplesize>
		<cohortsamplesize><![CDATA[963]]></cohortsamplesize>
		<numberofevents><![CDATA[172]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BUN, Cardiothoracic Ratio, LVEF, Lymphocytes]]></covariates>
		<mh><![CDATA[Aged; Algorithms; Biomarkers/blood; Cytokines/blood; Female; Heart Failure/blood/*mortality; Humans; Interleukin-6/blood; *Logistic Models; Male; Middle Aged; *Models, Cardiovascular; *ROC Curve; Receptors, Cytokine/blood; Retrospective Studies; Tumor Necrosis Factor-alpha/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-50]]></modelid>
		<pubmedid><![CDATA[21562057]]></pubmedid>
		<author><![CDATA[Subramanian]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[New predictive models of heart failure mortality using time-series measurements and ensemble models]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[963]]></modelsamplesize>
		<cohortsamplesize><![CDATA[963]]></cohortsamplesize>
		<numberofevents><![CDATA[172]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BUN, Cardiothoracic Ratio, LVEF, Lymphocytes]]></covariates>
		<mh><![CDATA[Aged; Algorithms; Biomarkers/blood; Cytokines/blood; Female; Heart Failure/blood/*mortality; Humans; Interleukin-6/blood; *Logistic Models; Male; Middle Aged; *Models, Cardiovascular; *ROC Curve; Receptors, Cytokine/blood; Retrospective Studies; Tumor Necrosis Factor-alpha/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-51]]></modelid>
		<pubmedid><![CDATA[21602286]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Family Practice]]></journal>
		<title><![CDATA[The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[404]]></modelsamplesize>
		<cohortsamplesize><![CDATA[404]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Angina, CRP, FEV]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Angina Pectoris/blood/complications; C-Reactive Protein/metabolism; Cause of Death; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Myocardial Ischemia/blood/*complications/*mortality; Netherlands/epidemiology; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive/*complications/*mortality; Severity of Illness Index; Spirometry; Vital Capacity]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-52]]></modelid>
		<pubmedid><![CDATA[21627687]]></pubmedid>
		<author><![CDATA[Cederholm]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Diabetic Medicine]]></journal>
		<title><![CDATA[A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[3661]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3661]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Duration of Symptoms, HbA1c, Albumin, Cerebrovascular Disease, Smoking, SBP, Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Age of Onset; Aged; Biomarkers/blood; Body Mass Index; Cardiovascular Diseases/drug therapy/*epidemiology; Cholesterol, HDL/blood; Cholesterol, LDL/blood; Confidence Intervals; Diabetes Mellitus, Type 1/drug therapy/*epidemiology; Diabetic Angiopathies/drug therapy/*epidemiology; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Registries; Risk Factors; Sensitivity and Specificity; Sweden/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-37]]></modelid>
		<pubmedid><![CDATA[22311929]]></pubmedid>
		<author><![CDATA[Strbian]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[1319]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1319]]></cohortsamplesize>
		<numberofevents><![CDATA[797]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Dense Cerebral Artery Sign, Early Infarct on CT, Age, Glucose, mRS, NIHSS, Time to Treatment]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-53]]></modelid>
		<pubmedid><![CDATA[21630313]]></pubmedid>
		<author><![CDATA[Agterof]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Journal of Hematology]]></journal>
		<title><![CDATA[A prognostic model for short term adverse events in normotensive patients with pulmonary embolism]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[210]]></modelsamplesize>
		<cohortsamplesize><![CDATA[210]]></cohortsamplesize>
		<numberofevents><![CDATA[12]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Malignancy, D-dimer, NT-proBNP, Pulse]]></covariates>
		<mh><![CDATA[Adult; Aged; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products/analysis; Heart Rate; Hospitals, Teaching; Humans; Male; Middle Aged; *Models, Biological; Natriuretic Peptide, Brain/blood; Neoplasms/complications; Netherlands; Peptide Fragments/blood; Prognosis; Pulmonary Embolism/blood/complications/*diagnosis/*physiopathology; Retrospective Studies; Risk Assessment/methods]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-54]]></modelid>
		<pubmedid><![CDATA[21653216]]></pubmedid>
		<author><![CDATA[Xie]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1734]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1734]]></cohortsamplesize>
		<numberofevents><![CDATA[81]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.784]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Diabetes, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Adult; Aged; Carotid Artery Diseases/epidemiology/*pathology/ultrasonography; China/epidemiology; Early Diagnosis; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Ischemia/epidemiology/*pathology/ultrasonography; Plaque, Atherosclerotic/epidemiology/pathology/ultrasonography; Prognosis; Tunica Intima/*pathology/ultrasonography; Tunica Media/*pathology/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-55]]></modelid>
		<pubmedid><![CDATA[21653216]]></pubmedid>
		<author><![CDATA[Xie]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1734]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1734]]></cohortsamplesize>
		<numberofevents><![CDATA[81]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.724]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Segments with Plaque, Intima-Media Thickness]]></covariates>
		<mh><![CDATA[Adult; Aged; Carotid Artery Diseases/epidemiology/*pathology/ultrasonography; China/epidemiology; Early Diagnosis; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Ischemia/epidemiology/*pathology/ultrasonography; Plaque, Atherosclerotic/epidemiology/pathology/ultrasonography; Prognosis; Tunica Intima/*pathology/ultrasonography; Tunica Media/*pathology/ultrasonography]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-56]]></modelid>
		<pubmedid><![CDATA[21684512]]></pubmedid>
		<author><![CDATA[Yap]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Identifying high risk in adults with congenital heart disease and atrial arrhythmias]]></title>
		<primaryindexcondition><![CDATA[Congenital Heart Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[378]]></modelsamplesize>
		<cohortsamplesize><![CDATA[378]]></cohortsamplesize>
		<numberofevents><![CDATA[40]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NYHA Class, Hypertension, Physiology, VHD]]></covariates>
		<mh><![CDATA[Adult; Atrial Fibrillation/*etiology/*mortality; Female; Follow-Up Studies; Heart Defects, Congenital/*complications/*mortality; Humans; Male; Ontario/epidemiology; Population Surveillance; Proportional Hazards Models; Risk Assessment; Risk Factors; Survival Rate]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-57]]></modelid>
		<pubmedid><![CDATA[21700252]]></pubmedid>
		<author><![CDATA[Mehran]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Jacc: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent int]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[17034]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17034]]></cohortsamplesize>
		<numberofevents><![CDATA[267]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Bivalirudin, Glycoprotein Inhibitor, Smoking, Sex, Biomarkers, Creatinine, STEMI, Heparin/Enoxaparin, WBC]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*adverse effects/mortality; Antithrombins/*therapeutic use; Confidence Intervals; Coronary Artery Disease/drug therapy/*therapy; Drug-Eluting Stents; Female; Health Status Indicators; Hemorrhage/etiology/*mortality; Heparin/therapeutic use; Hirudins; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction/drug therapy/*therapy; Myocardial Reperfusion; Peptide Fragments/*therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins/therapeutic use; Risk Assessment; Risk Factors; Triage]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-58]]></modelid>
		<pubmedid><![CDATA[21719139]]></pubmedid>
		<author><![CDATA[Zethelius]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Diabetes Research & Clinical Practice]]></journal>
		<title><![CDATA[A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR)]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Diabetes Mellitus]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[24288]]></modelsamplesize>
		<cohortsamplesize><![CDATA[24288]]></cohortsamplesize>
		<numberofevents><![CDATA[2488]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, Diabetes, BMI, HbA1c, SBP, Cholesterol, Albumin, Sex, Age, Previous CVD, Smoking]]></covariates>
		<mh><![CDATA[Adult; Aged; Cardiovascular Diseases/epidemiology/*etiology; Diabetes Mellitus, Type 2/*complications/epidemiology; Female; Humans; Male; Middle Aged; Observation; Registries; Risk Factors; Sensitivity and Specificity; Sweden]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-59]]></modelid>
		<pubmedid><![CDATA[21730309]]></pubmedid>
		<author><![CDATA[Gupta]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Development and validation of a risk calculator for prediction of cardiac risk after surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[211410]]></modelsamplesize>
		<cohortsamplesize><![CDATA[211410]]></cohortsamplesize>
		<numberofevents><![CDATA[1371]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.892]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ASA Physiological Status, Type of Surgery, Creatinine, Functional Status]]></covariates>
		<mh><![CDATA[Adult; Aged; *Algorithms; Female; Heart Arrest/*diagnosis/etiology; Humans; Male; Middle Aged; *Models, Cardiovascular; Myocardial Infarction/*diagnosis/etiology; Perioperative Period; Postoperative Complications/*diagnosis/etiology; ROC Curve; Risk Assessment/methods; Surgical Procedures, Operative/*adverse effects]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-60]]></modelid>
		<pubmedid><![CDATA[21757117]]></pubmedid>
		<author><![CDATA[Fang]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[6123]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6123]]></cohortsamplesize>
		<numberofevents><![CDATA[307]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, Hemorrhage, Hypertension, Renal Disease]]></covariates>
		<mh><![CDATA[Aged; Anticoagulants/*adverse effects/therapeutic use; Atrial Fibrillation/drug therapy; Female; Hemorrhage/*chemically induced; Humans; Male; Predictive Value of Tests; Risk Assessment; Risk Factors; Treatment Outcome; Warfarin/*adverse effects/therapeutic use]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-61]]></modelid>
		<pubmedid><![CDATA[21788210]]></pubmedid>
		<author><![CDATA[Badheka]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Angiology]]></journal>
		<title><![CDATA[Outcomes and risk prediction model for peripheral arterial disease in patients with stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Peripheral Vascular Disease (PVD)]]></outcome>
		<modelsamplesize><![CDATA[8290]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8290]]></cohortsamplesize>
		<numberofevents><![CDATA[220]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Claudication, CABG, Diabetes, Hypertension, Cholesterol, Smoking]]></covariates>
		<mh><![CDATA[Aged; Coronary Artery Disease/*complications; Humans; Middle Aged; Models, Statistical; Peripheral Arterial Disease/*epidemiology/*etiology; Prognosis; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-62]]></modelid>
		<pubmedid><![CDATA[21871277]]></pubmedid>
		<author><![CDATA[Weiss]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT)]]></title>
		<primaryindexcondition><![CDATA[Heart Transplant]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17079]]></modelsamplesize>
		<cohortsamplesize><![CDATA[21378]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Bilirubin, Creatinine, Sex, Dialysis, HF Etiology, Race, Circulatory Support, Ventricular Assist Device]]></covariates>
		<mh><![CDATA[Female; Follow-Up Studies; Heart Failure/mortality/*surgery; Heart Transplantation/*mortality; Humans; Kaplan-Meier Estimate; Male; Maryland/epidemiology; Middle Aged; Postoperative Period; Predictive Value of Tests; Prospective Studies; Risk Assessment/*methods; Risk Factors; Survival Rate/trends]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-63]]></modelid>
		<pubmedid><![CDATA[21883472]]></pubmedid>
		<author><![CDATA[Abbas]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of Interventional Cardiology]]></journal>
		<title><![CDATA[A novel mortality risk score for female patients undergoing endovascular interventions]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[292]]></modelsamplesize>
		<cohortsamplesize><![CDATA[292]]></cohortsamplesize>
		<numberofevents><![CDATA[71]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CHF, Creatinine]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Angioplasty, Balloon, Coronary/*mortality/statistics & numerical data; Female; Health Status Indicators; Humans; Michigan; Middle Aged; Mortality/*trends; Peripheral Arterial Disease/*mortality/therapy; Retrospective Studies; Risk Assessment/methods; Risk Factors; Sex Factors; Statistics as Topic; Statistics, Nonparametric]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-64]]></modelid>
		<pubmedid><![CDATA[21890661]]></pubmedid>
		<author><![CDATA[Sabate]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[British Journal of Anaesthesia]]></journal>
		<title><![CDATA[Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[3387]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3387]]></cohortsamplesize>
		<numberofevents><![CDATA[146]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.759]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Abnormal EKG, CKD, Cerebrovascular Disease, CHF, CAD, Hypotension, Transfusion]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Cerebrovascular Disorders/epidemiology/*etiology; Cohort Studies; Electrocardiography; Erythrocyte Transfusion/adverse effects; Female; Heart Diseases/epidemiology/*etiology; Humans; Incidence; Male; Middle Aged; Perioperative Period; Postoperative Complications/epidemiology/*etiology; Prospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-65]]></modelid>
		<pubmedid><![CDATA[21900079]]></pubmedid>
		<author><![CDATA[Yeh]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[18071]]></modelsamplesize>
		<cohortsamplesize><![CDATA[27107]]></cohortsamplesize>
		<numberofevents><![CDATA[2047]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.61]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Admission Symptoms, Age, Diabetes, Stent, Hypertension, NYHA Class, PCI, PVD, CABG]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis/economics/epidemiology/*prevention & control; Coronary Stenosis/*therapy; Cost-Benefit Analysis; *Drug-Eluting Stents/economics/statistics & numerical data; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Cardiovascular; Registries; Stents/economics/statistics & numerical data]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-66]]></modelid>
		<pubmedid><![CDATA[21900079]]></pubmedid>
		<author><![CDATA[Yeh]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[18071]]></modelsamplesize>
		<cohortsamplesize><![CDATA[27107]]></cohortsamplesize>
		<numberofevents><![CDATA[2047]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stenosis, Admission Symptoms, Age, Diabetes, Stent, Hypertension, NYHA Class, Number of Lesions Treated, PCI, PVD, Stent Diameter, Stent Length]]></covariates>
		<mh><![CDATA[Aged; *Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis/economics/epidemiology/*prevention & control; Coronary Stenosis/*therapy; Cost-Benefit Analysis; *Drug-Eluting Stents/economics/statistics & numerical data; Female; Humans; Male; Massachusetts/epidemiology; Middle Aged; *Models, Cardiovascular; Registries; Stents/economics/statistics & numerical data]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-67]]></modelid>
		<pubmedid><![CDATA[21905973]]></pubmedid>
		<author><![CDATA[Zittermann]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Scandinavian Cardiovascular Journal]]></journal>
		<title><![CDATA[Parameters of mineral metabolism predict midterm clinical outcome in end-stage heart failure patients]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[305]]></modelsamplesize>
		<cohortsamplesize><![CDATA[305]]></cohortsamplesize>
		<numberofevents><![CDATA[102]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Vitamin D, FGF, Magnesium, Parathyroid Hormone, Sodium]]></covariates>
		<mh><![CDATA[Biomarkers/blood; Disease-Free Survival; Female; Fibroblast Growth Factors/blood; Germany; Heart Failure/*blood/mortality/therapy; Heart Transplantation; Heart-Assist Devices; Humans; Kaplan-Meier Estimate; Logistic Models; Magnesium/blood; Male; Metabolic Diseases/*blood/mortality/therapy; Middle Aged; Parathyroid Hormone/blood; Pilot Projects; Prognosis; Risk Assessment; Risk Factors; Sodium/blood; Time Factors; Vitamin D/analogs & derivatives/blood]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-68]]></modelid>
		<pubmedid><![CDATA[21962315]]></pubmedid>
		<author><![CDATA[Woller]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[143975]]></modelsamplesize>
		<cohortsamplesize><![CDATA[143975]]></cohortsamplesize>
		<numberofevents><![CDATA[5288]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.874]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Bed Rest, Catheterization, Cancer, VTE]]></covariates>
		<mh><![CDATA[Area Under Curve; Bed Rest; Catheterization, Central Venous/adverse effects; Cohort Studies; Humans; Inpatients; *Models, Biological; Neoplasms/complications; Reproducibility of Results; Retrospective Studies; Risk Factors; Venous Thromboembolism/epidemiology/*etiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-69]]></modelid>
		<pubmedid><![CDATA[22090661]]></pubmedid>
		<author><![CDATA[Dorresteijn]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[27939]]></modelsamplesize>
		<cohortsamplesize><![CDATA[27939]]></cohortsamplesize>
		<numberofevents><![CDATA[652]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Antihypertensive Medication, Smoking, Family History, HbA1c, HDL Cholesterol, CRP, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[Aged; Aspirin/*administration & dosage/adverse effects; Cardiovascular Diseases/mortality/*prevention & control; Drug Administration Schedule; Female; Hemorrhage/chemically induced; Humans; Middle Aged; Myocardial Infarction/mortality/prevention & control; Platelet Aggregation Inhibitors/*administration & dosage/adverse effects; Primary Prevention; Risk Factors; Stroke/mortality/prevention & control; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-70]]></modelid>
		<pubmedid><![CDATA[22090661]]></pubmedid>
		<author><![CDATA[Dorresteijn]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[27939]]></modelsamplesize>
		<cohortsamplesize><![CDATA[27939]]></cohortsamplesize>
		<numberofevents><![CDATA[652]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, CRP]]></covariates>
		<mh><![CDATA[Aged; Aspirin/*administration & dosage/adverse effects; Cardiovascular Diseases/mortality/*prevention & control; Drug Administration Schedule; Female; Hemorrhage/chemically induced; Humans; Middle Aged; Myocardial Infarction/mortality/prevention & control; Platelet Aggregation Inhibitors/*administration & dosage/adverse effects; Primary Prevention; Risk Factors; Stroke/mortality/prevention & control; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-71]]></modelid>
		<pubmedid><![CDATA[22093204]]></pubmedid>
		<author><![CDATA[Roe]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[33640]]></modelsamplesize>
		<cohortsamplesize><![CDATA[67423]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.754]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Smoking, Diabetes, EKG, Family History, Hyperlipidemia, Hypertension, Heart Rate, Hematocrit, Creatinine, SBP, Troponin, Sex, CABG, HF, MI, PCI, PAD, Stroke, Race, Weight]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Arrhythmias, Cardiac/physiopathology; Female; Health Services for the Aged/*statistics & numerical data; Hospitalization/statistics & numerical data; Humans; Male; Medicare; *Models, Statistical; Mortality; Myocardial Infarction/*mortality/physiopathology; Proportional Hazards Models; Registries; Reproducibility of Results; Risk Factors; United States/epidemiology]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-72]]></modelid>
		<pubmedid><![CDATA[22111052]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Chonnam Medical Journal]]></journal>
		<title><![CDATA[A Novel Risk Stratification Model for Patients with Non-ST Elevation Myocardial Infarction in the Korea Acute Myocardial Infarction Registry (KAMIR): Limitation of the TIMI Risk Scoring System]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1446]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1446]]></cohortsamplesize>
		<numberofevents><![CDATA[220]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NT-proBNP, CAD, Killip Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-01]]></modelid>
		<pubmedid><![CDATA[20932590]]></pubmedid>
		<author><![CDATA[Plakht]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[A new risk score predicting 1- and 5-year mortality following acute myocardial infarction Soroka Acute Myocardial Infarction (SAMI) Project]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1885]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2756]]></cohortsamplesize>
		<numberofevents><![CDATA[237]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.858]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, COPD, LVH, CABG, Echocardiography, Obesity, Sodium, Renal Disease, Thrombolytics]]></covariates>
		<mh><![CDATA[Aged; Cohort Studies; Comorbidity; Coronary Angiography; Databases, Factual/*statistics & numerical data; Echocardiography; Female; Humans; Male; *Models, Statistical; Multivariate Analysis; Myocardial Infarction/*mortality/radiography/ultrasonography; Predictive Value of Tests; Prognosis; Prospective Studies; ROC Curve; Reproducibility of Results; Risk Assessment/methods; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-02]]></modelid>
		<pubmedid><![CDATA[22064650]]></pubmedid>
		<author><![CDATA[Podolecki]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Coronary Artery Disease]]></journal>
		<title><![CDATA[The risk of stroke in patients with acute myocardial infarction treated invasively]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[2520]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2520]]></cohortsamplesize>
		<numberofevents><![CDATA[52]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Nephropathy, Sex, GFR, Stroke/TIA, AMI, Smoking]]></covariates>
		<mh><![CDATA[Angioplasty, Balloon, Coronary/*adverse effects/mortality; Chi-Square Distribution; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction/complications/mortality/*therapy; Poland; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Stroke/*etiology/mortality; Time Factors; Treatment Outcome]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-03]]></modelid>
		<pubmedid><![CDATA[22071208]]></pubmedid>
		<author><![CDATA[Lown]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Association of frontal QRS-T angle--age risk score on admission electrocardiogram with mortality in patients admitted with an acute coronary syndrome]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1843]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1843]]></cohortsamplesize>
		<numberofevents><![CDATA[540]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, EKG, Cardiac Markers, HF, Heart Rate, PCI, P Axis, PR Interval, AMI, QRS, QT Interval, ST-Segment Depression, SBP, T Axis]]></covariates>
		<mh><![CDATA[Acute Coronary Syndrome/diagnosis/mortality/*physiopathology; Age Factors; Aged; Confidence Intervals; Diagnosis, Differential; *Electrocardiography; Female; Follow-Up Studies; Great Britain/epidemiology; Hospital Mortality/trends; Humans; Male; Odds Ratio; *Patient Admission; Prognosis; Prospective Studies; Risk Assessment/*methods; Risk Factors; Survival Rate/trends]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-04]]></modelid>
		<pubmedid><![CDATA[22095638]]></pubmedid>
		<author><![CDATA[Koyak]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Arrhythmia and Electrophysiology]]></journal>
		<title><![CDATA[Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?]]></title>
		<primaryindexcondition><![CDATA[Congenital Heart Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[ICD Shocks]]></outcome>
		<modelsamplesize><![CDATA[136]]></modelsamplesize>
		<cohortsamplesize><![CDATA[136]]></cohortsamplesize>
		<numberofevents><![CDATA[39]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CAD, Secondary Prevention Indication, VT]]></covariates>
		<mh><![CDATA[Adult; Defibrillators, Implantable/*adverse effects; Electrocardiography; Female; Follow-Up Studies; Heart Defects, Congenital/physiopathology/*therapy; Humans; Male; Prognosis; Risk Assessment/*methods; Risk Factors; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-05]]></modelid>
		<pubmedid><![CDATA[22114101]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[2331]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2331]]></cohortsamplesize>
		<numberofevents><![CDATA[1555]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.63]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CPX Test, Sex, KCCQ Symptom Stability, Nitrogen]]></covariates>
		<mh><![CDATA[Aged; Blood Urea Nitrogen; Chronic Disease; Cohort Studies; Comorbidity; Evidence-Based Medicine; Exercise Therapy; Female; Follow-Up Studies; Heart Failure/*epidemiology/*mortality/therapy; Humans; Male; Middle Aged; *Models, Statistical; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Sex Characteristics; Survival Rate; Systole/physiology; Ventricular Dysfunction, Left/*epidemiology/*mortality/therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-06]]></modelid>
		<pubmedid><![CDATA[22114101]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2331]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2331]]></cohortsamplesize>
		<numberofevents><![CDATA[387]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, CPX Test, Nitrogen, Sex]]></covariates>
		<mh><![CDATA[Aged; Blood Urea Nitrogen; Chronic Disease; Cohort Studies; Comorbidity; Evidence-Based Medicine; Exercise Therapy; Female; Follow-Up Studies; Heart Failure/*epidemiology/*mortality/therapy; Humans; Male; Middle Aged; *Models, Statistical; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Sex Characteristics; Survival Rate; Systole/physiology; Ventricular Dysfunction, Left/*epidemiology/*mortality/therapy]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-07]]></modelid>
		<pubmedid><![CDATA[22155702]]></pubmedid>
		<author><![CDATA[Holme]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[772]]></modelsamplesize>
		<cohortsamplesize><![CDATA[772]]></cohortsamplesize>
		<numberofevents><![CDATA[78]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.722]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Smoking, LVMI, Bilirubin, Heart Rate, CRP]]></covariates>
		<mh><![CDATA[Aged; Aged, 80 and over; Aortic Valve Stenosis/diagnosis/*mortality; Echocardiography, Doppler; Humans; Middle Aged; Norway/epidemiology; Prognosis; Prospective Studies; ROC Curve; Risk Assessment/*methods; Risk Factors; Severity of Illness Index; Survival Rate/trends]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-08]]></modelid>
		<pubmedid><![CDATA[22178250]]></pubmedid>
		<author><![CDATA[Grant]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Vascular and Endovascular Surgery]]></journal>
		<title><![CDATA[What are the risk factors for renal failure following open elective abdominal aortic aneurysm repair?]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[2347]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2347]]></cohortsamplesize>
		<numberofevents><![CDATA[140]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Abdominal Aortic Aneurysm, Respiratory Disease, Creatinine, Hypertension]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aortic Aneurysm, Abdominal/complications/*surgery; *Blood Vessel Prosthesis Implantation; Cohort Studies; Creatinine/blood; England/epidemiology; Female; Humans; Male; *Postoperative Complications; Prospective Studies; Renal Insufficiency/*epidemiology; Retrospective Studies; Risk Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-09]]></modelid>
		<pubmedid><![CDATA[22228238]]></pubmedid>
		<author><![CDATA[Widyastuti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Anaesthesiology]]></journal>
		<title><![CDATA[Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Post-Operative Shock]]></outcome>
		<modelsamplesize><![CDATA[4979]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4979]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.838]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Insufficiency, Degree of Urgency, Operation Type, Hemoglobin, Renal Dysfunction, Previous Cardiac Operation, MI, Hypertension]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Female; Heart Diseases/*etiology; Humans; Intraoperative Period; Logistic Models; Male; Middle Aged; Postoperative Complications/*etiology; Preoperative Period; Prospective Studies; ROC Curve; Risk Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-10]]></modelid>
		<pubmedid><![CDATA[22228238]]></pubmedid>
		<author><![CDATA[Widyastuti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Anaesthesiology]]></journal>
		<title><![CDATA[Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Post-Operative Shock]]></outcome>
		<modelsamplesize><![CDATA[4977]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4977]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.875]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Insufficiency, Degree of Urgency, Inotropes, Operation Type, Transfusion, MI, Renal Dysfunction, Hypertension, Vasoconstrictor Treatment]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Female; Heart Diseases/*etiology; Humans; Intraoperative Period; Logistic Models; Male; Middle Aged; Postoperative Complications/*etiology; Preoperative Period; Prospective Studies; ROC Curve; Risk Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-11]]></modelid>
		<pubmedid><![CDATA[22228238]]></pubmedid>
		<author><![CDATA[Widyastuti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Anaesthesiology]]></journal>
		<title><![CDATA[Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Post-Operative Shock]]></outcome>
		<modelsamplesize><![CDATA[4852]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4852]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CPB Time, Cardiac Insufficiency, Degree of Urgency, Inotropes, MI, Hypertension, Transfusion, Vasoconstrictor Treatment]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Female; Heart Diseases/*etiology; Humans; Intraoperative Period; Logistic Models; Male; Middle Aged; Postoperative Complications/*etiology; Preoperative Period; Prospective Studies; ROC Curve; Risk Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-12]]></modelid>
		<pubmedid><![CDATA[22244127]]></pubmedid>
		<author><![CDATA[Antoni]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Acute Coronary Syndrome (ACS)]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1484]]></cohortsamplesize>
		<numberofevents><![CDATA[87]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Heart Rate, Killip Class, Culprit Artery, LVEF, Troponin T, Three Vessel Disease]]></covariates>
		<mh><![CDATA[Aged; Angioplasty, Balloon, Coronary/*methods; Coronary Angiography; Echocardiography; *Electrocardiography; Female; Follow-Up Studies; Heart Failure/diagnosis/*epidemiology/etiology; Humans; Male; Middle Aged; Myocardial Infarction/*complications/diagnosis/therapy; Netherlands/epidemiology; Prognosis; Retrospective Studies; Risk Assessment/*methods; Risk Factors; Survival Rate/trends]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-13]]></modelid>
		<pubmedid><![CDATA[22374565]]></pubmedid>
		<author><![CDATA[Kang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Asia Pacific Journal of Clinical Nutrition]]></journal>
		<title><![CDATA[Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[3598]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3598]]></cohortsamplesize>
		<numberofevents><![CDATA[87]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Glucose, HDL Cholesterol, Sex, Waist Circumference, SBP, DBP, Triglycerides]]></covariates>
		<mh><![CDATA[Area Under Curve; Cardiovascular Diseases/*epidemiology; China/epidemiology; Cohort Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Metabolic Syndrome X/*epidemiology; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; ROC Curve; Risk Assessment]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-14]]></modelid>
		<pubmedid><![CDATA[22442175]]></pubmedid>
		<author><![CDATA[van Lammeren]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Clinical prediction rule to estimate the absolute 3-year risk of major cardiovascular events after carotid endarterectomy]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1138]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1138]]></cohortsamplesize>
		<numberofevents><![CDATA[148]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Clinical Presentation, Stenosis, Atherosclerotic Disease, Creatinine, Smoking, SBP, Antihypertensive Medication]]></covariates>
		<mh><![CDATA[Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases/*mortality; Carotid Stenosis/*surgery; Cohort Studies; *Endarterectomy, Carotid; Female; Follow-Up Studies; Humans; Hypertension/complications; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction/*epidemiology; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Smoking/adverse effects; Stroke/*epidemiology; Time Factors]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-15]]></modelid>
		<pubmedid><![CDATA[22456478]]></pubmedid>
		<author><![CDATA[Bouleti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[609]]></modelsamplesize>
		<cohortsamplesize><![CDATA[609]]></cohortsamplesize>
		<numberofevents><![CDATA[309]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Mitral Valve Area, AF, NYHA Class, Mean Mitral Gradient, Valve Calcification, Sinus Rhythm, Sex]]></covariates>
		<mh><![CDATA[Adult; Aged; Calcinosis/epidemiology/etiology; Calibration; *Catheterization; Female; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism/epidemiology/etiology; Male; Middle Aged; Mitral Valve/*physiopathology/surgery; Mitral Valve Insufficiency/epidemiology/surgery/*therapy/ultrasonography; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic/statistics & numerical data; Recurrence; Risk Assessment; Risk Factors; *Severity of Illness Index; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-73]]></modelid>
		<pubmedid><![CDATA[21846713]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2314701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2314701]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Prior Admission, Age, Antipsychotics, Cancer, CKD, COPD, Colitis, Ethnicity, HF, Sex, Smoking, Varicose Vein Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-74]]></modelid>
		<pubmedid><![CDATA[21846713]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2314701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2314701]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Prior Admission, Age, Antipsychotics, Cancer, CKD, COPD, Colitis, Ethnicity, HF, Sex, Smoking, Varicose Vein Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-75]]></modelid>
		<pubmedid><![CDATA[21846713]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2314701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2314701]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Prior Admission, Age, Antipsychotics, Cancer, CKD, COPD, Colitis, Ethnicity, HF, Sex, Smoking, Varicose Vein Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-76]]></modelid>
		<pubmedid><![CDATA[21846713]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2314701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2314701]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Prior Admission, Age, Antipsychotics, Cancer, CKD, COPD, Colitis, Ethnicity, HF, Sex, Smoking, Varicose Vein Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-77]]></modelid>
		<pubmedid><![CDATA[21846713]]></pubmedid>
		<author><![CDATA[Hippisley-Cox]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[BMJ]]></journal>
		<title><![CDATA[Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[2314701]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2314701]]></cohortsamplesize>
		<numberofevents><![CDATA[14756]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Prior Admission, Age, Antipsychotics, Cancer, CKD, COPD, Colitis, Ethnicity, HF, Sex, Smoking, Varicose Vein Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[11-001-78]]></modelid>
		<pubmedid><![CDATA[22149222]]></pubmedid>
		<author><![CDATA[Iida]]></author>
		<year><![CDATA[2011]]></year>
		<journal><![CDATA[Journal of Endovascular Therapy]]></journal>
		<title><![CDATA[Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stent Patency]]></outcome>
		<modelsamplesize><![CDATA[1017]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1017]]></cohortsamplesize>
		<numberofevents><![CDATA[787]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ABI, Sex, Cilostazol, Stent Fracture, TASC II C/D Lesion]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-16]]></modelid>
		<pubmedid><![CDATA[21315565]]></pubmedid>
		<author><![CDATA[Onat]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Nutrition, Metabolism & Cardiovascular Diseases]]></journal>
		<title><![CDATA[Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[1043]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1043]]></cohortsamplesize>
		<numberofevents><![CDATA[158]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.789]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CRP, Smoking, HDL Cholesterol, LDL Cholesterol, Diabetes, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-17]]></modelid>
		<pubmedid><![CDATA[21315565]]></pubmedid>
		<author><![CDATA[Onat]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Nutrition, Metabolism & Cardiovascular Diseases]]></journal>
		<title><![CDATA[Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[1189]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1189]]></cohortsamplesize>
		<numberofevents><![CDATA[144]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.806]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CRP, Smoking, HDL Cholesterol, LDL Cholesterol, Diabetes, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-18]]></modelid>
		<pubmedid><![CDATA[21526420]]></pubmedid>
		<author><![CDATA[Chen]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Heart and Vessels]]></journal>
		<title><![CDATA[Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[No Reflow]]></outcome>
		<modelsamplesize><![CDATA[320]]></modelsamplesize>
		<cohortsamplesize><![CDATA[320]]></cohortsamplesize>
		<numberofevents><![CDATA[81]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Collateral Circulation, IABP, Thrombus Score, SBP, Lesion Length]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-19]]></modelid>
		<pubmedid><![CDATA[21893137]]></pubmedid>
		<author><![CDATA[Kramer]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Heart Rhythm]]></journal>
		<title><![CDATA[Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[905]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2717]]></cohortsamplesize>
		<numberofevents><![CDATA[125]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.795]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, LVEF, PVD]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-20]]></modelid>
		<pubmedid><![CDATA[21979848]]></pubmedid>
		<author><![CDATA[Pannucci]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Burn Care and Research]]></journal>
		<title><![CDATA[Creation and validation of a simple venous thromboembolism risk scoring tool for thermally injured patients: analysis of the National Burn Repository]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[16851]]></modelsamplesize>
		<cohortsamplesize><![CDATA[22618]]></cohortsamplesize>
		<numberofevents><![CDATA[163]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[0.774]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Inhalation Injury, Total BSA Burned]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-21]]></modelid>
		<pubmedid><![CDATA[22104035]]></pubmedid>
		<author><![CDATA[Nakajima]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation Journal]]></journal>
		<title><![CDATA[Cardiac Event Risk in Japanese Subjects Estimated Using Gated Myocardial Perfusion Imaging, in Conjunction With Diabetes Mellitus and Chronic Kidney Disease]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2395]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2395]]></cohortsamplesize>
		<numberofevents><![CDATA[116]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, eGFR, LVEF, Stress Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-22]]></modelid>
		<pubmedid><![CDATA[22168963]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Heart and Lung Transplantation]]></journal>
		<title><![CDATA[Decision tree for adjuvant right ventricular support in patients receiving a left ventricular aassist device]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Right Ventricular Failure]]></outcome>
		<modelsamplesize><![CDATA[183]]></modelsamplesize>
		<cohortsamplesize><![CDATA[183]]></cohortsamplesize>
		<numberofevents><![CDATA[27]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ALT, Heart Rate, INR, Inotropes, RAP, TPG, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-23]]></modelid>
		<pubmedid><![CDATA[22168963]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Heart and Lung Transplantation]]></journal>
		<title><![CDATA[Decision tree for adjuvant right ventricular support in patients receiving a left ventricular aassist device]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Right Ventricular Failure]]></outcome>
		<modelsamplesize><![CDATA[183]]></modelsamplesize>
		<cohortsamplesize><![CDATA[183]]></cohortsamplesize>
		<numberofevents><![CDATA[27]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ALT, AST, Cardiac Index, Creatinine, INR, PTT, Right Ventricular Systolic Pressure, TPG]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-24]]></modelid>
		<pubmedid><![CDATA[22189201]]></pubmedid>
		<author><![CDATA[Jensen]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Atherosclerosis]]></journal>
		<title><![CDATA[Risk stratification of patients suspected of coronary artery disease: comparison of five different models]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[4871]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4871]]></cohortsamplesize>
		<numberofevents><![CDATA[2037]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.727]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CCS Angina Class, MI, Hypercholesterolemia, Hypertension, Sex, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-25]]></modelid>
		<pubmedid><![CDATA[22221678]]></pubmedid>
		<author><![CDATA[Agarwal]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Heart and Lung Transplantation]]></journal>
		<title><![CDATA[Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[339]]></modelsamplesize>
		<cohortsamplesize><![CDATA[339]]></cohortsamplesize>
		<numberofevents><![CDATA[88]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[DBP, Diffusion Capacity, Hypotension, Lung Disease, Pulmonary Artery Saturation, RVH, Creatinine, WHO Functional Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-26]]></modelid>
		<pubmedid><![CDATA[22228238]]></pubmedid>
		<author><![CDATA[Widyastuti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Anaesthesiology]]></journal>
		<title><![CDATA[Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Post-Operative Shock]]></outcome>
		<modelsamplesize><![CDATA[4979]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4989]]></cohortsamplesize>
		<numberofevents><![CDATA[284]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.838]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiac Insufficiency, Degree of Urgency, Operation Type, Hemoglobin, Renal Dysfunction, Previous Cardiac Operation, MI, Hypertension]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Female; Heart Diseases/*etiology; Humans; Intraoperative Period; Logistic Models; Male; Middle Aged; Postoperative Complications/*etiology; Preoperative Period; Prospective Studies; ROC Curve; Risk Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-27]]></modelid>
		<pubmedid><![CDATA[22228238]]></pubmedid>
		<author><![CDATA[Widyastuti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Anaesthesiology]]></journal>
		<title><![CDATA[Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Post-Operative Shock]]></outcome>
		<modelsamplesize><![CDATA[4977]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4989]]></cohortsamplesize>
		<numberofevents><![CDATA[284]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.875]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiac Insufficiency, Degree of Urgency, Inotropes, Operation Type, Transfusion, MI, Renal Dysfunction, Hypertension, Vasoconstrictor Treatment]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Female; Heart Diseases/*etiology; Humans; Intraoperative Period; Logistic Models; Male; Middle Aged; Postoperative Complications/*etiology; Preoperative Period; Prospective Studies; ROC Curve; Risk Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-28]]></modelid>
		<pubmedid><![CDATA[22228238]]></pubmedid>
		<author><![CDATA[Widyastuti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Anaesthesiology]]></journal>
		<title><![CDATA[Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Post-Operative Shock]]></outcome>
		<modelsamplesize><![CDATA[4852]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4989]]></cohortsamplesize>
		<numberofevents><![CDATA[284]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CPB Time, Cardiac Insufficiency, Degree of Urgency, Inotropes, MI, Hypertension, Transfusion, Vasoconstrictor Treatment]]></covariates>
		<mh><![CDATA[Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures/*adverse effects; Female; Heart Diseases/*etiology; Humans; Intraoperative Period; Logistic Models; Male; Middle Aged; Postoperative Complications/*etiology; Preoperative Period; Prospective Studies; ROC Curve; Risk Factors; Ventricular Function, Left]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-29]]></modelid>
		<pubmedid><![CDATA[22281226]]></pubmedid>
		<author><![CDATA[Okada]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Prediction protocol for neurological outcome for survivors of out-of-hospital cardiac arrest treated with targeted temperature management]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[66]]></modelsamplesize>
		<cohortsamplesize><![CDATA[66]]></cohortsamplesize>
		<numberofevents><![CDATA[40]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.95]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Re-Arrest, Time to CPR, Time to ROSC, Pupillary Light Reflex, VF/VT]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-30]]></modelid>
		<pubmedid><![CDATA[22286320]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[115]]></modelsamplesize>
		<cohortsamplesize><![CDATA[115]]></cohortsamplesize>
		<numberofevents><![CDATA[36]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.709]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-31]]></modelid>
		<pubmedid><![CDATA[22286320]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[115]]></modelsamplesize>
		<cohortsamplesize><![CDATA[115]]></cohortsamplesize>
		<numberofevents><![CDATA[20]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-32]]></modelid>
		<pubmedid><![CDATA[22286320]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[115]]></modelsamplesize>
		<cohortsamplesize><![CDATA[115]]></cohortsamplesize>
		<numberofevents><![CDATA[15]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-33]]></modelid>
		<pubmedid><![CDATA[22286320]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[115]]></modelsamplesize>
		<cohortsamplesize><![CDATA[115]]></cohortsamplesize>
		<numberofevents><![CDATA[6]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-34]]></modelid>
		<pubmedid><![CDATA[22286320]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[115]]></modelsamplesize>
		<cohortsamplesize><![CDATA[115]]></cohortsamplesize>
		<numberofevents><![CDATA[15]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-38]]></modelid>
		<pubmedid><![CDATA[22340818]]></pubmedid>
		<author><![CDATA[Kalogeropoulos]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[JACC: Cardiovascular Imaging]]></journal>
		<title><![CDATA[Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[3752]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3752]]></cohortsamplesize>
		<numberofevents><![CDATA[286]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.789]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[LVEF, Age, Albumin, Creatinine, Smoking, CHD, E/A Ratio, Glucose, Heart Rate, Large Left Atrium, LVH, NT-proBNP, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-39]]></modelid>
		<pubmedid><![CDATA[22361079]]></pubmedid>
		<author><![CDATA[Ky]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Multiple biomarkers for risk prediction in chronic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1513]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1513]]></cohortsamplesize>
		<numberofevents><![CDATA[317]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.798]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Troponin I, BNP, Creatinine, CRp, sFIt-1, ST2, Uric Acid]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-40]]></modelid>
		<pubmedid><![CDATA[22363051]]></pubmedid>
		<author><![CDATA[Degos]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[An Admission Bioclinical Score to Predict 1-Year Outcomes in Patients Undergoing Aneurysm Coiling]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[368]]></modelsamplesize>
		<cohortsamplesize><![CDATA[368]]></cohortsamplesize>
		<numberofevents><![CDATA[64]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[GCS Score, S100B, Troponin I]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-41]]></modelid>
		<pubmedid><![CDATA[22427285]]></pubmedid>
		<author><![CDATA[Beckers]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Acta Neurologica Belgica]]></journal>
		<title><![CDATA[Prediction of hospitalization duration for acute stroke in Belgium]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[367]]></modelsamplesize>
		<cohortsamplesize><![CDATA[367]]></cohortsamplesize>
		<numberofevents><![CDATA[184]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-42]]></modelid>
		<pubmedid><![CDATA[22434288]]></pubmedid>
		<author><![CDATA[Chong]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Singapore Medical Journal]]></journal>
		<title><![CDATA[Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Contrast Induced Neuropathy (CIN)]]></outcome>
		<modelsamplesize><![CDATA[770]]></modelsamplesize>
		<cohortsamplesize><![CDATA[770]]></cohortsamplesize>
		<numberofevents><![CDATA[87]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Contrast Volume, eGFR, Post-PCI CK]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-43]]></modelid>
		<pubmedid><![CDATA[22440586]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Age and Ageing]]></journal>
		<title><![CDATA[Developing predictive models of excellent and devastating outcome after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.879]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Lift Arms, PRE-SFS, Stroke Severity]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-44]]></modelid>
		<pubmedid><![CDATA[22440586]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Age and Ageing]]></journal>
		<title><![CDATA[Developing predictive models of excellent and devastating outcome after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.866]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Lift Arms, Verbal GCS, PRE-SFS, Walk Independently]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-45]]></modelid>
		<pubmedid><![CDATA[22440586]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Age and Ageing]]></journal>
		<title><![CDATA[Developing predictive models of excellent and devastating outcome after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.882]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Leukoaraiosis, Lift Arms, PRE-SFS, Stroke Severity]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-46]]></modelid>
		<pubmedid><![CDATA[22440586]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Age and Ageing]]></journal>
		<title><![CDATA[Developing predictive models of excellent and devastating outcome after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.861]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Verbal GCS, PRE-SFS, Stroke Severity, TACS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-47]]></modelid>
		<pubmedid><![CDATA[22440586]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Age and Ageing]]></journal>
		<title><![CDATA[Developing predictive models of excellent and devastating outcome after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.874]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Lives Alone, Verbal GCS, PRE-SFS, Stroke Severity, TACS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-48]]></modelid>
		<pubmedid><![CDATA[22440586]]></pubmedid>
		<author><![CDATA[Reid]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Age and Ageing]]></journal>
		<title><![CDATA[Developing predictive models of excellent and devastating outcome after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[538]]></modelsamplesize>
		<cohortsamplesize><![CDATA[538]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.861]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Leukoaraiosis, Verbal GCS, Stroke Severity, TACS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-49]]></modelid>
		<pubmedid><![CDATA[22442178]]></pubmedid>
		<author><![CDATA[Mazya]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[31627]]></modelsamplesize>
		<cohortsamplesize><![CDATA[31627]]></cohortsamplesize>
		<numberofevents><![CDATA[569]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aspirin, Clopidogrel, Glucose, Hypertension, NIHSS, Time to Treatment, SBP, Weight]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-50]]></modelid>
		<pubmedid><![CDATA[22442438]]></pubmedid>
		<author><![CDATA[Greving]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Predicting outcome after acute basilar artery occlusion based on admission characteristics]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[619]]></modelsamplesize>
		<cohortsamplesize><![CDATA[619]]></cohortsamplesize>
		<numberofevents><![CDATA[429]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Hyperlipidemia, NIHSS, Stroke, Time to Treatment]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-51]]></modelid>
		<pubmedid><![CDATA[22456478]]></pubmedid>
		<author><![CDATA[Bouleti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[609]]></modelsamplesize>
		<cohortsamplesize><![CDATA[609]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Mitral Valve Area, AF, NYHA Class, Mean Mitral Gradient, Valve Calcification, Sinus Rhythm, Sex]]></covariates>
		<mh><![CDATA[Adult; Aged; Calcinosis/epidemiology/etiology; Calibration; *Catheterization; Female; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism/epidemiology/etiology; Male; Middle Aged; Mitral Valve/*physiopathology/surgery; Mitral Valve Insufficiency/epidemiology/surgery/*therapy/ultrasonography; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic/statistics & numerical data; Recurrence; Risk Assessment; Risk Factors; *Severity of Illness Index; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-52]]></modelid>
		<pubmedid><![CDATA[22456478]]></pubmedid>
		<author><![CDATA[Bouleti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[609]]></modelsamplesize>
		<cohortsamplesize><![CDATA[609]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Mitral Valve Area, AF, NYHA Class, Mean Mitral Gradient, Valve Calcification, Sinus Rhythm, Sex]]></covariates>
		<mh><![CDATA[Adult; Aged; Calcinosis/epidemiology/etiology; Calibration; *Catheterization; Female; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism/epidemiology/etiology; Male; Middle Aged; Mitral Valve/*physiopathology/surgery; Mitral Valve Insufficiency/epidemiology/surgery/*therapy/ultrasonography; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic/statistics & numerical data; Recurrence; Risk Assessment; Risk Factors; *Severity of Illness Index; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-53]]></modelid>
		<pubmedid><![CDATA[22456478]]></pubmedid>
		<author><![CDATA[Bouleti]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[609]]></modelsamplesize>
		<cohortsamplesize><![CDATA[609]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Mitral Valve Area, AF, NYHA Class, Mean Mitral Gradient, Valve Calcification, Sinus Rhythm, Sex]]></covariates>
		<mh><![CDATA[Adult; Aged; Calcinosis/epidemiology/etiology; Calibration; *Catheterization; Female; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism/epidemiology/etiology; Male; Middle Aged; Mitral Valve/*physiopathology/surgery; Mitral Valve Insufficiency/epidemiology/surgery/*therapy/ultrasonography; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic/statistics & numerical data; Recurrence; Risk Assessment; Risk Factors; *Severity of Illness Index; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-54]]></modelid>
		<pubmedid><![CDATA[22489957]]></pubmedid>
		<author><![CDATA[Tosetto]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Thrombosis and Haemostasis]]></journal>
		<title><![CDATA[Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[1818]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1818]]></cohortsamplesize>
		<numberofevents><![CDATA[239]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, D-dimer, Sex, VTE]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-55]]></modelid>
		<pubmedid><![CDATA[22503568]]></pubmedid>
		<author><![CDATA[Chien]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Constructing a point-based prediction model for the risk of coronary artery disease in a Chinese community: A report from a cohort study in Taiwan]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[3430]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3430]]></cohortsamplesize>
		<numberofevents><![CDATA[171]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Sex, Smoking, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-56]]></modelid>
		<pubmedid><![CDATA[22503568]]></pubmedid>
		<author><![CDATA[Chien]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Constructing a point-based prediction model for the risk of coronary artery disease in a Chinese community: A report from a cohort study in Taiwan]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[3430]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3430]]></cohortsamplesize>
		<numberofevents><![CDATA[171]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Total Cholesterol, HDL Cholesterol, SBP, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-57]]></modelid>
		<pubmedid><![CDATA[22535795]]></pubmedid>
		<author><![CDATA[O'Connor]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[2015]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2015]]></cohortsamplesize>
		<numberofevents><![CDATA[294]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Albumin, BUN, Cholesterol, Diabetes, Heart Rate, HF, Respiratory Rate, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-58]]></modelid>
		<pubmedid><![CDATA[22536134]]></pubmedid>
		<author><![CDATA[De Feo]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[The Scientific World Journal]]></journal>
		<title><![CDATA[The Need for a Specific Risk Prediction System in Native Valve Infective Endocarditis Surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[440]]></modelsamplesize>
		<cohortsamplesize><![CDATA[440]]></cohortsamplesize>
		<numberofevents><![CDATA[40]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.88]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NYHA Class, Perivalvular Involvement, Blood Culture Results, Renal Failure, Ventilatory Support]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-59]]></modelid>
		<pubmedid><![CDATA[22547673]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk score for predicting long-term mortality after coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8597]]></cohortsamplesize>
		<numberofevents><![CDATA[2156]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, CHF, COPD, Diabetes, LVEF, Hemodynamic State, CAD, Ventricular Arrhythmia, Renal Failure, PAD, Open Heart Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-60]]></modelid>
		<pubmedid><![CDATA[22547673]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk score for predicting long-term mortality after coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8597]]></cohortsamplesize>
		<numberofevents><![CDATA[2156]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, CHF, COPD, Diabetes, LVEF, Hemodynamic State, CAD, Ventricular Arrhythmia, Renal Failure, PAD, Open Heart Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-61]]></modelid>
		<pubmedid><![CDATA[22547673]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk score for predicting long-term mortality after coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8597]]></cohortsamplesize>
		<numberofevents><![CDATA[2156]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, CHF, COPD, Diabetes, LVEF, Hemodynamic State, CAD, Ventricular Arrhythmia, Renal Failure, PAD, Open Heart Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-62]]></modelid>
		<pubmedid><![CDATA[22547673]]></pubmedid>
		<author><![CDATA[Wu]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Risk score for predicting long-term mortality after coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8597]]></cohortsamplesize>
		<numberofevents><![CDATA[2156]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cerebrovascular Disease, CHF, COPD, Diabetes, LVEF, Hemodynamic State, CAD, Ventricular Arrhythmia, Renal Failure, PAD, Open Heart Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-63]]></modelid>
		<pubmedid><![CDATA[22571183]]></pubmedid>
		<author><![CDATA[Kostalova]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Brain Injury]]></journal>
		<title><![CDATA[Towards a predictive model for post-stroke delirium]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Delirium]]></outcome>
		<modelsamplesize><![CDATA[100]]></modelsamplesize>
		<cohortsamplesize><![CDATA[100]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Bilirubin, GGT, ICH, Lesion Volume]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-64]]></modelid>
		<pubmedid><![CDATA[22571183]]></pubmedid>
		<author><![CDATA[Kostalova]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Brain Injury]]></journal>
		<title><![CDATA[Towards a predictive model for post-stroke delirium]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Delirium]]></outcome>
		<modelsamplesize><![CDATA[100]]></modelsamplesize>
		<cohortsamplesize><![CDATA[100]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ICH, Lesion Volume, SOFA-Max]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-65]]></modelid>
		<pubmedid><![CDATA[22573641]]></pubmedid>
		<author><![CDATA[Payabvash]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Location-weighted CTP analysis predicts early motor improvement in stroke: a preliminary study]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[49]]></modelsamplesize>
		<cohortsamplesize><![CDATA[80]]></cohortsamplesize>
		<numberofevents><![CDATA[18]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NIHSS, rMTT of Retrolenticular Internal Capsule, rMTT of Superior Parietal Lobule]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-66]]></modelid>
		<pubmedid><![CDATA[22573641]]></pubmedid>
		<author><![CDATA[Payabvash]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Location-weighted CTP analysis predicts early motor improvement in stroke: a preliminary study]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[25]]></modelsamplesize>
		<cohortsamplesize><![CDATA[80]]></cohortsamplesize>
		<numberofevents><![CDATA[8]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.9]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NIHSS, rCBF of Anterior Lower Insular Cortex, rCBF of Putamen]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-67]]></modelid>
		<pubmedid><![CDATA[22573641]]></pubmedid>
		<author><![CDATA[Payabvash]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Location-weighted CTP analysis predicts early motor improvement in stroke: a preliminary study]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[42]]></modelsamplesize>
		<cohortsamplesize><![CDATA[80]]></cohortsamplesize>
		<numberofevents><![CDATA[15]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[rMTT of Superior Temporal Gyrus]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-68]]></modelid>
		<pubmedid><![CDATA[22573641]]></pubmedid>
		<author><![CDATA[Payabvash]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Neurology]]></journal>
		<title><![CDATA[Location-weighted CTP analysis predicts early motor improvement in stroke: a preliminary study]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[23]]></modelsamplesize>
		<cohortsamplesize><![CDATA[80]]></cohortsamplesize>
		<numberofevents><![CDATA[7]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.92]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[rCB of Inferior Frontal Subgyral WM, rCBF of Parietal Lobe, rCBV of Caudate Nucleus]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-69]]></modelid>
		<pubmedid><![CDATA[22581736]]></pubmedid>
		<author><![CDATA[van Rees]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Heart]]></journal>
		<title><![CDATA[Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[900]]></modelsamplesize>
		<cohortsamplesize><![CDATA[900]]></cohortsamplesize>
		<numberofevents><![CDATA[150]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, LVEF, NYHA Class, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-70]]></modelid>
		<pubmedid><![CDATA[22584630]]></pubmedid>
		<author><![CDATA[Pannucci]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Annals of Surgery]]></journal>
		<title><![CDATA[Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery]]></title>
		<primaryindexcondition><![CDATA[Post-Operative]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[173501]]></modelsamplesize>
		<cohortsamplesize><![CDATA[259231]]></cohortsamplesize>
		<numberofevents><![CDATA[254]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cancer, Age, Type of Surgery, BMI, Pregnancy, OR Time]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-71]]></modelid>
		<pubmedid><![CDATA[22608950]]></pubmedid>
		<author><![CDATA[Park]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Risk-prediction model for ischemic stroke in patients hospitalized with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE])]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[63118]]></modelsamplesize>
		<cohortsamplesize><![CDATA[63118]]></cohortsamplesize>
		<numberofevents><![CDATA[217]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, Killip Class, Smoking, Weight, Age, Cardiac Biomarkers, ST-Segment Change, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-72]]></modelid>
		<pubmedid><![CDATA[22621801]]></pubmedid>
		<author><![CDATA[El-Chami]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Prediction of new onset atrial fibrillation after cardiac revascularization surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[18517]]></modelsamplesize>
		<cohortsamplesize><![CDATA[18517]]></cohortsamplesize>
		<numberofevents><![CDATA[3486]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.604]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Height, PVD, Weight]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-73]]></modelid>
		<pubmedid><![CDATA[22621801]]></pubmedid>
		<author><![CDATA[El-Chami]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Prediction of new onset atrial fibrillation after cardiac revascularization surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[18517]]></modelsamplesize>
		<cohortsamplesize><![CDATA[18517]]></cohortsamplesize>
		<numberofevents><![CDATA[3486]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.604]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Height, PVD, Weight]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-74]]></modelid>
		<pubmedid><![CDATA[22626816]]></pubmedid>
		<author><![CDATA[Fesmire]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Improving risk stratification in patients with chest pain: the Erlanger HEARTS3 score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[2148]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2148]]></cohortsamplesize>
		<numberofevents><![CDATA[202]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.959]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, EKG, CAD, Chest Pain, Risk Factors, Troponin, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-28]]></modelid>
		<pubmedid><![CDATA[23200237]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The New York risk score for in-hospital and 30-day mortality for coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10148]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10148]]></cohortsamplesize>
		<numberofevents><![CDATA[181]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, LVEF, Sex, Hemodynamic State, PVD, Previous MI, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-75]]></modelid>
		<pubmedid><![CDATA[22626816]]></pubmedid>
		<author><![CDATA[Fesmire]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Improving risk stratification in patients with chest pain: the Erlanger HEARTS3 score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Acute Coronary Syndrome (ACS)]]></outcome>
		<modelsamplesize><![CDATA[2148]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2148]]></cohortsamplesize>
		<numberofevents><![CDATA[315]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.902]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, EKG, CAD, Chest Pain, Risk Factors, Troponin, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-76]]></modelid>
		<pubmedid><![CDATA[22632800]]></pubmedid>
		<author><![CDATA[Gupta]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Development and validation of a risk calculator for prediction of mortality after infrainguinal bypass surgery]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[9556]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9556]]></cohortsamplesize>
		<numberofevents><![CDATA[170]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Corticosteroids, COPD, Dialysis, Functional Status, Age, Pain, SIRS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-77]]></modelid>
		<pubmedid><![CDATA[22665814]]></pubmedid>
		<author><![CDATA[Lee]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Annals of Internal Medicine]]></journal>
		<title><![CDATA[Prediction of heart failure mortality in emergent care: a cohort study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[7433]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12591]]></cohortsamplesize>
		<numberofevents><![CDATA[135]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.811]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cancer, Age, Creatinine, Troponin, Heart Rate, Metolazone, Oxygen Saturation, Potassium, SBP, EMS Transport]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-78]]></modelid>
		<pubmedid><![CDATA[22672301]]></pubmedid>
		<author><![CDATA[Li]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[CNS Neuroscience & Therapeutics]]></journal>
		<title><![CDATA[A New Simple Model for Prediction of Hospital Mortality in Patients with Intracerebral Hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[227]]></modelsamplesize>
		<cohortsamplesize><![CDATA[227]]></cohortsamplesize>
		<numberofevents><![CDATA[49]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.923]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, GCS Score, Glucose, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-79]]></modelid>
		<pubmedid><![CDATA[22676207]]></pubmedid>
		<author><![CDATA[Cioffi]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Echocardiography]]></journal>
		<title><![CDATA[Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1566]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1566]]></cohortsamplesize>
		<numberofevents><![CDATA[551]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aortic Valve Area Index, Left Atrial Systolic Force, Left Ventricular Mass]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-80]]></modelid>
		<pubmedid><![CDATA[22682012]]></pubmedid>
		<author><![CDATA[Iida]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Vascular and Endovascular Surgery]]></journal>
		<title><![CDATA[Anatomical Predictors of Major Adverse Limb Events after Infrapopliteal Angioplasty for Patients with Critical Limb Ischaemia due to Pure Isolated Infrapopliteal Lesions]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1057]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1057]]></cohortsamplesize>
		<numberofevents><![CDATA[496]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Lesion Calcification, Lesion Length, No-BA Run-Off, Target Lesion Diameter]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-81]]></modelid>
		<pubmedid><![CDATA[22683851]]></pubmedid>
		<author><![CDATA[Soveri]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Transplantation]]></journal>
		<title><![CDATA[A cardiovascular risk calculator for renal transplant recipients]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Renal Transplant]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1009]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2102]]></cohortsamplesize>
		<numberofevents><![CDATA[165]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.738]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHD, Creatinine, Diabetes, Smoking, Renal Replacement Therapy]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-82]]></modelid>
		<pubmedid><![CDATA[22727237]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[An International Model to Predict Recurrent Cardiovascular Disease]]></title>
		<primaryindexcondition><![CDATA[Cardiovascular Disease (CVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[33419]]></modelsamplesize>
		<cohortsamplesize><![CDATA[49689]]></cohortsamplesize>
		<numberofevents><![CDATA[2394]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ASA Therapy, AF, BMI, CHF, Cardiovascular Event, Diabetes, Nationality, Number of Vascular Beds, Sex, Smoking, Statin Use]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-83]]></modelid>
		<pubmedid><![CDATA[22727237]]></pubmedid>
		<author><![CDATA[Wilson]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Medicine]]></journal>
		<title><![CDATA[An International Model to Predict Recurrent Cardiovascular Disease]]></title>
		<primaryindexcondition><![CDATA[Cardiovascular Disease (CVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[33419]]></modelsamplesize>
		<cohortsamplesize><![CDATA[49689]]></cohortsamplesize>
		<numberofevents><![CDATA[1029]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ASA Therapy, AF, BMI, CHF, Cardiovascular Event, Diabetes, Nationality, Number of Vascular Beds, Sex, Smoking, Statin Use]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-84]]></modelid>
		<pubmedid><![CDATA[22745355]]></pubmedid>
		<author><![CDATA[Goliasch]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[547]]></modelsamplesize>
		<cohortsamplesize><![CDATA[547]]></cohortsamplesize>
		<numberofevents><![CDATA[211]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cholinesterase, Creatinine, HbA1c, Heart Rate, LVEF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-85]]></modelid>
		<pubmedid><![CDATA[22745355]]></pubmedid>
		<author><![CDATA[Goliasch]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[547]]></modelsamplesize>
		<cohortsamplesize><![CDATA[547]]></cohortsamplesize>
		<numberofevents><![CDATA[211]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, HbA1c, Heart Rate, LVEF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-86]]></modelid>
		<pubmedid><![CDATA[22762288]]></pubmedid>
		<author><![CDATA[Scrutinio]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Congestive Heart Failure]]></journal>
		<title><![CDATA[Amino-Terminal Pro-B-Type Natriuretic Peptide for Risk Prediction in Acute Decompensated Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[453]]></modelsamplesize>
		<cohortsamplesize><![CDATA[453]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.831]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BUN, COPD, Hemoglobin, LVEF, Sodium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-87]]></modelid>
		<pubmedid><![CDATA[22762288]]></pubmedid>
		<author><![CDATA[Scrutinio]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Congestive Heart Failure]]></journal>
		<title><![CDATA[Amino-Terminal Pro-B-Type Natriuretic Peptide for Risk Prediction in Acute Decompensated Heart Failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[453]]></modelsamplesize>
		<cohortsamplesize><![CDATA[453]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.844]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BUN, COPD, Hemoglobin, NT-proBNP, Sodium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-88]]></modelid>
		<pubmedid><![CDATA[22798325]]></pubmedid>
		<author><![CDATA[Hoffmann]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Pneumonia]]></outcome>
		<modelsamplesize><![CDATA[15335]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15335]]></cohortsamplesize>
		<numberofevents><![CDATA[1104]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Dysphagia, Sex, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-89]]></modelid>
		<pubmedid><![CDATA[22811458]]></pubmedid>
		<author><![CDATA[Menon]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10242]]></cohortsamplesize>
		<numberofevents><![CDATA[496]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Glucose, Ethnicity, Sex, NIHSS, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-90]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1256]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1256]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ICH, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-91]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1256]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1256]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ICH, Hemorrhage Volume, Infratentorial Location, IVH, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-92]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1256]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1256]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, GCS, ICH, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-93]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1256]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1256]]></cohortsamplesize>
		<numberofevents><![CDATA[197]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, GCS, ICH, Hemorrhage Volume, Infratentorial Location, IVH, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-94]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[171]]></modelsamplesize>
		<cohortsamplesize><![CDATA[171]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-95]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[171]]></modelsamplesize>
		<cohortsamplesize><![CDATA[171]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, ICH, Hemorrhage Volume, Infratentorial Location, IVH, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-96]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[171]]></modelsamplesize>
		<cohortsamplesize><![CDATA[171]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, GCS, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-97]]></modelid>
		<pubmedid><![CDATA[22814203]]></pubmedid>
		<author><![CDATA[Zahuranec]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Computed tomography findings for intracerebral hemorrhage have little incremental impact on post-stroke mortality prediction model performance]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[171]]></modelsamplesize>
		<cohortsamplesize><![CDATA[171]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.87]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, GCS, ICH, Hemorrhage Volume, Infratentorial Location, IVH, Sex, Ethnicity, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-98]]></modelid>
		<pubmedid><![CDATA[22819429]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[198460]]></modelsamplesize>
		<cohortsamplesize><![CDATA[198460]]></cohortsamplesize>
		<numberofevents><![CDATA[8335]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.815]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, Age, Deyo-Charlson Index, Albumin, Prior Hospitalizations, Medications, AF, BUN, BMI, CABG, Prior Physician Visits, COPD, Dementia, Creatinine, Diabetes, DBP, Functional Disease, Heart Rate, Stroke, Trauma, VHD, Liver Disease, Sex, Malnutrit]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-99]]></modelid>
		<pubmedid><![CDATA[22819429]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[198460]]></modelsamplesize>
		<cohortsamplesize><![CDATA[198460]]></cohortsamplesize>
		<numberofevents><![CDATA[1787]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.758]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, Age, Deyo-Charlson Index, Albumin, Prior Hospitalizations, Medications, AF, BUN, BMI, CABG, Prior Physician Visits, COPD, Dementia, Creatinine, Diabetes, DBP, Functional Disease, Heart Rate, Stroke, Trauma, VHD, Liver Disease, Sex, Malnutrit]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-100]]></modelid>
		<pubmedid><![CDATA[22819429]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[198460]]></modelsamplesize>
		<cohortsamplesize><![CDATA[198460]]></cohortsamplesize>
		<numberofevents><![CDATA[46836]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.821]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, Age, Deyo-Charlson Index, Albumin, Prior Hospitalizations, Medications, AF, BUN, BMI, CABG, Prior Physician Visits, COPD, Dementia, Creatinine, Diabetes, DBP, Functional Disease, Heart Rate, Stroke, Trauma, VHD, Liver Disease, Sex, Malnutrit]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-101]]></modelid>
		<pubmedid><![CDATA[22819429]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[198640]]></modelsamplesize>
		<cohortsamplesize><![CDATA[198640]]></cohortsamplesize>
		<numberofevents><![CDATA[14103]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, Age, Deyo-Charlson Index, Albumin, Prior Hospitalizations, Medications, AF, BUN, BMI, CABG, Prior Physician Visits, COPD, Dementia, Creatinine, Diabetes, DBP, Functional Disease, Heart Rate, Stroke, Trauma, VHD, Liver Disease, Sex, Malnutrit]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-102]]></modelid>
		<pubmedid><![CDATA[22840739]]></pubmedid>
		<author><![CDATA[Scali]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Preoperative prediction of mortality within 1 year after elective thoracic endovascular aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[224]]></modelsamplesize>
		<cohortsamplesize><![CDATA[224]]></cohortsamplesize>
		<numberofevents><![CDATA[33]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Intraoperative Procedures, Age, COPD, CAD, PAD]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-103]]></modelid>
		<pubmedid><![CDATA[22871801]]></pubmedid>
		<author><![CDATA[Van Hattum]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Thrombosis and Haemostasis]]></journal>
		<title><![CDATA[Long-term risk of vascular events after peripheral bypass surgery]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[482]]></modelsamplesize>
		<cohortsamplesize><![CDATA[482]]></cohortsamplesize>
		<numberofevents><![CDATA[287]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.68]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CLI or Claudication, Diabetes, Vascular Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-104]]></modelid>
		<pubmedid><![CDATA[22898595]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Heart, Lung, & Circulation]]></journal>
		<title><![CDATA[Risk model of prolonged intensive care unit stay in Chinese patients undergoing heart valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[2401]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3925]]></cohortsamplesize>
		<numberofevents><![CDATA[294]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.717]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, CABG, Other Cardiac Surgery, COPD, Preoperative State, LVEF, LBBB, Left Ventricle Weight, NYHA Class, Perivalvular Leakage, Tricuspid Valve Replacement]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-105]]></modelid>
		<pubmedid><![CDATA[22899767]]></pubmedid>
		<author><![CDATA[Forman]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Ventilatory power: a novel index that enhances prognostic assessment of patients with heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[875]]></modelsamplesize>
		<cohortsamplesize><![CDATA[875]]></cohortsamplesize>
		<numberofevents><![CDATA[82]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Circulatory Power, Ventilatory Power]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-106]]></modelid>
		<pubmedid><![CDATA[22981409]]></pubmedid>
		<author><![CDATA[Choke]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Journal of Vascular and Endovascular Surgery]]></journal>
		<title><![CDATA[Risk models for mortality following elective open and endovascular abdominal aortic aneurysm repair: a single institution experience]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[810]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1153]]></cohortsamplesize>
		<numberofevents><![CDATA[20]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, Open Repair, MI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-107]]></modelid>
		<pubmedid><![CDATA[22987084]]></pubmedid>
		<author><![CDATA[Romond]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of Clinical Oncology]]></journal>
		<title><![CDATA[Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Gr]]></title>
		<primaryindexcondition><![CDATA[Cancer]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[944]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1687]]></cohortsamplesize>
		<numberofevents><![CDATA[37]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, LVEF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-108]]></modelid>
		<pubmedid><![CDATA[22994439]]></pubmedid>
		<author><![CDATA[Zafrir]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Congestive Heart Failure]]></journal>
		<title><![CDATA[Risk Score Model for Predicting Mortality in Advanced Heart Failure Patients Followed in a Heart Failure Clinic]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[500]]></modelsamplesize>
		<cohortsamplesize><![CDATA[500]]></cohortsamplesize>
		<numberofevents><![CDATA[151]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Walk Distance, Age, Hyponatremia, Sex, Beta Blockers, QTc Interval, SBP, Uric Acid]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-109]]></modelid>
		<pubmedid><![CDATA[22999733]]></pubmedid>
		<author><![CDATA[Hawkins]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[11122]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11122]]></cohortsamplesize>
		<numberofevents><![CDATA[271]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Cardiac Surgery, Ipsilateral CEA, Stroke, Target Lesion Symptomatic]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-110]]></modelid>
		<pubmedid><![CDATA[22999733]]></pubmedid>
		<author><![CDATA[Hawkins]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[8550]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11122]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Cardiac Surgery, Ipsilateral CEA, Stroke, Target Lesion Symptomatic]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-111]]></modelid>
		<pubmedid><![CDATA[23008442]]></pubmedid>
		<author><![CDATA[Brooks]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[2231]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2365]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.634]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[LVEF, Myocardial Jeopardy Index, Revascularization, Number of Lesions]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-112]]></modelid>
		<pubmedid><![CDATA[23021331]]></pubmedid>
		<author><![CDATA[Bilchick]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17991]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17991]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AF, Age, CKD, COPD, Diabetes, LVEF, NYHA Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-113]]></modelid>
		<pubmedid><![CDATA[23021331]]></pubmedid>
		<author><![CDATA[Bilchick]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17991]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17991]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, Age, CKD, COPD, Diabetes, LVEF, NYHA Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-114]]></modelid>
		<pubmedid><![CDATA[23021331]]></pubmedid>
		<author><![CDATA[Bilchick]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17991]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17991]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, Age, CKD, COPD, Diabetes, LVEF, NYHA Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-115]]></modelid>
		<pubmedid><![CDATA[23021331]]></pubmedid>
		<author><![CDATA[Bilchick]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17991]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17991]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, Age, CKD, COPD, Diabetes, LVEF, NYHA Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-116]]></modelid>
		<pubmedid><![CDATA[23044297]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Chinese Medical Journal]]></journal>
		<title><![CDATA[Risk factors and risk index of cardiac events in pregnant women with heart disease]]></title>
		<primaryindexcondition><![CDATA[Pregnancy]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1741]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1741]]></cohortsamplesize>
		<numberofevents><![CDATA[165]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Cardiac Events, Cyanotic Heart Disease, NYHA Class, Oxygen Saturation, Pulmonary Artery Hypertension, Reduced Left Ventricular Systolic Function]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-117]]></modelid>
		<pubmedid><![CDATA[23048195]]></pubmedid>
		<author><![CDATA[Farooq]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6309]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6309]]></cohortsamplesize>
		<numberofevents><![CDATA[175]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.753]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine Clearance, LVEF, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-118]]></modelid>
		<pubmedid><![CDATA[23048195]]></pubmedid>
		<author><![CDATA[Farooq]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6309]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6309]]></cohortsamplesize>
		<numberofevents><![CDATA[175]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.791]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, Smoking, Diabetes, MI, PVD]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-119]]></modelid>
		<pubmedid><![CDATA[23094882]]></pubmedid>
		<author><![CDATA[Stavrakis]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Annals of Noninvasive Electrocardiology]]></journal>
		<title><![CDATA[Development and Validation of a Prognostic Index for Risk Stratification of Patients with Early Repolarization]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[595]]></modelsamplesize>
		<cohortsamplesize><![CDATA[852]]></cohortsamplesize>
		<numberofevents><![CDATA[122]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ACEI/ARB Use, Age, BMI, Early Repolarization Amplitude, QTc Interval, Race, Sulfonylurea Use]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-120]]></modelid>
		<pubmedid><![CDATA[23118919]]></pubmedid>
		<author><![CDATA[Kim]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[PLoS One]]></journal>
		<title><![CDATA[A cross-sectional study of individuals seeking information on transient ischemic attack and stroke symptoms online: a target for intervention?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[175]]></modelsamplesize>
		<cohortsamplesize><![CDATA[175]]></cohortsamplesize>
		<numberofevents><![CDATA[68]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.66]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Duration, Speech Disturbance, Unilateral Weakness]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-121]]></modelid>
		<pubmedid><![CDATA[23127975]]></pubmedid>
		<author><![CDATA[Wimmer]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Risk Prediction for Adverse Events After Carotid Artery Stenting in Higher Surgical Risk Patients]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[10186]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10186]]></cohortsamplesize>
		<numberofevents><![CDATA[366]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.691]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Arch Type, Dialysis, Stroke, TIA, Lesion Length, MI, Right-Sided Lesion, Cardiac Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-122]]></modelid>
		<pubmedid><![CDATA[23137507]]></pubmedid>
		<author><![CDATA[Rodríguez-Pascual]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[581]]></modelsamplesize>
		<cohortsamplesize><![CDATA[581]]></cohortsamplesize>
		<numberofevents><![CDATA[47]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.856]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CGA Score, NYHA Class, Pulmonary Edema, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-123]]></modelid>
		<pubmedid><![CDATA[23154781]]></pubmedid>
		<author><![CDATA[Kamouchi]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3067]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3067]]></cohortsamplesize>
		<numberofevents><![CDATA[175]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.636]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Cardiac Disease, CKD, Diabetes, Alcohol, Hypertension, Sex, Stroke, PAD, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-124]]></modelid>
		<pubmedid><![CDATA[23154781]]></pubmedid>
		<author><![CDATA[Kamouchi]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cerebrovascular Diseases]]></journal>
		<title><![CDATA[Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[2195]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2195]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.639]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Cardiac Disease, CKD, Diabetes, Alcohol, Hypertension, Sex, Stroke, PAD, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-125]]></modelid>
		<pubmedid><![CDATA[23174632]]></pubmedid>
		<author><![CDATA[Dangas]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[JACC: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stent Thrombosis]]></outcome>
		<modelsamplesize><![CDATA[4093]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6139]]></cohortsamplesize>
		<numberofevents><![CDATA[114]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Heparin, Aneurysm or Ulceration, Platelets, TIMI Flow, Smoking, PCI, Diabetes, Number of Vessels Treated, Type of ACS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-126]]></modelid>
		<pubmedid><![CDATA[23174634]]></pubmedid>
		<author><![CDATA[Palmerini]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[JACC: Cardiovascular Interventions]]></journal>
		<title><![CDATA[A New Score for Risk Stratification of Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) Risk Score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1692]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2538]]></cohortsamplesize>
		<numberofevents><![CDATA[123]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.67]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Cardiac Biomarkers or ST-Segment Deviation, Bifurcation Lesion, CAD, Diabetes, Renal Insufficiency]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-127]]></modelid>
		<pubmedid><![CDATA[23224919]]></pubmedid>
		<author><![CDATA[de la Camara]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Cardiology Journal]]></journal>
		<title><![CDATA[Role of biological and non biological factors in congestive heart failure mortality: PREDICE-SCORE: A clinical prediction rule]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[600]]></modelsamplesize>
		<cohortsamplesize><![CDATA[600]]></cohortsamplesize>
		<numberofevents><![CDATA[98]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.7631]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Functional Status, Physiopathology Diagnosis, Creatinine Clearance, Sodium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-128]]></modelid>
		<pubmedid><![CDATA[23233745]]></pubmedid>
		<author><![CDATA[Hoke]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[A validated risk score to predict outcomes after carotid stenting]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[602]]></modelsamplesize>
		<cohortsamplesize><![CDATA[602]]></cohortsamplesize>
		<numberofevents><![CDATA[211]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Contralateral Occlusion, Diabetes, Glycemic Control, HF, PAD, Quick, Lymphocytes]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-129]]></modelid>
		<pubmedid><![CDATA[23233745]]></pubmedid>
		<author><![CDATA[Hoke]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Circulation: Cardiovascular Interventions]]></journal>
		<title><![CDATA[A validated risk score to predict outcomes after carotid stenting]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[602]]></modelsamplesize>
		<cohortsamplesize><![CDATA[602]]></cohortsamplesize>
		<numberofevents><![CDATA[124]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Contralateral Occlusion, Diabetes, Glycemic Control, HF, PAD, Quick, Lymphocytes]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[12-001-130]]></modelid>
		<pubmedid><![CDATA[23280790]]></pubmedid>
		<author><![CDATA[del Río-Espínola]]></author>
		<year><![CDATA[2012]]></year>
		<journal><![CDATA[Annals of Neurology]]></journal>
		<title><![CDATA[A predictive clinical-genetic model of tissue plasminogen activator response]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhagic Transformation]]></outcome>
		<modelsamplesize><![CDATA[885]]></modelsamplesize>
		<cohortsamplesize><![CDATA[885]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AF, NIHSS, DBP, OTT, Genetic Alleles]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-01]]></modelid>
		<pubmedid><![CDATA[21636144]]></pubmedid>
		<author><![CDATA[Pfister]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[4951]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4951]]></cohortsamplesize>
		<numberofevents><![CDATA[233]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, Diuretic Use, HbA1c, Heart Rate, LDL Cholesterol, LBBB, Pioglitazone, Microalbuminuria, MI, RBBB]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-02]]></modelid>
		<pubmedid><![CDATA[21663982]]></pubmedid>
		<author><![CDATA[Mrdovic]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1676]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2096]]></cohortsamplesize>
		<numberofevents><![CDATA[191]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.83]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Acute Bundle Branch Block, Age, Anterior Infarction, Creatinine Clearance, Glucose, AV Block, Leukocytes, LVEF, TIMI Flow, MI, Reference Diameter]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-03]]></modelid>
		<pubmedid><![CDATA[21726908]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[NOS]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[284]]></modelsamplesize>
		<cohortsamplesize><![CDATA[284]]></cohortsamplesize>
		<numberofevents><![CDATA[69]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.892]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, NT-proBNP, MI, Sinus Rhythm, Sodium, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-04]]></modelid>
		<pubmedid><![CDATA[21726908]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[NOS]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[284]]></modelsamplesize>
		<cohortsamplesize><![CDATA[284]]></cohortsamplesize>
		<numberofevents><![CDATA[115]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.797]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, NT-proBNP, Potassium, MI, Sinus Rhythm, Urea]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-05]]></modelid>
		<pubmedid><![CDATA[21775001]]></pubmedid>
		<author><![CDATA[Wallmann]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Prediction of 30-day cardiac-related-emergency-readmissions using simple administrative hospital data]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hospital]]></secondaryindexcondition>
		<outcome><![CDATA[Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[24881]]></modelsamplesize>
		<cohortsamplesize><![CDATA[35531]]></cohortsamplesize>
		<numberofevents><![CDATA[1597]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ACS, Anemia, Area of Residence, CHF, Diabetes, Hypertension, Therapeutic Procedures, Emergency Admissions, Renal Disease]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-06]]></modelid>
		<pubmedid><![CDATA[21802750]]></pubmedid>
		<author><![CDATA[Van De Bruaene]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Predictive model for late atrial arrhythmia after closure of an atrial septal defect]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ASD Repair]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[155]]></modelsamplesize>
		<cohortsamplesize><![CDATA[155]]></cohortsamplesize>
		<numberofevents><![CDATA[39]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Arrhythmia, Sex, mPAP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-07]]></modelid>
		<pubmedid><![CDATA[22498473]]></pubmedid>
		<author><![CDATA[Støvring]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Preventive Cardiology]]></journal>
		<title><![CDATA[A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, SBP, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-08]]></modelid>
		<pubmedid><![CDATA[22498473]]></pubmedid>
		<author><![CDATA[Støvring]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Preventive Cardiology]]></journal>
		<title><![CDATA[A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, SBP, Smoking, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-09]]></modelid>
		<pubmedid><![CDATA[22694810]]></pubmedid>
		<author><![CDATA[Koster]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Cardiovascular Nursing]]></journal>
		<title><![CDATA[Prediction of delirium after cardiac surgery and the use of a risk checklist]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Delirium]]></outcome>
		<modelsamplesize><![CDATA[300]]></modelsamplesize>
		<cohortsamplesize><![CDATA[300]]></cohortsamplesize>
		<numberofevents><![CDATA[52]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Alcohol, Cognitive Impairment, Comorbidity, Delirium, EuroSCORE, Type of Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-10]]></modelid>
		<pubmedid><![CDATA[22759563]]></pubmedid>
		<author><![CDATA[Sumi]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Stroke]]></journal>
		<title><![CDATA[A modified Essen stroke risk score for predicting recurrent cardiovascular events: development and validation]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[3292]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3452]]></cohortsamplesize>
		<numberofevents><![CDATA[121]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.632]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Hypertension, Sex, CVD, MI, Smoking, Stroke Subtype, Waist Circumference]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-11]]></modelid>
		<pubmedid><![CDATA[22759563]]></pubmedid>
		<author><![CDATA[Sumi]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Stroke]]></journal>
		<title><![CDATA[A modified Essen stroke risk score for predicting recurrent cardiovascular events: development and validation]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[3588]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3588]]></cohortsamplesize>
		<numberofevents><![CDATA[133]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.64]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Diabetes, Hypertension, Sex, CVD, MI, Smoking, Stroke Subtype, Waist Circumference]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-12]]></modelid>
		<pubmedid><![CDATA[22795401]]></pubmedid>
		<author><![CDATA[Agostoni]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[2716]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2716]]></cohortsamplesize>
		<numberofevents><![CDATA[529]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.789]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Hemoglobin, LVEF, Modification of Diet in Renal Disease, Peak Oxygen Consumption, Sodium, VE/VCO2 Slope]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-13]]></modelid>
		<pubmedid><![CDATA[22814859]]></pubmedid>
		<author><![CDATA[den Exter]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Chest]]></journal>
		<title><![CDATA[A Clinical Prognostic Model for the Identification of Low-Risk Patients With Acute Symptomatic Pulmonary Embolism and Active Cancer]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Cancer]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1048]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1556]]></cohortsamplesize>
		<numberofevents><![CDATA[220]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Weight, Heart Rate, Immobilization, Metastases, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-14]]></modelid>
		<pubmedid><![CDATA[23095984]]></pubmedid>
		<author><![CDATA[Pocock]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[39372]]></modelsamplesize>
		<cohortsamplesize><![CDATA[39372]]></cohortsamplesize>
		<numberofevents><![CDATA[15851]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, Creatinine, Smoking, Diabetes, COPD, LVEF, Age, SBP, HF, Sex, ACEI/ARB Use, Beta Blockers, NYHA Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-15]]></modelid>
		<pubmedid><![CDATA[23095984]]></pubmedid>
		<author><![CDATA[Pocock]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Heart Journal]]></journal>
		<title><![CDATA[Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[39372]]></modelsamplesize>
		<cohortsamplesize><![CDATA[39372]]></cohortsamplesize>
		<numberofevents><![CDATA[15851]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[BMI, Creatinine, Smoking, Diabetes, COPD, LVEF, Age, SBP, HF, Sex, ACEI/ARB Use, Beta Blockers, NYHA Class]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-16]]></modelid>
		<pubmedid><![CDATA[23117494]]></pubmedid>
		<author><![CDATA[El Hachioui]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, & Psychiatry]]></journal>
		<title><![CDATA[Long-term prognosis of aphasia after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[130]]></modelsamplesize>
		<cohortsamplesize><![CDATA[147]]></cohortsamplesize>
		<numberofevents><![CDATA[104]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.91]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Barthel Index Score, Education, Phonology Score, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-17]]></modelid>
		<pubmedid><![CDATA[23117498]]></pubmedid>
		<author><![CDATA[Ayis]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, & Psychiatry]]></journal>
		<title><![CDATA[Predicting independent survival after stroke: a European study for the development and validation of standardised stroke scales and prediction models of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2033]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Able to Lift Arms, Able to Walk, Age, GCS, Prestroke Dependency]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-18]]></modelid>
		<pubmedid><![CDATA[23117498]]></pubmedid>
		<author><![CDATA[Ayis]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, & Psychiatry]]></journal>
		<title><![CDATA[Predicting independent survival after stroke: a European study for the development and validation of standardised stroke scales and prediction models of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2033]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Able to Lift Arms, Able to Walk, Age, GCS, Lives Alone, Prestroke Dependency]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-19]]></modelid>
		<pubmedid><![CDATA[23117498]]></pubmedid>
		<author><![CDATA[Ayis]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, & Psychiatry]]></journal>
		<title><![CDATA[Predicting independent survival after stroke: a European study for the development and validation of standardised stroke scales and prediction models of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2033]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BI in Acute Phase]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-20]]></modelid>
		<pubmedid><![CDATA[23117498]]></pubmedid>
		<author><![CDATA[Ayis]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, & Psychiatry]]></journal>
		<title><![CDATA[Predicting independent survival after stroke: a European study for the development and validation of standardised stroke scales and prediction models of outcome]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2033]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-21]]></modelid>
		<pubmedid><![CDATA[23152490]]></pubmedid>
		<author><![CDATA[Barlera]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial: proposal for a nomogram]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6975]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6975]]></cohortsamplesize>
		<numberofevents><![CDATA[1969]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Stenosis, BMI, COPD, Diabetes, eGFR, Hemoglobin, LVEF, NYHA Class, SBP, Sex, Uricemia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-22]]></modelid>
		<pubmedid><![CDATA[23152490]]></pubmedid>
		<author><![CDATA[Barlera]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial: proposal for a nomogram]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6975]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6975]]></cohortsamplesize>
		<numberofevents><![CDATA[1969]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Stenosis, BMI, COPD, Diabetes, eGFR, Hemoglobin, LVEF, NYHA Class, SBP, Sex, Uricemia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-23]]></modelid>
		<pubmedid><![CDATA[23159474]]></pubmedid>
		<author><![CDATA[Gupta]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Risk index for predicting perioperative stroke, myocardial infarction, or death risk in asymptomatic patients undergoing carotid endarterectomy]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[17692]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17692]]></cohortsamplesize>
		<numberofevents><![CDATA[324]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.64]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, Functional Status, Dyspnea, Revascularization, Angina]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-24]]></modelid>
		<pubmedid><![CDATA[23182157]]></pubmedid>
		<author><![CDATA[Robinson]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a U.S. regional cohort and comparison to existing scoring systems]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[242]]></modelsamplesize>
		<cohortsamplesize><![CDATA[242]]></cohortsamplesize>
		<numberofevents><![CDATA[91]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Arrest, Loss of Consciousness, Suprarenal Clamp]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-25]]></modelid>
		<pubmedid><![CDATA[23187295]]></pubmedid>
		<author><![CDATA[Papaioannou]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[American Journal of Medical Sciences]]></journal>
		<title><![CDATA[Predicting short-term mortality in patients with pulmonary embolism: a simple model]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[100]]></modelsamplesize>
		<cohortsamplesize><![CDATA[100]]></cohortsamplesize>
		<numberofevents><![CDATA[10]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.908]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[A-a Gradient, Charlson Comorbidity Index, CHF, Diabetes]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-26]]></modelid>
		<pubmedid><![CDATA[23196639]]></pubmedid>
		<author><![CDATA[Fu]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Angiology]]></journal>
		<title><![CDATA[Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Contrast Induced Neuropathy (CIN)]]></outcome>
		<modelsamplesize><![CDATA[668]]></modelsamplesize>
		<cohortsamplesize><![CDATA[668]]></cohortsamplesize>
		<numberofevents><![CDATA[105]]></numberofevents>
		<followupduration><![CDATA[N/A (Case-Control)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, CM Dose, Diabetes, eGFR, Emergency PCI, Hypotension, LVEF, MI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-27]]></modelid>
		<pubmedid><![CDATA[23200112]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Heart & Lung]]></journal>
		<title><![CDATA[A local risk prediction model for prolonged ventilation after adult heart valve surgery in a Chinese single center]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Ventilation]]></outcome>
		<modelsamplesize><![CDATA[2400]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3965]]></cohortsamplesize>
		<numberofevents><![CDATA[181]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.789]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CABG, Other Cardiac Surgery, Preoperative State, LVEF, Hypercholesterolemia, LBBB, Left Ventricle Weight, NYHA Class, Renal Failure, Tricuspid Insufficiency]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-29]]></modelid>
		<pubmedid><![CDATA[23212720]]></pubmedid>
		<author><![CDATA[Piccini]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K ant]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[14171]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14264]]></cohortsamplesize>
		<numberofevents><![CDATA[575]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.635]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine Clearance, Diabetes, DBP, Sex, Heart Rate, Vascular Disease, Hypertension, AF, HF, Stroke]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-30]]></modelid>
		<pubmedid><![CDATA[23218577]]></pubmedid>
		<author><![CDATA[Richter]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[349]]></modelsamplesize>
		<cohortsamplesize><![CDATA[349]]></cohortsamplesize>
		<numberofevents><![CDATA[195]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, COPD, Fractalkine, GDF-15, HGF, NT-proBNP, sFAS, sTRAIL]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-31]]></modelid>
		<pubmedid><![CDATA[23233328]]></pubmedid>
		<author><![CDATA[Becker]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Neurocritical Care]]></journal>
		<title><![CDATA[Predictors of outcome in patients with spinal cord ischemia after open aortic repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Post-Operative]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[75]]></modelsamplesize>
		<cohortsamplesize><![CDATA[75]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.81]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Paraplegia, Renal Failure, Surgical Repair]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-32]]></modelid>
		<pubmedid><![CDATA[23245855]]></pubmedid>
		<author><![CDATA[Takeda]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Neurology and Neurosurgery]]></journal>
		<title><![CDATA[A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Hematoma Expansion]]></outcome>
		<modelsamplesize><![CDATA[201]]></modelsamplesize>
		<cohortsamplesize><![CDATA[201]]></cohortsamplesize>
		<numberofevents><![CDATA[15]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Hematoma Heterogeneity, Hematoma Volume, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-33]]></modelid>
		<pubmedid><![CDATA[23262205]]></pubmedid>
		<author><![CDATA[Matsuo]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Gynecologic Oncology]]></journal>
		<title><![CDATA[Predictive model of venous thromboembolism in endometrial cancer]]></title>
		<primaryindexcondition><![CDATA[Cancer]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[516]]></modelsamplesize>
		<cohortsamplesize><![CDATA[516]]></cohortsamplesize>
		<numberofevents><![CDATA[42]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.853]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CA125, Extrauterine Disease, High Risk Histology, Thrombocytosis]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-34]]></modelid>
		<pubmedid><![CDATA[23265328]]></pubmedid>
		<author><![CDATA[Cowger]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[583]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1122]]></cohortsamplesize>
		<numberofevents><![CDATA[80]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, LVAD Volume, Creatinine, INR]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-35]]></modelid>
		<pubmedid><![CDATA[23265328]]></pubmedid>
		<author><![CDATA[Cowger]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[583]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1122]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, LVAD Volume, Creatinine, INR]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-36]]></modelid>
		<pubmedid><![CDATA[23265328]]></pubmedid>
		<author><![CDATA[Cowger]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[583]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1122]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, LVAD Volume, Creatinine, INR]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-37]]></modelid>
		<pubmedid><![CDATA[23273531]]></pubmedid>
		<author><![CDATA[Lo]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[A risk score for predicting coronary artery disease in women with angina pectoris and abnormal stress test findings]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[337]]></modelsamplesize>
		<cohortsamplesize><![CDATA[337]]></cohortsamplesize>
		<numberofevents><![CDATA[118]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.745]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Smoking, Abnormal Imaging Results, Exercise Capacity, HDL Cholesterol, BMI, Age, Family History]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-38]]></modelid>
		<pubmedid><![CDATA[23333880]]></pubmedid>
		<author><![CDATA[Greco]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Surgery]]></journal>
		<title><![CDATA[A model for predicting the risk of carotid artery disease]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[2885257]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2885257]]></cohortsamplesize>
		<numberofevents><![CDATA[71004]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[AAA, Age, CAD, Diabetes, Exercise, Family History, Diet, Hypertension, Cholesterol, PAD, Smoking, Race]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-39]]></modelid>
		<pubmedid><![CDATA[23333880]]></pubmedid>
		<author><![CDATA[Greco]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Surgery]]></journal>
		<title><![CDATA[A model for predicting the risk of carotid artery disease]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Coronary Artery Disease (CAD)]]></outcome>
		<modelsamplesize><![CDATA[2885257]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2885257]]></cohortsamplesize>
		<numberofevents><![CDATA[71004]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, Diabetes, Exercise, Family History, Diet, Hypertension, Cholesterol, Smoking, Race]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-40]]></modelid>
		<pubmedid><![CDATA[23336744]]></pubmedid>
		<author><![CDATA[Zakai]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Thrombosis and Haemostasis]]></journal>
		<title><![CDATA[Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[900]]></modelsamplesize>
		<cohortsamplesize><![CDATA[900]]></cohortsamplesize>
		<numberofevents><![CDATA[299]]></numberofevents>
		<followupduration><![CDATA[N/A (Case-Control)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Platelets, WBC, Fracture, Cancer, CHF, Inflammatory Disease, VTE, Respiratory Dysfunction, Tachycardia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-41]]></modelid>
		<pubmedid><![CDATA[23336744]]></pubmedid>
		<author><![CDATA[Zakai]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Thrombosis and Haemostasis]]></journal>
		<title><![CDATA[Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[900]]></modelsamplesize>
		<cohortsamplesize><![CDATA[900]]></cohortsamplesize>
		<numberofevents><![CDATA[299]]></numberofevents>
		<followupduration><![CDATA[N/A (Case-Control)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Fracture, Cancer, CHF, Inflammatory Disease, VTE, Respiratory Dysfunction, Tachycardia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-42]]></modelid>
		<pubmedid><![CDATA[23338659]]></pubmedid>
		<author><![CDATA[Grant]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[British Journal of Surgery]]></journal>
		<title><![CDATA[National risk prediction model for elective abdominal aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[11423]]></modelsamplesize>
		<cohortsamplesize><![CDATA[11423]]></cohortsamplesize>
		<numberofevents><![CDATA[312]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.781]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[AAA Diameter, Abnormal EKG, Sodium, WBC, Age, ASA Fitness Grade, Cardiac Disease, Creatinine, Sex, Open AAA Repair, Previous Aortic Surgery or Stent]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-43]]></modelid>
		<pubmedid><![CDATA[23355806]]></pubmedid>
		<author><![CDATA[Vlak]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, & Psychiatry]]></journal>
		<title><![CDATA[Lifetime risks for aneurysmal subarachnoid haemorrhage: multivariable risk stratification]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[824]]></modelsamplesize>
		<cohortsamplesize><![CDATA[824]]></cohortsamplesize>
		<numberofevents><![CDATA[250]]></numberofevents>
		<followupduration><![CDATA[N/A (Case-Control)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Family History, Hypercholesterolemia, Hypertension, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-44]]></modelid>
		<pubmedid><![CDATA[23357609]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Risk score for predicting in-hospital/30-day mortality for patients undergoing valve and valve/coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[13455]]></modelsamplesize>
		<cohortsamplesize><![CDATA[13455]]></cohortsamplesize>
		<numberofevents><![CDATA[542]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.781]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Valve Replacement, Cerebrovascular Disease, LVEF, Endocarditis, Sex, Hemodynamic State, Left Main Disease, Mitral Valve Repair, Mitral Valve Replacement, Multiple Valve Repair or Replacement, MI, Open Heart Operations, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-45]]></modelid>
		<pubmedid><![CDATA[23357609]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[Risk score for predicting in-hospital/30-day mortality for patients undergoing valve and valve/coronary artery bypass graft surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8373]]></modelsamplesize>
		<cohortsamplesize><![CDATA[8373]]></cohortsamplesize>
		<numberofevents><![CDATA[552]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.757]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Valve Replacement or CABG, LVEF, Endocarditis, Sex, BSA, Hemodynamic State, Left Main Disease, Mitral Valve Repair or CABG, Mitral Valve Replacement or CABG, Multiple Valve Repair or Replacement or CABG, PVD, MI, Open Heart Operations, PCI, Re]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-46]]></modelid>
		<pubmedid><![CDATA[23369703]]></pubmedid>
		<author><![CDATA[Ogata]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Atherosclerosis]]></journal>
		<title><![CDATA[New computer model for prediction of individual 10-year mortality on the basis of conventional atherosclerotic risk factors]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[365]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1851]]></cohortsamplesize>
		<numberofevents><![CDATA[316]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.827]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, HbA1c, Smoking, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-47]]></modelid>
		<pubmedid><![CDATA[23391666]]></pubmedid>
		<author><![CDATA[Einav]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Resuscitation]]></journal>
		<title><![CDATA[Brain biomarkers and management of uncertainty in predicting outcome of cardiopulmonary resuscitation: A nomogram paints a thousand words]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[158]]></modelsamplesize>
		<cohortsamplesize><![CDATA[158]]></cohortsamplesize>
		<numberofevents><![CDATA[32]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.868]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NSE, S100B, Arrhythmia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-48]]></modelid>
		<pubmedid><![CDATA[23395457]]></pubmedid>
		<author><![CDATA[Scrutinio]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Journal of Cardiology]]></journal>
		<title><![CDATA[Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure: derivation and validation of the ADHF/NT-proBNP risk score]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[453]]></modelsamplesize>
		<cohortsamplesize><![CDATA[824]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.839]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[COPD, eGFR, Hemoglobin, Sex, LVEF, NT-proBNP, SBP, Sodium, TR]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-49]]></modelid>
		<pubmedid><![CDATA[23403770]]></pubmedid>
		<author><![CDATA[Tsuda]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Interactive Cardiovascular and Thoracic Surgery]]></journal>
		<title><![CDATA[Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[168]]></modelsamplesize>
		<cohortsamplesize><![CDATA[172]]></cohortsamplesize>
		<numberofevents><![CDATA[10]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Creatinine, Total Bilirubin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-50]]></modelid>
		<pubmedid><![CDATA[23407372]]></pubmedid>
		<author><![CDATA[Prieto-Merino]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Human Hypertension]]></journal>
		<title><![CDATA[ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[15955]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15955]]></cohortsamplesize>
		<numberofevents><![CDATA[1240]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.664]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Smoking, Diabetes, Creatinine, Glucose, HDL Cholesterol, Antihypertensive Treatment, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-51]]></modelid>
		<pubmedid><![CDATA[23407372]]></pubmedid>
		<author><![CDATA[Prieto-Merino]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Human Hypertension]]></journal>
		<title><![CDATA[ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[15955]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15955]]></cohortsamplesize>
		<numberofevents><![CDATA[1240]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.648]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Smoking, Diabetes, Antihypertensive Treatment, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-52]]></modelid>
		<pubmedid><![CDATA[23433926]]></pubmedid>
		<author><![CDATA[Shirali]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[JACC: Cardiovascular Imaging]]></journal>
		<title><![CDATA[Predicting the Risk for Acute Type B Aortic Dissection in Hypertensive Patients Using Anatomic Variables]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hypertension]]></secondaryindexcondition>
		<outcome><![CDATA[Aortic Dissection]]></outcome>
		<modelsamplesize><![CDATA[109]]></modelsamplesize>
		<cohortsamplesize><![CDATA[109]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[0.974]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Aortic Arch Diameter, HVA Brachiocephalic, AR to Iliac BF Length]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-53]]></modelid>
		<pubmedid><![CDATA[23434110]]></pubmedid>
		<author><![CDATA[Pros]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Vascular and Endovascular Surgery]]></journal>
		<title><![CDATA[A Hospital Discharge Risk Score for 1-Year All-cause Mortality or Non-fatal Cardiovascular Events in Patients with Lower-extremity Peripheral Artery Disease, with and without Revascularisation]]></title>
		<primaryindexcondition><![CDATA[Peripheral Vascular Disease (PVD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[640]]></modelsamplesize>
		<cohortsamplesize><![CDATA[640]]></cohortsamplesize>
		<numberofevents><![CDATA[123]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[ABI, Age, Statins, CRP, eGFR, MI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-54]]></modelid>
		<pubmedid><![CDATA[23449266]]></pubmedid>
		<author><![CDATA[Yatsuya]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Development of a Point-based Prediction Model for the Incidence of Total Stroke]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[15672]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15672]]></cohortsamplesize>
		<numberofevents><![CDATA[790]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Sex, Diabetes, Antihypertensive Medication, Blood Pressure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-55]]></modelid>
		<pubmedid><![CDATA[23461541]]></pubmedid>
		<author><![CDATA[Harms]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Acta Neurologica Scandinavica]]></journal>
		<title><![CDATA[Predicting post-stroke pneumonia: the PANTHERIS score]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Pneumonia]]></outcome>
		<modelsamplesize><![CDATA[223]]></modelsamplesize>
		<cohortsamplesize><![CDATA[335]]></cohortsamplesize>
		<numberofevents><![CDATA[67]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.85]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, GCS, Respiratory Rate, WBC]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-56]]></modelid>
		<pubmedid><![CDATA[23478502]]></pubmedid>
		<author><![CDATA[Wallaert]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[4114]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4114]]></cohortsamplesize>
		<numberofevents><![CDATA[3373]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Stenosis, Occluded Contralaterl ICA, Age, CHF, COPD, Dialysis, eGFR, Diabetes, Statins, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-57]]></modelid>
		<pubmedid><![CDATA[23482598]]></pubmedid>
		<author><![CDATA[Ji]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Novel risk score to predict pneumonia after acute ischemic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Pneumonia]]></outcome>
		<modelsamplesize><![CDATA[8820]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14702]]></cohortsamplesize>
		<numberofevents><![CDATA[1005]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.797]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[GCS Score, Glucose, NIHSS, Age, AF, CHF, COPD, Smoking, OCSP Subtype, Pre-Stroke Dependence, Dysphagia]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-58]]></modelid>
		<pubmedid><![CDATA[23485798]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Cardiology]]></journal>
		<title><![CDATA[Development and Validation of a Clinical Risk Score Predicting the No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[No Reflow]]></outcome>
		<modelsamplesize><![CDATA[1615]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1615]]></cohortsamplesize>
		<numberofevents><![CDATA[342]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.757]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Beta Blockers, Age, Killip Class, Neutrophils, Glucose, Time to Hospital Admission]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-59]]></modelid>
		<pubmedid><![CDATA[23505300]]></pubmedid>
		<author><![CDATA[Schulze]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Circulation: Heart Failure]]></journal>
		<title><![CDATA[Preoperative assessment of high-risk candidates to predict survival after heart transplantation]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[822]]></modelsamplesize>
		<cohortsamplesize><![CDATA[822]]></cohortsamplesize>
		<numberofevents><![CDATA[107]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Albumin, Stroke, GFR, Cardiac Surgery, Retransplantation]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-60]]></modelid>
		<pubmedid><![CDATA[23512095]]></pubmedid>
		<author><![CDATA[Carluccio]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[747]]></modelsamplesize>
		<cohortsamplesize><![CDATA[747]]></cohortsamplesize>
		<numberofevents><![CDATA[224]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Deceleration Time, End-Systolic Volume Index, Left Atrial Volume Index, Pulmonary Artery Systolic Pressure, Tricuspid Annular Plane Systolic Excursion]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-61]]></modelid>
		<pubmedid><![CDATA[23522221]]></pubmedid>
		<author><![CDATA[Rankin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[27035]]></modelsamplesize>
		<cohortsamplesize><![CDATA[50231]]></cohortsamplesize>
		<numberofevents><![CDATA[2545]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Endocarditis, Age, Reoperation, Aortic Insufficiency, Stenosis, BSA, CHF, NYHA Class, Lung Disease, CABG, Creatinine, Diabetes, Dialysis, Sex, Immunosuppressive Treatment, IABP or Inotrope, Cardiac Surgery, MI, PVD, Status, Tricuspid Insufficiency]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-62]]></modelid>
		<pubmedid><![CDATA[23522221]]></pubmedid>
		<author><![CDATA[Rankin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Thoracic Surgery]]></journal>
		<title><![CDATA[The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[18686]]></modelsamplesize>
		<cohortsamplesize><![CDATA[50231]]></cohortsamplesize>
		<numberofevents><![CDATA[1424]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.722]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Reoperation, Aortic Insufficiency, BSA, Shock, CHF, NYHA Class, Lung Disease, CABG, Creatinine, CVD, Diabetes, Dialysis, LVEF, Immunosuppressive Treatment, Mitral Insufficiency, Stenosis, IABP or Inotrope, Cardiac Surgery, MI, PVD, Status]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-68]]></modelid>
		<pubmedid><![CDATA[23524053]]></pubmedid>
		<author><![CDATA[Naya]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[901]]></modelsamplesize>
		<cohortsamplesize><![CDATA[901]]></cohortsamplesize>
		<numberofevents><![CDATA[57]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.719]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Coronary Artery Calcium, Coronary Flow Reserve]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-69]]></modelid>
		<pubmedid><![CDATA[23525425]]></pubmedid>
		<author><![CDATA[Amin]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Dynamic TIMI Risk Score for STEMI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[19121]]></modelsamplesize>
		<cohortsamplesize><![CDATA[19121]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, STE or LBBB, Arrhythmia, CHF/Shock, Diabetes/Hypertension/Angina, Heart Rate, Killip Class, Major Bleed, Recurrent MI, Renal Failure, Stroke, SBP, Time to Treatment, Weight]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-70]]></modelid>
		<pubmedid><![CDATA[23525444]]></pubmedid>
		<author><![CDATA[Smith]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[200319]]></modelsamplesize>
		<cohortsamplesize><![CDATA[333865]]></cohortsamplesize>
		<numberofevents><![CDATA[28283]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Time of Arrival, AF, Stenosis, CAD, Diabetes, Dyslipidemia, Hypertension, Mode of Arrival, PVD, Stroke/TIA, Smoking, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-71]]></modelid>
		<pubmedid><![CDATA[23525444]]></pubmedid>
		<author><![CDATA[Smith]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[200319]]></modelsamplesize>
		<cohortsamplesize><![CDATA[333865]]></cohortsamplesize>
		<numberofevents><![CDATA[28283]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.86]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Time of Arrival, AF, CAD, Dyslipidemia, Sex, Mode of Arrival, NIHSS, PVD, Stroke/TIA, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-72]]></modelid>
		<pubmedid><![CDATA[23537808]]></pubmedid>
		<author><![CDATA[Alonso]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF Consortium]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[18556]]></modelsamplesize>
		<cohortsamplesize><![CDATA[18556]]></cohortsamplesize>
		<numberofevents><![CDATA[1186]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.765]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Antihypertensive Medication, Diabetes, DBP, HF, Height, MI, Race, Smoking, SBP, Weight]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-73]]></modelid>
		<pubmedid><![CDATA[23537808]]></pubmedid>
		<author><![CDATA[Alonso]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF Consortium]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Arrhythmia]]></outcome>
		<modelsamplesize><![CDATA[18556]]></modelsamplesize>
		<cohortsamplesize><![CDATA[18556]]></cohortsamplesize>
		<numberofevents><![CDATA[1186]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.767]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Antihypertensive Medication, Diabetes, DBP, HF, Height, MI, Race, Smoking, SBP, Weight]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-74]]></modelid>
		<pubmedid><![CDATA[23548173]]></pubmedid>
		<author><![CDATA[Alcocer]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Risk scoring system to predict 3-year survival in patients treated for asymptomatic carotid stenosis]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[506]]></modelsamplesize>
		<cohortsamplesize><![CDATA[506]]></cohortsamplesize>
		<numberofevents><![CDATA[70]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CKD, COPD, Coronary Intervention, Diabetes, Age]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-75]]></modelid>
		<pubmedid><![CDATA[23548173]]></pubmedid>
		<author><![CDATA[Alcocer]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Risk scoring system to predict 3-year survival in patients treated for asymptomatic carotid stenosis]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[352]]></modelsamplesize>
		<cohortsamplesize><![CDATA[352]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[CKD, COPD, Coronary Intervention, Diabetes, Age]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-76]]></modelid>
		<pubmedid><![CDATA[23549132]]></pubmedid>
		<author><![CDATA[Schellinger]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the Safety and Efficacy of NeuroFlo Sechnology in Ischemic Stroke trial]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[192]]></modelsamplesize>
		<cohortsamplesize><![CDATA[192]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NIHSS, Favorable Vascular Profile, AF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-77]]></modelid>
		<pubmedid><![CDATA[23566541]]></pubmedid>
		<author><![CDATA[Sutter]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[American Journal of Cardiology]]></journal>
		<title><![CDATA[Improving prediction of outcomes in African Americans with normal stress echocardiograms using a risk scoring system]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[548]]></modelsamplesize>
		<cohortsamplesize><![CDATA[548]]></cohortsamplesize>
		<numberofevents><![CDATA[47]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, CAD, Exercise, LVH, Smoking]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-78]]></modelid>
		<pubmedid><![CDATA[23570474]]></pubmedid>
		<author><![CDATA[Stiell]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Academic Emergency Medicine]]></journal>
		<title><![CDATA[A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[507]]></modelsamplesize>
		<cohortsamplesize><![CDATA[559]]></cohortsamplesize>
		<numberofevents><![CDATA[65]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.77]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[EKG, Heart Rate, Stroke or TIA, NT-proBNP, Intubation, Saturated Oxygen, Troponin, CO2, Urea]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-79]]></modelid>
		<pubmedid><![CDATA[23594831]]></pubmedid>
		<author><![CDATA[Schnabel]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Heart Failure]]></journal>
		<title><![CDATA[Risk assessment for incident heart failure in individuals with atrial fibrillation]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Congestive Heart Failure (CHF)]]></outcome>
		<modelsamplesize><![CDATA[725]]></modelsamplesize>
		<cohortsamplesize><![CDATA[725]]></cohortsamplesize>
		<numberofevents><![CDATA[161]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, MI, BMI, Diabetes, LVH, Murmur]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-80]]></modelid>
		<pubmedid><![CDATA[23598578]]></pubmedid>
		<author><![CDATA[Mejia]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Arquivos Brasileiros de Cardiologia]]></journal>
		<title><![CDATA[InsCor: a simple and accurate method for risk assessment in heart surgery]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2000]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3000]]></cohortsamplesize>
		<numberofevents><![CDATA[268]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Revascularization and Valve Surgery, Creatinine, LVEF, Sex, MI, Reoperation]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-81]]></modelid>
		<pubmedid><![CDATA[23603843]]></pubmedid>
		<author><![CDATA[Mrdovic]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Circulation Journal]]></journal>
		<title><![CDATA[Simple Risk Algorithm to Predict Serious Bleeding in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[2096]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2096]]></cohortsamplesize>
		<numberofevents><![CDATA[74]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Creatinine Clearance, Sex, Hemoglobin, Killip Class, Peptic Ulcer]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-82]]></modelid>
		<pubmedid><![CDATA[23607443]]></pubmedid>
		<author><![CDATA[Wang]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Nephrology]]></journal>
		<title><![CDATA[Derivation and validation of a prediction score for acute kidney injury in patients hospitalized with acute heart failure in a Chinese cohort]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[1010]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1709]]></cohortsamplesize>
		<numberofevents><![CDATA[341]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[HF, Age, Creatinine, NYHA Class, Furosemide Dose, Proteinuria, SBP, Sodium]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-83]]></modelid>
		<pubmedid><![CDATA[23610996]]></pubmedid>
		<author><![CDATA[Zheng]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Heart Valve Disease]]></journal>
		<title><![CDATA[Mortality risk model for heart valve surgery in China]]></title>
		<primaryindexcondition><![CDATA[Valve Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[13353]]></modelsamplesize>
		<cohortsamplesize><![CDATA[13353]]></cohortsamplesize>
		<numberofevents><![CDATA[260]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, NYHA Class, Valve Surgery, Creatinine]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-84]]></modelid>
		<pubmedid><![CDATA[23615051]]></pubmedid>
		<author><![CDATA[Shirakabe]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Circulation]]></journal>
		<title><![CDATA[Predictive Score for Survival After Percutaneous Cardiopulmonary Support in Cardiovascular Disease Patients: Evaluation of Pre-Procedural Information]]></title>
		<primaryindexcondition><![CDATA[Misc]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[105]]></modelsamplesize>
		<cohortsamplesize><![CDATA[105]]></cohortsamplesize>
		<numberofevents><![CDATA[21]]></numberofevents>
		<followupduration><![CDATA[N/A (Case-Control)]]></followupduration>
		<auroc><![CDATA[0.649]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Myocarditis, OHCA, PCPS, Time from Cardiac Arrest to PCPS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-85]]></modelid>
		<pubmedid><![CDATA[23628652]]></pubmedid>
		<author><![CDATA[Hornero]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Interactive Cardiovascular and Thoracic Surgery]]></journal>
		<title><![CDATA[A multicentre Spanish study for multivariate prediction of perioperative in-hospital cerebrovascular accident after coronary bypass surgery: the PACK2 score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[13096]]></modelsamplesize>
		<cohortsamplesize><![CDATA[26347]]></cohortsamplesize>
		<numberofevents><![CDATA[174]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[CKD or Creatinine, Arteriopathy, HF or LVEF, Surgery Priority]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-86]]></modelid>
		<pubmedid><![CDATA[23628652]]></pubmedid>
		<author><![CDATA[Hornero]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Interactive Cardiovascular and Thoracic Surgery]]></journal>
		<title><![CDATA[A multicentre Spanish study for multivariate prediction of perioperative in-hospital cerebrovascular accident after coronary bypass surgery: the PACK2 score]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[13096]]></modelsamplesize>
		<cohortsamplesize><![CDATA[26347]]></cohortsamplesize>
		<numberofevents><![CDATA[174]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Off-Pump Technique, PACK2 Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-87]]></modelid>
		<pubmedid><![CDATA[23667066]]></pubmedid>
		<author><![CDATA[Rahmanian]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Interactive CardioVascular and Thoracic Surgery]]></journal>
		<title><![CDATA[Impact of major non-cardiac complications on outcome following cardiac surgery procedures: logistic regression analysis in a very recent patient cohort]]></title>
		<primaryindexcondition><![CDATA[Cardiac Surgery]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[5318]]></modelsamplesize>
		<cohortsamplesize><![CDATA[5318]]></cohortsamplesize>
		<numberofevents><![CDATA[204]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.892]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Emergent Procedures, GI Complications, PVD, Cardiac Procedures, Hypertension, Dialysis, Respiratory Failure, Sepsis]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-88]]></modelid>
		<pubmedid><![CDATA[23676190]]></pubmedid>
		<author><![CDATA[Ramanan]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Development of a risk index for prediction of mortality after open aortic aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[2845]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2845]]></cohortsamplesize>
		<numberofevents><![CDATA[95]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Creatinine, Dyspnea, Platelets, Revascularization, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-89]]></modelid>
		<pubmedid><![CDATA[23683384]]></pubmedid>
		<author><![CDATA[Iannuzzi]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Vascular Surgery]]></journal>
		<title><![CDATA[Prediction of postdischarge venous thromboembolism using a risk assessment model]]></title>
		<primaryindexcondition><![CDATA[Post-Operative]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[562791]]></modelsamplesize>
		<cohortsamplesize><![CDATA[844159]]></cohortsamplesize>
		<numberofevents><![CDATA[2862]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Smoking, Days from Operation to Discharge, Major Complications, Dependent Functional Status, Operative Time, Steroid Use]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-90]]></modelid>
		<pubmedid><![CDATA[23709565]]></pubmedid>
		<author><![CDATA[Wimmer]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[14387]]></modelsamplesize>
		<cohortsamplesize><![CDATA[14387]]></cohortsamplesize>
		<numberofevents><![CDATA[177]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, GFR, Diabetes, Dialysis, Emergent Case, Sex, PAD, PCI, Troponin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-91]]></modelid>
		<pubmedid><![CDATA[23714787]]></pubmedid>
		<author><![CDATA[Enajat]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Plastic and Reconstructive Surgery]]></journal>
		<title><![CDATA[Pulmonary embolism after abdominal flap breast reconstruction: prediction and prevention]]></title>
		<primaryindexcondition><![CDATA[Post-Operative]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Breast Cancer]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[430]]></modelsamplesize>
		<cohortsamplesize><![CDATA[430]]></cohortsamplesize>
		<numberofevents><![CDATA[17]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.814]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[BMI, BRCA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-92]]></modelid>
		<pubmedid><![CDATA[23727215]]></pubmedid>
		<author><![CDATA[Hadamitzky]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry)]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[17793]]></modelsamplesize>
		<cohortsamplesize><![CDATA[17793]]></cohortsamplesize>
		<numberofevents><![CDATA[347]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Calcified Plaques, Proximal Segments, Stenosis]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-93]]></modelid>
		<pubmedid><![CDATA[23742144]]></pubmedid>
		<author><![CDATA[Fontanive]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Echocardiography]]></journal>
		<title><![CDATA[A multiparametric clinical and echocardiographic score to risk stratify patients with chronic systolic heart failure: derivation and testing]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[250]]></modelsamplesize>
		<cohortsamplesize><![CDATA[250]]></cohortsamplesize>
		<numberofevents><![CDATA[79]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.787]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, eGFR, Furosemide, ACE Inhibitors, Beta Blockers, LVEDVI, LVEF, Mitral Regurgitation, NT-proBNP, NYHA Class, TAPSE]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-94]]></modelid>
		<pubmedid><![CDATA[23763936]]></pubmedid>
		<author><![CDATA[Ong]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[American Journal of Emergency Medicine]]></journal>
		<title><![CDATA[Heart rate variability risk score for prediction of acute cardiac complications in ED patients with chest pain]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[309]]></modelsamplesize>
		<cohortsamplesize><![CDATA[309]]></cohortsamplesize>
		<numberofevents><![CDATA[25]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.835]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Heart Rate, LF/HF Ratio, Respiratory Rate, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-95]]></modelid>
		<pubmedid><![CDATA[23769488]]></pubmedid>
		<author><![CDATA[Mets]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology: Cardiovascular Imaging]]></journal>
		<title><![CDATA[Lung cancer screening CT-based prediction of cardiovascular events]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[1834]]></modelsamplesize>
		<cohortsamplesize><![CDATA[3648]]></cohortsamplesize>
		<numberofevents><![CDATA[145]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-96]]></modelid>
		<pubmedid><![CDATA[23782923]]></pubmedid>
		<author><![CDATA[Singer]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[7284]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7284]]></cohortsamplesize>
		<numberofevents><![CDATA[456]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHF< Diabetes, EGFR or ESRD, Sex, Hypertension, Proteinuria]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-97]]></modelid>
		<pubmedid><![CDATA[23782923]]></pubmedid>
		<author><![CDATA[Singer]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score]]></title>
		<primaryindexcondition><![CDATA[Arrhythmia]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[7284]]></modelsamplesize>
		<cohortsamplesize><![CDATA[7284]]></cohortsamplesize>
		<numberofevents><![CDATA[456]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.74]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CHF< Diabetes, EGFR or ESRD, Sex, Hypertension, Proteinuria]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-98]]></modelid>
		<pubmedid><![CDATA[23787234]]></pubmedid>
		<author><![CDATA[Hannan]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology: Cardiovascular Interventions]]></journal>
		<title><![CDATA[The New York State Risk Score for predicting in-hospital/30-day mortality following percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[54223]]></modelsamplesize>
		<cohortsamplesize><![CDATA[54223]]></cohortsamplesize>
		<numberofevents><![CDATA[558]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.89]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Number of Diseased Vessels, Age, CHF, COPD, LVEF, Sex, Hemodynamic State, Left Main Disease, Arrhythmia, PVD, MI, Renal Failure]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-99]]></modelid>
		<pubmedid><![CDATA[23797788]]></pubmedid>
		<author><![CDATA[Karthikesalingam]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[British Journal of Surgery]]></journal>
		<title><![CDATA[Predicting aortic complications after endovascular aneurysm repair]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[475]]></modelsamplesize>
		<cohortsamplesize><![CDATA[691]]></cohortsamplesize>
		<numberofevents><![CDATA[70]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Iliac Diameter, Sac Diameter]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-100]]></modelid>
		<pubmedid><![CDATA[23816022]]></pubmedid>
		<author><![CDATA[Huynh]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[American Heart Journal]]></journal>
		<title><![CDATA[Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[33162]]></modelsamplesize>
		<cohortsamplesize><![CDATA[33162]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Heart Rate, Killip Class, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-101]]></modelid>
		<pubmedid><![CDATA[23850903]]></pubmedid>
		<author><![CDATA[Kay]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[6037]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6037]]></cohortsamplesize>
		<numberofevents><![CDATA[169]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Abnormal Myocardium, Age, Sex]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-102]]></modelid>
		<pubmedid><![CDATA[23860709]]></pubmedid>
		<author><![CDATA[Faeh]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Epidemiology]]></journal>
		<title><![CDATA[Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[15454]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15454]]></cohortsamplesize>
		<numberofevents><![CDATA[1716]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, HbA1c, Sex, Smoking, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-103]]></modelid>
		<pubmedid><![CDATA[23860709]]></pubmedid>
		<author><![CDATA[Faeh]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Epidemiology]]></journal>
		<title><![CDATA[Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[15454]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15454]]></cohortsamplesize>
		<numberofevents><![CDATA[1716]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, Smoking, SBP, Total Cholesterol]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-104]]></modelid>
		<pubmedid><![CDATA[23860709]]></pubmedid>
		<author><![CDATA[Faeh]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Epidemiology]]></journal>
		<title><![CDATA[Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[15454]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15454]]></cohortsamplesize>
		<numberofevents><![CDATA[1716]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, HbA1c, Sex, Smoking, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-105]]></modelid>
		<pubmedid><![CDATA[23860709]]></pubmedid>
		<author><![CDATA[Faeh]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Epidemiology]]></journal>
		<title><![CDATA[Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts]]></title>
		<primaryindexcondition><![CDATA[Population Sample]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[15454]]></modelsamplesize>
		<cohortsamplesize><![CDATA[15454]]></cohortsamplesize>
		<numberofevents><![CDATA[1716]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, HbA1c, Sex, Smoking, SBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-106]]></modelid>
		<pubmedid><![CDATA[23868275]]></pubmedid>
		<author><![CDATA[de Man-van Ginkel]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[In-Hospital Risk Prediction for Post-stroke Depression: Development and Validation of the Post-stroke Depression Prediction Scale]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Depression]]></outcome>
		<modelsamplesize><![CDATA[410]]></modelsamplesize>
		<cohortsamplesize><![CDATA[410]]></cohortsamplesize>
		<numberofevents><![CDATA[54]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Barthel Index Item-Dressing, Angina, Depression, Hypertension]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-107]]></modelid>
		<pubmedid><![CDATA[23875619]]></pubmedid>
		<author><![CDATA[Ferreyro]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[BMC Cancer]]></journal>
		<title><![CDATA[Predictive score for estimating cancer after venous thromboembolism: a cohort study]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Cancer]]></outcome>
		<modelsamplesize><![CDATA[349]]></modelsamplesize>
		<cohortsamplesize><![CDATA[540]]></cohortsamplesize>
		<numberofevents><![CDATA[32]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Charlson Score, Surgery, VTE]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-108]]></modelid>
		<pubmedid><![CDATA[23875619]]></pubmedid>
		<author><![CDATA[Ferreyro]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[BMC Cancer]]></journal>
		<title><![CDATA[Predictive score for estimating cancer after venous thromboembolism: a cohort study]]></title>
		<primaryindexcondition><![CDATA[Venous Thromboembolism (VTE)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[349]]></modelsamplesize>
		<cohortsamplesize><![CDATA[540]]></cohortsamplesize>
		<numberofevents><![CDATA[83]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Albumin, Charlson Score, Surgery, VTE]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-109]]></modelid>
		<pubmedid><![CDATA[23879546]]></pubmedid>
		<author><![CDATA[Tolonen]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Biomarkers]]></journal>
		<title><![CDATA[The role of cardiorenal biomarkers for risk stratification in the early follow-up after hospitalisation for acute heart failure]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[124]]></modelsamplesize>
		<cohortsamplesize><![CDATA[124]]></cohortsamplesize>
		<numberofevents><![CDATA[33]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.7]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NT-proBNP, Cystatin, Troponin I]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-110]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[164]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.65]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-111]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[45]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-112]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[29]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-113]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[12]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-114]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[32]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-115]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Revascularization]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[83]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-116]]></modelid>
		<pubmedid><![CDATA[23881543]]></pubmedid>
		<author><![CDATA[Sinning]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Research in Cardiology]]></journal>
		<title><![CDATA[Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Cardiac Hospitalization]]></outcome>
		<modelsamplesize><![CDATA[328]]></modelsamplesize>
		<cohortsamplesize><![CDATA[328]]></cohortsamplesize>
		<numberofevents><![CDATA[128]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[EuroSCORE, SYNTAX Score]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-117]]></modelid>
		<pubmedid><![CDATA[23883557]]></pubmedid>
		<author><![CDATA[Kawaguchi]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Neurologia Medico-Chirurgica]]></journal>
		<title><![CDATA[Risk assessment for venous thromboembolism in patients with neuroepithelial tumors: pretreatment score to identify high risk patients]]></title>
		<primaryindexcondition><![CDATA[Cancer]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Venous Thromboembolism (VTE)]]></outcome>
		<modelsamplesize><![CDATA[395]]></modelsamplesize>
		<cohortsamplesize><![CDATA[395]]></cohortsamplesize>
		<numberofevents><![CDATA[43]]></numberofevents>
		<followupduration><![CDATA[Not Reported]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Corticosteroids, Paresis, D-dimer]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-118]]></modelid>
		<pubmedid><![CDATA[23906859]]></pubmedid>
		<author><![CDATA[Hubert]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prediction of Symptomatic Embolism in Infective Endocarditis]]></title>
		<primaryindexcondition><![CDATA[Endocarditis]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[565]]></modelsamplesize>
		<cohortsamplesize><![CDATA[847]]></cohortsamplesize>
		<numberofevents><![CDATA[72]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[0.72]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, AF, Diabetes, Length of Vegetation, Previous Embolism, Infection]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-119]]></modelid>
		<pubmedid><![CDATA[23916725]]></pubmedid>
		<author><![CDATA[Owolabi]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Clinical Neurology and Neurosurgery]]></journal>
		<title><![CDATA[Which risk factors are more associated with ischemic rather than hemorrhagic stroke in black Africans?]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[282]]></modelsamplesize>
		<cohortsamplesize><![CDATA[282]]></cohortsamplesize>
		<numberofevents><![CDATA[174]]></numberofevents>
		<followupduration><![CDATA[Diagnosis]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Disease, Sex, TIA, SBP, Diabetes]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-120]]></modelid>
		<pubmedid><![CDATA[23916938]]></pubmedid>
		<author><![CDATA[Takagi]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology]]></journal>
		<title><![CDATA[Prognostic Stratification of Patients with Vasospastic Angina]]></title>
		<primaryindexcondition><![CDATA[Chest Pain]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Vasospasm]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[1286]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1429]]></cohortsamplesize>
		<numberofevents><![CDATA[85]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Angina, Beta Blocker, OHCA, Multivessel Spasm, Stenosis, Smoking, ST-Segment Elevation]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-121]]></modelid>
		<pubmedid><![CDATA[23929748]]></pubmedid>
		<author><![CDATA[Sarraj]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[163]]></modelsamplesize>
		<cohortsamplesize><![CDATA[163]]></cohortsamplesize>
		<numberofevents><![CDATA[117]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.748]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, ASPECTS, Glucose, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-122]]></modelid>
		<pubmedid><![CDATA[23929748]]></pubmedid>
		<author><![CDATA[Sarraj]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Stroke]]></journal>
		<title><![CDATA[Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Functional Outcome]]></outcome>
		<modelsamplesize><![CDATA[163]]></modelsamplesize>
		<cohortsamplesize><![CDATA[163]]></cohortsamplesize>
		<numberofevents><![CDATA[117]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ASPECTS, Glucose, NIHSS]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-123]]></modelid>
		<pubmedid><![CDATA[23948642]]></pubmedid>
		<author><![CDATA[Bavry]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[18484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[20538]]></cohortsamplesize>
		<numberofevents><![CDATA[1841]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.75]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CKD, Diabetes, HF, Heart Rate, MI, Area of Residence, PAD, SBP, Smoking, Stroke/TIA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-124]]></modelid>
		<pubmedid><![CDATA[23948642]]></pubmedid>
		<author><![CDATA[Bavry]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[18484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[20538]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CKD, Diabetes, HF, Heart Rate, MI, Area of Residence, PAD, SBP, Smoking, Stroke/TIA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-125]]></modelid>
		<pubmedid><![CDATA[23948642]]></pubmedid>
		<author><![CDATA[Bavry]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[18484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[20538]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CKD, Diabetes, HF, Heart Rate, MI, Area of Residence, PAD, SBP, Smoking, Stroke/TIA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-126]]></modelid>
		<pubmedid><![CDATA[23948642]]></pubmedid>
		<author><![CDATA[Bavry]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[18484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[20538]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CKD, Diabetes, HF, Heart Rate, MI, Area of Residence, PAD, SBP, Smoking, Stroke/TIA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-127]]></modelid>
		<pubmedid><![CDATA[23948642]]></pubmedid>
		<author><![CDATA[Bavry]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Myocardial Infarction (MI)]]></outcome>
		<modelsamplesize><![CDATA[18484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[20538]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CKD, Diabetes, HF, Heart Rate, MI, Area of Residence, PAD, SBP, Smoking, Stroke/TIA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-128]]></modelid>
		<pubmedid><![CDATA[23948642]]></pubmedid>
		<author><![CDATA[Bavry]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American Heart Association]]></journal>
		<title><![CDATA[Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Stroke]]></outcome>
		<modelsamplesize><![CDATA[18484]]></modelsamplesize>
		<cohortsamplesize><![CDATA[20538]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, CKD, Diabetes, HF, Heart Rate, MI, Area of Residence, PAD, SBP, Smoking, Stroke/TIA]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-129]]></modelid>
		<pubmedid><![CDATA[23965198]]></pubmedid>
		<author><![CDATA[Li]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of Clinical Anesthesia]]></journal>
		<title><![CDATA[Risk factors for predicting postoperative complications after open infrarenal abdominal aortic aneurysm repair: results from a single vascular center in China]]></title>
		<primaryindexcondition><![CDATA[Aortic Diseases]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Procedural Complications]]></outcome>
		<modelsamplesize><![CDATA[316]]></modelsamplesize>
		<cohortsamplesize><![CDATA[316]]></cohortsamplesize>
		<numberofevents><![CDATA[153]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.78]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Aortic Occlusion Time, COPD, Emergency Operation, Cardiac Dysfunction]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-130]]></modelid>
		<pubmedid><![CDATA[23968699]]></pubmedid>
		<author><![CDATA[Brennan]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[JACC: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[724883]]></modelsamplesize>
		<cohortsamplesize><![CDATA[724883]]></cohortsamplesize>
		<numberofevents><![CDATA[10003]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Cardiac Arrest, Lung Disease, CVD, Diabetes, LVEF, PCI/Shock, GFR, NYHA Class, PAD, STEMI, Shock/Salvage]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-131]]></modelid>
		<pubmedid><![CDATA[23979268]]></pubmedid>
		<author><![CDATA[Conrad]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Annals of Surgery]]></journal>
		<title><![CDATA[A risk prediction model for determining appropriateness of CEA in patients with asymptomatic carotid artery stenosis]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[1791]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1791]]></cohortsamplesize>
		<numberofevents><![CDATA[1307]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.73]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, CAD, COPD, Creatinine, Diabetes, Neck Radiation, Statin]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-132]]></modelid>
		<pubmedid><![CDATA[23988439]]></pubmedid>
		<author><![CDATA[Shibazaki]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Neurology]]></journal>
		<title><![CDATA[Brain natriuretic peptide on admission as a biological marker of long-term mortality in ischemic stroke survivors]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ischemic]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[736]]></modelsamplesize>
		<cohortsamplesize><![CDATA[736]]></cohortsamplesize>
		<numberofevents><![CDATA[130]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Renal Failure, mRS Score, BNP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-133]]></modelid>
		<pubmedid><![CDATA[24034091]]></pubmedid>
		<author><![CDATA[Liu]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Chinese Medical Journal]]></journal>
		<title><![CDATA[Risk factors for perioperative major cardiac events in Chinese elderly patients with coronary heart disease undergoing noncardiac surgery]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Stable]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[482]]></modelsamplesize>
		<cohortsamplesize><![CDATA[482]]></cohortsamplesize>
		<numberofevents><![CDATA[61]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.71]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[ASA Grade, HF, Transfusion, Arrhythmia, DBP]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-134]]></modelid>
		<pubmedid><![CDATA[24048813]]></pubmedid>
		<author><![CDATA[Zheng]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Frontiers of Medicine]]></journal>
		<title><![CDATA[SinoSCORE: a logistically derived additive prediction model for post-coronary artery bypass grafting in-hospital mortality in a Chinese population]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[8602]]></modelsamplesize>
		<cohortsamplesize><![CDATA[9564]]></cohortsamplesize>
		<numberofevents><![CDATA[243]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.8]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, COPD, Renal Failure, Valve Surgery, LVEF, Arteriopathy, NYHA Class, AF, Critical Status]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-135]]></modelid>
		<pubmedid><![CDATA[24050858]]></pubmedid>
		<author><![CDATA[Rao]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Journal of the American College of Cardiology: Cardiovascular Interventions]]></journal>
		<title><![CDATA[An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Hemorrhage]]></outcome>
		<modelsamplesize><![CDATA[834696]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1043759]]></cohortsamplesize>
		<numberofevents><![CDATA[60194]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, BMI, Cardiac Arrest, CKD, Sex, Hemoglobin, Previous PCI, Urgency Status, Shock, STEMI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-136]]></modelid>
		<pubmedid><![CDATA[24079627]]></pubmedid>
		<author><![CDATA[Moodley]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[South African Medical Journal]]></journal>
		<title><![CDATA[The South African Vascular Surgical Cardiac Risk Index (SAVS-CRI): A prospective observational study]]></title>
		<primaryindexcondition><![CDATA[Post-Operative]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Vascular]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[788]]></modelsamplesize>
		<cohortsamplesize><![CDATA[788]]></cohortsamplesize>
		<numberofevents><![CDATA[136]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.736]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Chronic B-blockade, Diabetes, Ischemic Heart Disease, Cardiac Surgery]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-137]]></modelid>
		<pubmedid><![CDATA[24091095]]></pubmedid>
		<author><![CDATA[Pennekamp]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[European Journal of Vascular and Endovascular Surgery]]></journal>
		<title><![CDATA[Incompleteness of the circle of Willis is related to EEG-based shunting during carotid endarterectomy]]></title>
		<primaryindexcondition><![CDATA[Carotid Disease]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Shunt for Cerebral Perfusion]]></outcome>
		<modelsamplesize><![CDATA[431]]></modelsamplesize>
		<cohortsamplesize><![CDATA[431]]></cohortsamplesize>
		<numberofevents><![CDATA[65]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Contralateral Occlusion, Carotid Stenosis, Visible Anterior Segment, Visible Posterior Segment]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-138]]></modelid>
		<pubmedid><![CDATA[24112154]]></pubmedid>
		<author><![CDATA[Zhang]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Chinese Medical Journal]]></journal>
		<title><![CDATA[Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[ACS]]></secondaryindexcondition>
		<outcome><![CDATA[Major Adverse Cardiac Events (MACE)]]></outcome>
		<modelsamplesize><![CDATA[95]]></modelsamplesize>
		<cohortsamplesize><![CDATA[95]]></cohortsamplesize>
		<numberofevents><![CDATA[59]]></numberofevents>
		<followupduration><![CDATA[Moderate (3-6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[NT-proBNP, sST2]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-139]]></modelid>
		<pubmedid><![CDATA[24139933]]></pubmedid>
		<author><![CDATA[Abdelaal]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[JACC: Cardiovascular Interventions]]></journal>
		<title><![CDATA[Risk Score, Causes, and Clinical Impact of Failure of Transradial Approach for Percutaneous Coronary Interventions]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Technical Success]]></outcome>
		<modelsamplesize><![CDATA[1654]]></modelsamplesize>
		<cohortsamplesize><![CDATA[1654]]></cohortsamplesize>
		<numberofevents><![CDATA[75]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.76]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Shock, Sex, CABG]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-140]]></modelid>
		<pubmedid><![CDATA[24229682]]></pubmedid>
		<author><![CDATA[Hu]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[Chinese Medical Journal]]></journal>
		<title><![CDATA[Clinical analysis and risk stratification of ventricular septal rupture following acute myocardial infarction]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Ventricular Septal Rupture]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[70]]></modelsamplesize>
		<cohortsamplesize><![CDATA[70]]></cohortsamplesize>
		<numberofevents><![CDATA[39]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[MI, Sex, Killip Class, Time from AMI-VSR, Diabetes, Ventricular Aneurysm]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[13-001-141]]></modelid>
		<pubmedid><![CDATA[24309445]]></pubmedid>
		<author><![CDATA[Ishikawa]]></author>
		<year><![CDATA[2013]]></year>
		<journal><![CDATA[International Heart Journal]]></journal>
		<title><![CDATA[Usefulness of a simple prognostication score in prediction of the prognoses of patients with out-of-hospital cardiac arrests]]></title>
		<primaryindexcondition><![CDATA[Cardiac Arrest]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[750]]></modelsamplesize>
		<cohortsamplesize><![CDATA[750]]></cohortsamplesize>
		<numberofevents><![CDATA[44]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Arterial Blood pH, CPR, Etiology of Cardiac Arrest, CRP, GCS, Light Reflex, ROSC, Potassium, VF, Witnessed Cardiac Arrest]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-01]]></modelid>
		<pubmedid><![CDATA[23744891]]></pubmedid>
		<author><![CDATA[Oldenbeuving]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurology, Neurosurgery, and Psychiatry]]></journal>
		<title><![CDATA[An early prediction of delirium in the acute phase after stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Delirium]]></outcome>
		<modelsamplesize><![CDATA[527]]></modelsamplesize>
		<cohortsamplesize><![CDATA[527]]></cohortsamplesize>
		<numberofevents><![CDATA[62]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.84]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Infection, NIHSS, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-02]]></modelid>
		<pubmedid><![CDATA[23828326]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurointerventional Surgery]]></journal>
		<title><![CDATA[A predictive model of outcomes during cerebral aneurysm coiling]]></title>
		<primaryindexcondition><![CDATA[Unruptured Cerebral Aneurysm]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Unfavorable Discharge]]></outcome>
		<modelsamplesize><![CDATA[6056]]></modelsamplesize>
		<cohortsamplesize><![CDATA[6056]]></cohortsamplesize>
		<numberofevents><![CDATA[342]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Stroke, Coagulopathy, CAD]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-03]]></modelid>
		<pubmedid><![CDATA[23828326]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurointerventional Surgery]]></journal>
		<title><![CDATA[A predictive model of outcomes during cerebral aneurysm coiling]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Unfavorable Discharge]]></outcome>
		<modelsamplesize><![CDATA[4551]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4551]]></cohortsamplesize>
		<numberofevents><![CDATA[2402]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Stroke, CRF, Coagulopathy]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-04]]></modelid>
		<pubmedid><![CDATA[23828326]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurointerventional Surgery]]></journal>
		<title><![CDATA[A predictive model of outcomes during cerebral aneurysm coiling]]></title>
		<primaryindexcondition><![CDATA[Ruptured and Unruptured Cerebral Aneurysm]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[10607]]></modelsamplesize>
		<cohortsamplesize><![CDATA[10607]]></cohortsamplesize>
		<numberofevents><![CDATA[646]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CRF, Coagulopathy, Stroke]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-05]]></modelid>
		<pubmedid><![CDATA[23828326]]></pubmedid>
		<author><![CDATA[Bekelis]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Neurointerventional Surgery]]></journal>
		<title><![CDATA[A predictive model of outcomes during cerebral aneurysm coiling]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Hemorrhage]]></secondaryindexcondition>
		<outcome><![CDATA[Prolonged Length of Stay (LOS)]]></outcome>
		<modelsamplesize><![CDATA[4551]]></modelsamplesize>
		<cohortsamplesize><![CDATA[4551]]></cohortsamplesize>
		<numberofevents><![CDATA[2369]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, CRF, Stroke, CAD]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-06]]></modelid>
		<pubmedid><![CDATA[23834262]]></pubmedid>
		<author><![CDATA[Myint]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[International Journal of Stroke]]></journal>
		<title><![CDATA[The SOAR (Stroke subtype, Oxford Community Stroke Project classification, Age, prestroke modified Rankin) score strongly predicts early outcomes in acute stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[12355]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12355]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[Yes]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, OCSP Classification, Prestroke mRS, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-07]]></modelid>
		<pubmedid><![CDATA[23834262]]></pubmedid>
		<author><![CDATA[Myint]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[International Journal of Stroke]]></journal>
		<title><![CDATA[The SOAR (Stroke subtype, Oxford Community Stroke Project classification, Age, prestroke modified Rankin) score strongly predicts early outcomes in acute stroke]]></title>
		<primaryindexcondition><![CDATA[Stroke]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[12355]]></modelsamplesize>
		<cohortsamplesize><![CDATA[12355]]></cohortsamplesize>
		<numberofevents><![CDATA[]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.79]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Sex, OCSP Classification, Prestroke mRS, Stroke Subtype]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-08]]></modelid>
		<pubmedid><![CDATA[23907993]]></pubmedid>
		<author><![CDATA[Chen]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Catheterization and Cardiovascular Interventions]]></journal>
		<title><![CDATA[A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention]]></title>
		<primaryindexcondition><![CDATA[Coronary Artery Disease (CAD)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[Revascularization]]></secondaryindexcondition>
		<outcome><![CDATA[Renal Outcomes]]></outcome>
		<modelsamplesize><![CDATA[1500]]></modelsamplesize>
		<cohortsamplesize><![CDATA[2500]]></cohortsamplesize>
		<numberofevents><![CDATA[246]]></numberofevents>
		<followupduration><![CDATA[Short (< 3 months)]]></followupduration>
		<auroc><![CDATA[0.82]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, Anemia, Diabetes, eGFR, HDL Cholesterol, MI, Hypotension, LVEF, PCI]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-09]]></modelid>
		<pubmedid><![CDATA[23918791]]></pubmedid>
		<author><![CDATA[Kraaier]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Europace]]></journal>
		<title><![CDATA[Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[861]]></modelsamplesize>
		<cohortsamplesize><![CDATA[861]]></cohortsamplesize>
		<numberofevents><![CDATA[41]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, eGFR, AF, LVEF]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-10]]></modelid>
		<pubmedid><![CDATA[23968870]]></pubmedid>
		<author><![CDATA[Wakasa]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Thoracic and Cardiovascular Surgery]]></journal>
		<title><![CDATA[Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic cardiomyopathy: results of a Japanese multicenter study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Mortality]]></outcome>
		<modelsamplesize><![CDATA[596]]></modelsamplesize>
		<cohortsamplesize><![CDATA[596]]></cohortsamplesize>
		<numberofevents><![CDATA[122]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[0.69]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, INTERMACS Profile, LVEF, Mitral Regurgitation]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
	<node>
		<modelid><![CDATA[14-001-11]]></modelid>
		<pubmedid><![CDATA[23968870]]></pubmedid>
		<author><![CDATA[Wakasa]]></author>
		<year><![CDATA[2014]]></year>
		<journal><![CDATA[Journal of Thoracic and Cardiovascular Surgery]]></journal>
		<title><![CDATA[Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic cardiomyopathy: results of a Japanese multicenter study]]></title>
		<primaryindexcondition><![CDATA[Congestive Heart Failure (CHF)]]></primaryindexcondition>
		<secondaryindexcondition><![CDATA[N/A]]></secondaryindexcondition>
		<outcome><![CDATA[Composite (Non-MACE)]]></outcome>
		<modelsamplesize><![CDATA[596]]></modelsamplesize>
		<cohortsamplesize><![CDATA[596]]></cohortsamplesize>
		<numberofevents><![CDATA[232]]></numberofevents>
		<followupduration><![CDATA[Long (> 6 months)]]></followupduration>
		<auroc><![CDATA[]]></auroc>
		<calibrationreported><![CDATA[No]]></calibrationreported>
		<covariates><![CDATA[Age, INTERMACS Profile, LVEF, Mitral Regurgitation]]></covariates>
		<mh><![CDATA[]]></mh>
	</node>
</data>
